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Unsaturated amides have emerged as invaluable electrophilic motifs as evidenced by the 
recent FDA approval of acrylamide-containing drugs, afatinib, ibrutinib, and osimertinib, as 
treatments for lung and blood cancers. These Michael acceptors represent a class of irreversible, 
targeted covalent inhibitors that selectively react with a cysteine in the active site of a specific 
protein. Inspired by these successful drugs, 6,12-guaianolide isosteres equipped with electronically 
tunable α-methylene-γ-lactams are envisioned as compounds with great potential for exhibiting 
desired biological activities.  The guaianolide family was selected for study because it exhibits an 
exciting range of biological activities including inhibition of the NF-κB pathway. However, the 
indiscriminate reactivity of the α-methylene-γ-lactone embedded in many of these natural products 
raises many concerns. Towards this end, guaianolide isosteres have been prepared using an allenic 
Pauson-Khand reaction of α-methylene-γ-lactam tethered allene-ynes affording rapid access to the 
[5,7,5]-ring system characteristic of this class of compounds. In turn, these products are equipped 
with an unsaturated amide whose electrophilic reactivity is modulated by varying substituents at 
the lactam nitrogen. The allenic Pauson–Khand precursors were prepared using an 
allylboration/lactamization reaction to afford the alkynyl functionalized α-methylene-γ-lactam, a 
heretofore unprecedented transformation utilizing α-imino alkynes. Substituents on the sterically 
encumbered lactam nitrogen were introduced using Buchwald-Hartwig cross-coupling conditions. 
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v 
 Finally, the chemical reactivity of the 6,12-guaianolide isosteres towards biothiols was measured 
qualitatively and their activity as inhibitors of the NF-κB signaling pathway was demonstrated. 
The use of allenyl acetates in the allenic Pauson-Khand reaction with α-methylene-γ-lactam tethers 
was examined to synthesize lactam-containing guaianolide analogs with an α-acyloxy 
cyclopentenone. 
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1.0  THIOL REACTIVITY AND BIOLOGICAL ACTIVITY OF ACRYLAMIDES, α-
METHYLENE-γ-LACTONES, AND α-METHYLENE-γ-LACTAMS 
Portions of this chapter are adapted with permission from: Jackson, P. A.; Widen, J. C.; Harki, D. 
A.; Brummond, K. M. Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-
Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions. J. Med. Chem. 2017, 
60, 839-885 ©2017 American Chemical Society 
Acrylamides are an emerging motif in drug discovery because of the recent FDA approval of 
afatinib (1.1), ibrutinib (1.2), and osimertinib (1.3) as treatments for non-small cell lung cancer 
(1.1, 1.3) and various blood cancers (1.2, Figure 1).1-4 These drugs are irreversible inhibitors of 
the epidermal growth factor receptor (1.1, 1.3) or Bruton's tyrosine kinase (1.2), and they gain 
selectivity over other kinases by forming covalent bonds to unique cysteine residues in these 
enzymes.5-8 The success of acrylamides for targeting discreet cysteine residues in a number of 
kinases and the HCV protease has resulted in a renewed interest in covalent drugs.9-17 Acyclic 
acrylamides generally have limited reactivity with thiols because they are only weakly 
electrophilic, which limits nonspecific interactions with off-target proteins and endogenous thiols 
like glutathione; the positioning of the electrophile near a cysteine residue of a target protein 
through noncovalent interactions promotes covalent bond formation.18-19 Inspired by this emerging 
area and an interest in synthetic access to biologically relevant guaianolide analogs, we 
 2 
hypothesized that α-methylene-γ-lactams could serve as tunable isosteres of α-methylene-γ-
lactones by modifications to the lactam nitrogen. 
 
 
Figure 1.1. Recently approved, irreversible covalent drugs containing acrylamides. 
 
This thesis describes the synthesis of guaianolide analogs containing an isosteric 
replacement of the α-methylene-γ-lactone Michael acceptor with an α-methylene-γ-lactam. 
Guaianolides possess a range of biological properties, and they contain an electrophilic α-
methylene-γ-lactone which is often important for the observed bioactivity; examples of 
guaianolides include arglabin (1.4), eupatochinilide VI (1.5), moxartenolide (1.6), and 
chinensiolide B (1.7, Figure 1.2).20-24 However, the α-methylene-γ-lactone is also attributed to the 
toxicity of these compounds. By changing the nitrogen substituent of α-methylene-γ-lactam 
guaianolide analogs (e.g. 1.8), the rate of hetero-Michael addition of thiols as well as the biological 
activity can be significantly affected due to the change in electrophilic reactivity of acrylamides 
and α-methylene-γ-lactams when electronically diverse nitrogen substituents are installed. 
Guaianolides have been shown to inhibit the NF-κB (nuclear factor κB) pathway by forming a 
 3 
covalent bond between the α-methylene-γ-lactone and a sulfhydryl group of the p65 protein. 
Inhibition of the NF-κB pathway promotes apoptosis and is frequently overactive in many cancers 
and inflammatory diseases making it a desirable drug target.25-27  
 
Figure 1.2. Guaianolide natural products and a model for tunable α-methylene-γ-lactam analogs. 
 
To put this work in context, an introduction to covalent modifiers and examples of targeted 
covalent inhibition with acrylamides is presented. The hetero-Michael addition of thiols to α,β-
unsaturated amides or lactams is compared the that of α-methylene-γ-lactones. Previous studies on 
the isosteric replacement of lactones with lactams are presented, as well as the tunability of α,β-
unsaturated amide or lactam Michael acceptors. Methods for the synthesis of α-methylene-γ-
lactams are reviewed before the synthesis of novel α-methylene-γ-lactam guaianolide analogs, 
which are accessible in 10-12 synthetic operations from commercially available starting materials, 
is discussed. 
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1.1 TARGETED COVALENT INHIBITION IN DRUG DESIGN 
 
Covalent modifiers are an important class of compounds that, despite numerous successful 
examples, are typically avoided in target-directed drug discovery efforts.15 Protein reactive drugs 
inhibit protein function by forming covalent bonds with nucleophilic amino acids in proteins, in 
contrast with noncovalent drugs, which inhibit protein function by intermolecular interactions, and 
DNA reactive drugs that form covalent adducts with DNA bases. Covalent drugs are prevalent in 
the pharmaceutical industry, with at least 42 protein reactive covalent drugs being approved by the 
FDA as of 2011.16 Covalent drugs can bond to proteins or DNA via different mechanisms including 
acylation, alkylation, metal/metalloid binding, disulfide bond formation, hemiacetal formation, 
Michael addition, and the Pinner reaction.15 Of the approved covalent drugs, 14 are known to react 
with cysteine residues, and only five have been shown to undergo Michael addition (gemcitabine, 
floxuridine, afatanib (1.1), ibrutinib (1.2), and osimertinib (1.3)). One reason covalent drugs have 
been avoided in drug design is their potential for off-target reactivity that can lead to toxicity or an 
immune response,16 even though there has not been a systematic study demonstrating that covalent 
modifiers can lead to idiosyncratic effects.28 However, covalent inhibitors containing weak 
electrophiles that require a significant noncovalent interaction for covalent bond formation to 
occur (i.e. quiescent irreversible inhibitors), should be distinguished from strongly electrophilic 
compounds that bind to many accessible nucleophilic residues on a variety of proteins.16 Weakly 
 5 
electrophilic compounds bearing some noncovalent target affinity are more easily developed into 
biologically useful agents due to their enhanced predictability with respect to target binding.16 
The majority of covalent drugs were discovered through screening of natural product or 
synthetic compound libraries and were demonstrated to have covalent mechanisms of action after 
FDA approval; the most conspicuous examples being aspirin and β-lactam antibiotics.16 More 
recently, covalent drugs have gained popularity by virtue of their ability to modulate difficult 
molecular targets.16 For example, selective kinase inhibitors that form covalent adducts to rare 
cysteine residues located in the active sites of kinases have been reported. Kinases are notoriously 
difficult to target with high selectivity using noncovalent inhibitors due to sequence conservation 
and the similarity of the ATP (adenosine triphosphate) binding pocket among the more than 500 
human kinases.17 Covalent inhibition has also been used to target shallow binding pockets in HCV 
protease29 and is being investigated for targeting protein-protein interactions.30-33 Thus, covalent 
drugs offer an approach to expanding the druggable landscape of biological molecules.  
Covalent drugs can function as reversible and irreversible inhibitors of proteins. 
Irreversible inhibitors have been classified as covalent modifiers that undergo a reverse reaction 
slower than the rate of protein synthesis, while reversible covalent inhibitors undergo the reverse 
reaction faster than the rate of protein synthesis.16 Drugs that function as irreversible inhibitors 
have several advantages over ones that operate through noncovalent interactions alone. These 
include selectivity for specific proteins in the same family by targeting non-conserved residues in 
a binding site, small infrequent dosing due to a shutdown of protein function until that protein is 
resynthesized, and higher binding affinities. Covalent drugs have been shown to overcome drug 
resistance as seen with irreversible epidermal growth factor receptor (EGFR) inhibitors18-19 and 
hepatitus C viral (HCV) protease inhibitors.9 Mutations can cause drug resistance by changing the 
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shape of the active site and lowering the binding affinity by reducing noncovalent interactions 
(increasing ki), but a covalent mechanism of inhibition may avoid this resistance mechanism.16 If 
the amino acid that is to be covalently modified is itself mutated, it is possible that a drug can still 
act as a noncovalent inhibitor.  
Alternatively, rapidly reversible covalent inhibitors bind and release proteins like 
noncovalent inhibitors, but covalent bond formation provides a stronger binding affinity than most 
noncovalent interactions such as hydrogen bonding, van der Waals forces, π-stacking, and 
hydrophobic effects.28 When compared to noncovalent inhibitors, reversible covalent inhibitors 
can have longer residence times and afford increased selectivity by forming covalent bonds to 
uniquely positioned amino acids. For example, one strategy for increasing the selectivity of an 
inhibitor involves the attachment of a Michael acceptor to a noncovalent inhibitor at a site that will 
be proximal to a cysteine when bound to a protein; targeting cysteine residues in this way is known 
as targeted covalent inhibition.16 Bioinformatics has shown that 211 kinases contain a cysteine in 
the ATP binding pocket in the active conformation which is distributed over 27 distinct positions.34 
For the inactive kinase conformations, which have extended binding pockets, 16 additional 
cysteine positions in 193 kinases were identified. However, only a few of these positions have 
been exploited for targeted covalent inhibition.34  
Targeted covalent modifiers initially form a noncovalent complex with a target protein 
through noncovalent interactions. This is followed by covalent bond formation with a nucleophilic 
amino acid as depicted by Equation 1.1. The initial binding specificity, ki, can be improved by 
optimizing the noncovalent interactions between a small-molecule inhibitor and its protein target, 
similar to noncovalent drugs. The kinact (k2) is the rate at which the covalent modification occurs 
and is typically optimized by placing an electrophilic moiety in close proximity to a nucleophile 
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in the binding site. Alternatively, increasing the reactivity of the electrophilic moiety can increase 
the rate of covalent bond formation to a target protein. The potency and selectivity of covalent 
drugs can be measured by the specificity constant, which is equal to kinact/ki, and is considered a 
more reliable measure of potency for irreversible inhibitors than IC50 (half maximal inhibitory 
concentration) values.16, 35-37 This is because irreversible, covalent inhibitors display time-
dependent inhibition which is not accounted for in typical IC50 assays. IC50 measurements are 
commonly used for the characterization of irreversible inhibitors in biochemical assays with an 
associated time (i.e. IC50 for target inhibition after treatment with an inhibitor for 0.5 h) and, more 
appropriately, in cellular assays where the activity of the irreversible inhibitor is dependent on 
multiple factors such as cellular uptake, compound stability, and target inhibition.  
 
 
Equation 1.1 Covalent inhibition of an enzyme. 
 
As targeted covalent modification has been validated as an approach to drug development, 
a number of acrylamide-containing covalent inhibitors have displayed promising biological 
activity. In addition to the approved drugs afatanib (1), ibrutinib (2), and osimertinib (3), there 
have been a number of other acrylamide compounds that have shown potential as drugs and 
biological probes. 
Telaprevir (1.9) is a reversible covalent modifier that treats hepatitis C virus (HCV) by 
targeting a catalytic serine in the HCV protease. This serine is common across many viral and 
 8 
human proteases (Ser139 in HCV protease); a reversible covalent bond occurs by forming a 
hemiacetal between the hydroxyl group of serine and the ketoamide functionality of telaprevir.29 
The utility of telaprevir (1.9) inspired the development of irreversible HCV protease inhibitors 
1.10 and 1.11 which included an acrylamide motif on a structurally related scaffold (Figure 1.3).9 
Inhibitors 1.10 and 1.11 were designed to target Cys159, a unique amino acid to HCV protease 
identified using structural bioinformatics.9 In a fixed time point enzymatic assay, compounds 1.10 
and 1.11 with a Michael acceptor were potent inhibitors of HCV protease (IC50 = 4 and 2 nM for 
1.10 and 1.11, respectively) while compound 1.12 which lacks the acrylamide group, showed only 
weak  inhibition of HCV protease (IC50 = 1147 nM).9 A targeted covalent inhibition mechanism 
for compounds 1.10 and 1.11 was supported by mutation of Cys159 to serine, which resulted in a 
reduction in potency of 1.10 and 1.11, whereas 1.12 maintained a similar potency compared to the 
non-mutated protein. Co-crystallization of inhibitor 1.10 with HCV protease confirmed a covalent 
C–S bond between Cys159 and the acrylamide group.9 
 
 
Figure 1.3. HCV protease inhibitors. 
 
Gefitinib (1.13) is a small molecule inhibitor that targets mutated forms of EGFR in cancer 
cells. After FDA approval in 2003, it was discovered that EGFRs acquire resistance through 
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specific mutations within the binding pocket; nearly half of the patients had a T790M single point 
mutation responsible for resistance to therapy.6 To combat this acquired resistance, structural 
modifications were made to gefitinib (1.13) that included replacement of the 3-morpholino propyl 
group with a 4-dimethylaminobutenamide to produce afatinib (1.1), a compound designed to 
undergo a hetero-Michael addition with Cys797 in the active site of EGFR (Figure 1.4). Indeed, 
this second-generation EGFR inhibitor afatinib (1.1) was active at the nanomolar level against lung 
cancer cells containing this mutation.5-6 X-ray crystallography and in situ labeling followed by 
LC-MS/MS analysis confirmed a covalent bond between afatinib (1.1) and Cys797.10 Despite FDA 
approval, afatinib (1.1) was somewhat toxic and required large dosages due to low efficacy. It has 
been postulated that this toxicity is due to inhibition of wild-type EGFR and that the low efficacy 
was a result of diminished noncovalent binding of 1.1 to T790M EGFR.38 Third-generation EGFR 
inhibitors osimertinib (1.3) and rociletinib (1.14) were developed to selectively target T790M-
mutated EGFR over wild-type EGFR.39 Osimertinib  (1.3, AZD9291, Tagrisso) is an irreversible, 
mutant-selective EGFR inhibitor, developed by AstraZeneca, which was approved in November 
2015 for treatment of non-small cell lung cancer for patients with the T790M mutation of EGFR; 
osimertinib (1.3) has an IC50 value of 12 nM for EGFR with the L858R/T790M mutation and an 
IC50 value of 480 nM for wild-type EGFR.2, 8 Rociletinib (1.14, CO-1686, AVL-301) is another 
mutant selective covalent inhibitor of L858R/T790M EGFR, currently in clinical trials, with a ki 
of 21.5 nM against this mutation and a ki of 303.3 nM against wild type EGFR (Figure 1.4).40-41 
Recently, mutation of Cys797 to serine has been discovered as a mutation that imparts resistance 
to these covalent modifiers 1.1, 1.3, 1.13, 1.14, as the less nucleophilic serine fails to form a 
covalent bond with the acrylamide Michael acceptors.42 
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Figure 1.4. Reversible and irreversible EGFR inhibitors. 
 
Fibroblast growth factor receptors (FGFR1-4) and Bruton's tyrosine kinase (Btk) are 
tyrosine kinases related to EGFR and which are also susceptible to irreversible, covalent inhibition. 
Inhibitors of these enzymes were designed using a similar targeted covalent inhibition strategy to 
that described above. Noncovalent FGFR inhibitor PD173074 (1.15) lead to the design of FIIN-1 
(1.16) possessing an acrylamide group that reacts with Cys486 in the ATP binding pocket of 
FGFR1 to form a hetero-Michael adduct (Figure 1.5).11 Reduction of the acrylamide double bond 
of 1.16 resulted in a 24-fold decrease in activity for blocking proliferation and survival of FGFR1-
transformed Ba/F3 cells (EC50, 14 nM vs 340 nM) and a 100-fold decrease in activity against 
FGFR3-transformed Ba/F3 cells (EC50, 10 nM vs 1040 nM), demonstrating the importance of the 
Michael acceptor for effective inhibition.11  
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Figure 1.5. FGFR inhibitors. 
 
The Btk noncovalent inhibitor PCI-29732 (1.17) was used in the design of targeted 
covalent inhibitor ibrutinib (1.2, PCI-32765), which shows a 500-fold increase in selectivity for 
Btk over related kinases Lck/Yes-related novel tyrosine kinase (Lyn) and spleen tyrosine kinase 
(Syk) in Ramos cells; PCI-29732 (1.17) showed only a 4-fold selectivity for Btk in the same assay 
(Figure 1.6).12 This increased selectivity is a result of covalent bond formation between the 
acrylamide group of ibrutinib (1.2) and Cys481 in the ATP-binding pocket of Btk.7 Ibrutinib (1.2) 
favors inhibition of kinases containing a cysteine or serine at position 481 with >100-fold 
selectivity, inhibiting only a few kinases, Btk, Blk (B lymphocyte kinase), and Bmx (bone marrow 
tyrosine kinase gene in chromosome x, also called Etk), with subnanomolar potencies due 
similarities in their binding sites.7 Lou et al. propose that amino acids larger than cysteine or serine 
at the position equivalent to Cys481 of Btk clash with the pyrazolidine ring, leading to increased 
selectivity over kinases lacking a cysteine or serine at this position, but there is no evidence of 
serine undergoing covalent bond formation to 1.2.7 Ibrutinib (1.2) was approved by the FDA in 
2013 for the treatment of mantle cell lymphoma and in 2014 for the treatment of chronic 
lymphocytic leukemia; it is predicted to reach peak annual sales of $5 billion a year and is currently 
in clinical trials for the treatment of other types of cancers.3-4, 43 Spebrutinib (1.18, AVL-292, CC-
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292) is similar in structure to ibrutinib (1.2) and is an irreversible Btk inhibitor under investigation 
for the treatment of chronic lymphocytic leukemia as well as rheumatoid arthritis and multiple 
myeloma (Figure 1.6).44-45 The recent approvals of several covalent drugs utilizing an acrylamide 
motif have led to the development of acrylamide-containing, irreversible inhibitors for a number 
of protein targets which are difficult to target noncovalently due to similarities with other proteins. 
By utilizing rare cysteine residues in the active sites of various proteins, target selectivity can be 
achieved. Identification of unique cysteine residues in kinases through analysis of available crystal 
structures, sequencing information, and proteomics methods have identified 404 kinases with 
cysteines in the active site. These cysteines are located at 43 distinct positions (27 positions for 
active conformations in 211 kinases and 16 positions for inactive conformations in 193 kinases), 
indicating potential for the development of selective, covalent kinase inhibitors.34, 46-47 
 
 
Figure 1.6. Btk inhibitors. 
 
Screening of covalent inhibitors for kinase inhibitions led to the development of pan JNK 
(c-jun NH2-terminal kinase) inhibitors 1.19-1.21 (Figure 1.7).13 JNK-IN-11 (1.19), the most potent 
inhibitor tested with IC50 values of 0.5-1.3 nM for inhibition of JNK1/2/3, also showed significant 
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inhibition against several other kinases. However, JNK-IN-8 (1.20) showed excellent selectivity 
for JNK1/2/3 over other kinases with only a small decrease in activity (IC50 of 1-18.7 nM for 
inhibition of JNK1/2/3). Incorporation of an acrylamide motif was necessary for in vivo potency 
and selectivity for JNK1/2/3 in a panel of 200 kinases using a fixed time point enzymatic assay; 
without this group, the activity of each inhibitor was reduced 100-fold.13 Covalent kinase inhibitors 
for Bmx and cyclin dependent kinase 7 (CDK7) have also been developed using this strategy.48-49 
 
 
Figure 1.7. Pan JNK 1/2/3 inhibitors. 
 
Gaining specificity to a target protein through targeted covalent inhibition has been 
demonstrated as a successful strategy in the examples presented above. An acrylamide group is 
often used as the Michael acceptor in these approaches because it is weakly electrophilic, limiting 
an off-target reactivity. An alternative strategy to incorporating weakly electrophilic groups at key 
locations in an inhibitor is the inclusion of strong electrophiles that form rapidly reversible 
covalent bonds in a non-biological environment, such as cyanoacrylamides.50 The additional 
electron-withdrawing cyano group increases the reaction kinetics of the thiol addition, but in turn 
decreases the equilibrium constant, possibly by decreasing the pKa of the α-proton on the Michael 
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adduct.51 Designing inhibitors with sufficient noncovalent affinity to place the acrylamide near an 
a cysteine residue in a binding pocket is required for covalent bond formation to occur, thus 
minimizing side reactions with other cellular thiols, such as GSH and solvent-exposed cysteines 
on other proteins.16, 28, 52 Several reviews have been published on the development and use of 
irreversible kinase inhibitors.17, 46, 52-55 The development and approval of several acrylamide-
containing targeted covalent modifiers demonstrate that this is a valid strategy for drug 
development. In order to develop new targeted covalent modifiers, the thiol reactivity of other 
electrophiles needs to be better understood. 
 
1.2. BIOLOGICAL ACTIVITY AND THIOL REACTIVITY OF α-METHYLENE-γ-
LACTONES, α-METHYLENE-γ-LACTAMS, MACROCYCLIC α-METHYLENE 
LACTAMS, AND ACRYLAMIDES 
 
The biological activity and thiol reactivity of various α-methylene-γ-lactones, α-methylene-γ-
lactams, macrocyclic α-methylene lactams, and acrylamides are presented for comparison of these 
different structures. As not a lot of information is available for direct comparison of these various 
electrophiles, the bioactivity and thiol reactivity is presented in various ways depending on the 
availability; this includes rate data for thiol addition, yields of thiol addition reactions, evidence 
for protein adduct formation, and toxicity of isosteric α-methylene-lactones and lactams. 
Sesquiterpene lactones are a major class of natural products and several reviews have covered the 
biological importance and therapeutic potential of α-methylene-γ-lactone-containing 
compounds.56-58 α-Methylene-γ-lactones react with biologically relevant thiols such as cysteine 
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and glutathione (GSH) via a hetero-Michael addition reaction to form thiol adducts both in a flask 
and in biologically relevant systems.59-62  
Examples of sesquiterpene lactone natural products containing an α-methylene-γ-lactone 
for which thiol reactivity data is available include melampomagnolide B (1.22), parthenolide 
(1.23), costunolide (1.24), anhydroverlatorin (1.25), and verlatorin (1.26, Figure 1.8).63-67 The α-
methylene-γ-lactone is responsible for the many of the observed biological activities of 
sesquiterpene lactones, as reduction of the exocyclic methylene generally eliminates biological 
activity, with a few exceptions.22-24, 68 α-Methylene-γ-lactams are much less common in natural 
products, and their biological activity and thiol reactivity are not as well studied as their lactone 
counterparts.69 However, α-methylene-γ-lactams are generally categorized as less toxic than the 
isosteric lactones. Lactams such as pukeleimide (1.27), anatin (1.28), gelegamine (1.29), and 
bisavenanthramide B-6 (1.30) are some of the only natural products known that possess α-
methylene or α-alkylidene moieties on small rings. (Figure 1.8).69 70 Macrocyclic α-methylene-
lactams such as the microcystins and rakicidin A have been shown to react with thiols and are also 
discussed in this section. 
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Figure 1.8. Natural products with α-methylene-γ-lactones (A) or α-methylene-γ-lactams (B). 
 
1.2.1. Comparison of the Biological Activities of Isosteric α-Methylene-γ-lactams and α-
Methylene-γ-lactones  
 
The biological activities of synthetic, small molecule α-methylene-γ-lactams have been compared 
to the corresponding lactones when small libraries of these compounds were prepared. A recent 
review highlights the biological activity of natural product α-methylene-γ-lactones and lactams.71 
In most cases the lactam is less active than the lactone, but few studies have examined the effects 
of changing the nitrogen substituent, instead focusing on the substituents at the β and γ-positions 
of the lactones and lactams, while the nitrogen remained unsubstituted or methylated. Additionally, 
the reduced toxicity observed for α-methylene-γ-lactams compared to isosteric α-methylene-γ-
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lactones could be beneficial in cases where the bioactivity for a particular target or pathway is 
maintained. 
Table 1.1 compares the cytotoxicity of isosteric α-methylene-γ-lactams and lactones with 
various γ-substituents.72-73  The cytotoxicity of α-methylene-γ-lactones ranges from 1.3-32.5 μM 
in the mouse lymphocytic leukemia cell line L-1210, while the corresponding lactams range from 
20.0 to >100 μM. The L-1210 cell line is the only one where a lactam is more cytotoxic than the 
lactone, although 1.31a and 1.32a are fairly close in cytotoxicity (entries 1-2). The human 
leukemia cell lines (HL-60 and NALM-6) show a much greater difference in cytotoxicity between 
the α-methylene-γ-lactones (IC50 = 20-100 μM) and the isosteric lactams (IC50 = 83-989 μM, Table 
1.1). 
Table 1.1. Comparison of cytotoxicity of γ-substituted α-methylene-γ-lactams and lactones. 
 
Entry Compound R1 R2 Cytotoxicity (IC50, μM) 
    L-1210 HL-60 NALM-6 
1 1.31a Me H 20.0 640 658 
2 1.32a Me - 32.5 77.4 41.0 
3 1.31b Et H >100 894 387 
4 1.32b Et - 6.0 39.5 51.6 
5 1.31c n-pentyl H 59.0 397 82.7 
6 1.32c n-pentyl - 20.0 99.4 23.6 
7 1.31d Bn H 93.0 490 420 
8 1.32d Bn - 15.5 42.7 5.4 
9 1.31e CH2-3,4-OMeC6H3 H 79.0 402 507 
10 1.32e CH2-3,4-OMeC6H3 - 4.3 46.3 6.0 
11 1.31f Ph Me >50 989 553 
12 1.32f Ph - 1.4 36.9 9.1 
13 1.31g 4-BrC6H4 Me >50 220 141 
14 1.32g 4-BrC6H4 - 1.3 20.3 85.3 
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Table 1.2 compares the cytotoxicities of β, γ-substituted α-methylene-γ-lactams 1.33-1.34 
to the structurally similar lactone 1.35 and isoxazolidinone 1.36.74-76 As above, the α-methylene-
γ-lactams 1.33-1.34 are significantly less toxic than the lactone 1.35 and isoxazolidinone 1.36, 
which each show similar cytotoxicity values in the 3 cell lines tested. Surprisingly, the γ-ethyl 
lactam 1.34 is 5-8 fold more cytotoxic than the γ-methyl substituted lactam 1.33, suggesting that 
thiol reactivity is not the only factor that influences the cytotoxicity of these compounds, but 
molecular recognition or lipophilicity may play a role. 
 
Table 1.2. Cytotoxicity of β-aryl-γ-alkyl substituted α-methylene-γ-lactams, lactones, and 
isoxazilidinones. 
 Cell line Cytotoxicity (IC50, μM) 
Compound  
    
 L-1210 - 43 1.6 0.7 
HL-60 516 66 1.2 5.1 
NALM-6 434 81 0.6 4.6 
     
 
Hall and coworkers synthesized a library of α-methylene and α-arylidene-γ-lactones and 
lactams which were screened for inhibition of homoserine transacetylase (HTA).77 HTA is an 
essential enzyme involved in the biosynthesis of methionine, which is found in fungi, gram 
positive and some gram negative bacteria, but not in more complex eukaryotes; it is a potential 
target for new antibiotics. Out of 111 compounds screened, ten hits were obtained and five hits 
were confirmed upon further testing. IC50 values were obtained for two α-methylene-γ-lactams 
1.37 and 1.38 which inhibited HTA with IC50 values of 144 and 140 μM, respectively (Figure 1.9). 
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Figure 1.9. α-Methylene-γ-lactam inhibitors of homoserine transacetylase (HTA). 
 
 
  α-Methylene-γ-lactams  are  generally less  toxic  than  isosteric  α-methylene-γ-lactones, 
although  the reasons for this  are  unclear from the data available. One possibility is the  reduced 
electrophilic  reactivity  of  α-methylene-γ-lactams  compared  to  α-methylene-γ-lactones. 
 
1.2.2. Thiol Reactivity of α-Methylene-γ-lactones 
 
Thiol adduct formation can be used to predict the potential of α-methylene-γ-lactones to form 
covalent adducts to cysteine residues in proteins. Rapid formation of thiol adducts can indicate 
that an electrophile will react indiscriminately with solvent exposed cysteine residues. 
Parthenolide (1.23), costunolide (1.24), verlatorin (1.25), and anhydroverlatorin (1.26) were all 
confirmed to react with cysteamine in DMSO-d6, a 1H NMR method that measured the 
disappearance of the α-methylene peaks of the lactone.78 Costunolide (1.24), possessing an α-
methylene-lactone was used as a benchmark for measuring conjugate addition, as thiol addition to 
1.24 has been documented.79-80 Unactivated thiols dodecanethiol or N-acetyl-cysteamine did not 
react with costunolide (1.24) in 24 h with toluene, chloroform, MeCN, MeOH, or DMSO 
solvents.78 Cysteamine is an activated thiol due to the free amine which can act as a base for 
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deprotonating the thiol or a hydrogen bond donor to activate the carbonyl of the α-methylene-γ-
lactone towards conjugate addition. Hetero-Michael addition of cysteamine to 1.24 occurred 
slowly in methanol or acetonitrile and instantaneously in DMSO. Using this data Michael 
acceptors were classified as reactive or nonreactive based on whether they formed adducts with 
cysteamine. The reactive compounds were further classified as reversible or irreversible based 
upon the reversibility of the hetero-Michael addition upon 10-fold dilution with CDCl3. This 
method also demonstrated the selectivity of cysteamine for thiol addition with Michael acceptors 
as no reaction with the peroxide of 1.25 or the epoxide of 1.26 was detected. 
 
 
Scheme 1.1. α-Methylene-γ-lactones that react with cysteamine in 1H NMR assay. 
 
The reactivity of three α-methylene-γ-lactone-containing natural products, elephantopin 
(1.43), eupatundin, (1.44), and vernolepin (1.45) with endogenous nucleophiles, such as lysine and 
cysteine, was measured in a kinetic study by Kupchan et al. in aqueous phosphate buffer (pH = 
7.4, Scheme 1.2).59 The reaction with lysine formed less than 25% of an adduct after 6 d at rt, 
while cysteine reacted with the α-methylene-γ-lactone moiety of these compounds to form thiol 
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adducts within minutes. The second order rate constant for addition of cysteine to the exocyclic α-
methylene-γ-lactone of elephantopin (1.43) was 2600 M-1min-1 while addition to the acyclic 
methacrylate of 1.46 to form 1.47 was about 26 times slower with a rate constant of 100 M-1min-
1. The rate constant for cysteine addition to eupatundin (1.44) was 2500 M-1min-1, while vernolepin 
(1.45) reacted the fastest with cysteine with a rate constant of 12000 M-1min-1. 
 
Scheme 1.2. Cysteine adduct formation with α-methylene-γ-lactone natural products. 
Helenalin (1.50) is a natural product containing a cyclopentenone and an exocyclic α-
methylene-γ-lactone, which reacts with biological thiols cysteine and glutathione (GSH). 
Characterization of the thiol adducts of helenalin (1.51-1.52) by NMR showed that GSH addition 
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preferentially occurred at the cyclopentenone, while cysteine addition occurred at the α-methylene-
γ-lactone when a single equivalent of thiol was added (Scheme 1.3).61 When  excess glutathione 
or cysteine was reacted with helenalin (1.50), addition to both Michael acceptors was observed. 
The rate of glutathione addition to the cyclopentenone was found to be about 10-fold faster than 
the rate of glutathione addition to the α-methylene-γ-lactone (0.08 M-1min-1 compared to 0.008 M-
1min-1). Cysteine addition to helenalin (1.50) added to the α-methylene-γ-lactone in less than 5 
min, while requiring approximately 17 hours to completely react with the cyclopentenone. The 
rate of glutathione addition to related pseudoguaianolide compounds showed a dependency on the 
pH, where the rate increased at a more basic pH, as would be expected.62  
 
Scheme 1.3. Chemoselectivity of glutathione and cysteine addition to helenalin. 
The thiol reactivity of α-methylene-γ-lactones has been demonstrated for a variety of 
complex natural products, and the rates of thiol addition have been compared to other Michael 
acceptors such as enones or α,β-unsaturated esters. The rate of thiol addition was sensitive to the 
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pH of a solution as well as the structure of the thiol used. Although the thiol reactivity of α-
methylene-γ-lactones has been studied, little is known about the isosteric α-methylene-γ-lactams. 
 
1.2.3. Thiol Reactivity of α-Methylene-γ-lactams 
 
The thiol reactivity of α-methylene-γ-lactams or 3-methylenepyrrolidin-2-ones is not well 
documented, especially compared the reactivity of α-methylene-γ-lactones. In general, α-
methylene lactams are less reactive towards thiols than the corresponding lactones and formation 
of the thiol adducts usually requires more forcing conditions.81-85 For example, α-methylene-γ-
lactam 1.53 required thioacetic acid solvent and heating to 50 °C to obtain adduct 1.54 in 58% 
yield;85 for lactams 1.55, 1.56, and oxindole 1.57, thiols were used in excess, and base additives 
were needed to effect thiol addition in good yields (Scheme 1.4).81-82 For oxindole 1.58, thiol 
addition occurred with an acidic pH between 5 and 5.5 to give adduct 1.63 in 93% yield (based on 
GSH).83  
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Scheme 1.4. Thiol adduct formation with α-methylene-γ-lactams and oxindoles. 
 
Although α-methylene-γ-lactams are less susceptible to thiol addition than the isosteric α-
methylene-γ-lactones, it is clear from the limited available data that more work is needed to better 
understand the thiol reactivity of α-methylene-γ-lactams. 
 
1.2.4. Thiol Reactivity and Biological Activity of Macrocyclic α-Methylene Lactams 
 
Although α-methylene-γ-lactams are relatively uncommon in natural products, macrocyclic α-
methylene lactams are present in natural products such as the microcystins and rakicidin A. The 
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thiol reactivity and biological activity of macrocyclic α-methylene lactams are presented in this 
section to provide insight into the thiol reactivity of α-methylene-γ-lactams. 
Microcystins are heptapeptides containing a dehydroalanine moiety, one member from this 
class of compounds, 1.64, is depicted in Figure 1.10. Microcystins have been reported to form 
covalent bonds with noncatalytic cysteine residues in serine/threonine phosphatases (PP1 and 
PP2A).86 Moreover, GSH and cysteine have both been shown to add to the exocyclic double bond 
of the unsaturated amide of microcystins; these thiol adducts were tested and showed an 
approximate 8-fold reduction in LD50 values compared to unconjugated microcystins in mice.87 
Mutation studies involving the conversion of Cys273 to alanine resulted in the inability of 
microcystin LR 1.64 to form a covalent adduct, but the inhibition of C273A mutant PP1 by 1.64 
was not significantly affected, suggesting that there is considerable noncovalent affinity of 
microcystin LR 1.64 for PP1. Covalent targeting by macrocycle 1.64 was further confirmed by a 
co-crystal structure of the compound covalently bound to Cys273 of PP1.88-89  
 
 
Figure 1.10. Example of a microcystin. 
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Rakicidin A (1.65) shows cytotoxicity against some cancer cell lines and contains a 4-
amido-2,4-pentadienoate moiety that is critical for bioactivity (Scheme 1.5). An analog of 
Rakicidin A 1.66 was prepared and shown to form adduct 1.67 with methyl thioglycolate through 
1,6-addition.90 When monitoring the reaction by 1H NMR, a different thiol adduct was the major 
product detected after 24 h, but this compound could not be isolated and only adduct 1.67 was 
detected after a longer reaction time of 72 h. The initial adduct formed was proposed to arise from 
thiol addition to the γ carbon, which could occur via 1,4-addition of methyl thioglycolate to the 
acyl-imine tautomer of Rakicidin A analog 1.66. 
Scheme 1.5. Rakicidin A and analog: a 1,6-addition product with methyl thioglycolate. 
 
Thiol  adduct  formation  to  macrocyclic  α-methylene lactams  occurs  with  both  small
molecule thiols as well as cysteines in proteins. Although microcystin LR showed covalent bond
formation  to  Cys273  in  a  co-crystal  structure, the inhibition of a C273A  mutant  of  PP1  by
microcystin LR was only  minimally affected, suggesting that noncovalent  binding between the
macrocycle and PP1 promotes covalent bond formation. 
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1.2.5. Thiol Reactivity of Acrylamides 
 
The thiol reactivity of acrylamides has been studied due to their incorporation into targeted 
covalent modifiers as discussed in section 1.1. Examples that show the various effects of the 
nitrogen substituent and substituents at the α and/or β-positions of acrylamides are presented in 
this section. It is hypothesized that α-methylene-γ-lactams should display similar reactivities to 
acrylamides. Generally, acrylamides are weakly electrophilic and relatively unreactive towards 
thiols. These acyclic α,β-unsaturated amides are similar in electrophilic reactivity to α-methylene-
γ-lactams. However, there are exceptions and these include the placement of an additional electron 
withdrawing group at the α position of the acrylamide.50 The relative thiol reactivities of 
acrylamides possessing different substituents were compared in a competition assay with a limiting 
amount of GSH.18-19 Two acrylamides (2.5 mM of each) were reacted with GSH (1.25 mM) in a 
THF-H2O-MeOH mixture at rt for 20-24 h and the amount of adduct formation was calculated by 
integration of HPLC peaks. These conditions were chosen to give low conversion to GSH adducts 
so that the ratios of GSH adducts formed would reflect kinetic control. The Lewis basic 
aminomethylene group of 1.69 afforded more of the GSH adduct relative to acrylamide 1.68 (entry 
1, Table 1.3A). β-Morpholinomethylene 1.77 afforded less of a GSH adduct than an N,N 
dimethylaminomethylene 1.69 (entry 2). Competition experiments between acrylamide 1.69 and 
propynamide 1.71 showed the acrylamide to be more reactive towards GSH (entry 3). Methyl 
substituted propynamide 1.73 is more reactive than β-methyl acrylamide 1.72 (entry 4 ).18-19 
However, acrylamide 1.68 is more reactive than a methyl substituted propynamide 1.73 (entry 5). 
The morpholinomethylene group at the α position of the acrylamide 1.74 is more reactive than β-
morpholinomethylene acrylamide 1.70 (entry 6).18-19 Comparison of cis 1.75 and trans 1.72 β-
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methyl substituted acrylamides shows no difference in reactivity as equal amounts of each GSH 
adduct was formed (entry 7). Isomerization of cis acrylamide 1.75 to the trans isomer under the 
reaction conditions is possible. For unreactive samples, excess base (diisopropylamine or 
triethylamine) was added to the reaction mixture to promote GSH adduct formation (entries 4, 5, 
and 7, Table 1). Utilizing a different heterocyclic scaffold, β-methyl substituted acrylamide 1.76 
showed no reactivity with glutathione whereas 1.77 possessing a N,N-dimethylmethanamine at the 
β position showed increased reactivity (entry 1, Table 1.3B). The authors initially proposed that 
under aqueous conditions, the dimethylamino group would exist primarily in its protonated form, 
which would lead to an increase in the electrophilicity of the Michael acceptor through induction. 
However, this hypothesis was revised because inhibitor 1.78 bearing a trimethylmethanium ion 
did not react with GSH, therefore it was proposed that an intramolecular base catalysis is operating 
to increase the reactivity of GSH (entries 2 and 3).18-19  
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Table 1.3. Kinetic competition experiments between acrylamides and GSH. 
 
a) Two inhibitors (2.5 mM each) were allowed to react with a limiting quantity of GSH (1.25 mM), 
20-24 h, rt; b) 12 equiv diisopropylethylamine were added; c) 1000 equiv triethylamine were added 
 
Recently, scientists at Amgen examined the GSH reactivity of a series of arylacrylamides 
with the structure of 1.79 (Scheme 1.6).91 In their study, 34 N-arylacrylamides were incubated with 
a large excess of GSH at 37 °C in buffer (pH = 7.4) containing 1-1.5% DMSO. The progress of 
the reactions was monitored by LC-MS. The consumption of the acrylamide was determined by 
MS (using the total ion current) where the ratio of acrylamide to internal standard decreased over 
time.92 The relative rates of GSH addition to N-arylacrylamides are arranged in decreasing order 
in Scheme 1.6 and range from 2.03 x 10-3 min-1 (t1/2 = 343 min) for the slowest reacting p-
Entry R (A) R (B) %a 
Conversion 
 Entry R (A) R (B) %a 
Conversion 
   A B     A B 
1 
  
2 23  1 
  
0 10 
2 
  
17 0  2 
  
0 0 
3 
  
33 8  3 
  
15 0 
4 
  
8b 42b  
5 
  
36c 6c  
6 
  
41 0  
7 
  
8b 8b  
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methoxyphenyl acrylamide to 115 x 10-3 min-1 (t1/2 = 6 min) for the fastest reacting o-nitrophenyl 
acrylamide. Substitution of the aryl ring of N-arylacrylamides at the ortho and para positions 
impacted the reaction rate more than substituents at the meta position.91 Additionally, some 
substituents had different effects depending on their position on the ring. For example, the methyl 
ester increased the rate of thiol addition when it was at the ortho or para positions due to resonance. 
However, when the methyl ester was in the meta position, this ester had the same effect as a 
methoxy group. These rates showed correlation to the chemical shifts of Hβ1 and Cβ, as well as 
calculated kinetic reaction barriers, where downfield chemical shifts corresponded to increased 
rates of GSH addition. 
 
 
Scheme 1.6. Relative rates of GSH addition to N-arylacrylamides.  
 
Similarly, scientists at Pfizer studied a more diverse set of acrylamides substituted with N-
aryl, N-alkyl, and/or substituents at the α or β position of the double bond (Table 1.4).93 The 
acrylamide was incubated with 10 equivalents of GSH in buffer (pH = 7.4) containing 10% 
acetonitrile at 37 °C using either LC-MS or 1H NMR to measure the consumption of the 
acrylamide. The researchers found that the rate of GSH addition using 10% dimethylacetamide in 
buffer (pH of 7.4) was slower than the rate measured using 10% acetonitrile as the cosolvent for 
five samples tested.93 This is just one example of how experimental conditions can influence the 
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rates of reactions, making direct comparisons between different studies difficult. The most reactive 
acrylamides 1.81-1.85 had no substitution at the α or β carbon and were N-substituted with aryl or 
heteroaryl groups (entries 1-5, Table 1.4). Substitution of the β carbon with a trifluoromethyl group 
1.86 increased reactivity relative to the unsubstituted acrylamide 1.89 (compare entries 6 and 9). 
Alkyl substitution at the α or β carbons greatly reduced reactivity, but some reactivity was regained 
with certain β-aminomethyl substituents (compare entries 12 and 14 to entries 15-21).93 The half-
lives of three nonreactive acrylamides 1.95-1.97 were measured at a higher temperature (60 °C); 
the half-life of cyclobutene containing acrylamide 1.95 decreased to 20 h (versus > 60 h at 37 °C), 
while α-methyl acrylamide 1.96 and cyclopentene containing acrylamide 1.97 were still 
nonreactive (entries 15-17). 
 The thiol reactivity of acrylamides can be tuned by changing the substituents on the 
nitrogen atom of the acrylamide or by changing the α or β substituents of the alkene. For example, 
N-aryl acrylamides react with thiols faster than N-alkyl acrylamides; electron-donating aryl groups 
on the nitrogen slow the hetero-Michael addition reaction of thiols relative to electron-withdrawing 
aryl groups as one might expect. Alkyl substituents at the α or β position of α,β-unsaturated amides 
slow thiol adduct formation, but β-aminomethylene substituents increase the rate of thiol addition 
relative to alkyl substitution.  
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Table 1.4. Half-lives for the reaction of various acrylamides with GSH. 
 
Reactive t1/2 < 8 h Mildly Reactive t1/2 = 15 - 41 h Non-Reactive t1/2 > 60 h 
Entry Acrylamide t1/2 
(h)a 
Entry Acrylamide t1/2 
(h)a 
Entry Acrylamide t1/2 
(h)a 
1 
 
0.13 8 
 
15 15 
  
> 60 
/20b 
2 
 
0.44 9 
 
17 16 
 
> 60 
/58b 
3 
 
0.88 10 
 
25 17 
 
> 60 
/ 
>60b 
4 
 
1.6 11 
 
27 18 
 
> 60 
5 
 
3.5 12 
 
28 19 
 
> 60 
6 
 
4.0 13 
 
33 20 
 
> 60 
7 
 
8.0 14 
 
41 21 
 
> 60 
b) Half-lives (t1/2) of acrylamides (1 mM) when reacted with GSH (10 mM) at pH = 7.4 at 37 °C 
with 10% MeCN. b) t1/2 measured at 60 °C.93 
 
Another method for tuning the reactivity of Michael acceptors is by placing two electron-
withdrawing groups at the α-position, which generates Michael acceptors that easily undergo the 
reverse Michael reaction to regenerate the original Michael acceptor. Covalent inhibitors that form 
reversible, covalent adducts could offer advantages over irreversible inhibitors because they can 
have similar effects on the selectivity and potency with less potential for off-target side effects.94 
Taunton's lab has demonstrated the tunability of acrylonitrile Michael acceptors by changing the 
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α-substituent to various electron withdrawing substituents and showed that thiol addition to the 
acrylonitriles was highly sensitive to the strength of the electron withdrawing α-substituent.50-51, 94  
 The tunable electrophilicity of acrylamides by changing the nitrogen substituent to 
electronically diverse substituents have been demonstrated. α-Methylene-γ-lactams should be 
similarly tunable through modifications to the lactam nitrogen. 
 
1.3. ISOSTERIC REPLACEMENT OF LACTONES WITH LACTAMS IN NATURAL 
PRODUCTS: BIOLOGICAL STABILITY, ACTIVITY, AND THIOL REACTIVITY 
 
Macrocyclic lactams are more stable to hydrolysis and esterase cleavage than the corresponding 
lactones. This has led to the preparation of various lactam analogs (or aza-analogs) of lactone 
natural products.95-98 Generally, these lactam analogs have been prepared to increase the biological 
stability of compounds, but in a few cases electrophilic Michael acceptors (such as enones) have 
been replaced by less electrophilic unsaturated amides. This section contains natural product, 
macrocyclic lactones for which lactam analogs have been prepared. Additionally, the replacement 
of electrophilic enones and lactones with less reactive, unsaturated amides and comparisons of 
thiol reactivity are presented. 
The most notable example of lactone to lactam replacement in macrocycles is the lactam 
analog of epothilone B 1.102 (ixabepilone, 1.103), which was synthesized at Bristol-Myers 
Squibb. Ixabepilone (1.103) was nearly as cytotoxic as the parent compound with an IC50 value of 
3.6 nM while the lactone natural product 1.102 had an IC50 of 0.42 nM. Ixabepilone (1.103) was 
more stable to esterase cleavage and was approved by the FDA in 2007 for the treatment of breast 
cancer (Figure 1.11).99-100  
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Figure 1.11. Epothilone B and lactam analog ixabepilone. 
 
Lactam analogs of artemisinin (1.104) were prepared and showed similar activity for 
inhibition of a chloroquine resistant strain of Plasmodium falciparum (the parasite that causes 
malaria), however, compounds 1.107 and 1.108 were 9-fold and 22-fold more potent than 
artemisinin (1.104) for inhibition of P. falciparum.97  
 
 
Figure 1.12. Artemisinin and lactam analogs. 
 
Sarcophine (1.110) displays anticancer and antidepressant activities, but the lactam analogs 
1.111-1.112 did not show significant cytotoxicity in several cell lines. Sarcophine (1.110) and the 
lactam analogs 1.111-1.112 all showed weak antimalarial activity (the highest activity was an IC50 
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of 529-4100 ng/mL compared to artemisinin (1.104) which has an IC50 of 13 ng/mL against 
Plasmodium falciparum).101  
 
 
Figure 1.13. Sarcophine and γ-lactam analogs. 
 
Macrosphelides (1.113-1.114) are a class of macrocyclic lactones that are under 
investigation as anticancer drug leads (Figure 1.14).102 The lactam analogs of the macrosphelides 
varied in their ability to induce apoptosis, with N-unsubstituted lactam 1.116 having no activity, 
while the activity of the N-phenyl lactam 1.117 was comparable to that of lactone 1.115.103 N-
benzyl lactam 1.118 was the most active compound tested (about 2-fold more active than lactone 
1.115), inducing early apoptosis in 43% of human lymphoma cells (U937) at a 10 μM 
concentration.  
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Figure 1.14. Macrosphelide natural products and lactam analogs. 
 
Salicylhalamide A (1.119) is an antitumor compound that inhibits mammalian vacuolar-
type (H+)-ATPase inhibitor containing a 12-membered macrolide (Figure 1.15).98 Lactam analog 
1.121 showed growth inhibition of 5-cancer cell lines with IC50 values from 117-506 nm. 
Similarly, a lactam analog of natural product (-)-A26771B (1.122) shows moderate antibiotic 
activity and improved pharmacokinetic properties, such as maintaining antibacterial activity when 
human serum was added to the culture media.104 The minimum inhibitory concentration (MIC) for 
lactone 1.122  was 2-16 μg/mL while lactam 1.123 was 5-10-fold more active against most strains 
of bacteria and even showed activity against 2 strains that were not inhibited by the natural product 
1.122.  
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Figure 1.15. Salicylihalamide A and A26771B with lactam analogs. 
 
Lactam analogs of other natural products that were prepared in order to increase the 
metabolic stability and/or improve the biological activity compared to the isosteric lactones 
include (-)-galiellalactone,  brefeldin C, and a number of gangliosides represented by GD3 lactam, 
but biological data for these lactams was not reported.95, 105-106 In addition to hydrolytic stability, 
amides or lactams have been incorporated into natural products to reduce the electrophilic 
reactivity of enones or α-methylene-γ-lactones. 
Resorcylic acid lactones (RALs), such as hypothemycin (1.124), are a family of 
benzannulated macrolides with a 12- or 14-member macrolactone and many contain a cis-enone. 
RALs have demonstrated numerous biological properties including antifungal, antibiotic, 
antitumor, and antiviral activities by inhibiting heat shock protein 90 (HSP90), mitogen activated 
protein kinases (MAPKs), herpes simplex virus 1 (HSV1) and the NF-κB pathway (Figure 
1.16).107-109 The cis-enone functionality of many RALs leads to irreversible inhibition of a subset 
of kinases by hetero-Michael addition of a conserved cysteine located in the ATP binding pocket; 
studies with hypothemycin (1.124) have shown ATP-competitive, time-dependent inhibition of 
these kinases.110-111 The kinact/Ki of hypothemycin (1.124) ranges from 160-120,000 M-1s-1 for 
various kinases and reacts much slower with small molecule thiols β-mercaptoethanol and 
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glutathione displaying second order rate constants (k2) of 3.6 and 6.6 M-1s-1, respectively, thus 
showing that reactions with kinase targets are faster than the reaction with free thiols.111 
The related enone natural product LL-Z1640-2 (1.126) forms adducts with dithiothreitol 
(DTT).112 The design of lactam analogs of resorcylic acid lactones, which are known to react with 
thiols, by replacing an enone in the 14-membered ring with an α,β-unsaturated amide demonstrated 
the tunability of this functionality.113 The enone natural product L-783,277 (1.125) and the 
isosteric lactam with N-acetyl (1.128) substitution both form thiol adducts with cysteamine in 
DMSO-d6, as monitored by 1H NMR, and they show similar inhibition of mitogen-activated 
protein kinase interacting kinase 1 and 2 (MNK1/2) in enzymatic assays. The IC50 of enone 1.125 
was 0.33 μM for inhibition of MNK1 and 0.061 μM for inhibition of MNK2, while the N-acetyl 
lactam 1.128 inhibited MNK1 and 2 with IC50 values of 1.3 and 8.9 μM, respectively. The N-
unsubstituted lactam 1.127 failed to react with thiols and showed weak inhibition of MNK1 (IC50 
> 50 μM) and MNK2 (IC50 = 41.7μM).113 The growth inhibition of MDAMB435s breast cancer 
cells was also similar for natural product 1.125 (GI50 = 7.5 μM) and the corresponding N-acetyl 
lactam 1.128 (GI50 = 8.5 μM).  
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Figure 1.16. Natural product resorcylic acid lactones tunable lactam analog. 
 
Although the replacement of macrocyclic lactones in natural products with lactams to 
increase their stability to hydrolysis is a known strategy, the replacement of lactone Michael 
acceptors is less common, and replacement of an α-methylene-γ-lactone with an α-methylene-γ-
lactam is even more rare. One example of this replacement is a lactam-containing parthenolide 
analog 1.131, which had no anticancer activity, despite parthenolide (1.23) being cytotoxic to 
cancer cells in the low micromolar range when tested in 6 different cancer cell lines (Figure 
1.17).114 
 
Figure 1.17. Parthenolide and lactam analog. 
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Strigolactones are phytohormones with potential activity as seed germination stimulators 
and plant growth regulators. Synthetic strigolactone GR-24 (1.132) is commonly employed in 
plant studies (Scheme 1.7).115 Lactone 1.132 reacts with benzyl thiol preferably at the α-
methylene-γ-lactone to form 1.133 in 50% conversion after 3 h; 1.134, arising from addition of 
benzyl thiol to the butenolide ring, was not observed. Lactam analog 1.135 showed the opposite 
regiochemistry when reacted under identical conditions with benzyl thiol.115 In this case, only 
addition of benzyl thiol to the butenolide ring to form 1.136 was observed, highlighting the reduced 
electrophilicity of α-methylene-γ-lactams compared to α-methylene-γ-lactones. Lactam 1.135 was 
more potent for induction of seed germination than lactone 1.132 (a dose of 0.0001 mg/L of 1.135 
gave a 92.6% germination while the same dose of 1.132 gave only a 24.6 germination). 
Additionally, seed germination was impacted by the stereochemistry of the vinyl ether group, 
where a lactam with the opposite stereochemistry of 1.135 at the vinyl ether was completely 
inactive at all concentrations tested. 
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Scheme 1.7. Thiol additions to synthetic strigolactone and strigolactam. 
The isosteric replacement of lactones with lactams has been demonstrated to improve 
hydrolytic stability of macrocycles and reduce the electrophilic reactivity of α-methylene-γ-
lactones. 
1.4. CONCLUSION 
The recent approval of several covalent drugs and the success of targeted covalent inhibitors for 
enhancing the ligand binding selectivity for structurally related proteins, increasing the binding 
affinity for proteins with shallow binding sites, and the ability to overcome drug resistance has led 
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to a renewed interest in covalent drug design. When considering α,β-unsaturated carbonyls in the 
design of covalent inhibitors, it is important to understand the factors that govern their ability to 
form adducts with thiols, especially under biologically relevant conditions (pH = 6-8). Thiol adduct 
formation is one of the major pathways for covalent inhibition of proteins and is also a major 
pathway for covalent inhibitor deactivation when adducts are formed with free cellular thiols such 
as GSH. The ability to tune the electrophilicity of α,β-unsaturated carbonyls through careful 
selection of the type of carbonyl and selective modifications to the surrounding structure plays an 
important role in the future of covalent inhibitor design in order to maximize selectivity and 
efficacy for a desired protein. The factors that govern the reversibility of thiol adduct formation is 
another important consideration, since rapidly reversible covalent bonds offer a strong interaction 
that complements the typical noncovalent interactions used in the design of reversible inhibitors. 
To summarize, the rate of thiol addition to α,β-unsaturated carbonyls, under biologically relevant 
conditions, decreases in the order of enals > enones > α,β-unsaturated esters > acrylamides > α,β-
unsaturated carboxylic acids.116 However, substituents at the α or β positions of a Michael acceptor 
can greatly influence the rate of thiol addition. Electron donating groups such as alkyl or electron 
rich aryl groups at the α or β position significantly reduce the rate of thiol addition relative to 
unsubstituted Michael acceptors. Electron withdrawing groups at the α position increase the rate 
of hetero-Michael addition, but also make the resulting adducts more prone to the reverse Michael 
reaction.  
The reduction in thiol reactivity of α-methylene-γ-lactams compared to isosteric lactones 
is generally accompanied by a reduction in toxicity. However, in some cases, the bioactivity for a 
specific target or pathway is maintained by lactam isosteres of lactones. The tunability of the 
electrophilic reactivity of acrylamides and the increased stability of lactams compared to lactones 
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in biological systems led to the hypothesis that α-methylene-γ-lactams could serve as tunable 
isosteres for α-methylene-γ-lactones in guaianolide natural products. These lactams would have 
tunable electrophilicity by changing the substituent on the lactam nitrogen. Guaianolides are a 
large class of sesquiterpene lactones possessing a range of biological properties; many 
guaianolides contain an electrophilic α-methylene-γ-lactone which is often important for the 
observed bioactivity.20-24 Our lab has previously shown that the allenic Pauson-Khand reaction of 
allene-ynes tethered by an α-methylene-γ-lactone can form the [5,7,5]-fused ring system of 
guaianolides.117-118 Thus, methods to synthesize α-methylene-γ-lactams in order to prepare lactam-
containing guaianolide analogs were examined. 
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2.0. METHODS OF α-METHYLENE-γ-LACTAM SYNTHESIS 
 
2.1. INTRODUCTION 
 
α-Methylene-γ-lactams are uncommon in natural products and bioactive compounds, but they have 
been used as synthetic intermediates towards γ-lactam-containing natural products and pyrolidine-
containing alkaloids. Some notable examples include the synthesis of isocynometrine (2.2) from 
2.1,119 salinosporamide (2.4) from 2.3,120 kainic acid (2.6) from 2.5,121 jamtine (2.8) from 2.7,122 
and the tricyclic core 2.10 of daphnilongeranin B (2.11) from 2.9 (Scheme 2.1).123 The use of α-
methylene-γ-lactams as synthetic intermediates towards natural products and a growing interest in 
their biological activity has led to the development of various synthetic methods to access this 
structure. 
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Scheme 2.1. α-Methylene-γ-lactams as synthetic intermediates. 
 
There are a number of methods to synthesize α-methylene-γ-lactams such as: a) 
intramolecular Baylis-Hillman reactions (section. 2.2), b) the addition of nitro compounds to 
Baylis Hillman alcohols, acetates, or allylbromides followed by reduction of the nitro group to an 
amine and subsequent cyclization (section 2.2), c) addition of allyl metal reagents (formed by the 
insertion of a metal into an allyl bromine bond) that react with imines (section 2.3), d) reaction of 
allylboronates with imines (section 2.3), e) reactions of α-dialkoxyphosphoryl lactams with 
aldehydes (section 2.4), f) conversion of α-unsubstituted-γ-lactams to the α-methylene-γ-lactams 
(section 2.5), g) radical cyclizations and other reactions (section 2.6). A 2011 review by Janecki 
and coworkers summarizes methods to access α-methylene and α-alkylidene lactams and lactones; 
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the major methods to synthesize α-methylene-γ-lactams are summarized in Scheme 2.1, and the 
advantages and disadvantages to each of these methods is discussed in this chapter.69 
 
 
Figure 2.1. Summary of methods to form α-methylene or α-alkylidene-γ-lactams. 
 
2.2. SYNTHESIS OF α-METHYLENE-γ-LACTAMS USING MORITA-BAYLIS-
HILLMAN REACTIONS 
 
Intramolecular Morita-Baylis-Hillman reactions of β-oxoacrylamides with aldehydes or ketones 
are one method for the synthesis of α-methylene-γ-lactams. For example, the reaction of 2.12 
produces lactam 2.13 in 52-88% yield (Scheme 2.2).124-125 Corey and coworkers have shown this 
method to be applicable to functionally dense precursors by the conversion of 2.14 to 2.15 in 90% 
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yield which was ultimately transformed into salinosporamide A (2.4).120 The advantages of this 
method are the mild conditions to perform the Baylis-Hillman cyclization and the 
diastereoselectivity achievable with chiral bases (although this can be substrate dependent). The 
disadvantages are the long reaction times required and the potentially difficult synthesis of β-
oxoacrylamides with the desired functionality. 
Scheme 2.2. Intramolecular Morita-Baylis-Hillman reactions to form α-methylene-γ-lactams. 
A related method for the synthesis of α-methylene-γ-lactams is the intermolecular Morita-
Baylis-Hillman reaction with nitro compounds or α-diester amides followed by cyclization of the 
resulting adducts. Nucleophilic addition of acetate 2.16 to nitro compound 2.17 gives adduct 2.18; 
reduction of the nitro compound and cyclization gives α-methylene-γ-lactams 2.19 in 53-78% 
yields (Scheme 2.3).126-127 Alternatively, carbonate protected diethylamino malonate can be added 
to the Baylis-Hillman adduct 2.20 which cyclizes following removal of the tert-butoxy carbonyl 
(Boc) group to afford lactams 2.21 or 2.22 in various ratios and yields ranging from 76-96% 
depending on the aryl substituent; DABCO favors α-methylene-γ-lactams 2.21 in good yields but 
without stereoselectivity while DIPEA favors formation of arylidene lactams 2.22 in good 
 48 
yields.128 Another synthesis that uses Baylis-Hillman adducts is a multicomponent reaction to form 
α-amino nitriles such as 2.23. α-Amino nitriles such as 2.23 were converted to α-methylene-γ-
lactams such as 2.24 with a nitrile at the γ-position in 52-92% using catalytic DBU.129  
 
Scheme 2.3. Synthesis of α-methylene-γ-lactams using Morita-Baylis-Hillman adducts. 
 
The advantage of these methods is the modular installation of substituents at the β- and γ- 
positions of the lactam, but in all examples an aryl group is installed at one of these positions which 
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limits the substrate scope. Additionally, reduction of the nitro group can require harsh conditions, 
while amides result in selectivity problems. 
 
2.3. SYNTHESIS OF α-METHYLENE-γ-LACTAMS FROM ALLYLMETAL 
REAGENTS (DERIVED FROM ALLYLBROMIDES) OR ALLYLBORONATES 
 
The reaction of allylbromides with indium or zinc forms allylmetal reagents that when reacted with 
imines form α-methylene-γ-lactams. These reactions generally require substituted imines that 
result in N-substituted α-methylene-γ-lactams, and they often give alkylidene lactams resulting 
from a byproduct.130-132 For example, N-methyl imine 2.25 reacts with an allylzinc reagent formed 
from allylbromide 2.26 to give lactams 2.27-2.29 in a 85% overall yield and 5:1:2 ratio of 
2.27:2.28:2.29 (Scheme 2.4).132 When chiral imine 2.30 was reacted with the same allylzinc 
reagent, complete selectivity for the trans lactam afforded 2.31 in 86% yield. 
 
 
Scheme 2.4. Allylzinc addition to an imine to form α-methylene-γ-lactams. 
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In addition to zinc, indium has been reacted with imines 2.33 and bromomethyl acrylic acid 
(2.34) to afford γ-amino acids 2.35 that were cyclized with dicyclohexyl carbodiimide (DCC) and 
4-pyrrolidinopyridine (4-PPY) to form γ-substituted α-methylene-γ-lactams 2.36 in yields of 32-
49% over 2 steps (Scheme 2.5).133 This reaction resulted in lower yields than the allylmetal 
reagents derived from zinc, but carboxylic acids could be used in place of esters. 
 
Scheme 2.5. Indium promoted addition to imines and cyclization. 
 
Chiral sulfinyl imines 2.37 react with alkoxycarbonyl allylbromides 2.38 to give α-
methylene-γ-lactams 2.39 with good yields (51-89%), diastereoselectivities (97:3 to 99:1 
trans:cis), and enantioselectivities (92-98% ee, Scheme 2.8).134-135 The sulfinyl group was removed 
with HCl in dioxane to give N-unsubstituted lactams 2.39. The diastereo- and enantioselectivities 
of these reactions is impressive and the tolerance of aryl, alkyl, and alkenyl substituents on the 
sulfinyl imine is useful. However, only relatively simple allyl bromides were employed, and it was 
anticipated that additional functionality such as an allene or a functional group that could be 
converted to an allene would not tolerate these conditions. 
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Scheme 2.5. Enantioselective synthesis of α-methylene-γ-lactams with chiral sulfinyl imines. 
A convenient procedure using 2-alkoxycarbonyl allylboronates for the synthesis of α-
methylene-γ-lactams is the 3-component reaction reported by Hall and coworkers.136 In this case, 
E-allylboronates 2.40 reacted with in-situ formed imines to give cis-lactams 2.42 selectively while 
Z-allylboronates 2.41 provided trans-lactams 2.43 selectively (Scheme 2.7).  Most aryl aldehydes 
provided the α-methylene-γ-lactams in moderate to good yields (> 60%). However, a benzyl and 
alkyl aldehyde gave lower yields of 35 and 39% which was attributed to enamine formation under 
the basic conditions. Chiral allylboronates such as 2.44 react with imines to form α-methylene-γ-
lactams stereoselectively.137 In these cases, chiral allylboronate 2.44, prepared from the achiral 
pinacolboronate, reacted slowly (1-2 weeks) with activated imines 2.45-2.49 to give α-methylene-
γ-lactams 2.51-2.55 in moderate to good yields (58-92%) and enantioselectivities greater than 95% 
after acidic work-up (Scheme 2.8). Alkyl and benzyl imines 2.45-2.46 required additional stirring 
with toluene sulfonic acid to effect lactamization, but silyl imines 2.47-2.49 provided lactams 2.54-
2.55 directly.  
 Scheme 2.7. 3-Component reaction between allylboronate, aldehyde, and ammonia. 
Scheme 2.8. Enantioselective lactamization with chiral allylboronates and imines. 
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The  advantages  of  α-methylene-γ-lactam formation from  allylboronates is  the  broad 
substrate scope and the ability to enact  lactamization enantioselectively with  chiral boronates. 
This  method  was selected  to form  α-methylene-γ-lactams with  the required  functionality to 
synthesize guaianolide analogs since similar allylboronates have been utilized in our lab for the 
synthesis of guaianolides containing an  α-methylene-γ-lactone ring.117-118 We  also envisioned 
that once the feasibility  of this  allylboronate approach  was demonstrated, this  method would 
allow the enantioselective synthesis of lactam-containing guaianolide analogs. 
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2.4. USE OF DIALKOXYPHORPHORYL REAGENTS TO INSTALL THE α-
METHYLENE MOIETY 
 
A different approach to α-methylene-γ-lactams is through the installation of the α-methylene group 
after cyclization. One method to accomplish this is through the synthesis of α-dialkoxyphosphoryl 
lactams which can be converted to the α-methylene-γ-lactam with base and formaldehyde.74, 76, 138 
One advantage to this method is the ability to form α-alkylidene lactams using various aldehydes 
in addition to α-methylene lactams formed using formaldehyde, but a drawback to this method is 
the number of steps involved in the synthesis, including reduction of a nitro group to an amine and 
protection/deprotection of the lactam nitrogen. An example of this strategy is the conversion of 
dialkoxyphosphoryl lactam 2.56 to α-methylene-γ-lactam 2.57 in 52-80% yield using a Horner-
Wadsworth-Emmons reaction with formaldehyde (Scheme 2.9). The poor diastereoselectivity for 
cyclization to the lactam is another drawback of this method. 
 
Scheme 2.9. Synthesis of α-methylene-γ-lactams from dialkoxyphosphoryl reagents. 
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2.5. INSTALLATION OF THE α-METHYLENE MOIETY ON AN α-UNSUBSTITUTED-
γ-LACTAM VIA THE LACTAM ENOLATE 
 
The α-methylene group can be installed by amide α-enolate formation, addition to an electrophile, 
followed by elimination. Thus, γ-lactams unsubstituted at the α-position can be converted to α-
methylene-γ-lactams, but tertiary amides and strongly basic conditions are required. The 
conversion of (-)-eburnamonine (2.58) from a δ-lactam to α-methylene-δ-lactam 2.59 proceeded 
in 28% yield and is one of the few examples with a functionalized starting material; this strategy 
has been applied to a number of other acyclic ketones, lactones, and lactams with yields ranging 
from 59-98% in less sterically congested systems (Scheme 2.10).139 The use of Eschenmoser’s salt 
to add α-methylene substituents to ketones and lactones is common, but not many examples have 
been reported for the α-methylenation of lactams.140 In one example, N-Boc lactam 2.60 is 
converted to α-methylene lactam 2.62 in 67% yield over 2-steps.141 The advantage of this method 
is a late stage introduction of the potentially reactive Michael acceptor, but most examples of this 
methodology involve relatively unfunctionalized lactams and the yields are only moderate.142-143  
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Scheme 2.10. Installation of an α-methylene moiety from the enolate of γ-lactams. 
 
 
2.6. CONCLUSION 
 
Radical cyclizations, Wittig olefinations, and intramolecular, palladium-catalyzed cyclizations of 
acrylamides and alkenes are three other methods used to form α-methylene-γ-lactams. 119, 144-146 
The major strategies for the synthesis of α-methylene-γ-lactams involve Morita-Baylis-Hillman 
reactions, Wittig-type reactions of dialkoxyphosphoryl reagents or addition/elimination 
procedures to install the α-methylene subunit, and allylmetal or allylboronate reactions with 
imines. The major advantage of reactions with allylzinc and allylboronate reagents is the ability to 
enact enantioselective formation of α-methylene-γ-lactams through the use of chiral imines or 
chiral allylboronates. Our lab has previously demonstrated the utility of allylboronate reactions 
with aldehydes for the preparation of α-methylene-γ-lactone-tethered allene-ynes which were 
transformed into guaianolides via an allenic Pauson-Khand reaction.117-118 Thus, it was proposed 
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that allylboronates with the required functionality could be prepared and reacted with imines 
instead of aldehydes to synthesize α-methylene-γ-lactam-containing guaianolide analogs. 
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3.0. PREPARATION OF LACTAM ANALOGS OF 6,12-GUAIANOLIDES  
 
3.1. INTRODUCTION 
 
 
 
 
  
Inspired by the ability to tune the electrophilic reactivity of acrylamides towards biothiols and by 
the  incorporation  of  an acrylamide  motif into three  recently FDA-approved  targeted covalent 
modifiers 1.1-1.3, replacing the α-methylene-γ-lactone of the 6,12-guaianolide  structure with an 
α-methylene-γ-lactam was  proposed  as  a method  to  reduce  the indiscriminate  reactivity and 
increase  the   relevance  of  this   bioactivity-rich   class  of  sesquiterpene  lactones in  the  drug 
discovery process.  Lactam isosteres  are known to be more stable to esterase hydrolysis than the 
corresponding   lactones,  95,  97-99,  101,  103-104,  147   but   few  examples   of   α-methylene-γ-lactone 
replacement  with an α-methylene-γ-lactam  have been reported, as discussed in section 1.3.96, 114
As  naturally  occurring  α-methylene-γ-lactams  are   rare,   and   comparisons   of   isosteric   α- 
methylene-γ-lactones   and   lactams   reveal   the  latter  to  be   considerably  less  toxic,  it  was 
hypothesized that α-methylene-γ-lactam isosteres  of 6,12-guaianolides would result in less toxic 
compounds that would maintain similar bioactivities to their lactone counterparts.69, 71  
 
 
Figure 3.1. Examples of 6,12-guaianolides that contain an α-methylene-γ-lactones. 
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The 6,12-guaianolides represent a class of natural products possessing an angular [5,7,5]-
fused ring system where one of the five-membered rings is a γ-lactone (Figure 3.1).21 This 
compound class is replete with functionality, which is likely an evolutionary response to enhance 
the compounds’ selectivity for specific protein targets.20 Another well recognized structural feature 
of many guaianolides is the methylene group adjacent to the lactone carbonyl, a motif that is 
present in 3% of all natural products.22 This moiety can covalently modify proteins, which is one 
source of bioactivity associated with compounds possessing it, but the reactivity of the α-
methylene-γ-lactone is also blamed for its cytotoxicity. α,β-Unsaturated carbonyl-containing 
compounds are often removed from screening libraries due to their perceived indiscriminate 
reactivity.148-150 However, the recent interest in targeted covalent inhibitors demonstrates that a 
better understanding of the mechanisms of action of natural products containing reactive 
functionality is needed.  
Certain guaianolides, such as cumambrin A (3.2), have been shown to inhibit the p50/p65 
transcription factor heterodimer from binding to DNA, the most downstream process in the NF-
κB signaling pathway, by forming a covalent bond between the α-methylene-γ-lactone and the 
sulfhydryl group (Cys-38) of the p65 protein (Figure 3.1).25 Inhibition of the NF-κB (nuclear factor 
κB) pathway promotes apoptosis and is frequently overactive in cancer and inflammatory 
diseases.26-27 Thus, it represents a desirable drug target (the NF-κB pathway is discussed in more 
detail in Section 3.11). 
 
 
 
 
 59 
3.1.1. Synthetic Strategies to Access 6,12-Guaianolides 
 
Naturally occurring, 6,12-guaianolides possess a preponderance of oxygen-containing groups, 
multiple stereogenic carbons, and conformationally mobile five- and seven-membered rings that 
make stereochemistry difficult to control.20-21 The challenges of synthesizing these compounds and 
their analogs cannot be overstated.22, 151 Some common strategies to access the 6,12 guaianolides 
are discussed below. In these strategies, the lactone moiety is generally installed at a late stage in 
the synthesis due to its reactivity.  
Semisynthesis from abundant and/or commercially available natural products, such as 
parthenolide (3.6) or α-santonin (3.9), is one method that has been used to synthesize some 6,12-
guaianolides. For example, parthenolide (3.6) was converted to micheliolide (3.7) in 90% yield 
using toluene sulfonic acid (Scheme 3.1).152 This could be further modified with mCPBA and 
Martin’s sulfurane to generate arglabin (3.3); a water soluble dimethylamino adduct of arglabin 
was in clinical trials for cancer treatment.  
 
Scheme 3.1. Semisynthesis of arglabin from parthenolide. 
 
Another semisynthesis procedure uses α-santonin (3.9), which affords the [5,7,5] ring 
system 3.10 of 6,12-guaianolides after UV irradiation under acidic conditions (Scheme 3.2). 
Examples of guaianolides that have been synthesized by this method in less than 5 synthetic steps 
 60 
include achillin,153 estafiatin,154 and compressanolide.155 In 2017, Baran and coworkers published 
an 11-step synthesis of thapsigargin, where irradiation of a more functionalized cross-conjugated 
cyclohexenone provided the 5,7-fused ring system of thapsigargin.  
Other total syntheses of 6,12-guaianolides have used radical cascades, ring closing 
metathesis, and ring expansion to access the 5,7-hydroazulene core of guaianolides, with further 
functionalization to install the γ-lactone. Examples include the radical cascade of highly 
functionalized cyclopentane 3.11 to provide [5,7,5]-ring system 3.12 in 99% yield, which afforded 
cladanthiolide (3.13) upon further modification (Scheme 3.2).156 Ring closing metathesis of 
functionalized cyclopentane 3.14 provided 5,7-ring system 3.15 in 88% yield, which was used in 
a 42-step total synthesis of thapsigargin (3.16).157 Ring expansion of perhydroazulene 3.17 
provided the 5,7-fused ring system 3.18 in 74% yield, which was then transformed into estafiatin 
(3.19).158 [2 + 2] Cycloaddition of cycloheptatriene 3.20 and ring expansion provided the 5,7-ring 
system 3.22 in 52% yield over 3 steps; several more steps provided 6,12-guaianolide 3.23.159 These 
methods have primarily been used in target-directed syntheses of one specific natural product and 
are not easily adapted to the synthesis of analogs. Additionally, the ring expansion methods have 
only been performed on substrates with limited functionality. 
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Scheme 3.2. Methods to form 5,7-ring system in the total syntheses of guaianolides. 
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The synthetic utility of the allenic Pauson–Khand reaction (APKR) for preparation of the 
structurally complex framework of 6,12-guaianolides has been demonstrated by our group in the 
past. This strategy involved an early introduction of the α-methylene-γ-lactone motif into the 
cyclization precursor showcasing the functional group compatibility and mild reaction conditions 
used for the APKR process.117-118 In these cases, monosubstituted allenes 3.24-3.25 underwent the 
APKR with aryl and silyl substituted alkynes to provide [5,7,5]-ring system 3.28-3.29 in good 
yields above 90%, while a methyl-substituted and terminal alkyne 3.26-3.27 gave 51 and 67% 
yields of APKR products 3.30-3.31 (Scheme 3.3). More oxygenated allene-yne 3.32, containing a 
disubstituted allene, provided guaianolide analog 3.33 in 64% yield after the APKR and tert-
butyldiphenylsilyl (TBDPS) removal. Others have shown the extraordinary utility of the APKR 
for accessing molecularly complex 5,7-ring systems. Notably, Baran has used the APKR of allene-
yne 3.34 to access 3.35 in multigram quantities; this common intermediate was used in the step-
economical syntheses of both (+)-ingenol 3.36 and (+)-phorbol 3.37 (Scheme 3.4).160-162 The 
advantages of the APKR include broad substrate compatibility and rapid access to the 5,7,5-ring 
system of guaianolides which allows the preparation of various analogs. One disadvantage is that 
the allene can be difficult to install in some cases. Additionally, lower yields of the APKR were 
observed for substrates with terminal or methyl substituted alkynes and for 1,1-disubstituted 
allenes, although this was recently solved by our lab using high dilution conditions.163 
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Scheme 3.3. Synthesis of guaianolide analogs using an APKR. 
 
Scheme 3.4. APKR to prepare precursor to ingenol and phorbol. 
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3.1.2. Pauson-Khand Reactions with Amide or Lactam Tethers 
 
The utility and functional group compatibility of the allenic Pauson-Khand reaction led to the 
hypothesis that an APKR of an α-methylene-γ-lactam tethered allene-yne would be a viable route 
to guaianolide analogs containing an α-methylene-γ-lactam in place of the naturally occurring α-
methylene-γ-lactone. Pauson-Khand reactions mediated or catalyzed by dicobalt octacarbonyl 
have been performed using amide and lactam tethers, including an APKR to form a 7-membered 
ring. In one example, ene-yne 3.38 with an unsaturated γ-lactam tether provided [5,6,5]-fused ring 
system 3.39 in 74% yield using stoichiometric dicobalt octacarbonyl (Scheme 3.5).164 Ene-yne 
3.40 with an amide tether, provided tetracycle 3.41 in 54% yield under cobalt catalyzed 
conditions.165 Amide rotation likely led to the need for the high temperature in this reaction Cobalt-
mediated APKR of allene-yne 3.42, tethered by a β-lactam, provided [4,7,5]-fused tricycle 3.43 in 
40% yield after isomerization of the alkene.166 Although lactams and amides have been used in the 
Pauson-Khand reaction and APKR, only tertiary amides and cobalt mediated or catalyzed reactions 
have been reported to the best of my knowledge. 
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Scheme 3.5. Pauson-Khand reactions with lactam and amide tethers. 
 
 Our group has demonstrated that tertiary benzamide or sulfonamide tethered allene-ynes 
undergo the rhodium catalyzed APKR in good yields. Benzamide 3.44 provides fused bicycle 3.45 
in 78% yield (Scheme 3.6).167 Sulfonamide 3.46 provides fused 5,7-ring system 3.47 in 96% yield 
with complete transfer of chirality from the enantiomerically enriched allene.168 To my knowledge, 
there are no examples of a rhodium-catalyzed, Pauson-Khand reaction with α-methylene-γ-lactam 
tethers. Indeed, most examples of Pauson-Khand or APKRs with cobalt or rhodium involve tertiary 
amides. In the allenic alder-ene reaction of secondary amide 3.48, 6-membered rings such as 3.49 
could be formed, albeit at higher temperatures and longer reaction times than the corresponding 
benzamides; 7-membered rings were not formed when secondary amide 3.50 was used in this 
reaction, despite the successful formation of a 7-membered ring with the corresponding benzamide 
(Scheme 3.10).169 This could indicate a potential problem in the APKR with secondary amides as 
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rhodium biscarbonyl chloride dimer is used as the catalyst in both reactions, although under the 
carbon monoxide atmosphere in APKR, the rhodium will coordinate to an additional molecule of 
CO, thus changing the active catalyst. Additionally, it is possible that the secondary amide of 3.50 
requires higher temperatures to form the required conformation for cyclization. The mechanisms 
for both the allenic alder-ene reaction and the APKR involve formation of a 5-member rhodium 
metallacycle 3.53 as a result of oxidative addition of the rhodium catalyst (Scheme 3.8). In the 
case of the allenic alder-ene reaction, the rhodium metallacycle undergoes β-hydride elimination 
followed by reductive elimination to give the product and regenerate the Rh(I) catalyst. In the 
APKR, rhodium metallacycle 3.53 undergoes carbonyl insertion to give 3.54, followed by 
reductive elimination to afford 3.55 and regenerate the catalyst. 
 
 
Scheme 3.6. APKR with tertiary amide tethers. 
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Scheme 3.7. Rhodium catalyzed allenic Alder-ene reactions with secondary amides. 
 
 
Scheme 3.8. Mechanism of allenic Pauson-Khand reaction. 
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3.1.3. Retrosynthetic Design of α-Methylene-γ-lactam Guaianolide Analogs 
 
Based on the success of α-methylene-γ-lactone-tethered allene-ynes in the APKR and precedent 
for amides or lactams in PK reactions, it was hypothesized that lactam guaianolide isosteres such 
as 3.56, could be prepared using an APKR and an early introduction of the α-methylene-γ-lactam. 
To test this hypothesis, compound 3.56 was envisioned as an initial target with an N-methyl group 
to protect the lactam and render the α-methylene group less reactive (Scheme 3.9). In turn, the C-
4 phenyl group serves to lower the volatility of precursors in the early stages of the synthetic 
sequence and to provide a compound that could be benchmarked against similar α-methylene-γ-
lactones in terms of chemical reactivity, NF-κB pathway inhibition, and cellular toxicity. Working 
retrosynthetically, it was predicted that the tricyclic ring system of 3.56 could be obtained from 
allene-yne 3.57 using the APKR. It was anticipated that the rate of the formal cycloaddition 
reaction would be slower than the corresponding lactone derivative because of the developing A1,3 
interaction between the N-methyl group of the lactam and phenyl groups, an interaction not present 
in the lactone-containing systems, but it was predicted that this steric hindrance should not prevent 
the APKR from occurring. 
 The allenyl group of 3.57 should be available from methyl ketone 3.58, using a 3-step 
reaction sequence involving Grignard addition of ethynyl magnesium bromide, acetylation of the 
tertiary alcohol, and a formal SN2’ hydride addition with triphenylphosphine copper hydride 
hexamer to form the allene.170 Triphenylphosphine copper hydride hexamer (Stryker’s reagent) is 
commonly used for conjugate reductions of α,β-unsaturated ketones and aldehydes.171 Indeed, the 
α-methylene unit of similar α-methylene-γ-lactones was reduced to a methyl substituent when 
Stryker’s reagent was used to form the allene, thus requiring protection of the α-methylene via 
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Michael addition of an amine that was eliminated after allene formation to regenerate the α-
methylene-γ-lactone (Dr. François Grillet, unpublished data). It was hypothesized that the lower 
electrophilicity of α-methylene-γ-lactams would lower the propensity for α-methylene reduction 
in these systems relative to methylene-γ-lactones; conjugate reductions of α,β-unsaturated 
aldehydes, ketones, esters, and lactones, have been reported, but not amides or lactams.171 Finally, 
it was proposed that α-methylene-γ-lactam 3.58 could be formed using a 3-component reaction 
between propynal 3.59, ammonium hydroxide, and allylboronate 3.60 (Scheme 3.11).136 Alkynals 
have not been used previously in this 3-component reaction for the preparation of α-methylene--
lactams; only aryl and alkyl aldehydes were reported. The requisite allylboronate 3.60 could be 
prepared from known alkynoate 3.61 using diisobutylaluminum hydride (DIBALH) and 
chloromethylpinacol boronate 3.62 as has been demonstrated by our lab and others to prepare 
similar allylboronates.117-118, 136-137, 172 The stereochemistry of the allylboronate controls the 
stereochemistry of lactam 3.58, with the Z-isomer providing the trans lactam and the E-isomer 
providing the cis lactam (not shown). Thus, this route has the potential to provide access to both 
cis and trans lactam isomers. We also envisioned that this strategy could be employed to generate 
N-unsubstituted lactams, which could be modified at a late stage in the synthesis to introduce 
electronically diverse substituents on the lactam nitrogen through substitution or amide-aryl halide 
coupling reactions. Thus, this synthetic approach would provide a method to tune the 
electrophilicity of the α-methylene-γ-lactam Michael acceptor.173 
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Scheme 3.9. Retrosynthetic analysis of α-methylene-γ-lactam guaianolide analog. 
 
3.2. FEASIBILITY OF ALLENIC PAUSON-KHAND APPROACH TO α-METHYLENE-
γ-LACTAM CONTAINING GUAIANOLIDE ISOSTERES 
 
The synthesis of APKR precursor 3.57 began with the preparation of alkynoate 3.61 in 3 steps 
from 2,4-pentanedione (3.63) in multi-gram quantities. Alkylation of 2,4-pentanedione was 
achieved by refluxing 3.63 with propargyl chloride and potassium carbonate in ethanol for 24 h 
(Scheme 3.10). This afforded ketone 3.64 in 49% yield through loss of ethyl acetate. Ketone 3.64 
was purified by filtration to remove potassium carbonate, concentration by simple distillation at 
atmospheric pressure, and vacuum distillation at 45 mmHg and 90 °C; the spectral data matched 
that reported in the literature.174 Ketone 3.64 was protected as the ketal by treatment with ethylene 
glycol and catalytic para-toluene sulfonic acid (pTSA) in refluxing benzene to provide ketal 3.65 
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in 71% yield after aqueous work up, concentration by simple distillation at atmospheric pressure, 
and vacuum distillation at 30 mmHg and 120 °C. The purified ketal 3.65 contained about 10% 
benzene based on integration of the 1H NMR resonance for benzene at 7.19 ppm and the terminal 
alkyne resonance at 1.87 ppm.175 Ketal 3.65 was treated with n-butyllithium at -78 °C to form the 
lithium acetylide which was reacted with methyl chloroformate for 3 h at rt to afford alkynoate 
3.61 in 72% isolated yield after purification by column chromatography.176  
 
Scheme 3.10. Synthesis of 2-alkoxycarbonyl allylboronate. 
 
Alkynoate 3.61 was treated with with DIBALH and chloromethyl pinacolboronate using 
the procedure first reported by Vilieras et al., and previously utilized by our group in the synthesis 
of α-methylene-γ-lactones, to afford allylboronate 3.60 in 77% yield along with 10% of alkene 
byproduct 3.66, arising from the quench of the intermediate vinyl aluminum species with a 
hydrogen source (Scheme 3.12).117-118, 137 Difficulties were encountered during this reactions, but 
we ultimately settled on the following optimized process. This reaction was performed using 
catalytic quantities of both copper iodide and methyl lithium (10 mol%) which were stirred at -30 
°C for 20 min; hexamethylphosphoramide (HMPA), toluene, and DIBALH (1 M solution in 
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hexanes or toluene) were added and stirred for 2 h at -30 °C. A solution of alkynoate 3.61 in toluene 
was then added to the DIBALH solution and this was allowed to warm to -20 °C for 5 h. 
Chloromethyl pinacolboronate 3.62 dissolved in toluene was added to the alkynoate solution and 
the reaction was allowed to warm to rt. After 16 h at rt, the reaction was quenched by dropwise 
addition of 1 N HCl after dilution with diethyl ether, followed by sequential washing of the organic 
layer with small portions of 1 N HCl, saturated aqueous ammonium bicarbonate, water, and brine. 
Removal of the solvent by rotary evaporation followed by filtration of the crude residue through a 
plug of silica gel gave allylboronate 3.60 in yields ranging from 40-90%. This reaction was 
performed over 10 times and the yields were typically 60-80% with 10-20% of alkene byproduct 
3.66, which had the same Z:E ratio as the allylboronate. Additionally, this reaction was performed 
on 2-3 g of alkynoate 3.61 with minimal changes in yield or byproduct formation. 
Allylboronate 3.60 was obtained as a mixture of isomers in a ratio between 2 and 3 to 1 
(Z:E). The ratio was determined by integration of the 1H NMR resonances at 5.92 ppm (Z) and 
6.71 ppm (E) corresponding to Ha of 3.60 (Scheme 3.10). The Z and E isomers were identified by 
analogy to similar allylboronates formed under the same conditions which reported the E-isomer 
as having a chemical shift further downfield than the Z-isomer.117, 136-137 The ratio of allylboronate 
3.60 to alkene 3.66 was determined by the integration of allylboronate proton Ha to the β proton 
of the unsaturated alkenes which appeared as a doublet of triplets at 6.98 ppm (E) and 6.26 ppm 
(Z). The E and Z isomers were inseparable by flash chromatography. The alkene byproduct 3.66 
could be separated from allylboronate 3.60 by chromatography, but allylboronate 3.60 was 
unstable when exposed to silica gel for extended periods of time, resulting in decreased yields (20-
40%). Therefore, the mixture of products was filtered through a plug of silica gel and the 
allylboronate isomers and alkene byproducts were taken onto the next synthetic step as a mixture. 
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As long as the allylboronate contained less than 20% of the alkene byproduct, the yield of the 
following lactamization reaction was not affected. If larger amounts of the alkene byproduct were 
taken on to the lactamization reaction, it resulted in lower yields and made the lactam difficult to 
purify due to the presence of other byproducts.  
In order to obtain optimal yields and minimal byproduct formation for this reaction, 
chloromethyl pinacolboronate needed to be freshly distilled, even though no change in the 1H 
NMR of this compound was detected upon storage. The toluene was also freshly distilled from 
calcium hydride, while the HMPA was distilled over calcium hydride with reduced pressure and 
then stored over 4 Å molecular sieves. It was important to know the exact concentration of 
DIBALH; in many cases where significant amounts (>20%) of the alkene byproducts were 
obtained, the DIBALH concentration was between 0.6 and 0.8 M, not 1 M as the bottle stated 
(determined by titration with p-anisaldehyde using Hoye's no D NMR procedure).177 This led to 
incomplete formation of the allylboronate. However, if excess DIBALH was used, reduction of 
the ester to the alcohol was observed as a minor byproduct. 
Formation of allylboronates from alkynoates can be performed without catalytic copper 
iodide and methyl lithium, but these reactions require longer reaction times.118, 178 The mechanism 
for this reaction in the absence of copper iodide and methyl lithium involves a 1,4-conjugate 
addition of DIBALH to alkynoate 3.61 to form vinyl aluminum intermediate 3.67, which can 
isomerize via allene 3.68 to vinyl aluminum 3.69. 179 These two vinyl aluminum species are 
trapped with chloromethyl pinacolboronate to give Z-allylboronate 3.60a and E-allylboronate 
3.60b as a mixture of Z and E isomers (Scheme 3.11). Copper iodide and methyl lithium form 
methyl copper which can activate the DIBALH by formation of a negatively charged aluminum 
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species such as 3.70 that then undergoes conjugate reduction to a vinyl aluminum species, but this 
mechanism has not been elucidated (Scheme 3.12).180 
 
Scheme 3.11. Formation of allylboronate via vinyl aluminum intermediates. 
 
Scheme 3.12. Activation of DIBALH with CuMe. 
 
Chloromethyl pinacolboronate 3.62 was prepared as previously described.181 A mixture of 
trimethyl borate (3.71) and bromochloromethane (3.72) in THF was treated with n-butyllithium at 
-78 °C and stirred for 1 h at this temperature (Scheme 3.13). Trimethylsilylchloride (TMSCl) was 
added at -78 °C and the reaction was allowed to warm to rt with stirring, then allowed to stand 
overnight (16 h) without stirring. Pinacol (3.73) was added at rt, and the reaction was stirred for 1 
h, then partitioned between water and ether (1:1). Concentration of the organic layer after drying 
over magnesium sulfate gave the crude residue which was purified by fractional distillation at 12 
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mmHg and 90-110 °C to afford pure chloromethyl pinacolboronate 3.62. In addition to small 
amounts of THF and ether that were not removed by rotary evaporation, the major impurity of the 
crude residue was bromobutane which distilled at 12 mmHg and 45-60 °C.  
 
 
Scheme 3.13. Synthesis of chloromethyl pinacolboronate. 
 
In order to test if propynals were viable substrates for the 3-component lactamization 
reaction, phenyl propynal and aqueous ammonia were stirred together in ethanol for 30 minutes, 
then an ethanol solution of allylboronate 3.60 (2:1 Z:E) was added and the reaction was stirred for 
16 h to provide lactams 3.74a and 3.74b in 47% combined yield, and as a 4:1 trans (3.74a) to cis 
(3.74b) isomeric mixture (Scheme 3.14). The lactams could be identified by new methylene 
resonances in the 1H NMR spectrum at 6.10 and 5.40 ppm for 3.74a and 3.74b. Broad amide 
singlet resonances appeared between 6-7 ppm for the lactams 3.74a,b, and these chemical shifts 
changed depending on the concentration of the lactam in the NMR sample. The cis and trans 
methylene and amide signals were indistinguishable for trans and cis isomers 3.74a,b. However, 
the isomers could be distinguished by the chemical shift of the resonance for the hydrogen attached 
to the γ-carbon of the lactam ring, labeled Hb in Scheme 3.15, which appeared as a doublet at 4.2 
ppm for trans lactam 3.74a and as a doublet at 4.7 ppm for the cis lactam 3.74b; integration of 
these doublets indicated a trans:cis ratio of about 4:1. This three component reaction was originally 
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reported by Hall and Elford for aryl or alkyl aldehydes and 2-alkoxycarbonyl allylboronates at 70 
°C to afford α-methylene-γ-lactams after 4 h (see Section 2.2).77, 136 Propynals are also viable 
substrates in this reaction and propynals do not need to be heated for a reaction to occur.77, 136 
Indeed, initial attempts to perform this reaction at 70 °C led to significant decomposition of the 
starting materials and only small amounts (<20%) of the lactam products were isolated. 
Additionally, attempts to perform this reaction with less basic ammonium acetate in place of 
ammonium hydroxide did not lead to any product formation. 
 
 
Scheme 3.14. Three-component reaction to form α-methylene-γ-lactams. 
Scheme 3.15. Synthesis of 3-phenyl propynal. 
 
3-Phenyl propynal 3.59 was prepared using 3 different methods. Oxidation of 3-phenyl 
propargyl alcohol 3.75 with pyridinium chlorochromate (PCC) gave only 50% of the desired 
aldehyde 3.59, and the toxicity of PCC made this route unappealing (Scheme 3.15). Oxidation of 
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alcohol 3.75 with manganese dioxide (MnO2) provided 3-phenyl propynal 3.59 in 82% yield when 
MnO2 was prepared from potassium permanganate and manganese sulfate, but 5-10 equivalents 
of MnO2 were required for complete oxidation of alcohol 3.75.182 Attempts to oxidize 3.75 with 
commercially available MnO2 failed to go to completion even when a large excess (20 equiv) of 
MnO2 was employed. The fastest, highest yielding, and most economical formation of propynals 
was achieved using the Bouveault aldehyde synthesis where the lithium acetylide of phenyl 
acetylene 3.76 was treated with dimethylformamide followed by an aqueous work-up with 
monobasic potassium phosphate to form propynal 3.59 in 92% yield.183  
With a successful method to synthesize α-methylene-γ-lactams containing an alkyne 
substituent at the γ-position, efforts to install an allene were pursued. Towards this end, trans-
lactam 3.74a was isolated and the lactam nitrogen was blocked by treatment with sodium hydride 
and methyl iodide to provide N-methyl lactam 3.77 in 71% yield. The ketal of 3.77 was hydrolyzed 
by refluxing with pyridinium para-toluenesulfonate (PPTS) in a 20:1 acetone to water solvent 
which afforded ketone 3.78 in 77% yield (Scheme 3.16). Ketone 3.78 was identified by the 
appearance of a new carbonyl resonance in the 13C NMR at 207.1 ppm and a downfield shift of 
the methyl singlet resonance from 1.33 to 2.17 ppm. Treatment of ketone 3.78 with ethynyl 
magnesium bromide at 0 °C in THF for 3 h provided tertiary propargyl alcohol 3.79 in 77% yield 
as a 1:1 mixture of alcohol diastereomers. The diastereomers were apparent in the 13C NMR 
spectrum which showed a 1:1 ratio of peaks for most carbons. The hydroxyl group of 3.79 was 
transformed into an acetoxy group by treatment with acetic anhydride, dimethylaminopyridine, 
and triethylamine in DCM for 3 h, affording 3.80 in 73% yield. Acetate 3.80 was identified by a 
new singlet resonance at 2.03 ppm that integrated for three hydrogens in the 1H NMR and a new 
carbonyl resonance at 169.4 ppm of the 13C NMR. Acetate 3.80 was converted to APKR precursor 
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3.57 via a formal SN2' hydride addition using triphenylphosphine copper hydride hexamer 
(Stryker's reagent) in 53% yield. To our delight, the α-methylene group was unaffected by Styker’s 
reagent, as was predicted for weakly electrophilic α-methylene-γ-lactams. Allene-yne 3.57 was 
identified by the terminal allene resonance which appeared as a multiplet at 4.66-4.64 ppm in the 
1H NMR and new resonances in the 13C NMR at 201.2, 97.7, and 75.2 corresponding to the central 
allene carbon, the terminal allene carbon, and the internal allene carbon, respectively. The APKR 
was performed by dropwise addition of a toluene solution of allene-yne 3.57 to a dilute solution 
of rhodium(I) biscarbonyl chloride dimer (10 mol%) in toluene over 1 h at 110 °C under a carbon 
monoxide atmosphere.163 After addition of the allene-yne 3.57 was complete, the reaction was 
heated for an additional 30 min to afford the desired [5,7,5]-fused tricycle 3.56 in 75% yield, thus 
demonstrating that the proposed route to access guaianolide analogs with a lactam replacing a 
lactone was achievable. These slow addition conditions have been shown to improve the yield of 
the APKR for methyl substituted allenes and alkynes due to a more dilute solution of rhodium 
catalyst and allene-ynes.163 This was the first reported APKR with an α-methylene-γ-lactam tether. 
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Scheme 3.16. Feasibility of allenic cyclocarbonylation approach to guaianolide analogs. 
 
3.3. TRANSITION STATE ANALYSIS FOR LACTAMIZATION REACTION 
 
Hall and Elford reported complete diastereospecificity for conversion of pure Z-crotylboronate 
3.83 to trans α-methylene-γ-lactam 3.85 and pure E-crotylboronate 3.86 to cis α-methylene-γ-
lactam 3.88; they proposed a chair-like transition state 3.84 with the primary aldimine substituent 
in a pseudoequatorial position trans to the boronate to account for this diastereospecificity (Scheme 
3.17).136 These transition states are formed from the Z imine 3.82, which is in equilibrium with the 
E imine 3.81 under the aqueous conditions employed. 
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Scheme 3.17. Proposed transition states for diastereospecific α-methylene-γ-lactam formation 
from crotylboronates and primary aldimines. 
 
Alternatively, boat-like transition states were proposed by Villiéras and coworkers for their 
chiral allylboronates containing a chiral boronate in place of the pinacolborane and their reaction 
with secondary aldimines; they proposed that imines such as 3.90 would form in the E 
conformation due to the nitrogen substituent and would not equilibrate under their conditions 
(Scheme 3.18).137 In this case, a chair-like transition state (3.97) for Z-crotylboronate 3.89 would 
be unfavored due to 1,3-diaxial interactions, and indeed the Z-crotylboronate 3.89 was converted 
to the trans lactam 3.92. A boat-like transition state 3.91 or 3.95 was proposed to account for the 
observed diastereospecificity in these cases, however, it has recently been demonstrated that 
allylboroxines catalyze the E/Z isomerization of imines.184 Thus, if boronates behave similar to the 
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boroxines, isomerization of the imines would allow chair-like transition states that involve the Z 
imine as discussed above. 
 
 
Scheme 3.18. Proposed transition states for diastereospecific α-methylene-γ-lactam formation 
from chiral crotylboronates and secondary aldimines. 
 
It is proposed that Z-allylboronate 3.60a goes through chair-like transition state 3.100 to 
give trans lactam 3.74a, similar to the transition states proposed by Hall and Elford (Scheme 3.19). 
Under conditions that utilize aqueous ammonia, the imine exists in equilibrium with the aldehyde 
3.59 and both E and Z imine isomers 3.98 and 3.99, therefore, the Z-imine can form chair-like 
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transition state 3.100 where the alkyne is trans to the boronate. A boat-like transition state 3.101, 
which is formed from the E imine 3.98 and places the alkyne substituent on the same face as the 
boronate, can also be drawn for conversion of the Z-allylboronate to the trans lactam 3.74a. For 
Z-allylboronate 3.60a to be converted to a cis lactam, it would need to go through the unfavorable 
chair-like transition state 3.103 with 1,3-diaxial interactions between the alkyne and the ester, as 
well as 1,3-diaxial interactions between alkyne and the boronate. Boat-like transition state 3.104 
formed from the Z-imine 3.99 would also provide the cis lactam 3.74b. There does not appear to 
be much difference between the boat-like transition states 3.101 and 3.104, so if these substrates 
went through a boat-like transition state, it is unlikely that 3.101 would be favored over 3.104 and 
diastereospecific reactions would not be observed.  
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Scheme 3.19. Possible transition states for Z-allyboronate addition to primary aldimines. 
 
The conversion of E-allylboronate 3.60b to cis lactam 3.74b likely goes through the chair-
like transition state 3.106 for the reasons described above (Scheme 3.20). Chair-like transition state 
3.106 is less favorable then transition state 3.100 because the alkyl group is in the pseudo-axial 
position leading to a 1,3-diaxial interaction with a methylene hydrogen. Boat-like transition state 
3.107 can also be drawn to account for the conversion of E-allylboronate to cis lactam 3.74b, but 
this transition state includes an unfavorable flagpole interaction between the alkyl substituent and 
the boronate. Since the transition states for the E-allylboronate are less-favorable than those drawn 
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for the Z-allylboronate, a slower conversion to cis lactam 3.74b is likely and decomposition of the 
E-allylboronate could occur during the lactam forming reaction. This would explain the change in 
ratio of Z:E allylboronate (2:1) when converting the mixture to trans and cis lactams (4:1) and is 
the most likely explanation based on the complete diastereospecificity reported for similar 
systems.136-137, 185 This change in ratio was also reported by our lab for the triflic acid promoted 
conversion of similar allylboronates to lactones.117 The larger alkyl substituent (R) in our systems 
has a bigger impact in the transition state than the smaller methyl groups described above. An 
alternative possibility, is that the E-allylboronate could go through a different, transition state such 
as transition states 3.109 or 3.110 to give the trans lactam 3.74a. In this case transition state 3.110 
still contains an unfavorable flagpole interactions, but transition state 3.109 is reasonable because 
the alkyne in these systems is less bulky than a phenyl substituent, which was reported by Hall or 
Vilieras in the previous examples (See Schemes 3.17 and 3.18). Thus, enrichment of the trans 
lactam by formation from both the Z and E allylboronates is possible, although cis lactam 
formation from E allylboronate is likely favored. 
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Scheme 3.20. Possible transition states for E-allyboronate addition to primary aldimines. 
 
3.4. EXPANDING THE SCOPE OF THE ALLENIC PAUSON-KHAND APPROACH TO 
α-METHYLENE-γ-LACTAM CONTAINING GUAIANOLIDE ISOSTERES 
 
With a successful APKR in hand, efforts to expand the scope of this strategy for the preparation 
of other lactam-containing guaianolide analogs were pursued. Modifications of the lactam nitrogen 
at a late stage in the synthesis, by substitution reactions with electrophiles or coupling reactions 
with aryl halides, would provide a general synthetic route to lactam containing guaianolide analogs 
with various nitrogen substituents. In turn, these nitrogen substituents could be used to tune the 
electrophilicity of the α-methylene-γ-lactam Michael acceptor. Additionally, the scope of alkynes 
tolerated in the cyclocarbonylation strategy were explored. Towards this end, a silyl substituted 
propynal was hypothesized as a starting material which would afford silyl-substituted alkynes; 
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these could be modified at a late stage by removal of the silyl group, providing terminal alkynes 
that could be further modified through substitution or coupling reactions.  
 
3.4.1. Feasibility of Secondary Amides in the APKR  
 
First, the feasibility of secondary amides in the APKR was examined by synthesizing an allene-
yne with an α-methylene-γ-lactam tether containing a secondary amide. This was accomplished 
by a synthetic protocol analogous to the synthesis of N-methyl lactam 3.56 described above. A 4:1 
mixture of ketals 3.74a (trans) and 3.74b (cis) lactams were hydrolyzed with PPTS in acetone and 
water (20:1) at reflux for 16 h to afford ketones 3.58a,b in 71% as a 4:1 mixture of trans (3.58a) 
and cis (3.58b) isomers (Scheme 3.21). Ketones 3.58a,b were identified by the disappearance of 
the ketal multiplet at 3.98-3.89 ppm in 3.74. The trans and cis lactam isomers of 3.58a,b could be 
separated by silica gel column chromatography or taken on to the next step as a mixture without 
impacting the yield, as evidenced by the similar yields obtained when the isolated trans lactam 
3.58a was carried through the synthesis compared to the yields below, where mixtures of the trans 
and cis lactams were used. Additionally, the ratio of trans to cis lactams did not change throughout 
the synthesis. In most cases, the lactams were taken on as a mixture, and only separated for 
characterization purposes, since they were more easily separable at later stage in the synthesis.  
Ketones 3.58a,b were reacted with ethynyl magnesium bromide (4 equiv) in THF at 0 °C 
for 3 h, followed by quenching with saturated ammonium chloride and stirring vigorously for 15-
30 min before extraction into ether. This provided propargyl alcohols 3.112a,b in 76% yield, as a 
1:1 mixture of alcohol diastereomers (Scheme 3.21). For the cis lactams, alkyne singlet resonances 
were observed at 2.36 and 2.38 for both diastereomers of 3.112b. The trans lactam diastereomers 
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of 3.112a were indistinguishable by 1H NMR, although the 13C NMR showed two diastereomers 
as two peaks with nearly the same chemical shift (< 0.2 ppm difference). The hydroxyl group of 
3.112a,b was chemoselectively modified by stirring with pivalic anhydride and substoichiometric 
scandium triflate (0.4 equiv) to give pivalates 3.113a,b in 70% combined yield. When acetylation 
was attempted using acetic anhydride, DMAP, and triethylamine the nitrogen was also acetylated 
(these products are discussed in Chapter 4). As with the propargyl alcohol 3.112a, the 
diastereomers of trans lactam 3.113a were only distinguishable by 13C NMR, but the diastereomers 
of cis pivalate 3.113b could be distinguished in the 1H NMR spectrum by two singlet resonances 
for the terminal alkyne at 2.42 and 2.36. Pivalates 3.113a (trans) and 3.113b (cis) were separated 
by column chromatography, and the isolated yields of 3.113a (57%) and 3.113b (13%) reflected 
the ratio of the starting material determined by 1H NMR.  
 
 88 
Scheme 3.21. Feasibility of secondary amides in the APKR. 
 
Propargyl pivalate 3.113a was converted to allene-yne 3.114 in 33% yield when reacted 
with Stryker’s reagent. This low yield is in part due to a competing reduction of the α-methylene 
group providing 3.115, and is discussed in further detail in Section 3.4.3 on the optimization of 
this allene forming reaction. The reaction of cis pivalate 3.113b with Stryker’s reagent is also 
discussed later in section 3.4.4. Allene-yne 3.114 was subjected to the APKR conditions utilizing 
slow addition of the allene-yne to rhodium biscarbonyl chloride dimer (110 mol%) in toluene to 
provide  [5,7,5]-fused tricycle 3.116 in 79% yield. This demonstrated that secondary amides were 
tolerated in the APKR. This also represents the first APKR with a secondary amide. Thus, it was 
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envisioned that the lactam nitrogen could be modified at a late stage in the synthetic sequence to 
modulate the electrophilic reactivity of the α-methylene-γ-lactam. 
 
3.4.2. Synthesis of α-Methylene-γ-lactams Containing a Silyl-substituted Alkyne 
 
In order to make late stage modifications to the terminus of the alkyne, the feasibility of silyl-
substituted propynals in the 3-component lactamization reaction was tested. Triisopropylsilyl 
(TIPS) propynal 3.118 was prepared by reacting the lithium acetylide of triisopropylsilylacetylene 
3.117 with DMF followed by acidic work-up with monobasic potassium phosphate to provide 
propynal 3.118 in nearly quantitative yields (Scheme 3.22).183 Propynal 3.118 was reacted with 
allylboronate 3.60 in ethanol and ammonium hydroxide to afford lactams 3.121a (trans) and 
3.121b (cis) in a 53% yield and a 3.5:1 trans (3.121a) to cis (3.121b) ratio, as determined by 
integration of the resonances for Hb at 4.2 ppm for the trans isomer and 4.7 ppm for the cis isomer. 
These lactams 3.121a,b containing a TIPS-substituted alkyne were subjected to the same synthetic 
sequence as lactams 3.74a,b with a phenyl-substituted alkyne and the reactions proceeded in 
similar yields. Trimethylsilyl (TMS) propynal 3.119 was subjected to the lactamization reaction, 
but the TMS group was unstable to the strongly basic conditions, and none of the desired lactam 
was obtained. 
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Scheme 3.22. Synthesis of α-methylene-γ-lactams using silyl-substituted propynals. 
 
The ketals were hydrolyzed by refluxing lactams 3.121a,b in an acetone/water (20:1) 
solvent containing PPTS to give ketones 3.122a,b in 70% yield, with a 4:1 trans:cis isomeric ratio 
(Scheme 3.23). As with the phenyl substituted alkyne examples, little change in the ratio of 
trans:cis isomers was observed going from ketal 3.121a,b to ketone 3.122a,b, where the ratio was 
determined by the same 1H NMR signals as ketals 3.121a,b at 4.2 and 4.7 ppm. Ketones 3.122a/b 
were used to synthesize the desired allenes in three synthetic steps. Reaction of ketones 3.122a,b 
with ethynyl magnesium bromide in THF for 3 h at 0 °C afforded propargyl alcohols 3.123a,b in 
86% yield, each as a 1:1 mixture of propargyl alcohol diastereomers. The trans lactam 
diastereomers of 3.123a were indistinguishable by 1H NMR, although the 13C NMR showed two 
equimolar diastereomers as two peaks for most carbons. Cis propargyl alcohol 3.123b 
diastereomers displayed two distinct alkyne resonances at 2.44 and 2.42 ppm, and two doublets 
were visible for the hydrogen on the γ-carbon of the lactam at 4.49 for 3.123b. The hydroxyl 
groups of 3.123a,b were transformed into pivalates 3.124a,b in 60% combined yield by stirring 
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with pivalic anhydride and substoichiometric scandium triflate (0.4 equiv). Pivalates 3.124a and 
3.124b were separated by column chromatography to give 46% of 3.124a and 14% of 3.124b. 
These were taken on as single isomers for the remainder of the synthesis. Pivalate 3.124a was 
identified by a new carbonyl carbon at 177 ppm in the 13C NMR spectrum and a singlet integrating 
for nine hydrogens at 1.1 ppm in the 1H NMR spectrum. As with the propargyl alcohol 3.123a, the 
diastereomers of trans lactam 3.124a were only distinguishable by 13C NMR, but the diastereomers 
of cis pivalate 3.124b could be distinguished in the 1H NMR spectrum by two singlet resonances 
for the terminal alkyne at 2.52 and 2.51. The 13C NMR also showed two nearly equivalent peaks 
for most carbons which differed by less than 0.2 ppm. The isolated yields of 3.124a and 3.124b 
reflected the ratios of the starting material determined by 1H NMR. Pivalate 3.124a was reacted 
with Stryker’s reagent to provide allene-yne 3.125 in 46% yield, along with 11% of 3.126, an 
overreduction product resulting from reduction of the α-methylene group to a methyl group. The 
stereochemistry of the lactam methyl group on 3.126 was assigned by comparison of experimental 
1H NMR coupling constants to calculated coupling constants vide infra (Section 3.6) Conditions 
for the synthesis of allenes from propargylic carboxylates using Stryker’s reagent were examined 
before further modifications to the alkyne terminus or lactam nitrogen were pursued.   
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Scheme 3.23. Synthesis of 1,1-disubstituted allenes with N-unsubstituted lactams. 
 
3.4.3. Optimization of Allene Formation from Propargyl Pivalates using Stryker’s Reagent 
 
Because the copper hydride was reacting with the α-methylene group of the lactam, efforts to 
increase the chemoselectivity and the yield for the transformation of propargyl pivalates to allenes 
ensued. Optimization studies involved changing the reaction temperature, equiv of Stryker’s 
reagent, reaction time, quench and work-up methods, scale, and source of Stryker’s reagent. 
Propargyl pivalates 3.113a or 3.124a were converted to 1,1-disubstituted allenes 3.114 or 3.125 in 
28-89% yields via a formal SN2' reaction with triphenylphosphine copper hydride hexamer 
(Stryker's reagent), and these allenes were identified by new resonances in the 1H NMR 
corresponding to the hydrogens on the allene terminus at 4.6 ppm for 3.114 and 3.125. This 
reaction was typically performed by addition of Stryker’s reagent (0.9 equiv, weighed in a 
glovebox) to a solution of propargyl pivalate 3.113a or 3.124a in degassed (by bubbling nitrogen 
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through solution for 10 min), wet toluene (containing 2 equiv water relative to propargyl pivalate) 
at rt and stirring for 0.5-5 h with a concentration of 0.04 M. The reaction was quenched either by 
addition of saturated ammonium chloride solution to the reaction mixture followed by dilution 
with diethyl ether or by pouring the reaction mixture into a biphasic, 1:1 mixture of saturated 
ammonium chloride and diethyl ether. In most cases the reaction mixture was stirred for 30 min 
with the ammonium chloride to facilitate precipitation of triphenylphosphine and 
triphenylphosphine oxide byproducts. Two work up procedures were utilized. The first involved 
filtration of both the organic and aqueous layers through Celite, separation of these layers, and 
extraction of the aqueous layer (3x) with diethyl ether. The second involved separation of the 
organic and aqueous layers, extraction of the aqueous layer with diethyl ether (3x), then filtration 
of the combined organic layers through Celite. The first work up procedure helped reduce the 
formation of emulsions during extraction. Addition of water (2-20 equiv) to reductions using 
Stryker’s reagent has been shown to increase the reaction rate and decrease the formation of side 
products, presumably by rapidly quenching the intermediate copper species formed during the 
reaction, and it was observed that addition of water reduced the reaction time from 3-4 h to 0.5-1 
h when the reaction was conducted at rt (Table 3.1, compare entries 4 and 7).186-187 A few minor 
side products were observed in most cases with this reaction. These byproducts are the result of 
the reduction of the α-methylene moiety to provide methyl lactams 3.115 or 3.126 due to a 
conjugate reduction reaction (Scheme 3.24). These was identified by a disappearance of the α-
methylene hydrogen resonances from the 1H NMR spectrum and the appearance of a methyl 
doublet at 1.0 ppm. The two other common side products are believed to be reduction of the 
internal alkyne or the allene based upon 1H NMR resonances. A doublet at 6.64 ppm (J = 11.4 Hz) 
for Hb and doublet of doublets at 5.55 ppm (J = 11.4, 9.7 Hz) for Ha is consistent with the reduction 
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of the internal alkyne to cis alkene (A) 3.127 or 3.128; reductions of alkynes to cis alkenes with 
Stryker’s reagent have been reported.188 Two multiplets at 5.05-4.91 and 5.78-5.61 ppm are likely 
due to the reduction of the allene to a terminal alkene (B) 3.129 or 3.130, but these minor 
byproducts were isolated but were not pure enough for full characterization. The product ratios 
presented in Table 3.1 were determined by integration of the 1H NMR resonances of product 
mixtures after column chromatography. 
 
 
Scheme 3.24. Formation of 1,1-disubstituted allenes using Stryker’s reagent. 
 
 The procedure employed for this reaction varied slightly among entries. In entry 1, a 
solution of pivalate 3.113a in toluene (0.05 M) was added to a solution of Stryker’s reagent in dry 
toluene (0.1 M) at rt all at once and stirred for 4 h. This reaction was quenched by addition of 
saturated, aqueous ammonium chloride solution to the reaction mixture, dilution with ether, and 
filtration through Celite. The layers were separated and the organic layer was washed with brine, 
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dried over magnesium sulfate, filtered, concentrated, and purified by silica gel flash column 
chromatography. This reaction gave a 53% overall yield and a 90:10 ratio of desired allene 3.114 
to α-methylene reduction product 3.115 and only trace amounts of other byproducts (entry 1). For 
entry 2, the same procedure was followed, except that the concentration was increased to 0.06 M 
and the vial was evacuated and filled with nitrogen three times after addition of all reagents, which 
likely increased the concentration further in this small-scale reaction. Entry 2 provided a 61% 
overall yield with a 72:6:22 ratio of desired allene 3.114 to α-methylene reduction product 3.115 
to alkyne reduction 3.127, where the increased concentration likely lead to an increase in alkyne 
reduction product 3.127 (entry 2). For entry 3, Stryker’s reagent was added directly to a solution 
of pivalate 3.113a in toluene (0.04 M); when ammonium chloride was added, it was stirred 
vigorously for 5 min before diluting with ether (a blue aqueous layer was observed) and the 
remainder of the work up was performed as described for entries 1-2. This provided a good overall 
yield of 89%, with a ratio of 75:11:14 of desired allene 3.114 to α-methylene reduction product 
3.115 to alkyne reduction 3.127 (entry 3). For entry 4, pivalate 3.124a (0.04 M, with a TIPS-
substituted alkyne instead of the Ph alkyne in entries 1-3) was added to a solution of Stryker’s 
reagent (0.1 M), analogous to entries 1-2. An aliquot of the reaction mixture showed that the 
reaction was complete after 2.5 h by 1H NMR, but it was left to stir for a total of 4.5 h. To quench 
this reaction, saturated ammonium chloride was added to the reaction and this was stirred 15 
minutes open to air, then diluted with ether and the layers separated providing an overall yield of 
47% with an 85:15 ratio of desired allene 3.125 to allene reduction product 3.130 (entry 4). The 
large triisopropyl silyl substituent on the internal alkyne may have prevented reduction of this 
alkyne by the bulky Stryker’s reagent, instead leading to the allene reduction byproduct 3.130 that 
was observed in only trace amounts for entries 1-3.  
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In entry 5, water was added to the pivalate 3.113a solution(0.04 M in toluene containing 
0.01 mL of water) because water has been reported to speed up reactions with Stryker’s reagent.171, 
187 An aliquot of the reaction after 1 h showed the disappearance of the terminal alkyne resonance 
of the starting material by 1H NMR, so the reaction was quenched and an overall yield of 43% 
with a 65:10:25 ratio of desired product 3.114 to α-methylene reduction product 3.115 to alkyne 
reduction 3.127 was obtained (entry 5). Thus, water sped up the rate of allene formation, but it also 
led to an increase in the alkyne reduction product 3.127 (entry 5). For entry 6, N-methyl substituted 
lactam 3.91 was used to see if a more electron-rich α-methylene-γ-lactam would be less susceptible 
to reduction. An aliquot showed consumption of the starting material after 30 min, again 
demonstrating the increase in the rate of reaction with the addition of water. This N-methyl lactam 
3.91 gave a good overall yield of 70% and showed only trace amounts of α-methylene reduction 
product (75:trace:25 desired product 3.65 to α-methylene reduction product to alkyne and allene 
reduction, entry 6). This is attributed to the reduced electrophilicity of the α-methylene when an 
electron-donating alkyl group was attached to the lactam nitrogen. For entry 7, the temperature 
was reduced to 0 °C to slow the reduction of the α-methylene moiety. Performing the reaction at 
0 °C resulted in only trace amounts of the undesired byproducts 3.126, 3.128, and 3.130 being 
isolated when propargyl pivalate 3.124a was reacted with Stryker’s reagent providing an overall 
yield of 64% (entry 7). The reaction conditions from entry 7 were repeated for entry 8 with pivalate 
3.113a and the desired allene 3.114 was obtained in 52% yield with only trace amounts of 
byproducts. Entries 9-10 were performed under the same conditions as entries 7-8 except a 
different bottle of Stryker’s reagent from Sigma-Aldrich was used. Entry 9 gave a lower yield 
possibly due to the small scale, but entry 10 gave the same yield as entry 8 (52%), with only trace 
amounts of α-methylene reduction and other side-products detected. 
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 Entry 11 was performed using the same procedures as entries 7-10 except that a new bottle 
of Stryker’s reagent purchased from Acros was used and the reaction was quenched after 1 h 
because an aliquot after 45 min showed consumption of the starting material by 1H NMR. This 
resulted in a good overall yield (73%) but a large amount of the α-methylene reduction product 
3.126 was obtained (60:40 desired allene 3.125 to α-methylene reduction product 3.126). This led 
us to try a lower temperature of -10 °C and to decrease the amount of Stryker’s reagent from 1 
equiv to 0.8 equiv in entry 12. The reaction was monitored by quenching aliquots of the reaction 
mixture, extraction into ether, concentrating, and obtaining a 1H NMR spectrum. This reaction 
appeared nearly complete after 90 min (3:1 prod:SM). After column purification, the overall yield 
was 66% with a 63:25:12 ratio of desired allene 3.125, α-methylene reduction product 3.126, and 
SM (3.124a) with only trace amounts of other byproducts detected. From this it was concluded 
that the Stryker’s reagent from Acros was more active than that from Sigma Aldrich, but due to 
the increase in yields, attempts to optimize allene formation with Stryker’s reagent from Acros 
were pursued. In entry 13, the temperature was lowered to -20 °C, 0.9 equiv of Stryker’s was used. 
We sought to find an optimal temperature that would allow for allene formation but not for α-
methylene reduction. This resulted in a slightly lower overall yield of 58% with a 4:1 ratio of 
desired allene 3.125 to α-methylene reduction 3.126, but no SM was recovered and only trace 
amounts of alkyne or allene reduction products 3.128 and 3.130 were observed under these 
conditions (entry 13). Although the allene with a TIPS alkyne (3.125) was separable from 
overreduction product 3.126, the allene with a phenyl alkyne (3.114) was inseparable from 3.115, 
so further decreasing the amount of overreduction product was desired.  
For entry 14, the temperature was lowered to -78 °C and the rest of the procedure was the 
same as in entry 13. This eliminated the formation of overreduction product 3.126 and gave a good 
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overall yield of 71%, but a nearly 1:1 ratio of desired product to recovered starting material was 
obtained (entry 14). For entry 15, the reaction was kept at -78 °C for 3.5 h instead of 1.5 h as in 
entry 14. An aliquot of the reaction mixture taken after 2 h showed a nearly complete reaction with 
a 5:1 ratio of product 3.114 to starting material 3.113a. However, when the reaction was quenched 
after 3.5 h, a 67:26 ratio of starting material 3.113a to product 3.114 was obtained along with 7% 
of the α-methylene reduction product 3.115 (entry 15). This could be due to the reaction not being 
quenched immediately upon addition of saturated ammonium chloride, or due to the warming of 
the small aliquot upon removal from the reaction mixture. It appears that the allene formation and 
conjugate reduction reactions have similar energetic barriers, although an intermediate temperature 
(between -20 and -78 °C) was not tested. Additionally, Stryker’s reagent is only partially soluble 
in toluene, so very low temperatures could be inhibited by poor solubility of the 
triphenylphosphine copper hydride hexamer. For entry 16, water was not added to the reaction in 
an effort to prevent the reduction of the α-methylene moiety. The reaction was stirred at -78 °C for 
20 min, then -30 °C for 30 min, then -10 °C for 30 min, then 0 °C for 150 min. Aliquots of the 
reaction mixture showed a 10:1 ratio of starting material 3.124a to product 3.125 by 1H NMR after 
stirring at -78 °C with no α-methylene reduction detected and this ratio remained the same as the 
reaction was warmed slowly to 0 °C for 30 min. After stirring for an additional hour at 0 °C, an 
aliquot of the reaction mixture showed a 2:2:1 mixture of desired product 3.125 to α-methylene 
reduction 3.126 to starting material 3.124a. The reaction was quenched after a total of 4 h as 
described for entries 12-15 and a 60% overall yield was obtained with the same ratio of products 
as the second aliquot (2:2:1, entry 16). This suggested that water was not contributing to the 
reduction of the α-methylene moiety, but the absence of water significantly slowed the rate of the 
reaction, especially at lower temperatures. 
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Due to the increased amount of α-methylene reduction products 3.115/3.116 obtained when 
using Stryker’s reagent purchased from Acros (entries 11-16), a new bottle of Stryker’s from 
Sigma-Aldrich was purchased and used in entry 17. For entry 17, the conditions from entries 8-10 
were repeated using the same amount of Stryker’s reagent (1 equiv) and the same concentration of 
pivalate (0.04 M). This provided a 53% overall yield with a ratio of 52:7:10:12:19 of the desired 
product 3.114 to α-methylene reduction product 3.115 to starting material 3.113a to allene 
reduction 3.129 to an unidentified byproduct (entry 17). Due to the variability in product ratios 
when using different sources of Stryker’s reagent, it was synthesized from copper (II) acetate, 
triphenylphosphine, and diphenylsilane according to the method reported by Lee and Yun.189 This 
synthetic Stryker’s reagent was used in entry 18 providing a 40% overall yield with a 69:6:12:13 
ratio of desired allene 3.114 to α-methylene reduction product 3.115 to byproducts 3.127 and 3.129 
and a new byproduct. This previously unencountered byproduct was isolated by column 
chromatography and appeared to be allene formation due to the allene resonance at 4.6 ppm. 
Reduction of the α-methylene was also apparent in this byproduct due to disappearance of the 
resonances at 6.11 and 5.41 ppm in the 1H NMR corresponding to the hydrogens on the α-
methylene group and the appearance of a methyl doublet at 1.2 ppm. Reduction of the lactam 
carbonyl to an alcohol is proposed due to a disappearance of the carbonyl carbon at 169 ppm and 
a new peak at 67 ppm of the 13C NMR. The resonances for the other hydrogens on the lactam were 
shifted upfield considerably from 4.3 and 3.0 ppm in the α-methylene reduction product 3.115 to 
2.5 and 2.0 ppm in this byproduct.  
In entry 19, 0.9 equiv of Stryker’s reagent from Aldrich was used at a reaction temperature 
of -10 °C for 2 h. This provided an overall yield of 70% and a ratio of 70:16:14 of desired product 
3.114, α-methylene reduction product 3.115, and allene reduction product 3.129 (entry 19). Entry 
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20 utilized the same conditions as entry 19 but was quenched by pouring the reaction into 0 °C 
saturated ammonium chloride as in entries 12-18. This reaction gave a lower overall yield (31%) 
than most entries, but it provided the best ratio of desired product 3.114 to α-methylene reduction 
product 3.115 to allene reduction product 3.129 of 80:10:10 (entry 20). In entry 21, the same 
procedure as entries 19-20 was followed, except that 0 °C saturated ammonium chloride was added 
to the reaction for the quench. In this case, a 56% overall yield was obtained with a 90:10 ratio of 
desired allene 3.114 to α-methylene reduction product 3.115 and only trace amounts of the allene 
reduction product 3.129 was observed (entry 21). Entry 22 followed the same procedure as entries 
20-21, except for the work-up, which involved filtration through Celite after stirring the reaction 
with ammonium chloride, but before extracting with ether (the same work-up as in entries 4-18). 
This provided an overall yield of 38% with a 94:6 ratio of desired allene 3.114 to α-methylene 
reduction product 3.115 with no starting material and only trace amounts of other byproducts. In 
entry 23, the reaction with rt saturated ammonium chloride, and it was stirred 2 h instead of the 
normal 30 min. A new bottle of Stryker’s reagent from Aldrich was also used in entry 23. The 
longer quenching time may have led to the low yield of 28%. The ratio of products was 84:8:8 of 
the desired allene 3.114 to the α-methylene reduction product 3.115 to alkyne reduction product 
3.127 (entry 23). Entry 24 followed the same procedure as entry 19, and the difference from entries 
20-23 was that rt saturated ammonium chloride was added to the reaction during the quench. In 
this case, a good overall yield of 78% was obtained with a 77:23 ratio of desired allene 3.125 to α-
methylene reduction product 3.126. For entry 25 the same conditions from entry 24 were employed 
on a larger scale (440 mg compared to 220 mg). This provided an overall yield of 49% with a 
72:19:9 ratio of the desired allene 3.125 to α-methylene reduction product 3.126 to starting 
material 3.124a. The larger scale of this entry may account for the reduction in overall yield when 
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compared to entry 24, however, the yield of this reaction was somewhat variable, with an average 
yield of 55 ± 15%. 
Initially, these reactions were quenched by addition of rt, saturated ammonium chloride 
solution to the reaction. The biphasic mixture was stirred open to the atmosphere for 20-30 minutes 
causing triphenylphosphine oxide byproducts to precipitate from the mixture. In other cases, the 
reaction was quenched by addition of 0 °C ammonium chloride solution and pouring the reaction 
mixture into a 0 °C mixture of ammonium chloride and ether. The work-up was also performed 
two different ways: filtration through Celite prior to extraction or filtration through Celite after 
extraction. These alternate quenching and work-up protocols made little difference in the yield of 
the reaction or the ratio of desired allenes to α-methylene reduction products although the 
variability in the yield and product ratios made a conclusion difficult. Thus, to test the effect of 
quenching and work-up procedure on the yield and ratio of products, a single reaction was divided 
into two equal portions and the two major quenching and work-up procedures were performed in 
entry 26. For this reaction, the typical reaction conditions were employed (0.04 M, -10 °C, 2 equiv 
water), but before quenching 1 equiv of mesitylene was added as an internal standard. Then, half 
of the reaction mixture was removed via syringe and added to 0 °C ammonium chloride solution 
(quench procedure E). Room temperature ammonium chloride was added to the remainder of the 
reaction mixture (still in ice bath at 0 °C, quench procedure D), and the two solutions were stirred 
for 30 minutes open to the atmosphere. After 30 minutes, the first half of the reaction mixture 
(quench E) was diluted with ether and filtered through Celite; the aqueous layer was extracted with 
ether (2 x 25 mL), the combined organic layers were dried over magnesium sulfate, and this was 
gravity filtered, concentrated, and a 1H NMR was obtained. Meanwhile, the second half of the 
reaction mixture (quench D) was diluted with ether, the layers separated, the aqueous layer 
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extracted with ether (2 x 25 mL), the combined organic layers dried over magnesium sulfate, then 
filtered through Celite, concentrated, and a 1H NMR obtained. The amount of crude product after 
concentration was nearly the same (203 mg for the first method, 197 mg for the second method) 
and the NMRs showed about the same ratio of products to mesitylene (~1:3). There were still 
triphenylphosphine byproducts in these crude products, and the ratio of product to mesitylene was 
determined by integration of the allene resonance at 4.6 ppm and mesitylene CH3 resonance at 2.3 
ppm. After column chromatography, a 61% overall yield was obtained with a 67:9:24 ratio of 
desired allene 3.125 to α-methylene reduction product 3.126 to starting material 3.124a (entry 26).  
To summarize the results presented in Table 3.1, the order of addition of reagents made 
little difference in the yield or ratio of products (compare entries 1 and 4). The addition of water 
(2 equiv) to the reaction sped up product formation 2-3 fold but did not significantly affect the 
ratio of desired allene 3.114/3.125 to other byproducts 3.127-3.130 (compare entries 2 and 5). 
Lowering the reaction temperature from rt to 0 °C provided the desired allenes 3.114 or 3.125 in 
moderate yields with minimal formation of undesired byproducts (compare entry 4 to 7 and entry 
5 to 8). However, significant differences in product ratios were obtained using different sources of 
Stryker’s reagent under similar conditions (compare entry 7 to 11 and 10 to 18). It should be noted 
that the source of Stryker’s reagent was visibly different, with the older bottles from Aldrich (90%, 
entries 1-10, stored in glovebox for about 2 years) having a dark, brick red color; the bottles from 
Acros (97%, entries 11-16) and the synthetic Stryker’s reagent had a bright red, almost orange 
color; and the new bottles from Aldrich (90%, entries 17, 19-25) were brown with only a slight 
red tint. Reducing the reaction temperature to -10 or -20 °C helped reduce byproduct formation 
compared to reactions ran at 0 °C (compare entries 11 and 13). Further reducing the reaction 
temperature to -78 °C resulted in longer reaction times that did not prevent the formation of α-
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methylene reduction product 3.115/3.126 and starting material was recovered (compare entry 13 
to 14, 15 and 16). Additionally, removing water from the reaction and allowing to warm slowly 
from -78 °C to 0 °C did not prevent the overreduction product 3.126 from forming. The amount of 
Stryker’s reagent could be reduced from 1 to 0.9 equiv but lowering the amount to 0.8 equiv 
resulted in the recovery of starting material and similar amounts of byproducts compared to 0.9 
equiv (compare entries 11-13). α-Methylene-γ-lactam 3.113a with a phenyl substituted alkyne 
gave increased amounts of alkyne reduction product 3.127 with less α-methylene reduction 3.115, 
while substrates with a TIPS alkyne gave increased amounts of α-methylene reduction 3.126 and 
less alkyne reduction 3.128 (compare entry 18 to 24). This could be due to the bulkiness of the 
TIPS substituent or the electron donating ability of the silyl group, both of which would decrease 
the reactivity of the internal alkyne towards reduction by Stryker’s reagent. Finally, allene 3.125, 
with a TIPS substituent on the alkyne, could be separated from the reduced product 3.126 by 
column chromatography. However, separation of allene 3.114 from the reduced product 3.115 was 
not achieved with column chromatography, therefore 3.114 and 3.115 were taken on to the next 
synthetic step as a mixture. 
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Table 3.1. Reaction optimization for formation of 1,1-disubstituted allenes. 
Entry Notebook 
Page 
SM Source 
Stryker’s 
Equiv 
Stryker’s/
Solvent 
Conc (M) 
Temp 
(°C) 
Time 
(h) 
Total 
yield 
(%) 
Desired (3.114/3.125): 
overreduction 
(3.115/3.126):SM 
:byproducts (A,B) 
Scale of 
Lactam 
Que-
nch 
Work
-up 
1 6-166 3.113a Aldrich-1a 1 (0.04) rt 4b 53 90:10:0:trace 20 mg D H 
2 6-172 3.113a Aldrich-1a 1 (0.06) rt 3b 61 72:6:0:22A 19 mg D H 
3 6-194 3.113a Aldrich-1 1 (0.04) rt 4b 89 75:11:0:14A 140 mg D H 
4 7-74 3.124a Aldrich-1a 1 (0.04) rt 4.5b 47 85:0:0:15B 60 mg D I 
5 7-82 3.113a Aldrich-1 1 (0.04) rt 1.5 43 65:10:0:25A 107 mg D I 
6 7-134 3.91 Aldrich-1 1 (0.04) rt 1 70 75:trace:0:25A/B 80 mg G I 
7 7-164 3.124a Aldrich-1 1 (0.04) 0 1.5 64 100:trace:0:trace 110 mg D I 
8 7-186 3.113a Aldrich-1 1 (0.04) 0 2 52 100:trace:0:trace 145 mg D I 
9 7-198 3.113a Aldrich-2 1 (0.04) 0 1.5 35 100:trace:0:0 24 mg D I 
10 7-209 3.113a Aldrich-2 1 (0.04) 0 1.5 52 100:trace:0:trace 145 mg D I 
11 8-52 3.124a Acros-1 1 (0.04) 0 1 73 60:40:0:trace 110 mg D I 
12 8-54 3.124a Acros-1 0.8 (0.04) -10 2 66 63:25:12:trace 110 mg E I 
13 8-62 3.124a Acros-1 0.9 (0.04) -20 2 58 80:20:0:trace 110 mg E I 
14 8-64 3.124a Acros-1 0.9 (0.04) -78 1.5 71 52:0:48:trace 110 mg E I 
15 8-80 3.113a Acros-1 0.9 (0.03) -78 3.5 44 26:7:67:trace 110 mg E I 
16 8-86 3.124a Acros-2 0.9 (0.03) -78c 4b 60 42:38:19:trace 110 mg E I 
17 8-98 3.113a Aldrich-3 1 (0.04) 0 2 53 52:7:10:12A:19J 110 mg E I 
18 8-110 3.113a Synthetic 1 (0.04) 0 2 40 69:6:0:12A/B:13K 110 mg E I 
19 8-202 3.113a Aldrich-3 0.9 (0.04) -10 2 70 70:16:0:14B 110 mg D H 
20 9-28 3.113a Aldrich-3 0.9 (0.04) -10 1.5 31 80:10:0:10B 122 mg E H 
21 9-34 3.113a Aldrich-3 0.9 (0.04) -10 1.5 56 90:10:0:trace 122 mg F H 
22 9-42 3.113a Aldrich-3 0.9 (0.04) -10 2 38 94:6:0:trace 122 mg F I 
23 9-52 3.113a Aldrich-4 0.9 (0.04) -10 2 28 84:8:0:8A 122 mg G H 
24 9-86 3.124a Aldrich-4 0.9 (0.04) -10 2 78 77:23:0:trace 220 mg D I 
25 9-102 3.124a Aldrich-4 0.9 (0.04) -10 2 49 72:19:9:trace 440 mg D H 
26 9-108 3.124a Aldrich-4 0.9 (0.04) -10 2 61 67:9:24:trace 250 mg E/D H/I 
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a) propargyl pivalate added to solution of Stryker’s; b) no water added to reaction; c) kept at -78 
°C for 1 h, then slowly warmed to -20 over 1 h, then to -10 for 1 h, then to 0 °C for 1 h; d) rt 
saturated NH4Cl added to reaction at reaction temperature, diluted with ether, and stirred 30 min 
open to air while allowing to warm to rt; e) reaction poured into 0 °C biphasic mixture of 
saturated NH4Cl and diethyl ether and stirred 30 min open to air at rt; f) 0 °C saturated 
ammonium chloride was added to the reaction; g) stirred 2 h open to air after addition of rt 
saturated ammonium chloride; h) filtration through Celite after quench but before extraction; i) 
extraction into ether then filtration of combined organic layers through Celite; j) unidentified 
byproduct; k) carbonyl reduction byproduct 
 
Toluene and benzene are the most common solvents employed in reactions with Stryker’s 
reagent, but it has been reported that THF can reduce the reaction time for conjugate reduction 
reactions of α-methylene-γ-lactones and unsaturated esters.190 This reaction was not attempted 
because it was predicted that THF would increase the amount of undesired α-methylene reduction 
products 1.115 and 1.126 by increasing the rate of conjugate reduction. However, the increased 
solubility of Stryker’s reagent in THF compared to aromatic solvents could allow for the reaction 
to be performed at lower temperatures which may facilitate selective allene formation over 
conjugate reduction. Conditions that utilized Stryker’s reagent or related copper hydride reagents 
with different ligands (e.g. P(OiPr)3, Me2PPh) and silanes as hydrogen donors under catalytic 
conditions were also not attempted, since these conditions were optimized for conjugate reduction 
or carbonyl reduction.171, 191 Catalytic copper hydride reductions utilizing Xantphos or N-
heterocyclic carbene ligands and hydrosilane hydrogen donors have been reported for propargylic 
carbonates, but these conditions were only reported to form 1,3-disubstituted and 1,1,3-
trisubstituted allenes as no terminal alkyne starting materials were reported.192-193 The mechanisms 
proposed in these studies involved syn-addition of copper hydride across the alkyne, followed by 
anti-β-elimination of the carbonate, and finally regeneration of the copper hydride catalyst through 
transmetallation with a silane. Based on these studies, it is expected that the mechanism for allene 
formation with Stryker’s reagent involves a similar pathway. Thus, formation of π complex 3.131 
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between the alkyne and copper hydride reagent followed by syn-addition of copper hydride across 
the alkyne bond to form 3.132. Finally, anti-β-elimination of pivalate 3.132 provides the desired 
allene 3.125 (Scheme 3.25). 
 
 
Scheme 3.25. Proposed mechanism for allene formation with Stryker’s reagent. 
 
3.4.4. Allene Formation using Stryker’s Reagent with Cis-substituted Lactams 
 
Cis-substituted lactams 3.113b and 3.124b were more susceptible to conjugate reduction than 
trans-substituted lactams discussed above. Treatment of cis-substituted lactams with Stryker’s 
reagent provided allenes 3.133 or 3.135 in low overall yields of 25-52% and various ratios of the 
desired allenes 3.133 or 3.135 to 3.134 or 3.136 where the α-methylene was reduced to a methyl 
group; unfortunately, these compounds were inseparable by column chromatography (Table 3.2). 
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These reactions were conducted by adding Styker’s reagent to a degassed solution of propargyl 
pivalate in wet toluene (2 equiv water) and quenched by addition of saturated ammonium chloride 
to the reaction mixture. For 3.124b, the desired allene 3.135 was obtained as the major product in 
ratios of 10:1 (3.135:3.136) with a 52% overall yield along with 16% recovered starting material 
(Table 3.2, entry 1). In a separate experiment using a bottle of Stryker’s reagent from Acros, the 
desired allene 3.135 was obtained in a 2.5:1 ratio with the reduced product 3.136 and a 25% 
combined yield (entry 2). For pivalate 3.113b, the desired allene 3.133 was obtained as the minor 
isomer in a ratio of 1:2 with overreduction product 3.134 and a 36% overall yield in one case (entry 
4). Using the same conditions with a different bottle of Stryker’s reagent from Acros provided 
only the overreduced α-methyl lactam 3.134 in 34% yield (entry 3). The reduced compounds 3.134 
and 3.136 could be identified by absence of the two α-methylene hydrogen resonances and an 
appearance of a methyl doublet at 1.2 ppm in the 1H NMR. The ratio of desired allene 3.133 or 
3.135 to reduced compounds 3.134 and 3.136 was determined by integration of Hb on the γ-carbon 
of the lactam which was shifted upfield by 0.2 ppm for the reduced compounds 3.134 and 3.136. 
These reduced compounds appeared to be single diastereomers based upon the 1H NMR, and the 
stereochemistry of the methyl group was determined by comparison to calculated values after the 
allenic Pauson-Khand reaction (vide infra). Since the cis lactams were the minor isomer, only 
small amounts of cis pivalates 3.113b and 3.124b were available to optimize conditions for the 
allene formation. As the desired allene-ynes and the over-reduction products were inseparable by 
column chromatography, they were taken on to the next synthetic step as a mixture, except in the 
single instance where only the over-reduction product was obtained.  
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Table 3.2. Formation of allenes from cis-substituted lactams.  
 
Entry Notebook 
Page 
R Source 
Stryker’s 
Temp 
(° C) 
Time 
(h) 
Total 
Yield (%) 
Ratio 
1 7-156 TIPS Aldrich-1 0 2 52a 10:1 (3.135:3.136) 
2 8-40 TIPS Acros-1 0 1 25 2.5:1 (3.135:3.136) 
3 7-192 Ph Aldrich-2 0 1.5 36 0:1 (3.133:3.134) 
4 8-46 Ph Acros-1 0 1 34 1:2 (3.133:3.134) 
a) 16% recovered starting material 
 
3.4.5. Investigation of Alternative Reactions for 1,1-Disubstituted Allene Formation 
 
Due to the problems of overreduction in the allene formation reactions using Stryker’s reagent, 
especially with cis-substituted lactams, it was proposed that protection of the lactam nitrogen with 
an electron donating silyl-substituent would reduce the electrophilicity of the α-methylene-γ-
lactam and thus prevent the reduction of this moiety. This was based partially on the success with 
N-methyl lactam 3.91, which provided an improved yield of the desired allene 3.65 and only trace 
amounts of α-methylene reduction even at rt (Table 3.1, entry 6). Silyl-protected lactams have 
been used to prevent reaction of N-unsubstituted lactams, and they are reportedly stable to 
chromatographic purification as well as lithium bases such as nBuLi and LDA; similarly, N-silyl 
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indoles are stable to chromatographic purification but unstable to storage.194-195 To test this 
hypothesis, 3.113a,b (2:1) was reacted with tert-butyldimethylsilyl chloride (TBS, 10 equiv), 
triethylamine (15 equiv), and dimethylaminopyridine (10 mol%) in refluxing DCM to afford TBS 
protected lactam 3.137a,b in 73% yield as a 2:1 mixture of trans and cis isomers (Scheme 3.26). 
Lactam 3.137a,b was identified by disappearance of the amide hydrogen resonance in the 1H NMR 
as well as a new singlet resonance at 1.03 ppm that integrated for 9 hydrogens and 2 singlet 
resonances at 0.41 and 0.39 ppm that integrated for 3 hydrogens each, corresponding to the silyl 
protecting group. Reaction of N-silyl lactam 3.137a,b with Stryker’s reagent (0.9 equiv) provided 
allenes 3.138a,b in 38% overall yield as a 10:1 ratio of 3.138a,b to the overreduction product as 
determined by 1H NMR integration of Ha. Additionally, 6% of the desilylated lactams 3.114 and 
3.133 were isolated after chromatographic purification. Removal of the silyl protecting group was 
achieved by stirring 3.138a,b in THF with 1 N HCl for 0.5 h, affording desilylated lactams 3.114 
(trans)/3.133 (cis) in 67% with a small amount of over-reduction products 3.115 (trans)/3.134 (cis). 
 
Scheme 3.26. Feasibility of N-silyl protection. 
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As the cis-substituted lactams were more prone to overreduction than the trans-substituted 
lactams this silyl-protection strategy was tested with pure cis lactam 3.113b. The reaction of 
3.113b with tert-butyldimethylsilyl chloride provided N-silyl lactam 3.137b in 60% yield (Scheme 
3.27). Reaction of 3.137b with Stryker’s reagent for 1.5 h at -10 °C provided allene 3.138b in 25% 
yield, with no overreduction product as determined by crude 1H NMR; 37% of the starting material 
was also recovered. Protection of the trans-lactam 3.113a as the N-silyl lactam 3.137a occurred in 
45% yield, with 38% of the starting material recovered. N-Silyl lactam 3.137a provided allene 
3.138a in 30% yield with a 7% yield of the over-reduction product. Although the methylene moiety 
of the N-silyl lactams appeared slightly less vulnerable to conjugate reduction by Stryker’s reagent, 
the low to moderate yields obtained for silyl protection and deprotection, stability of the silyl 
group, low yields for the allene formation, and our inability to prevent reduction of the α-
methylene-γ-lactam led us to consider alternative strategies for the formation of 1,1-disubstitued 
allenes from a ketone moiety. 
 
Scheme 3.27. Use of N-silyl α-methylene-γ-lactams in the formation of 1,1-disubstituted allenes. 
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 Several alternative strategies to form 1,1-disubstituted allenes from a ketone moiety were 
examined and tested on our lactam substrate (Scheme 3.28). The first was a modification to Myer’s 
deoxyallenylation that displaces the propargyl alcohol of 3.112a with nitrobenzenesulfonyl 
hydrazide followed by loss of nitrogen gas and toluene sulfinic acid to give allenes.196-197 Another 
strategy we examined was the Petasis allenylation, which converts the ketone of 3.122a directly 
to the allene using a divinyl dicyclopentadienyl titanium reagent.198 The final strategy examined 
was the Tsuji reduction, which converts a propargyl carbonate or formate to the allene under 
palladium catalyzed conditions.199-201 
Scheme 3.28. Alternative strategies to access 1,1-disubstituted allenes. 
 
The exploration of alternative allene formation conditions began by attempting a recently 
reported Lewis and Brønsted acid catalyzed reductive deoxyallenylation of propargyl alcohols 
using 2-nitrobenzenesulfonylhydrazide (NBSH), which provided mono-, 1,1-di, and 1,1,3-
trisubstituted allenes in yields of 42-89%.197 This reaction is complementary to previously reported 
allene formations using NBSH by Myers, which were applicable to primary and secondary 
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propargyl alcohols as Mitsonobu conditions were used to displace the alcohol, providing 
intermediate. Upon warming of the intermediate hydrazide to rt, spontaneous loss of nitrogen and 
p-toluenesulfinic acid occur to generate monosubstituted and 1,3-disubstituted allenes in yields of 
51-91%.196 The Lewis and Brønsted acid catalyzed conditions were applicable to secondary and 
tertiary alcohols, although, in the formation of 1,1-disubstituted allenes, all of the reported 
substrates were benzylic, tertiary alcohols. Despite this observation, propargyl alcohol 3.112a was 
submitted to the reported conditions by dissolving 3.112a in nitromethane, followed by addition 
of NBSH (3.141), silver triflate, and triflic acid in that order (Scheme 3.29). The reaction was 
stirred at rt for 1 h, but no reaction was observed by TLC, so it was heated to 35 °C for 30 min. 
The reaction still showed starting material, but several new spots were observed, and the NBSH 
had been consumed. After quenching with saturated ammonium bicarbonate solution, extraction 
with Et2O, and chromatographic purification, 50% of the starting material was recovered and the 
other compounds observed by TLC appeared to be byproducts of NBSH such as sulfinic acid. 
Since no formation of the desired allene was detected, and because only benzylic alcohols were 
reported in the literature, this transformation was not pursued further. 
 
 
Scheme 3.29. Attempt at deoxyallenylation of tertiary, alkyl propargyl alcohol. 
 113 
 
The Petasis allenylation is a transformation that converts a ketone or aldehyde directly into 
an allene via a titanocene alkenylidene intermediate.198 The titanocene is formed by treating 
bis(cyclopentadienyl) titanium(IV) dichloride (Cp2TiCl2) with 2 equiv of an alkenyl Grignard 
reagent which reacts with carbonyls to form allenes in a single pot. Petasis reported yields of 77-
88% for this reaction with propynals and aryl aldehydes, 72 and 81% for a vinyl and aryl ketone, 
respectively, and 40% for a cyclohexanone derivative.198 This reaction was performed according 
to the literature procedure, which involved dropwise addition of vinyl magnesium bromide (4 
equiv) to a -40 °C solution of Cp2TiCl2 (2 equiv) in THF, slow warming of this solution to 0 °C 
over 2.5 h, addition of ketone 3.122a  (1 equiv) dissolved in THF, and allowing this to warm to rt 
(Scheme 3.30). The reaction was monitored by TLC but did not reach completion after 3 h. After 
purification, only 6% of the desired allene 3.125 was isolated, along with 46% of recovered starting 
material. A longer reaction time (22 h) and increased amount of titanium reagent (4 equiv) gave a 
slightly higher yield of 16%, but only 10% of the starting material was recovered. This reaction 
was then performed with ketone 3.149, containing an N-aryl lactam, because it was proposed that 
the secondary amide could be reacting or coordinating to the titanium reagent. The intermediate 
titanium species are reported to be minimally stable and unable to be isolated.198 Additionally, 
only a minimal increase in yield was observed upon longer reaction times with the secondary 
amide 3.122a, thus this reaction was quenched after 4 h, despite the observation of starting material 
by TLC; 17% of desired allene 3.150 was isolated and 44% of the starting material 3.149 was 
recovered. A previous post-doc in our lab, Dr. Bo Wen, had attempted this reaction on a similarly 
structured lactone (Ph substituted alkyne instead of TIPS) and obtained similarly low yields of 10-
20%.202 Considering these results and that Petasis had obtained only a moderate yield of 40% for 
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a dialkyl ketone, other methods for allene formation were explored. In the synthesis of (±)-
bakuchiol, allenylation of a simple dialkyl ketone under these conditions provided the allene in 
only a 4% yield, while conditions reported by Tsuji provided the allene in 65% yield from a 
propargyl carbonate.203 
 
 
Scheme 3.30. Petasis allenylation. 
 
The next method attempted for the formation of 1,1-disubstituted allenes was the palladium 
catalyzed hydrogenolysis of propargyl carbonates or formates, first reported by Tsuji.199-201 
Secondary and tertiary propargyl carbonates with alkyl or aryl substituents were treated with 
tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct, n-butylphosphine (2:1 ligand:Pd), 
and ammonium formate to provide allenes in yields of 66-87% (Scheme 3.31). Additionally, 
propargyl formates underwent a similar reaction without addition of ammonium carbonate. Tsuji’s 
conditions were only applied to terminal alkynes. More recently, Sawamura et al. reported that 
propargyl formates treated with palladium(II) acetylacetonate and diphenylphosphinoethane (1:1) 
provided 1,3-di or 1,1,3-trisubstituted allenes in good yields of 83-99%.204  
In order to test the Tsuji reduction, we set out to make propargyl carbonates using the same 
conditions applied to formation of propargyl pivalates discussed above. Other conditions to form 
carbonates, such as deprotonation and reaction with methyl chloroformate or quenching of a 
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Grignard reaction with methyl chloroformate were expected to react with the lactam nitrogen. 
Treatment of propargyl alcohol 3.124a with scandium(III) triflate and diethyl dicarbonate failed 
to provide carbonate any product, and only starting material (80%) was recovered after 22 h 
(Scheme 3.31). Carbonate 3.144 was prepared by quenching the Grignard reaction of ketone 
3.122a and ethynyl magnesium bromide with methyl chloroformate. The ester on the lactam 
nitrogen could be removed under basic conditions.199, 203 As expected, these conditions provided 
carbonate 3.144, where the nitrogen and oxygen atoms both reacted. However, the product 3.144 
was obtained in only a 10% yield. Upon submission of carbonate 3.144 to the Tsuji reduction 
conditions, no product was obtained, and only starting material was detected in the crude 1H NMR 
spectrum. 
 
Scheme 3.31. Propargyl carbonate formation and Tsuji reduction attempts. 
 
 An N-formyl group is removed under milder conditions than an N-ester moiety (sodium 
carbonate205 vs sodium methoxide).206 Thus, we sought to prepare propargyl formates from 
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propargyl alcohols under several reported conditions. It was expected that formylation of the 
lactam nitrogen in addition to formylation of the propargyl alcohol would occur, but the N-formyl 
group could be easily removed with sodium carbonate under mild conditions. Attempts to 
formylate tertiary propargyl alcohol 3.124a with iodine in neat formic acid,207 para-
toluenesulfonic acid in neat formic acid,208 or acetic anhydride and formic acid in pyridine200 all 
failed to formylate either the hydroxyl group or the lactam nitrogen. Tertiary formates are reported 
to be unstable (Scheme 3.32).201 
 
Scheme 3.32. Attempts to formylate tertiary, propargyl alcohol. 
 
After these failed attempts to form allenes, the formylation and Tsuji reduction conditions 
were tested on a model substrate 3.146 to determine if the lactam was the problem in these 
reactions. Addition of ethynyl magnesium bromide to 3-tert-butyl cyclohexanone (3.145) in THF 
at 0 °C provided the intermediate alkoxide (Scheme 3.33). TLC indicated consumption of the 
starting material in 1 h, so methyl chloroformate was added and the reaction was allowed to warm 
to rt for 3 h to afford propargyl carbonate 3.146 in 69% yield after aqueous work-up and 
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chromatographic purification. Similarly, cyclohexanone 3.145 was treated with ethynyl 
magnesium bromide and quenched with saturated ammonium chloride to provide propargyl 
alcohol 3.147 in 56% yield. Propargyl carbonate 3.146 was subjected to the Tsuji reduction 
conditions described above, but this reaction provided none of the expected allene, despite a 
cyclohexyl propargyl carbonate being reported to undergo allene formation in 66% yield by Tsuji. 
The palladium catalyst was purified according to the method reported by Ananikov, who also 
reported that commercially available tris(dibenzylideneacetone)dipalladium(0) commonly 
contained significant amounts (up to 40%) of palladium nanoparticles.209 The simple purification 
procedure involved dissolving tris(dibenzylideneacetone)dipalladium(0) in excess chloroform, 
filtering off the insoluble impurities, concentrating, dissolving in a minimal amount of chloroform, 
adding acetone (4:1 with CHCl3), and cooling to -20 °C overnight in the freezer. The purified 
tris(dibenzylideneacetone)dipalladium(0) was filtered, washed with acetone, and dried under 
vacuum. When propargyl carbonate 3.146 was subjected to the Tsuji reduction conditions using 
the purified palladium catalyst, 56% of the expected allene was obtained. However, this reaction 
required 4 d at rt to reach completion, so propargyl formates were pursued to obtain allene 1,1-
disubstituted allenes in a higher yield and shorter reaction time. 
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Scheme 3.33. Propargyl carbonate formation and Tsuji reduction on model substrate. 
 
In order to formylate tertiary, propargyl alcohol 3.147, a 4th set of formylation conditions 
were tested, using 2-hydroxy pyridine with dicyclohexylcarbodiimide (DCC) and formic acid to 
generate N-formyl pyridone 3.148, which is the active formylating reagent (Scheme 3.34).204, 210 
Propargyl alcohol 3.147 was added to a premixed solution of 2-hydroxy pyridine, DCC, and formic 
acid in DCM at 0 °C and the resulting mixture was allowed to warm to rt for 16 h. TLC indicated 
that starting material was still present, therefore, additional 2-hydroxy pyridine, DCC, and formic 
acid were mixed at 0 °C and added to the solution which was then allowed to stir for an additional 
24 h (40 h total rxn time). This reaction still failed to go to completion, but after purification, 50% 
of the desired formate 3.149 was obtained; 50% of the starting material 3.147 was also recovered. 
This reaction was repeated with 3 equivalents of formylating reagents (2-hydroxy pyridine, DCC, 
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formic acid) to provide only 13% of formate 3.149 with 71% recovered starting material after 16 
h. Formylation with para-toluene sulfonic acid and formic acid also failed to give formate 3.149. 
Allene formation using formate 3.149 under the conditions reported by Sawamura et al. failed to 
provide any detectable product by TLC after 3 d at rt. 
 
 
Scheme 3.34. Formylation of model substrate and attempted decarboxylative hydrogenolysis. 
 
Based on the lower yield obtained for allene formation in model systems 3.146 and the 
difficulty in forming tertiary propargyl formates or carbonates, especially with the lactam 
substrates, these conditions were not further pursued. Thus, allene formation from propargyl 
pivalates was performed with Stryker’s reagent, despite the moderate yields and chemoselectivity 
of this reaction. 
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3.4.6. Modification of the Lactam Nitrogen of Allene-ynes  
 
The aryl substituent of N-aryl acrylamides has been shown to influence the rate of glutathione 
addition to acrylamides, with electron withdrawing substituents increasing the rate and electron 
donating substituents decreasing the rate (see Chapter 1).91, 93 It was proposed that coupling an aryl 
halide to the lactam nitrogen using either copper or palladium catalyzed conditions developed by 
Buchwald and coworkers would provide N-aryl and N-heteroaryl α-methylene-γ-lactams.173, 211 
Additionally, it was proposed that modifying the lactam nitrogen with electronically different aryl 
groups would provide a method of systematically changing the electrophilicity of the Michael 
acceptor by changing the electron withdrawing strength of the aryl substituent.50-51, 94 
Functionalization of the lactam nitrogen after the APKR has obvious advantages when considering 
the preparation of the widest array of analogs. However, the secondary amide of lactam-tethered 
allene-ynes was modified to investigate both the scope of the allenic Pauson-Khand reaction and 
the effects of the nitrogen substituent on the electrophilicity of the α-methylene-γ-lactam Michael 
acceptor. 
Buchwald’s copper catalyzed amide arylation has been shown to form N-aryl amides and 
lactams from 4, 5, and 6 membered lactams 3.150, primary alkyl or aryl amides, and secondary 
alkyl or aryl formamides 3.154 in good yields of 63-99% (Scheme 3.35). These conditions use 
copper iodide (1-10 mol%) as the copper(I) source; 1,2-diamine ligands 3.151 or 3.152 (2:1 
copper:ligand ratio); aryl and heteroaryl iodides or bromides; potassium phosphate, cesium 
carbonate, or potassium carbonate as a base; and toluene or 1,4-dioxane as the solvent at 80-110 
°C for 15-24 h. These conditions proved general and tolerant of various functional groups, but 
were problematic for sterically hindered, secondary alkyl amides; they have also not been shown 
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to arylate α-methylene-γ-lactams or substituted γ-lactams such as β,δ-substituted α-methylene-γ-
lactam 3.114. 
 
 
Scheme 3.35. Copper catalyzed amidation of aryl halides. 
 
 Mechanistic studies on the copper-catalyzed arylation of amides by Buchwald and others 
have shown that N-arylation reactions go through a 2-stage process involving nucleophile 
formation in the first stage followed by copper mediated aryl-halide activation (Scheme 3.36). 
Furthermore, these studies have shown that a copper(I)-nucleophile complex must form prior to 
aryl halide activation.212 Based on the observation that high concentrations of amide 3.156 and 
1,2-diamine ligands 3.162 increase the catalyst efficiency and that stoichiometric amounts of 
preformed copper(I) amidates 3.157 react to form N-aryl lactams upon addition of a 1,2-diamine 
ligand and aryl iodide 3.158, it was proposed that the catalytically active species in the reaction is 
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copper(I) amidate 3.157 (Scheme 3.36).212 In stoichiometric reactions, copper(I) amidates existed 
as oligomers 3.161 in solution, as shown by broad peaks in the 1H NMR spectrum, which 
sharpened upon addition of a 1,2-diamine 3.162 to form a single, monomeric species with a copper 
to amide ratio of 1:1. The copper(I) amidate oligomers 3.161 exist in rapid equilibrium with the 
catalytically active copper(I) amidate 3.157 and the copper(I)-ligated diamine complex 3.160.  
Buchwald and coworkers observed that electron-deficient aryl iodides underwent the N-
arylation more rapidly than electron-rich or electron neutral aryl iodides for both stoichiometric 
and catalytic reactions.212 The relatively low ρ-value of +0.48 derived from the Hammet plot of 
para-substituted aryl iodides and the low enthalpy of activation (ΔH‡ = 6.8 kcal/mol) suggest that 
little bond cleavage or build-up of negative charge occurs in the transition state for aryl iodide 
activation, implying that oxidative addition is not the rate-determining step in the second stage of 
N-arylation; in contrast, oxidative addition of Pd(0) has a rho value of 2.3 and enthalpy of 
activation equal to 18.4 kcal/mol and is the rate determining step.212 This led to the proposal that 
the rate determining step in stage 2 of the copper(I) catalyzed N-arylation with aryl iodides is either 
copper(II)-radical anion formation to give complex 3.163 or η2 complex formation to give 3.164. 
In the first case, radical anion-copper(II) complex 3.163 could undergo rapid halide transfer to 
copper(II), radical combination to form copper(III) species, and reductive elimination to provide 
N-aryl lactam 3.159. Electron-deficient aryl iodides would facilitate the initial single electron 
transfer from copper to the aryl iodide in this case.212 Alternatively, slow formation of an η2 
complex 3.164 followed by fast oxidative addition to give 3.165 and fast reductive elimination to 
provide N-aryl lactam 3.159 is possible. In this case, electron-deficient aryl iodides could facilitate 
formation of the η2 complex by lowering the LUMO of the aryl iodide.  
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Scheme 3.36. Proposed mechanism for copper catalyzed N-arylation (Buchwald).212 
 
Buchwald reported that potassium carbonate was superior to potassium phosphate or 
cesium carbonate when N-arylation reactions were performed with aryl bromides because N-
arylation of the 1,2-diamine ligand led to catalyst deactivation when the less reactive aryl bromides 
were used and that stronger bases increased the amount of N-arylated diamine.173 Thus, it was 
proposed that sterically hindered lactam 3.114 would slow the reaction with aryl iodides. N-
arylation of 3.114 with iodobenzene was initially attempted in toluene at 80 °C for 24-48 h with 
potassium carbonate as the base and N,N-dimethylcyclohexyldiamine (3.166) as the diamine 
ligand, but only 16-27% yield of N-aryl lactam 3.168 was obtained along with 20-25% recovered 
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starting material (Scheme 3.37). Using a less bulky diamine ligand, N,N-dimethylethylenediamine 
(3.167), the active copper-ligated diamine was expected to react faster with lactam 3.114, but this 
gave similar yields as N,N-dimethylcyclohexyldiamine 3.166. Similar yields were also obtained 
when the amount of copper iodide and 1,2-diamine ligand were increased to 30-40 mol% CuI and 
60-80 mol% ligand. 
 
 
Scheme 3.37. N-Arylation of lactams with potassium carbonate as a base. 
 
A stronger base should facilitate formation of the copper-lactam complex (e.g. 3.157, 
Scheme 3.36). Thus, N-arylation of allene-yne 3.114 was performed with cesium carbonate as a 
base. This provided N-phenyl lactam 3.168 in 44% yield and complete conversion of the starting 
material based on TLC analysis. The lactam nitrogen was arylated with various aryl iodides using 
these optimized conditions: 20 mol% copper iodide, 40 mol% N,N-dimethylethylenediamine, 1.2 
equiv aryl iodide, 2 equiv cesium carbonate, and 1 equiv lactam 3.114 were stirred in toluene at 
80 °C in a sealed tube, under a nitrogen atmosphere for 20 h. These conditions allowed the 
installation of electron withdrawing and an electron donating groups, affording N-aryl lactams 
3.168-3.172 in 42-63% yield (Scheme 3.38). Arylation with 4-iodobenzotrifluoride, 4-iodoanisole, 
and 4-iodobenzonitrile provided lactams 3.168-3.171 in 47, 63, and 42% yields, respectively. 
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Arylation of lactam 3.114 with 2-iodothiophene demonstrates the feasibility of installing a 
heteroaryl substituent using this methodology. Compounds 3.168-3.172 could be identified by 
disappearance of the broad singlet resonance between 5-7 ppm in the 1H NMR, corresponding to 
the hydrogen on the lactam nitrogen, as well as new resonances in the aromatic region of the 1H 
NMR spectra. The increased conversion of starting material to N-aryl lactam when cesium 
carbonate was used as a base compared to potassium carbonate suggests that formation of the 
copper(I)-amidate was slowed by the weaker base and that reaction with the aryl iodide was not 
the slow step, which is consistent with the studies by Buchwald on the less sterically hindered, 
unsubstituted 2-pyrrolidinone.  
 
 
Scheme 3.38. N-Arylation of lactam-tethered allene-ynes. 
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Arylation of the lactam nitrogen in tricycle 3.116 using Buchwald’s copper or palladium 
catalyzed conditions resulted in recovery of starting material (80 °C) or decomposition (110 °C). 
These results are consistent with the crystal structure of tricycle 3.116 showing that the lactam 
nitrogen is hindered by the phenyl substituent of the cyclopentenone, which is why the N-arylation 
of this substrate failed (Figure 3.2).173, 211 
In addition to the N-aryl lactams above, lactams with stronger electron withdrawing groups 
on the nitrogen were proposed to significantly increase the electrophilicity of the α-methylene-γ-
lactam Michael acceptor. Moreover, if lactam tethered allene-ynes were tolerant to deprotonation 
and nucleophilic addition to an electrophile, then the substrates available by a late stage 
modification methodology would include N-aryl, N-acyl, and N-alkyl lactams. Tosyl lactam 3.173 
was formed in 39% yield by deprotonation of the lactam nitrogen of 3.114 and addition to tosyl 
chloride (Scheme 3.39). This reaction resulted in some reaction of the sodium hydride with the α-
methylene, as noted by disappearance of the α-methylene hydrogens from the 1H NMR of some 
byproducts. Other unidentified decomposition products resulted in this low yield. Although these 
yields were moderate, these substrates demonstrated the moderate stability of our lactam-tethered 
allene-ynes to a strong base (NaH) and to nucleophilic acyl substitution reactions. Further 
optimization of substitution reactions involving deprotonation of the secondary amide with a 
strong base are needed for these reactions to be synthetically useful. However, this provided a 
substrate with a strong electron withdrawing group for thiol reactivity and bioactivity studies. As 
tert-butyl carbonate is a common amide protecting group, its stability to the APKR was of interest. 
An A1,3-interaction between the tert-butyl group and the phenyl ring of the APKR product was 
expected, and we wished to examine the feasibility of bulky nitrogen substituents as well as 
carbonates as substrates in the APKR. Towards this end, the nitrogen of lactam 3.114 was protected 
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with a carbonate group using di-tert-butyl dicarbonate, triethylamine, and dimethylaminopyridine 
to give carbonate 3.174 in 57% yield. 
 
 
Scheme 3.39. Nucleophilic addition of lactams to electrophiles. 
 
3.4.7. Modifications to the Alkyne Terminus 
 
It was hypothesized that the alkyne could be modified by removing the triisopropyl silyl 
substituent and utilizing the resulting terminal alkyne to perform substitution or coupling reactions. 
Additionally, various alkyne substituents were pursued to examine the scope of the APKR with 
lactam-tethered allene-ynes. Installation of a methyl group at the terminus of the alkyne would 
provide tricycles that are identical to the 6,12-guaianolide skeleton with a lactam in place of the 
lactone (Section 3.1, Figure 3.1). The terminal alkyne could potentially be modified by 
Sonogashira coupling reactions to diversify the aryl substituent on the alkyne at a late stage in the 
synthetic sequence. 
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The TIPS group was removed from alkyne 3.125 to give the corresponding terminal alkyne 
3.175 in 77% yield. 1H NMR showed disappearance of the singlet resonance at 1.0 ppm 
corresponding to the hydrogens on the TIPS group, and a new doublet resonance appeared at 2.39 
ppm for 3.175, corresponding to the terminal alkyne hydrogen (Scheme 3.40). Bis-methylation of 
lactam 3.175 at the alkyne terminus and the lactam nitrogen was attempted by deprotonating this 
substrate with 2 equiv of lithium diisopropylamide (LDA) and reacting with methyl iodide, but an 
inseparable mixture of bismethylated lactam 3.176 and N-methylated lactam 3.177 were obtained 
in a 1:1 ratio and 64% overall yield. This mixture was subjected to LDA and methyl iodide a 
second time to achieve bismethylation, but an inseparable mixture of products 3.176 and 3.177 
was obtained in a low yield of 33% and only a slightly better ratio of 2:1. nButyllithium was used 
as a base instead of LDA, but this gave a mixture of the mono and bismethylation in 45% yield 
and a 2:1 ratio; other unidentified impurities were also observed in the 1H NMR spectrum.  
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Scheme 3.40. Modification of alkyne substituents. 
 
 It was proposed that alkyne methylation would be easier to achieve if the lactam nitrogen 
was unreactive. Thus, arylation of the secondary amide of 3.125 under the arylation conditions 
discussed in the previous section afforded the N-arylated lactam in 77% yield (Scheme 3.41). The 
TIPS substituent of was removed with TBAF to afford terminal alkyne 3.178 79% yield. The 
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tertiary amide of 3.178 was expected to be unreactive to the alkyne methylation conditions. As 
decomposition of alkynes containing a secondary amide was evident when strong bases were used, 
deprotonation of alkyne 3.178 was first attempted with lithium hexamethyldisilazane (LiHMDS) 
which is one of the weaker bases capable of deprotonating an alkyne. With methyl iodide as the 
electrophile, and keeping the reaction at -78 °C, reaction of terminal alkyne 3.178 provided a 2:1 
ratio of starting material to product 3.179 with a quantitative crude yield after aqueous work-up. 
This ratio was determined by integration of the resonances corresponding to the hydrogen at the 
γ-position of the lactam (labeled Ha) at 4.48 ppm for terminal alkyne 3.178 and 4.42 for internal 
alkyne 3.179. Using similar conditions, but allowing the reaction to react for 2 h at -78 °C then 
warm to 0 °C for 1 h resulted in decomposition, as evidenced by disappearance of the α-methylene 
resonances from the crude 1H NMR spectrum. Using LDA as the base, as in the reaction above 
also resulted in decomposition and a 13% yield of an unknown byproduct that still retained the 
terminal alkyne.  
 
Scheme 3.41. Alkyne methylation with tertiary amide. 
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Exploration of alkyne methylation with 1-decyne (3.180) demonstrated that the 
methylation of a terminal alkyne with methyl iodide and nBuLi as the base required about 2 h at -
78 °C for complete methylation (Scheme 3.42). However, the use of a stronger base (nBuLi) with 
lactam 3.178 and keeping the reaction at -78 °C resulted in decomposition, where disappearance 
of the α-methylene resonances in the 1H NMR was observed. For secondary amide 3.175 above, 
less decomposition was observed when nBuLi was used as the base. Deprotonation of the 
secondary amide should stabilize both the α-methylene and the lactam carbonyl from nucleophilic 
attack, which is why tertiary amide 3.178 is less stable to a strong base. When 1-decyne 3.180 was 
deprotonated with LiHMDS and methylated with methyl iodide, a 1:1 mixture of product to 
starting material was obtained after 6 h at -78 °C even when a large excess (10 equiv) of methyl 
iodide was used, indicating that this reaction is slow when kept at low temperatures. Indeed, many 
literature procedures that utilize methyl iodide as the alkylating reagent involve warming to 0 °C 
or rt. Investigations of alkyne methylation with a more reactive methylating reagent, methyl 
triflate, are ongoing, as these reactions proceed at low temperatures with LiHMDS as a base.213  
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Scheme. 3.42. Alkyne methylation at low temperatures with model substrate. 
 
 Procedures to methylate the terminal alkyne of lactam 3.175 or 3.178 are still being tested. 
An alternative method to synthesize methyl alkynes would be to install the methyl alkyne during 
the lactamization reaction by using 2-butynal as the aldehyde in place of phenyl or TIPS propynal, 
but late stage modification is more advantageous. Future work could also involve Sonagashira 
coupling on the terminal alkyne to install various alkenyl and aryl substituents. 
Terminal alkynes of cis lactams were prepared analogously to the trans lactams. In one 
case, the TIPS substituent was removed from a mixture of alkynes (3:1) 3.135:3.136 with 
tetrabutylammonium fluoride (TBAF) to give terminal alkynes 3.182 and 3.183 in 67% yield, and 
a slightly decreased ratio of α-methylene lactam 3.182 to α-methyl lactam 3.183 from 3:1 in the 
starting material to 2:1 in the products; lactams 3.182 and 3.183 were still inseparable by column 
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chromatography Scheme 3.43). The ratio was determined by integration of Hb at 4.4 ppm for α-
methylene lactam 3.182 and 4.2 ppm for α-methyl lactam 3.183 in the 1H NMR spectrum. 
 
 
Scheme 3.43. Removal of TIPS substituent from cis lactams to generate terminal alkynes. 
 
3.5. ALLENIC PAUSON-KHAND REACTION OF α-METHYLENE-γ-LACTAM 
TETHERED ALLENE-YNES 
 
With the α-methylene-γ-lactam-tethered allene-ynes in hand, the scope of the allenic Pauson-
Khand reaction was examined. 1,1-disubstituted allenes underwent the APKR to give the fused 
tricyclic structures 3.56, 3.116, 3.184-3.192 in yields of 41-79%. The typical conditions used in 
this reaction utilized 10 mole percent of rhodium biscarbonyl chloride, 1 atmosphere of carbon 
monoxide gas with toluene at 110 °C. The reaction was conducted by slow addition of an allene-
yne to the rhodium catalyst over 1 h via a syringe pump and stirring for 0.5 h after addition of the 
allene-yne was complete.163  
In most cases, this gave complete consumption of the starting material as observed by TLC. 
As discussed in the feasibility studies, the N-methyl allene-yne 3.57 underwent the 
cyclocarbonylation reaction in 75% yield, and the allene-yne with an unsubstituted nitrogen, 3.114, 
gave a similar yield of 79% (Table 3.3, entries 1-2). TIPS-substituted alkyne 3.125 afforded 3.184 
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in 47% yield (entry 3). The longer reaction time for 3.125 vs 3.114 (4 h vs 1.5 h) is likely due to 
the developing A1,3 interaction between the TIPS group and the lactam. Moreover, a structurally 
related lactone-tethered-allene-yne with a less bulky trimethylsilyl group on the alkyne underwent 
an APKR in high yields and reaction times similar to a phenyl substituted alkyne.117 Terminal 
alkynes were tolerated well in the APKR as evidenced by the cyclocarbonylation reaction of 
allene-yne 3.175 to provide lactam 3.185 in 62% yield (entry 4). Allene-ynes 3.168-3.171 where 
tertiary amides were substituted with an N-phenyl, N-para-trifluoromethyl phenyl, N-para-
cyanophenyl, , or N-para-methoxy phenyl gave yields of 69, 67, 72, and 76% of tricycles 3.186-
3.189, respectively (entries 5-8). The reaction time nor the yield were significantly impacted by 
the electronic nature of the aryl group on the lactam nitrogen. With a thiophene group on the 
nitrogen atom, allene-yne 3.172 provided lactam 3.190 in 67% yield demonstrating that heteroaryl 
groups are tolerated in this APKR (entry 8). The APKR of N-tosyl and N-Boc allenes 3.173 and 
3.174 gave yields of 69 and 40% for tricycle formation, respectively (entries 9-10). The lower 
yield of lactam 3.192 is attributed to the thermal instability of the Boc group at 110 °C.214  
Entries 1-2 and 5-7 in Table 2 demonstrate that the APKR with a phenyl substituted alkyne 
is tolerant of alkyl, aryl (electron donating or withdrawing), sulfonyl, carbonate, and N-
unsubstituted α-methylene-γ-lactam tethers. Entries 3-4 demonstrate the tolerance of TIPS-
substitution and terminal alkynes in the APKR. The structure of the [5,7,5]-ring system of 3.116 
was confirmed by X-ray crystallography (Figure 3.2). All compounds synthesized by the APKR 
are shown in Scheme 3.45. 
In addition to the typical reaction conditions described above, the reaction was performed 
by adding the allene in a single portion to the rhodium catalyst and stirring for 1 h at 110 °C 
followed by cooling to rt and filtering through a plug of silica gel without the addition of polymer 
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bound triphenylphosphine for entries 1-2, 4, 10-11 in Table 1; yields of 75, 75, 42, 63, and 41% 
for entries 1, 2, 4, 10, and 11 under these conditions compared to yields of 75, 79, 62, 69, and 40%, 
respectively, under the slow addition conditions revealed that the yield was not significantly 
affected by slow addition of the allene or by rhodium scavenging with polymer bound 
triphenylphosphine. The exception to this was terminal alkyne 3.175, which gave an improved 
yield under the more dilute conditions. 
 
Table 3.3. Allenic Pauson-Khand Reaction (APKR) with trans-substituted α-methylene-γ-lactam 
tethered allene-ynes. 
 
Entry Allene R1 R2 
Time 
(min) Prod. 
Method A 
Yield (%)  
Method B 
Yield (%)a 
1 3.57 Me Ph 90 3.56 75 75 
2 3.114 H Ph 90 3.116 79 75 
3 3.125 H TIPS 300 3.184 47 ND 
4 3.175 H H 90 3.185 62 42 
5 3.168 Ph Ph 90 3.186 69 ND 
6 3.169 4-CF3-C6H4 Ph 90 3.187 67 ND 
7 3.171 4-CN-C6H4 Ph 120 3.188 72 ND 
8 3.170 4-OMe-C6H4 Ph 90 3.189 76 ND 
9 3.172 2-thiophene Ph 90 3.190 66 ND 
10 3.173 Tosyl Ph 90 3.191 69 63 
11 3.174 Boc Ph 90 3.192 40 41 
These reactions were typically complete within 30 min after a slow addition of the allene to the 
rhodium catalyst over 1 h (Method A) a) Only minor changes in yields were observed when allene 
was added in a single portion and stirred for 1 h (Method B). 
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Figure 3.2. Crystal structure of tricycle 3.116, showing the trans lactam. 
 
Scheme 3.44. APKR with trans-substituted α-methylene-γ-lactam tethered allene-ynes. 
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Next, the impact of the α-methylene group on the efficiency and facileness of the APKR 
was examined, using allene-ynes 3.134 and 3.194 (Scheme 3.45). The α-methyl substituted lactam 
3.134, with cis substituted allene and alkyne groups, afforded the APKR product 3.193 in 77% 
yield in 60 min when the allene was added in a single portion to the rhodium catalyst. This 
demonstrated that the APKR can form cis-fused [5,7,5] ring systems and that the α-methylene did 
not impact the APKR. α-Methyl substituted lactam 3.194, synthesized by removal of the TIPS 
group from allene-yne 3.126 with TBAF, underwent the APKR in 90 min to afford 3.195 in 78% 
yield as a 9:1 mixture of methyl diastereomers. A higher yield of 3.195 was obtained when 
compared to the corresponding trans α-methylene-γ-lactam 3.175 (78% vs 62%) with a terminal 
alkyne. The dr remained the same as the allene-yne starting materials where 3.193 was obtained 
as single diastereomer, and 3.195 was obtained with a 9:1 dr (determined by integration of Ha in 
the 1H NMR spectrum which appeared as a doublet at 4.50 ppm for the major diastereomer and 
4.56 ppm for the minor diastereomer). Since the resonances in the 1H NMR of tricyclic products 
3.193 and 3.195 were more distinct than the resonances in the allene-yne starting materials, the 
tricyclic products were used to determine the relative stereochemistry of the methyl substituent 
(see Section 3.6). The relative stereochemistry 3.193 and 3.195 was assigned by comparing 
calculated coupling constants to experimental coupling constants. It is predicted that the major 
diastereomer is the result of thermodynamic protonation of the intermediate copper enolate formed 
during the conjugate reduction of the α-methylene moiety by Stryker’s reagent to give the α,β trans 
isomer. 
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Scheme 3.45. APKR with α-methyl lactams. 
 
Acylation of secondary amide 3.116, containing a phenyl substituent on the 
cyclopentenone ring, proceeded slowly (20 h to completion by TLC) to afford 3.196 in a 40% 
yield. Acylation of tricycles 3.185 and 3.195, with no α-substituents on the cyclopentenone, 
reached completion in 2-3 h affording acylated lactams 3.197 and 3.198 in 78 and 46% yields, 
respectively.  
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Scheme 3.48. N-Acylation of tricyclic APKR products. 
 
 
3.6. ASSIGNMENT OF RELATIVE STEREOCHEMISTRY OF α-METHYL-γ-
LACTAMS BY CALCULATION AND NMR ANALYSIS 
 
The stereochemistry of the methyl substituents of 3.193 and 3.195 was assigned by calculating the 
coupling constants for both possible isomers using Spartan. The lowest energy conformers were 
calculated using MMFF, and 1H NMR data was calculated for the lowest energy conformer using 
B3LYP/6-31G* functionals. Cis-fused tricycle could have the stereochemistry shown in 3.193a, 
where the methyl substituent is trans to the 7-membered ring or the stereochemistry shown in 
3.193b where the methyl substituent is on the same face as the 7-membered ring. The calculations 
indicated that 3.193a with the methyl substituent on the opposite face as the 7-membered ring was 
0.5 kcal/mol more stable than 3.193b, and it was predicted that the more stable isomer would be 
the major diastereomer. This diastereomer would arise from conjugate reduction of the α-
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methylene  double  bond  followed  by  thermodynamic  quenching  of  the  resulting  enolate.   The 
calculated 1H NMR coupling constants for the two possible methyl isomers were compared to the 
experimental  coupling  constants,  and  the  calculated  values  for 3.193a were  closer  to  the 
experimental values. For Ha, the calculated coupling constant was 7.3 Hz for 3.193a and 6.7 Hz 
for 3.193b, while the experimental value was 7.6 Hz (Table 3.4, entry 1). For Hb, the experimental 
coupling constants of 2.4 and 7.2 Hz were closer to the calculated coupling constants for 3.193a, 
1.3 and 6.6 Hz, than they were to 3.193b, 6.6 and 7.5 Hz (entry 2). The coupling constants could 
not be determined for Hc due to the complexity of the 1H NMR spectrum and the calculated values 
for Hd, He, Hf, Hg, and Hh were not significantly different for the two possible isomers (entries 3- 
8).  Thus,  the  relative  stereochemistry  with  the  methyl  substituent  trans  to  the  7-membered  ring
(3.193a) was assigned to the experimentally obtained compound based on the coupling constants 
of Ha and Hb.
  The relative  stereochemistry  of the trans-fused lactam with  an α-methyl substituent was 
determined analogously to the cis-fused lactam above. The two possible isomers 3.195a, with the 
methyl substituent trans to the closest  ring substituent,  and 3.195b, with the  methyl group cis to 
the closest ring substituent are shown below (Table 3.5). Calculations from Spartan indicated that 
3.195a  was  2.5 kcal/mol  more stable  than  3.195b,  and thus  it was  predicted that  the relative 
stereochemistry  would match  that shown  in 3.195a. The calculated coupling constant  for Ha of
3.195a was 10.0 Hz which matched the experimental value, but the calculated  coupling constant 
for Ha of 3.195b was 9.7 Hz  (Table 3.5, entry 1).  The experimental coupling constants for Hb of
7.0 and 11.0 Hz were much closer to the calculated values of 3.195a of 6.6 and 11.1 Hz than they 
were to the calculated  coupling constants of 3.195b,  6.6 and 8.8 Hz (entry 2).  The experimental 
coupling constants for Hc did not match either of the calculated values well, while the calculated
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coupling constants for the remaining hydrogens were not significantly different between 3.195a
and 3.195b (entries 3-8). Thus, the relative  stereochemistry with the methyl substituent trans to 
the  nearest  ring  substituent  as  shown in 3.195a  was assigned to the experimentally obtained 
product based on the coupling constants of Ha and Hb. 
 
Table 3.4. 1H NMR Calculations Compared to Experimental Data for 3.193. 
 
Entry Hydrogen Calculated δ 3.193a ppm Calculated δ 3.193b ppm Experimental δ ppm 
1 Ha 4.95 (J = 7.3 Hz) 4.84 (J = 6.7 Hz) 4.98 (J = 7.6 Hz) 
2 Hb 2.11 (J = 1.3, 6.6 Hz) 2.45 (J = 6.6, 7.5 Hz) 2.46 (J = 2.4, 7.2 Hz)  
3 Hc 2.40 (J = 1.3, 1.9, 5.1, 7.3 
Hz) 
2.60 (J = 1.6, 5.6, 6.7, 7.5 
Hz) 
2.35-2.23 (m)  
4 Hd 2.09 (J = 0.8, 5.1, 12.9 Hz) 1.99 (J = 0.8, 1.6, 7.3 Hz) 2.05 (J = 4.6, 10.4, 14.0 Hz) 
5 He 1.76 (J = 0.9, 1.9, 7.2 Hz) 1.86 (J = 0.8, 5.6, 12.8 
Hz) 
2.35-2.23 (m) 
6 Hf 2.74 (J = 0.9, 12.9 Hz) 2.70 (J = 0.8, 12.8 Hz) 2.55 (J = 8.0, 11.2 Hz) 
7 Hg 2.05 (J = 0.8, 7.2 Hz) 2.03 (J = 0.8, 7.3 Hz) 1.84 (J = 2.5, 6.0 Hz) 
8 Hh  1.20 (J = 6.6 Hz) 1.16 (J = 6.6 Hz) 1.22 (J = 7.2 Hz) 
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Table 3.5. 1H NMR Calculations Compared to Experimental Data for 3.195. 
 
Entry Hydrogen Calculated δ 3.195a ppm Calculated δ 3.195b ppm Experimental δ ppm 
1 Ha 4.41 (J = 10.0 Hz) 4.50 (J = 9.7) 4.51 (J = 10.0 Hz)  
2 Hb 1.99 (J = 6.6, 11.1 Hz) 2.33 (J = 6.6, 8.8 Hz) 2.27 (7.0, 11.0 Hz) 
3 Hc 1.93 (J = 8.5, 9.2, 10.0, 
11.1 Hz) 
2.39 (J = 7.9, 8.8, 9.7, 9.9 
Hz) 
2.21 (J = 2.0, 6.5, 12.5 Hz) 
4 Hd 2.18 (J = 4.7, 8.5, 12.5 
Hz) 
1.82 (J = 4.8, 7.9, 12.4 
Hz) 
2.31-2.25 (m) 
5 He 1.48 (J = 2.4, 4.9, 9.2 Hz) 1.78 (J = 2.3, 5.0, 9.9 Hz) 1.74 (J = 3.0, 6.0, 9.5 Hz) 
6 Hf 2.67 (J = 4.9, 12.5 Hz) 2.61 (J = 5.0, 12.4 Hz) 2.73 (J = 6.5, 11.5 Hz) 
7 Hg 1.95 (J = 2.4, 4.7 Hz) 1.99 (J = 2.3, 4.8 Hz) 1.91 (J = 2.5, 7.5 Hz) 
8 Hh 1.13 (J = 6.6 Hz) 1.10 (J = 6.6 Hz) 1.19 (J = 7.0 Hz) 
 
 
3.7. APKR WITH CIS-FUSED, LACTAM-TETHERED ALLENE-YNE SUBSTRATES 
 
Although the only cis lactam-tethered allene-yne that was isolated as a pure compound was the α-
methyl lactam 3.207 discussed above, mixtures of 3.135 and 3.136 or 3.182 and 3.183 were 
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subjected to the APKR slow addition conditions. Cis lactams with TIPS-substituted alkynes 3.135 
and 3.136 (3:1), afforded a 3:1 mixture of tricyclic products 3.199 and 3.201 in 40% combined 
yield, a yield comparable to trans lactam 3.125 (Table 3.3, entry 3). The product ratio of 3.199 to 
3.201 was determined by integration of Hb in the 1H NMR spectrum which appeared as doublets 
at 5.01 and 4.65 ppm for 3.199 and 3.201, respectively. Lactams 3.199 and 3.201 were separated 
for characterization purposes. An APKR time of 180 min was required for this TIPS-substituted 
alkyne, just like the trans lactam 3.125. Terminal alkynes 3.182 and 3.183 (3:1), provided a 3:1 
mixture of fused tricycles 3.201 and 3.202 in 41% combined yield. The product ratio of 3.201 to 
3.202 was determined by integrating Hb, which appeared as doublets at 4.72 and 4.54 ppm for 
3.201 and 3.202, respectively. Based upon these two examples, there are only subtle differences 
between the cis and trans lactams in the APKR.   
 
 
Scheme 3.47. APKR of mixtures of α-methylene and α-methyl-γ-lactams. 
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3.8. ANALYSIS OF 13C AND 1H NMR DATA FOR ESTIMATING THE 
ELECTROPHILIC REACTIVITY OF α-METHYLENE-γ-LACTAM GUAIANOLIDE 
ANALOGS 
 
13C NMR can be used to estimate the electrophilicity of a given carbon, where resonances shifted 
downfield correspond to more electrophilic carbon atoms. For example, scientists at Amgen 
showed that, for a series of N-aryl acrylamides containing electron-donating and electron-
withdrawing aryl substituents, the chemical shift of the β-carbon and the β-hydrogen correlated 
well with the rate of glutathione (GSH) addition to these acrylamides (see Chapter 1 for rate 
data).91 The chemical shifts of the β-carbons ranged from 125.6-128.7 ppm and showed a 
correlation coefficient (R2) of 0.80 to the rates of GSH addition to these acrylamides. The chemical 
shifts of the most downfield β-hydrogens ranged from 5.65-5.86 ppm and correlated to the rate of 
GSH addition with an R2 of 0.71 for these structurally similar acrylamides.91 When more 
structurally diverse acrylamides were compared, such as N-aryl, N-alkyl and/or acrylamides with 
substituents at the α or β position of the alkene, the 13C NMR chemical shifts of the α and β-carbons 
did not correlate to the rates of glutathione addition.93  
 Based upon work described by Amgen, the chemical shifts of the α-carbons, β-carbons, 
and β-hydrogens were tabulated for tricyclic α-methylene-γ-lactams in Table 3.6 as the first step 
in establishing whether this data could be used to estimate electrophilic reactivity. The α and β 
carbons (Cα and Cβ) were assigned based on the DEPT135 spectra, while the more downfield β-
hydrogen was assigned as Hβ2. Overall, the results show that stronger electron withdrawing 
substituents on the nitrogen atom result in a downfield shift of the β-carbon that correlates to the 
expected electron withdrawing capacity of the substituent. For example, a methyl substituent and 
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a hydrogen on the lactam nitrogen showed chemical shifts of the β-carbon at 115.55 and 115.33 
(entries 1-2); it was observed that the cyclopentenone substituent had little effect on the chemical 
shift of the β-carbon (compare entries 2, 3, and 5). Surprisingly, cis lactam 3.199 showed a 
significant increase in the chemical shift of the β-carbon from 115.73 ppm for trans lactam 3.184 
to 118.48 ppm for 3.199, potentially indicating that cis α-methylene-γ-lactams are more 
electrophilic than trans substituted α-methylene-γ-lactams (entries 3-4). This increase is likely due 
to strain in the product because, prior to the APKR, the cis and trans lactams had similar chemical 
shifts for Cβ (117.2 for cis and 117.0 for trans). N-aryl lactams 3.186-3.189 had β-carbons that 
were shifted downfield relative to N-methyl or N-unsubstituted lactams 3.56, 3.116, 3.184-3.185, 
and their chemical shifts ranged from 116.66 for para-methoxy aryl lactam 3.189 to 118.81 for 
para-cyano aryl lactam 3.188; the chemical shifts increased with the electron withdrawing capacity 
of the aryl substituent (entries 6-9). Thiophene substituted lactam 3.190 had a β-carbon chemical 
shift of 117.77 ppm, which was further downfield than the electronically neutral phenyl substituted 
lactam 3.186 and electron-rich methoxy aryl substituted lactam 3.189 but further upfield than the 
electron-poor trifluoromethyl and cyano aryl substituted lactams 3.187 and 3.188 (compare entry 
10 to entries 6-9). Substitution of the nitrogen atom with stronger electron withdrawing groups 
such as an acyl, tosyl, and carbonate substituent resulted in a downfield shift of the β-carbon 
compared to the N-aryl lactams; the chemical shifts of the β-carbons ranged from 119.48-121.43 
for these strong electron-withdrawing nitrogen substituents (entries 11-13). 
  
 
 
 
 146 
Table 3.6. 13C and 1H NMR data for α-methylene-γ-lactam guaianolide analogs. 
 
                    
Entry R1 R2 Cmpd. 
Cβ 
(ppm) 
Cα 
(ppm) 
Hβ1 
(ppm) 
Hβ2 
(ppm) 
1 Me Ph 3.56 115.55 143.18 6.101 5.339 
2 H Ph 3.116 115.33 143.14 5.983 5.272 
3 H TIPS 3.184 115.73 143.11 6.071 5.306 
4 Ha TIPSa 3.199 118.48 143.43 6.211 5.463 
5 H H 3.185 115.77 143.86 6.061 5.316 
6 Ph Ph 3.186 117.11 143.64 6.243 5.505 
7 4-CN-C6H4 Ph 3.188 118.81 142.64 6.299 5.548 
8 4-CF3-C6H4 Ph 3.187 118.15 143.05 6.281 5.518 
9 4-OMe-C6H4 Ph 3.189 116.66 143.73 6.215 5.441 
10 2-thiophene Ph 3.190 117.77 141.83 6.698 5.493 
11 Ac Ph 3.196 120.64 142.78 6.295 5.540 
12 Tosyl Ph 3.191 121.43 145.31 6.158 5.434 
13 Boc Ph 3.192 119.88 142.78 6.290 5.500 
a) Cis-lactam 
 
3.9. THIOL REACTIVITY OF α-METHYLENE-γ-LACTAMS 
 
To measure the relative electrophilic reactivity of α-methylene--lactams and to test whether the 
chemical shift of the β-carbon in the 13C NMR was an accurate predictor of this, four different 
lactams were reacted with excess cysteamine, a thiol that purportedly mimics biothiols, in 
chloroform-d (see Chapter 1).78 First, the α-methylene--lactam 3.116 possessing an NH group 
was reacted with cysteamine (15 equiv) in chloroform-d. The progress of the hetero-Michael 
addition reaction was monitored by the disappearance of the α-methylene hydrogen resonances in 
the 1H NMR (Scheme 3.49). Lactam 3.116 required 9 d for the complete disappearance of these 
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resonances. Two diastereomeric products were formed in a ratio of 2:1 as determined by 
integration of Hf and Hf’. The major diastereomer (shown) is predicted based upon this being the 
most thermodynamically stable isomer. 
 
 
 
Scheme 3.49. 1H NMR monitoring of cysteamine addition to an α-methylene-γ-lactam. 
 
The moderately electron withdrawing trifluoromethyl aryl substituted lactam 3.187 reacted 
completely with cysteamine in 2.5 d under the same conditions; the dr could not be determined 
due to impurities obscuring the resonance of Ha in the spectrum (Scheme 3.50). Lactam 3.196, 
possessing a strong electron withdrawing acetyl group on the lactam nitrogen reacted completely 
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in 55 min, and lactam 3.191, also containing a strongly electron withdrawing N-tosyl substituent, 
reacted completely in less than 10 min. The dr was determined by integration of Ha, and the major 
diastereomer was predicted to be the trans, trans isomers shown. Efforts to purify thiol adducts 
3.203-3.206 to confirm structure were thwarted by their instability to column chromatography. 
Therefore, N-methyl lactam 3.56 was reacted with tert-butyl thiol in a buffered solution to form 
thiol adduct 3.207 in 23% yield as a 1.5:1 ratio of diastereomers. The thiol adduct 3.207 was 
purified by extraction into dichloromethane and full characterization of this mixture confirmed the 
structural identity of thiol adducts 3.203-3.207 and that only one equivalent of thiol was added to 
the exocyclic alkene of 3.207.  
 
Scheme 3.50. Thiol additions to α-methylene-γ-lactams. 
 
The chemical shift of β-carbon in the 13C NMR was the most accurate predictor of 
electrophilic reactivity, which consistently shifted further downfield as stronger electron-
 149 
withdrawing groups were installed. The chemical shift correlated well with the rate of cysteamine 
addition (compare entries 2, 8, 11, and 12, Table 3.6). The chemical shift of the α-carbon in the 
13C NMR did not correlate to the electrophilic reactivity of the α-methylene-γ-lactam. Indeed, in 
some cases the α-carbon was shifted upfield when electron withdrawing substituents were attached 
to the lactam nitrogen (compare entries 1 and 8 or entries 2 and 11, Table 3.6). The β-hydrogens 
tended to shift downfield as stronger electron withdrawing groups were installed on the lactam 
nitrogen (compare entries 1 and 7 or 2 and 8). However, N-aryl lactams had β-hydrogens which 
were further downfield than the N-tosyl and N-Boc lactams (compare entries 6 and 13 or entries 9 
and 12).  
 
3.9.1 Rate of Glutathione (GSH) Addition to an α-Methylene-γ-lactam: Rate Constant and 
Half-life 
  
To measure the electrophilic reactivity of α-methylene-γ-lactams to known acrylamides, the rate 
of glutathione (GSH) addition to N-trifluoromethylaryl lactam 3.187 was benchmarked against the 
rate of known N-aryl acrylamide 3.208. When acrylamide 3.208 was reacted with GSH in 
phosphate buffer at 37 °C (conditions meant to mimic a biological environment), the half-life was 
39.5 min (Scheme 3.51).91 The consumption of electrophiles 3.208 and 3.187 was measured by 
calculating the peak area ratios (peak area electrophile/peak area of stable internal standard) from 
the mass spectrum relative to the stable internal standard, phenacetin (3.209). The relative 
abundance of the electrophiles was determined from the total ion concentration. Although this 
method does not give the actual concentrations of the electrophiles due to differences in ionization 
efficiencies, the decrease of the electrophile concentration over time can be determined since the 
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internal standard does not change. The rate constants were then calculated by fitting this data to 
the pseudo-first-order kinetic equation (Equation 3.1). Half-lives were calculated according to 
Equation 3.2. It was hypothesized that α-methylene-γ-lactams would react slower than acrylamides 
as alkyl substituents at the α-position of α,β-unsaturated carbonyls generally decrease the 
electrophilic reactivity.116 MS experiments were performed with the assistance of Dr. Bhaskar 
Ghodugu at the University of Pittsburgh. 
 
Scheme 3.51. Experimental conditions to compare the rate of GSH addition to an acrylamide 
compared to an α-methylene-γ-lactam. 
 
 
Equation 3.1. Rate equation for GSH addition to acrylamides (or α-methylene lactams). 
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Equation 3.2. Calculation of half-life from pseudo-first order rate constants.            
 
The rate of glutathione addition to acrylamide 3.208 was calculated as 0.018 min-1 which 
corresponds to a half-life of 38.5 min (Figure 3.3, A), compared to the literature value of 39.5 min. 
Although the rate and half-life are close to the literature value, the y-intercept is expected to be 1 
(observed y-intercept = -0.3835). This could be due to differences in the ionization efficiencies or 
differences in the initial concentrations of reagents. The rate of glutathione addition to tricycle 
3.187 was calculated as 0.0162 min-1, corresponding to a half-life of 42.8 min (Figure 3.3, B). As 
expected, α-methylene-γ-lactam-containing guaianolide analogs react slower with GSH than the 
corresponding acrylamides, although more examples are needed to confirm this observation. 
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Figure 3.3: Depletion of acrylamide 3.208 (A) or tricycle 3.187 (B) over time.  
 
The reaction mixture was prepared by adding 2 μL of each 1 mM DMSO stock solutions 
of acrylamide 3.208, tricycle 3.187, and phenacetin 3.209 to 1.794 mL of 67 mM phosphate buffer 
(pH = 7.4). This was divided into two 900 μL portions (1 control and 1 reaction). To the control 
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vial was added 100 μL of phosphate buffer. To the reaction vial was added 100 μL of 50 mM GSH 
solution (in phosphate buffer) and both were lowered into an oil bath set to 37 °C and allowed to 
react without stirring. Thus, the final concentrations of reagents in the reaction vial were: 1 μM of 
acrylamide 3.208, 1 μM of tricycle 3.187, 1 μM of phenacetin (3.209), and 5000 μM GSH all in 
67 mM, pH = 7.4 phosphate buffer. Aliquots (50 μL) of the reaction mixture were taken every 15 
min for 2 h, placed in an autosampler vial, and injected into a Thermo Scientific Q-Exactive 
Orbitrap MS with separation of the compounds by HPLC using the method described below. The 
ions were observed using single ion monitoring in ESI+ mode. The compounds were separated 
using a Thermo Scientific Hypersil GOLD column 1.9 μM (2.1 x 100 mm) using a gradient of 5-
95% of 0.1% formic acid in acetonitrile (B) to 0.1% formic acid in water (A). Table 3.7 shows the 
time and gradient used for compound separation. 
 
Table 3.7. Gradient of 0.1% formic acid in MeCN (B) to 0.1% formic acid in H2O (A). 
Time (min) Mobile Phase B (%) = 0.1% formic acid in MeCN 
1 5% 
5 95% 
6 95% 
8 5% 
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3.10. BIOLOGICAL ACTIVITY OF α-METHYLENE-γ-LACTAM GUAIANOLIDE 
ISOSTERES: CYTOTOXICITY AND NF-ΚB PATHWAY INHIBITION 
 
Experiments in this section were performed by our collaborators in Professor Daniel Harki’s 
laboratory at the University of Minnesota (John Widen, Henry Schares, Joseph Hexum) 
 
3.10.1. Introduction to the NF-κB Pathway 
 
Inhibition of the NF-κB (nuclear factor κB) pathway promotes apoptosis, and this pathway is 
frequently overactive in cancer and inflammatory diseases.26-27 Thus, it represents a desirable drug 
target. Natural products and synthetic small molecules are known to inhibit the NF-κB (nuclear 
factor κB) pathway through a variety of mechanisms.21, 26, 151 One such mechanism is the alkylation 
of Cys38, located in the DNA-binding domain of p65 (also referred to as RelA), and this inhibits 
DNA binding of the NF-κB heterodimer, made up of p50 and p65 subunits. Inhibition of DNA 
binding has been proposed as a general mechanism of action for inhibition of the NF-κB pathway 
by guaianolides and other Michael acceptors.25 Indeed, mutation of Cys38 to serine in p65 resulted 
in a protein that was resistant to DNA-binding inhibition by helenalin (3.212, Scheme 3.52).215  
Figure 3.4 summarizes the NF-κB pathway and shows where in the pathway different 
compounds have been shown to inhibit.26 The NF-κB pathway is activated in response to numerous 
stimuli, which in turn activate the inhibitor of NF-κB kinase (IKK). When NF-κB is inactive, it is 
sequestered in the cytoplasm of the cell by the protein IκB (inhibitor of NF-κB). When IKK is 
activated, it phosphorylates IκB, leading to degradation of IκB by the proteasome. Upon 
degradation of IκB, the p50/p65 heterodimer is released and is free to enter the nucleus where it 
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binds to DNA. Once bound to DNA, NF-κB increases the rate of transcription for anti-apoptotic 
genes, as well as proteins involved in cell proliferation and cell invasion. The NF-κB pathway can 
be inhibited at various stages. These include blocking stimuli that activate IKK (nonsteroidal anti-
inflammatory drugs (NSAIDS), thalidomide), inhibition of IκB phosphorylation by IKK, 
prevention of nuclear translocation (silibinin), and prevention of DNA-binding by the p50/p65 
heterodimer (sesquiterpene lactones). 
 
Figure 3.4. Summary of NF-κB pathway with major points of inhibition. Reprinted with 
permission from Macmillan Publishers Ltd: Nature Reviews Drug Discovery, 2008, 7, 1031-1040, ©2008. 
 DNA binding by the p50/p65 heterodimer is the most downstream process in the canonical 
NF-κB signaling pathway. Inhibition of DNA-binding is favorable because targeting upstream 
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proteins results in off-target effects due to the involvement of those proteins in other cellular 
pathways.27 Certain sesquiterpene lactones, such as helenalin (3.212) and simplified analog 3.214 
inhibit the DNA binding of the p50/p65 transcription factor heterodimer by forming a covalent 
bond between the α-methylene-γ-lactone and the sulfhydryl group (Cys-38) of the p65 protein 
(Scheme 3.53).216-217 Covalent labeling of Cys38 on p65 was observed by MS analysis of peptide 
fragments after trypsin digestion. A peptide corresponding to YKC38EGR bound to helenalin was 
detected, and a peptide corresponding to C38EGR bound to simplified helenalin analog 3.214 was 
detected.217 Protein pull-down studies also demonstrated that p65 was covalently labeled by 3.214, 
but IκBα, p50, and IKKα/β were not covalently labeled. Thus, covalent inhibition of p65 is a 
potential method for inhibiting the NF-κB pathway. 
 
Scheme 3.52. Reaction of helenalin or analog with Cys38 of p65. 
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3.10.2. Inhibition of the NF-κB Pathway by α-Methylene-γ-lactam Guaianolide Analogs 
 
Helenalin (3.212) is an 8,12-guaianolide; 6,12 guaianolides are thought to inhibit the NF-κB 
pathway in a similar fashion. Previously, guaianolide analogs 3.216 and 3.217 containing an α-
methylene-γ-lactone were synthesized in our lab and displayed inhibition of the NF-κB pathway 
at low μM levels, similar to the natural product parthenolide (3.218, Figure 3.5).118 Thus, it was 
hypothesized that α-methylene-γ-lactam guaianolide analogs would also inhibit the NF-κB 
pathway and that this inhibition would occur through prevention of DNA-binding by the p50/p65 
heterodimer. As discussed in Chapter 1 on thiol reactivity, α-methylene-γ-lactams are less reactive 
towards thiols than similar lactones. if alkylation of Cys38 on p65 is promoted by noncovalent 
interactions, the reduced electrophilic reactivity of α-methylene-γ-lactams would reduce the 
amount of off-target reactivity when compared to α-methylene-γ-lactones.217 However, this 
reduced electrophilic reactivity could prevent or slow alkylation of Cys38 of p65, thus reducing or 
eliminating inhibition of the NF-κB pathway by α-methylene-γ-lactams. This is why ability to tune 
the electrophilic reactivity of α-methylene-γ-lactams is important, as tunable guaianolide analogs 
could enable the development of α-methylene-γ-lactam guaianolide analogs that maximize 
covalent inhibition while minimizing off-target reactions.  
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Figure 3.5. Synthetic guaianolide analogs and natural product parthenolide with remaining NF-
κB activity following treatment of cells with inhibitor. 
 
Based on the ability of 6,12-guaianolides to inhibit the NF-κB pathway, this pathway would 
provide a testing ground for comparisons of bioactivity between α-methylene-γ-lactams and α-
methylene-γ-lactones, both in terms of NF-κB inhibition and cytotoxicity. Experiments to 
determine inhibition of the NF-κB pathway and cytotoxicity of α-methylene-γ-lactam guaianolide 
analogs was performed by our collaborators in the Harki laboratory (John Widen, Henry Schares, 
Joseph Hexum) at the University of Minnesota. NF-κB inhibition was measured using a stably 
transfected A549 cell line containing a luciferase gene driven by NF- κB activation. Induction of 
the NF-κB pathway with TNFα (tumor necrosis factor α) results in an increase in reporter 
luminescence corresponding to NF-κB activation. Upon inhibition of the NF-κB pathway, reporter 
luminescence is decreased. Induced cells without inhibitor and non-induced cells were used as 
controls to measure the relative NF-κB activity of cells treated with an inhibitor. Select compounds 
3.56, 3.185, 3.186, 3.187, 3.189, 3.191, 3.196 were dosed at 50, 20, 10, and 5 μM to cells before 
inducing with TNF-α for eight hours (Figure 3.6). These compounds were chosen to examine the 
effect of different nitrogen substituents (e.g. electron donating and electron withdrawing) on NF-
κB inhibition. Additionally, these compounds were tested for cytotoxicity at the same 
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concentrations by measuring the cell viability after 48 h using A549 cells and an Alamar blue 
assay. In this assay, A549 cells were treated with inhibitors 3.56, 3.185, 3.186, 3.187, 3.189, 3.191, 
3.196  for 48 h (Figure 3.6).218 At the 46 h mark, Alamar blue (cell viability reagent) was added to 
the cells. The Alamar blue assay evaluates the ability of metabolically active cells to convert 
resazurin (a nonfluorescent compound) to resorufin (a red fluorescent compound). The amount of 
fluorescence provides the number of live cells relative to a control which was not treated with any 
inhibitors. The goal was to explore the potential of α-methylene-γ-lactam guaianolide analogs as 
biologically active compounds and potentially discover a compound with good NF-κB pathway 
inhibition and minimal toxicity. The hypothesis was that an α-methylene-γ-lactam with 
intermediate electrophilic reactivity would maximize NF-κB inhibition and minimize cellular 
toxicity. 
α-Methylene-γ-lactam 3.185 (NH) or 3.56 (NMe), did not inhibit the NF-κB pathway at 
any concentration (5, 10, 20, 50 μM) tested (Figure 3.6). These two lactams were also not cytotoxic 
as evidenced by cell viabilities above 80% when cells were treated with 50 μM of 3.185 or 3.56 
(Figure 3.7). α-Methylene-γ-lactams 3.186 (NPh) and 3.189 (N-4-OMe-C6H4) were also not 
cytotoxic at the highest concentration (50 μM) tested. However, both lactams 3.186 and 3.189 
showed weak inhibition of the NF-κB pathway at 20 μM, and at 50 μM these compounds reduced 
NF-κB activity to 54% or 60%, respectively, relative to the control. Lactam 3.191, (NTs), reduced 
NF-κB activity to 33% relative to induced levels at 5 μM and to noninduced levels at 10 μM. 
However, lactam 3.191 was cytotoxic, reducing cell viability by 20% at 5 μM and by 36% at 10 
μM. α-Methylene-γ-lactam 3.196 (NAc) displayed NF-κB inhibition with 59% remaining NF-κB 
activity at 10 μM and 29% remaining activity at 20 μM. A concentration of 50 μM 3.196 reduced 
NF-κB activity to noninduced levels, but was cytotoxic with only 62% cell viability compared to 
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nontreated cells. The most promising biological activity was displayed by α-methylene-γ-lactam 
3.187 (N-4-CF3-C6H4). Lactam 3.187 reduced NF-κB activity to 62% at 10 μM, 21% at 20 μM, 
and to non-induced levels (6%) at 50 μM. Additionally, 3.187 was only minimally cytotoxic (88% 
cell viability relative to nontreated cells) at the highest concentration (50 μM) tested. Figure 3.8 
shows the correlation between NF-κB activity and cellular toxicity for most α-methylene-γ-
lactams tested by plotting the percentage of NF-κB activity relative to the percentage of cell 
viability. Lactam 3.187, containing the 4-trifluoromethyl phenyl substituent, is the outlier on this 
graph, where NF-κB inhibition is not accompanied by an increase in cytotoxicity. 
 
 
Figure 3.6. Graph of NF-κB activity relative to induced levels for α-methylene-γ-lactams. In 
order the lactams are 3.189 (R = 4-OMe-C6H4), 3.56 (R = Me), 3.186 (R = Ph), 3.187 (R = 4-
CF3-C6H4), 3.196 (R = Ac), 3.191 (R = Ts), 3.185 (R = H). 
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Figure 3.7. Graph of cell viability relative to nontreated cells for α-methylene-γ-lactams. In 
order the lactams are 3.189 (R = 4-OMe-C6H4), 3.56 (R = Me), 3.186 (R = Ph), 3.187 (R = 4-
CF3-C6H4), 3.196 (R = Ac), 3.191 (R = Ts), 3.185 (R = H). 
 
In order to confirm that NF-κB inhibition was not an artifact of the luciferase assay, α-
methylene-γ-lactams were also tested for NF-κB inhibition in HEK293 cells using a SEAP 
(secreted embryonic alkaline phosphatase) assay; similar NF-κB inhibition was observed.219 
Cytotoxicity of HEK293 cells was also measured using the Alamar blue assay described above. In 
the SEAP assay, a decrease in alkaline phosphatase production corresponds to a decrease in NF-
κB activity. In this case, the alkaline phosphatase cleaves a phosphate from an indole phosphate to 
generate a chemiluminescent indole, much the same way that oxidation of luciferin by luciferase 
produces luminescence. These mechanistically distinct measurements of NF-κB inhibition in two 
different cell lines provide confidence that the NF-κB pathway is inhibited by α-methylene-γ-
lactams. 
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In summary, α-methylene-γ-lactams containing electron withdrawing substituents (3.187, 
3.196, 3.191) displayed comparable NF-κB activity to the lactones 3.216 and 3.217 previously 
prepared in our lab (Figure 3.6 and 3.7). In the case of 3.187, containing a 4-trifluoromethyl phenyl 
substituent, increased NF-κB inhibition was not accompanied by increased cytotoxicity. 
Additionally, lactams containing a secondary amide (3.185), electron donating alkyl (2.56) or aryl 
(3.189) groups, and an electronically neutral phenyl group (3.186) were not cytotoxic even at high 
concentrations. Although, these lactams were inactive in the NF-κB pathway, their lack of 
cytotoxicity means they could be used to inhibit other biological targets. Finally, inhibition of the 
NF-κB pathway and cytotoxicity were related to the electrophilic reactivity of various α-
methylene-γ-lactams. There is a correlation between time of reactivity with cysteamine in the 1H 
NMR studies (see section 3.10) and amount of inhibition of the NF-κB pathway for the derivatives 
3.187, 3.196, and 3.191 where shorter reaction times relate to increased inhibitory activity. 
Additionally, compounds 3.196 and 3.191 that reacted rapidly with cysteamine (<10 min and 60 
min to react completely, respectively) were cytotoxic, while 3.187, which reacted more slowly 
with cysteamine (2.5 d to react completely) was not cytotoxic.  
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Figure 3.8. Plot of NF-κB activity and cellular toxicity for α-methylene-γ-lactams. 
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4.0. ALLENYL ACETATES IN THE ALLENIC PAUSON-KHAND REACTION WITH 
α-METHYLENE-γ-LACTAM-TETHERED ALLENE-YNES AND AN UNEXPECTED [2 
+ 2] CYCLOADDITION PRODUCT 
 
4.1. INTRODUCTION 
 
6,12-Guaianolides contain various degrees of oxidation, which is one representation of their 
molecular complexity when considering their synthetic accessibility.  Oxidation level has been 
calculated by considering the 6,12-guaianolide skeleton 4.1 as having an oxidation level of zero 
(Figure 4.1). From this starting point, each additional alkene, hydroxyl, or ether attached directly 
to the guaianolide skeleton raises the oxidation level by 1; epoxides or carbonyls raise the oxidation 
level by 2.118 Thus, thapsigargin (4.2) and eupatochinilide VI (4.3) have oxidation levels of 7, 
moxartenolide (4.4) has an oxidation level of 6, ixerin (4.5) has an oxidation level of 5, arglabin 
(4.6) and leucodin (4.7) have oxidation levels of 4, and compressanolide (4.8) has an oxidation 
level of 2. Others have considered the oxidation level as the number of skeletal carbons with an 
oxygen substituent; alkenes are not counted.220 Thus, the guaianolide skeleton would have an 
oxidation level of 3, while thapsigargin would have an oxidation level of 9. Preparing more 
oxygenated [5,7,5]-guaianolide analogs would be beneficial because many guaianolide natural 
products contain higher oxidation levels. Using the principles of redox economy,221 it was 
proposed that an APKR between allenyl acetates and an alkyne tethered by an α-methylene-γ-
lactam would enable a redox economical method for the preparation of 6,12-guaianolide analogs 
containing an α-methylene-γ-lactam in place of the α-methylene-γ-lactone, with an additional α-
acyloxy substituent on the cyclopentenone ring. 
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Figure 4.1. Oxidation level of naturally occurring 6,12-guaiainolides. 
 
Our group has previously demonstrated the ability of allenyl acetates to undergo the APKR 
to form α-acetoxy cyclopentenones.222 For example, allenyl acetate 4.9 (1.3:1 dr) was subjected to 
rhodium biscarbonyl chloride dimer to form α-acetoxy cyclopentenone fused to 7-membered ring 
4.10 with a 2.3:1 dr. This increase in diastereoselectivity is a result of the allenyl acetate 
undergoing a rapid scrambling of axial chirality.222 
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Scheme 4.1. APKR of allenyl acetate to form α-acetoxy cyclopentenone. 
 
Thus, more highly oxygenated lactam analogs such as the [5,7,5]-guaianolide 4.11 was 
envisioned. Retrosynthetically, it was proposed that [5,7.5]-guaianolide analog 4.11 containing an 
α-acetoxy cyclopentenone could be formed from an APKR of 4.12 containing an α-methylene-γ-
lactam tether between the alkyne and the allenyl acetate (Scheme 4.2). The allenyl acetate could 
be prepared from propargyl acetate 4.13 using a formal [3,3] sigmatropic rearrangement catalyzed 
by rhodium(II) trifluoroacetate dimer or gold(III) chloride, and this acetate would be generated by 
acetylation of propargyl alcohol 4.14, whose synthesis was described in Chapter 3. 
 
Scheme 4.2. Retrosynthetic analysis of lactam guaianolide analog 4.14. 
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4.2. PREPARATION OF ALLENYL ACETATES FROM PROPARGYL ALCOHOLS 
 
 To prepare the allenyl acetate substrates for the APKR the hydroxyl group of 4.15 or 4.16 
(synthesis in section 3.4) were acylated with acetic anhydride, triethylamine, and catalytic 4-
dimethylaminopyridine. This reaction was accompanied by N-acylation to afford bisacylated 
products 4.17 or 4.18 in 57 and 42% yields, respectively (Scheme 4.3). Bisacylated products 4.17 
and 4.18 were identified by the disappearance of the amide peaks at 6.98 or 5.90 ppm from 4.15 
and 4.16, respectively, and the appearance of two new methyl singlets at 1.99 ppm and 2.56 ppm 
for 4.17 and 4.18, respectively, in the 1H NMR spectrum. The 1H NMR resonance corresponding 
to Ha shifted downfield from 4.3 to 4.9 ppm for 4.17 and from 4.1 to 4.6 ppm for 4.18. Two new 
carbonyl carbon peaks in the 13C NMR spectra at 171 and 166 ppm of 4.17 and 4.18 also 
demonstrated that bisacetylation had occurred. Attempts to shorten the reaction time in order to 
selectively acylate the alcohol over the amide nitrogen only led to mixtures of N-acylation (without 
O-acylation) and bisacylation, indicating that the nitrogen of the lactam was reacting faster than 
the tertiary alcohol. Nevertheless, these bisacylation 4.17 or 4.18 were reacted with rhodium(II) 
trifluoroacetate dimer (5 mol%) in toluene at 60 °C for 1 h to provide allenyl acetates 4.19 or 4.20 
in yields of 83 and 91%, respectively. This demonstrated the feasibility of allenyl acetate formation 
in the presence of a tertiary amide. The allenyl acetates 4.19 and 4.20 could be identified by a 
disappearance of the alkynyl hydrogen singlet at 2.6 ppm from 4.17 and 4.18, as well as a new 
allenyl hydrogen resonance at 7.3 ppm in the 1H NMR spectra of both 4.19 and 4.20. The central 
allene carbon was detected at 190 ppm in the 13C NMR spectra.  
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Scheme 4.3. Synthesis of allenyl acetates. 
 
4.3. APKR OF ALLENYL ACETATES WITH N-ACETYL α-METHYLENE-γ-LACTAM 
TETHER 
 
Allenyl acetate 4.19 was subjected to the typical APKR conditions using rhodium biscarbonyl 
chloride dimer (10 mol%) in toluene at 110 °C under a carbon monoxide atmosphere. This 
provided the APKR product 4.21 in only 12% yield as a 1.4:1 ratio of acetate diastereomers. A 
byproduct 4.22 arising from [2+2] cycloaddition between the proximal double bond of the allene 
and the α-methylene of the lactam was obtained in 19% yield (Scheme 4.4). The structure of the 
[2 + 2] cycloaddition product was confirmed by 2D NMR analysis (see Section 4.7). A similar 
product 4.25 was obtained as a byproduct by a former member of our group Dr. François Grillet. 
For example, 4.23 afforded a mixture of 4.24 and 4.25 under APKR conditions (Scheme 4.5). In 
this case, a crystal structure was obtained to confirm the structure of the [2 + 2] cycloaddition 
product (Figure 4.2).223 The NMR data for the lactone 4.25 and lactam 4.22 were similar, and the 
[2 + 2] cycloadduct structure was assigned by analogy to the lactone. 
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Scheme 4.4. APKR of allenyl acetate and alkyne tethered by an α-methylene-γ-lactam. 
 
Scheme 4.5. APKR of allenyl acetate and alkyne tethered by an α-methylene-γ-lactone. 
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Figure 4.2: Crystal structure of [2 + 2] cycloaddition product from lactone. 
 
4.4. PROPOSED MECHANISM FOR THE [2 + 2] CYCLOADDITION 
 
The cycloaddition reaction is postulated to proceed via an initial carbon-carbon bond forming 
process between the electron-rich central carbon of the allene and the electron-deficient carbon of 
the α-methylene-γ-lactam to form the intermediate 7-membered ring 4.26 (Scheme 4.6). The 
resulting enolate 4.26 then forms a bond between the α-carbon of the γ-lactam and the methyl 
substituted alkene carbon to form the cyclobutane and the alkenyl acetate 4.22. Thus, an electron-
deficient alkene promotes the first step of the proposed mechanism. Alternatively, the [2 + 2] 
cycloaddition product could arise from a radical process, where initial bond formation between the 
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terminus of the alkene and the proximal allene double bond forms diradical intermediate 4.27. 
Radical combination then affords the cyclobutane product 4.22. Both radical and ionic process 
have been proposed for allene-alkene cycloadditions in the literature (for further discussion on 
mechanistic studies of allene-alkene cycloadditions in the literature see Section 4.8). 
 
 
Scheme 4.6. Proposed mechanisms for cyclobutane formation. 
 
The reaction of an allene and alkene to form cyclobutane derivatives via a [2 + 2] 
cycloaddition was reviewed in 2009 by Alcaide and coworkers.224 These reactions have been 
carried out under photochemical or thermal conditions as well as with Lewis acid or transition 
metal catalysis. Photochemical [2 + 2] cycloadditions of allenes and alkenes require an α.β-
unsaturated carbonyl as the alkene portion to generate a diradical that reacts with the allene and 
involve irradiation with UV light between 250-300 nm. Although light was not excluded from our 
reactions with allenyl acetates, ambient light would not be expected to promote triplet enone 
formation.224-227. 
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Since the concerted, thermal [2 + 2] cycloaddition is forbidden by frontier molecular orbital 
theory and the Woodward-Hoffmann rules, thermally induced cycloadditions of allenes and 
alkenes generally invoke a stepwise diradical mechanism.224 For thermal intramolecular 
cycloadditions of allenes and alkenes, the regioselectivity is usually determined by the sterics of 
the allene and alkene substituents. For example, regioselectivity in the thermal, intramolecular [2 
+ 2] cycloadditions of alkenes and sulfonyl allenes depended on the substitution of the alkene.228 
Terminal alkene 4.28 reacts with the distal double bond of the sulfonyl allene to give 
bicycl0[4.2.0]octane 4.30 (Scheme 4.7). Alternatively, 1,1-disubstituted alkene 4.31 reacts with 
the proximal double bond of the sulfonyl allene to give bicyclo[3.2.0]heptane 4.33. A radical 
mechanism is supported by the rates of these reactions. Monosubstituted alkene 4.28, which 
generates primary radical 4.29 (R = R’ = H), requires 22 h to go to completion, while a 
trisubstituted alkene which forms a tertiary radical reacts completely in 45 min (not shown). 
 
 
Scheme 4.7. Regioselectivity in thermal, intramolecular [2 + 2] cycloadditions of alkenes and 
phenylsulfonyl allenes. 
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Lewis acid catalyzed allene-alkene cycloadditions between an electron-poor allenes and 
electron-rich alkenes are the most common.229 Recently, Brown and coworkers have reported 
enantioselective Lewis acid catalyzed, intermolecular cycloaddition of allenoates with alkenes.230-
231 In this case trifluoroethyl allenoate 4.35 was reacted with alkene 4.34 to give cyclobutane 
product 4.36 in an 87% yield and 90:10 er; internal, linear alkenes gave lower yields, but good 
enantiomeric ratios (Scheme 4.8).231 In these cases, the Lewis acid is thought to activate the 
allenoate for nucleophilic attack by the alkene, via short-lived ionic intermediates because lower 
yielding reactions were afforded with electron withdrawing substituents on the alkene.229-231  
 
 
Scheme 4.8. Enantioselective, Lewis acid catalyzed [2 + 2] cycloaddition of alkenes and 
allenoates. 
 
 In one example, using a cationic, gold catalyst (4.39), Toste and coworkers showed that 
alkyl substituted allenes such as 4.38 reacted intramolecularly with styrenyl alkenes to form 
bicyclo[3.2.0]heptanes, such as 4.40, in good yields and enantioselectivities (Scheme 4.9).232 The 
catalytic cycle involves a stepwise mechanism where a nucleophilic alkene adds to the gold(I) 
activated allene 4.41 to form carbocation intermediate 4.42 (Scheme 4.10).232-233 The vinyl gold 
species then reacts with the carbocation to form cyclobutane 4.40. This mechanism was supported 
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by trapping the intermediate carbocation with methanol to give the corresponding cyclopentane. 
Other gold-catalyzed, enantioselective [2 + 2] cycloadditions of allenes and alkenes are thought to 
proceed through a similar mechanism.233-234 
 
 
Scheme 4.9. Gold-catalyzed [2 + 2] cycloaddition of allenes and alkenes. 
 
 
Scheme 4.10. Catalytic cycle for gold-catalyzed [2 + 2] cycloaddition of allenes and alkenes. 
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4.5. OPTIMIZATION OF CONDITIONS TO SELECTIVELY OBTAIN THE APKR 
PRODUCT OR THE [2 + 2] CYCLOADDITION PRODUCT FROM ALLENYL 
ACETATES WITH AN α-METHYLENE-γ-LACTAM TETHER 
 
Different conditions were examined to selectively form the APKR product or the [2 + 2] product. 
These included lowering the temperature, changing the rhodium catalyst, changing the solvent, 
and decreasing the amount of carbon monoxide in the atmosphere. The results of these conditions 
are shown in Table 4.1. It was hypothesized that the [2 + 2] cycloaddition reaction was the result 
of a thermal-only process. Thus, removing the catalyst afforded a 71% yield of the [2 + 2] 
cycloadduct 4.22 in 71% yield (Table 4.1, entry 2). Using these same reaction conditions, 4.20 
afforded a 51% yield of cycloadduct 4.44 and none of the APKR product 4.43 (entry 3). No efforts 
were made to further optimize the [2 + 2] cycloaddition. We next turned to developing conditions 
that would provide the APKR product in high yield. Lowering the temperature led to an increased 
yield of the [2 + 2] product 4.22 of 33%, but none of the APKR product 4.21 was obtained (entry 
4). Changing the solvent from toluene to dichloroethane had a similar effect, providing the [2 + 2] 
product 4.22 in 45% yield with none of the APKR product 4.21 (entry 5). Activated rhodium 
catalysts that promote the APKR at lower temperatures and increase the rate of the APKR may 
increase the yield of the [5,7,5]-fused ring system. Previous work in our lab had showed that 
treatment of rhodium(I) biscarbonyl chloride dimer with triphenylphosphine and silver 
tetrafluoroborate (to form Rh(CO)2(PPh3)2) gave a catalyst that was active at lower temperatures 
and quickly formed APKR products with allenyl acetates. This active catalyst was reacted in a 
10% carbon monoxide, 90% argon atmosphere, as 100% carbon monoxide leads to displacement 
of the triphenylphosphine ligand by carbon monoxide. With this activated catalyst at 50 °C, the 
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highest yield (25%) of the APKR product 4.21 was obtained as a 1.4:1 ratio of acetate 
diastereomers, but the [2 +2] product 4.22 was still the major product obtained in 34% yield (entry 
6). At room temperature, activated catalyst Rh(CO)2(PPh3)2 gave none of the APKR product 4.21, 
29% yield of [2 +2] product 4.22, and 17% of an α,β-unsaturated aldehyde arising from 
decomposition of the allenyl acetate (entry 5). As previous APKR with allenyl acetates were more 
successful with a silyl-substituted alkyne (TMS), it was proposed that lactam 4.20 with a TIPS 
substituent would increase the rate of the APKR. Thus, TIPS substituted alkyne 4.23 was subjected 
to typical APKR conditions with rhodium biscarbonyl chloride dimer. However, TIPS substituted 
alkyne 4.20 did not give any of the APKR product 4.43 under these conditions or with the activated 
catalyst at 50 °C (entries 8-9). The [2 + 2] product 4.44 was obtained in 56% yield at 110 °C with 
rhodium biscarbonyl chloride as the catalyst (entry 8). With the activated catalyst 
(Rh(CO)2(PPh3)2), a 13% yield of [2 + 2] product 4.44 was obtained along with 45% of the α,β-
unsaturated aldehyde due to decomposition of the allenyl acetate (entries 8-9). This was not 
surprising, as the TIPS alkyne was shown to slow the APKR with 1,1-disubstituted allenes, and it 
is not expected to affect the rate of [2 + 2] cycloaddition (see Table 3.3, entry 3). Thus, thermal-
only conditions to form the [2 + 2] cycloadduct selectively were identified.  Efforts to find 
conditions for the selective formation of the APKR product were not pursued further because under 
all reaction conditions investigated, formation of the [2 + 2] product outcompeted the formation 
of the APKR suggesting that the Rh-catalyst may be functioning as a Lewis acid to facilitate the 
[2 + 2] cycloaddition. 
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Table 4.1. APKR or [2 + 2] cycloaddition with allenyl acetates. 
 
Entry R = Catalyst 
Atmos-
phere 
Temp 
(°C) Solvent 
Time 
(h) 
Yield 
PK 
(%) 
Yield 
[2+2] 
(%) 
Yield 
total 
(%) 
1 Ph 
[Rh(CO)2Cl]2 
(10 mol%) CO 110 PhMe 6 12 19 31 
2 Ph None N2 110 PhMe 4 0 71 71 
3 TIPS None N2 110 PhMe 5 0 51 51 
4 Ph 
[Rh(CO)2Cl]2 
(10 mol%) CO 70-90 PhMe 7 0 33 33 
5 Ph 
[Rh(CO)2Cl]2 
(10 mol%) CO 90 DCE 6 0 45 45 
6 Ph 
[Rh(CO)2Cl]2 
(10 mol%), PPh3 
(30 mol %), 
AgBF4 (22 mol 
%) 
10% 
CO in 
Ar 50 DCE 2 25 34 60 
7 Ph 
[Rh(CO)2Cl]2 
(10 mol%), PPh3 
(30 mol %), 
AgBF4 (22 mol 
%) 
10% 
CO in 
Ar 25 DCE 4 0 29 46* 
8 TIPS 
[Rh(CO)2Cl]2 
(10 mol%) CO 110 PhMe 2 0 56 56 
9 TIPS 
[Rh(CO)2Cl]2 
(10 mol%), PPh3 
(30 mol %), 
AgBF4 (22 mol 
%) 
10% 
CO in 
Ar 50 DCE 2 0 13 58* 
          
          
* The remainder of the overall yield was due to α,β-unsaturated aldehyde formation from 
decomposition of the allenyl acetate. 
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4.6. DESIGN AND SYNTHESIS OF LESS-ELECTRON DEFICIENT α-METHYLENE-γ-
LACTAMS FOR ALLENIC PAUSON-KHAND REACTIONS USING ALLENYL 
ACETATES 
 
Since both the α-methylene-γ-lactone 4.23 and the N-acetyl α-methylene-γ-lactams 4.19-4.20 
contain an electron-deficient alkene, and the proposed reaction mechanism is stepwise ionic, it was 
proposed that a less electron deficient alkene may suppress the [2 + 2] cycloaddition reaction. To 
test this hypothesis, the syntheses of allenyl acetates or pivalates with an unsubstituted or 
methylated lactam nitrogen were pursued, as these systems have less electrophilic alkenes, as 
evidenced by the slower rate of thiol addition to an N-unsubstituted lactam (Section 3.10). As 
mentioned above, selective O-acylation was difficult due to competitive N-acylation, thus the 
corresponding pivalate 4.45 was formed as discussed in Chapter 3. Based on previous results in 
our lab, the pivalate and various other acyloxy groups undergo the formal [3,3] sigmatropic 
rearrangement catalyzed by rhodium(II) trifluoroacetate dimer to the corresponding allenyl 
acyloxy systems. However, when pivalate 4.45 was reacted with catalytic rhodium(II) 
trifluoroacetate dimer, only starting material was recovered, quantitatively (Scheme 4.11). 
Because the unsubstituted lactam nitrogen may deactivate the catalyst by coordination of the 
secondary amide to rhodium, N-methyl lactam 4.46 was subjected to the rhodium catalyzed 
rearrangement. This system afforded similar results with a 79% overall yield consisting of a 3:1 
ratio of recovered starting material to allenyl acetate 4.47. Similarly, the reaction of unsubstituted 
NH lactam 4.45 afforded the desired allenyl pivalate in an inseparable 2:1 ratio of desired product 
4.48 to starting material 4.45, but only a 44% yield was obtained, which was attributed to 
decomposition of the starting material or product. The ratio of product to starting material was 
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determined by integration of the allenyl pivalate hydrogen at 7.31 ppm and the terminal alkyne 
hydrogen at 2.53 ppm of the 1H NMR spectrum. The diastereomeric ratio was unable to be 
determined due to overlapping resonances in the 1H NMR of the starting material and product. 
 
 
Scheme 4.11. Formation allenyl pivalates or acetates with N-unsubstituted or N-methyl lactams. 
 
 Since allenyl pivalate 4.48 was unable to be separated from propargyl pivalate 4.45, the 
mixture was subjected to the typical APKR conditions. Allenyl pivalate 4.48 (2:1 with 4.45) was 
reacted with rhodium biscarbonyl chloride dimer in toluene at 110 °C for 2 h to afford tricycle 
4.49 in 44% yield and a 3:1 dr and no [2 + 2] product 4.50 (Scheme 4.12). The dr was determined 
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by integration of the proton resonance α to the pivaloyloxy group which appeared as a singlet at 
5.66 ppm for the major diastereomer and 5.54 ppm for the minor diastereomer. This result suggests 
that allenic Pauson-Khand reactions between allenyl pivalates and alkynes with an α-methylene-
γ-lactam tether containing only weakly electrophilic alkenes are possible without formation of the 
[2 + 2] product. However, the formation of allenyl pivalates attached to N-unsubstituted lactams 
still requires optimization. One possibility for this is to perform the rearrangement with a gold(III) 
chloride catalyst instead of the rhodium(II) trifluoroacetate dimer. 
 
Scheme 4.12. APKR of allenyl pivalate with N-unsubstituted lactam tether. 
 
4.7. STRUCTURE CONFIRMATION OF THE [2 + 2] CYCLOADDITION PRODUCT 
BY 2D NMR ANALYSIS 
 
The structure of tricyclic compound 4.44 was determined by 1H, 13C, DEPT, HSQC, HMBC, and 
COSY NMR analyses. This NMR data is presented in Table 4.2, while key COSY and HMBC 
correlations are summarized in Figure 4.3. The compound showed the same exact mass as the 
starting material 4.20, suggesting that a skeletal reorganization had occurred. Absence of the 
allenyl and alkenyl resonances in 1H NMR spectrum strongly suggested a reaction between these 
two groups. Additionally, an upfield shift of the hydrogen at position 4 from 5.59 ppm in the SM 
4.20 to 4.19 ppm in the product 4.44 was observed. A triplet at 7.02 ppm resulted from an upfield 
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shift of the allenyl acetate hydrogen of the SM from 7.32 ppm. Two new doublet of doublets 
appeared at 3.30 and 2.43 ppm and were assigned to geminal hydrogen atoms at position 9 on the 
cyclobutane ring; coupling constants of 2.7 Hz and COSY analysis showed that these two 
hydrogen atoms were coupled to the triplet at 7.02 ppm and to each other. This geminal coupling 
is indicative of a cyclobutane or cyclopentane ring. The hydrogen at position 3 in the SM 4.20 was 
a multiplet at 3.0 ppm and shifted upfield to become the triplet at 2.71 ppm in the product 4.44. 
Two methyl singlets were observed in the 1H NMR spectrum at 2.50 and 2.13 ppm, similar to the 
two acetyl methyl groups of the starting material. The third methyl singlet shifted from 1.83 ppm 
in the SM to 1.20 ppm in the product, suggesting it was no longer connected to an alkene. 
Multiplets at 2.25 and 2.03 ppm showed COSY correlations to the triplet at 2.71 ppm, 
demonstrating that these hydrogen atoms were at position 5; these multiplets also showed COSY 
correlations to the doublet of doublets at 1.92 ppm and the doublet of triplets at 1.55 ppm, so these 
resonances were assigned to the protons at position 6 of the product 4.44. DEPT and HSQC spectra 
confirmed that position 5 was a CH2 group correlating to the 1H NMR resonances for geminal 
hydrogens at 2.25 and 2.03, while the resonances at 1.92 and 1.55 were a CH2 corresponding to 
position 6. A singlet at 1.04 ppm of the 1H NMR integrates for 21 and corresponds to the hydrogens 
of the triisopropyl silyl group.  
13C NMR showed three carbonyl peaks at 174.4, 170.3, and 167.9 ppm corresponding to 
the lactam carbonyl and the two acetyl groups. The central allene carbon of the allenyl acetate SM 
4.20 at 189.7 was gone. Only two olefin resonances were observed at 129.2 and 126.6 ppm 
compared to five olefin resonances in the SM (189.9, 142.7, 122.5, 114.7, and 110.8), indicating 
that the allene and α-methylene of the lactam were transformed in the reaction. The alkyne carbon 
resonances at 105.3 and 85.6 ppm did not change from SM to product. Two new quaternary 
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carbons at 59.9 and 57.2 ppm were identified from their absence in HSQC and DEPT spectra. The 
acetyl methyl groups (positions 17 and 18) were identified as the peaks at 21.0 and 25.4 ppm by 
their single HMBC correlations to the carbonyl peaks at 170.3 and 167.9 ppm (positions 16 and 
19) respectively, and HSQC correlations to the 1H NMR resonances at 2.50 and 2.13 ppm. HSQC 
and DEPT helped identify the carbons at positions 3 and 4 as the resonances at 51.2 and 51.6 ppm. 
HSQC was also used to assign the 13C NMR resonance at 20.7 to the methyl group at position 15 
and the resonance at 28.4 ppm to position 9 in the product 4.44. 
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Table 4.2. NMR Data for [2 + 2] cycloaddition product 4.44. 
 
Position δC, Type δH, mult., (J in Hz) HMBC COSY 
1 174.4, C     
2 59.9, C     
3 51.2, CH 2.71, t, (7.0) 4, 6, 9, 11 H-4, H-5a,b 
4 51.6, CH 4.19, d, (7.5) 5, 11, 12 H-3 
5 30.0, CH2 a 2.29-2.22, m 2, 6, 7 
H-3, H-5b, H-
6a,b 
   b 2.05-2.01, m  
H-3, H-5a, H-
6a,b 
6 38.5, CH2 a 1.92, dd, (6.5, 13.3) 7, 8, 13  H-5a,b, H-6b 
   b 1.56, dt, (6.5, 13.3)  H-5a,b, H-6a 
7 57.2, C     
8 126.7, C     
9 28.4, CH2 a 3.30, dd, (2.7, 17.0) 1, 4, 8, 10 H-9b, H-10 
   b 2.43, dd, (2.7, 17.0)  H-9a 
10 129.2, CH 7.02, t, (2.7) 8, 9 H-9a,b 
11 105.4, C     
12 85.6, C     
13 20.7, CH3 1.20, s 2, 6, 7, 8,    
14 18.7, CH3 1.04, s 15   
15 11.2, CH 1.04, s 14   
16 167.9, C     
17 21.0, CH3 2.13, s 19   
18 25.4, CH3 2.50, s 16   
19 170.3, C       
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The key HMBC correlations show that the hydrogen at C-3 correlates to the carbons at C-
4, 6, 9, and 11 and the hydrogen at position 4 correlates to the carbon at C-5 and the two alkyne 
carbons at C-11 and 12. The hydrogens at C-5 correlate to quaternary carbons 2 and 7, as do the 
hydrogens of the methyl group at C-15. The hydrogens at C-13 correlate to the alkene carbon at 
position 8, as do the hydrogens from C-9 and 6. The hydrogens on C-9 correlate to the carbonyl 
C-1 and the alkene C-10. 
 
 
Figure 4.3. Important COSY and HMBC correlations used to confirm the structure of [2 + 2] 
cycloaddition product. 
 
4.8. CONCLUSION 
 
These literature examples are representative of the different conditions to promote the [2 + 2] 
cycloaddition between an allene and an alkene to form cyclobutane derivatives. Various 
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mechanisms are invoked in the [2 + 2] cycloadditions of allenes and alkenes depending on the 
conditions. These mechanisms involve diradicals, under photochemical and thermal conditions, or 
ionic intermediates under Lewis acidic or gold-catalyzed conditions. Although ionic intermediates 
are less commonly invoked in thermally-induced reactions, the presence of the acetate on the allene 
of our substrates is unprecedented in the literature on [2 + 2] cycloadditions of allenes. Considering 
that the [2 + 2] cycloaddition appears to be shut down with less electrophilic alkenes, it is more 
likely that the electron-rich allenyl acetate adds to the α-methylene-γ-lactam via an ionic process 
rather than a diradical process. Considering that the cycloaddition occurred at rt in the presence of 
a rhodium catalyst, the cationic rhodium(I) could be acting as a Lewis acid by coordinating to the 
lactam carbonyl, and thus increasing the electrophilicity of the α-methylene moiety. 
 The [2 + 2] cycloaddition of allenyl acetates with electron poor alkenes could offer a useful 
method for methylenecyclobutane formation, although further study is needed to examine the 
scope and synthetic utility of this reaction. Additionally, it was shown that the APKR could be 
favored over the [2 + 2] cycloaddition when less electron poor α-methylene-γ-lactams, such as 
those containing a secondary amide, were subjected to the APKR conditions 
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APPENDIX A 
EXPERIMENTAL PROCEDURES AND COMPOUND CHARACTERIZATION DATA 
1. General Methods 
2. General Procedures 
i. General Procedure A: α-Methylene Lactam Formation from 
Allylboronate 
ii. General Procedure B: Hydrolysis of Ketal 
iii. General Procedure C: Addition of Ethynyl Magnesium Bromide to 
Ketone 
iv. Acetylation of Alcohol with Triethylamine, Dimethylaminopyridine, 
and Acetic Anhydride 
v. General Procedure D: Formation of Propargyl Pivalate from 
Propargyl Alcohol 
vi. General Procedure E: Conversion of Propargyl Ester to 1,1-
Disubstituted Allenes Using (Triphenylphosphine)copper Hydride 
Hexamer 
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vii. General Procedure F: Removal of Triisopropyl silyl (TIPS) 
Substituent from Alkyne 
viii. Protection of Lactam Nitrogen with tert-Butyl Carbonate 
ix. General Procedure G: Arylation of Lactam Nitrogen with Aryl 
Iodides 
x. General Procedure H: Allenic Pauson-Khand Reaction (Slow 
Addition of Allene-yne to Rhodium(I) Catalyst) 
xi. General Procedure I: Alternative Procedure for Allenic Pauson-
Khand Reaction 
xii. General Procedure J: Acetylation of Lactam Nitrogen 
xiii. General Procedure K: Monitoring the Reaction of α-Methylene-γ-
lactams with Cysteamine by 1H NMR 
xiv. Hetero-Michael Addition of tert-Butyl Thiol to an α-Methylene-γ-
lactam 
xv. General Procedure L: Formation of Allenyl Acetates via Formal [3,3] 
Sigmatropic Rearrangement of Propargyl Acetates 
xvi. Allenic Pauson-Khand Reaction of Allenyl Acetates Accompanied by 
a [2+2] Cycloaddition  
General Methods 
Commercially available compounds were used as received unless otherwise noted. 
Dichloromethane (DCM), tetrahydrofuran (THF), and diethyl ether (Et2O) were purified by 
passing through alumina using the Sol-Tek ST-002 solvent purification system. Triethylamine 
was distilled from calcium hydride (CaH2) and stored over 4 Å molecular sieves. Acetic 
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anhydride (Ac2O) was shaken with phosphorus pentoxide (P2O5), decanted, fractionally distilled 
from anhydrous potassium carbonate (K2CO3) and stored over 4 Å molecular sieves. 
Hexamethylphosphoramide (HMPA) was vacuum distilled from CaH2 and stored over 4 Å 
molecular sieves. Deuterated chloroform (CDCl3) was stored over anhydrous K2CO3. All 
reaction temperatures designated are bath temperatures. Silica gel (40-63 μm particle size, 60 Å 
pore size) purchased from Sorbent Technologies was used for the purification of compounds by 
flash chromatography. TLC analyses were performed on Silicycle SiliaPlate G silica gel glass 
plates (250 μm thickness). 1H NMR and 13C NMR spectra were recorded on Bruker Avance 300 
MHz, 400 MHz, or 500 MHz spectrometers. Spectra were referenced to residual chloroform 
(7.26 ppm, 1H, 77.16 ppm, 13C). Chemical shifts are reported in ppm, multiplicities are indicated 
by s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet), p (pentet), and m (multiplet). 
Coupling constants, J, are reported in hertz (Hz). All NMR spectra were obtained at rt unless 
otherwise specified. IR spectra were obtained using a Nicolet Avatar E.S.P. 360 FT-IR. ESI mass 
spectroscopy was performed on a Waters Q-TOF Ultima API, Micromass UK Limited high 
resolution mass spectrometer. 
Synthesis of Allylboronate xx 
 
  
 
   
 
 
 
 
  
    
      
   
  
  
Hex-5-yn-2-one  (3.64): Hexynone 3.64 was  synthesized  according  a  literature  procedure.174 A 
flame-dried,  250-mL,  single-necked,  round-bottomed  flask,  equipped  with  a  magnetic  stir  bar, 
septum,  and  nitrogen  inlet  needle  was  charged  with  2,4-pentanedione 3.63 (30  mL,  290  mmol)
and  ethanol  (120  mL,  2.2  M).  Propargyl  chloride  (37  mL,  260  mmol)  was added  via  syringe 
followed by potassium carbonate (48 g, 350 mmol) in a single portion. The septum was removed 
and a reflux condenser equipped with a septum and nitrogen inlet needle was attached, and the 
reaction was heated to reflux in an 85 °C oil bath for 24 h. Upon completion of the reaction as 
observed by TLC, the mixture was cooled to rt and filtered via vacuum filtration to remove the 
solids.  The  solid  was  washed  with  ethyl  acetate.  Ethyl  acetate  and  ethanol  were  removed  by 
simple distillation at atmospheric pressure. The residue was diluted with diethyl ether (100 mL), 
transferred  to  a  separatory  funnel,  washed  with  deionized  water  (50  mL),  then  brine  (50  mL), 
dried  over  magnesium  sulfate,  gravity  filtered,  and  concentrated  by  simple  distillation  at 
atmospheric  pressure.  The  residue  was  further  purified  by  simple,  vacuum  distillation  (45 
mmHg, 85-90 °C) to give 12.5 g of product in a 49% yield. The spectral data matched literature 
values.174
Data for 3.64: (PAJ 6-104, 12.5 g, 49%)
1H NMR (300 MHz, CDCl3)
δ 2.67, (t, J = 7.2 Hz, 2H), 2.42 (dt, J = 2.7, 7.1 Hz, 2H), 2.16 (s, 3H), 1.93 (t, J = 
2.7 Hz, 1H) ppm
13C NMR (100 MHz, CDCl3)
δ 206.3, 82.7, 68.6, 42.0, 29.8, 12.8 ppm
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TLC  Rf = 0.46 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
 
 
 
 
  
   
    
   
 
2-(But-3-ynyl)-2-methyl-1,3-dioxolane  (3.65). Following  a  procedure  analogous  to  that 
previously  reported,175 a  flame-dried,  200-mL,  single-necked,  round-bottomed  flask  equipped 
with  a  magnetic  stir  bar  was  charged  with  hex-5-yn-2-one 3.64 (12.5  g,  131  mmol),  benzene
(130 mL), ethylene glycol (8.8 mL, 160 mmol), and p-toluenesulfonic acid (0.497 g, 2.61 mmol)
in  that  order.  A  Dean-Stark  trap  and  reflux  condenser  were  attached  and  the  solution  was 
refluxed  in  a  100 °C  oil  bath.  After  15  h,  TLC  showed  complete  consumption of  the  starting 
material. The solution was allowed to cool to rt, diluted with diethyl ether (80 mL), transferred to 
a separatory funnel, then washed successively with saturated sodium bicarbonate (100 mL) and 
brine  (100  mL).  The  organic  layer  was  dried  over  magnesium  sulfate,  gravity  filtered,  and 
diethyl  ether  and  benzene  were  removed  by  simple  distillation  at  atmospheric  pressure. 
Following the removal of solvent, the product was purified by vacuum distillation at 30 mmHg. 
Two  fractions  were  collected, the  first  contained  benzene  with  trace  amounts  of  product  (bp  = 
40-50 °C) and the second contained product with less than 10% benzene (bp = 113-120 °C, 13.0 
g,  71%),  as  determined  by  integration  of  the  benzene  resonance  at  7.19  and  terminal  alkyne 
resonance at 1.87 ppm.
Data for 3.65: (PAJ 6-106, 13.0 g, 71%)
1H NMR (300 MHz, CDCl3)
δ 3.96-3.86 (m, 4H), 2.25 (dt, J = 2.7, 7.5 Hz, 2H), 1.92-1.88 (m, 2H), 1.87 (s,
1H) 1.30 (s, 3H) ppm
13C NMR (100 MHz, CDCl3)
190
 
  
  δ 109.2, 84.5, 67.9, 65.0 (2C), 38.1, 23.9, 13.3 ppm 
TLC  Rf = 0.55 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
 
 
 
 
 
  
   
     
  
Methyl 5-(2-methyl-1,3-dioxolan-2-yl)pent-2-ynoate (3.61): Following a procedure analogous 
to that previously reported,176 a flame-dried, 200-mL, single-necked, round-bottomed flask under 
a nitrogen atmosphere equipped with a magnetic stir bar, septum, and nitrogen inlet needle, was 
charged  with  alkyne 3.65 (2.10  g,  15.0  mmol)  and  tetrahydrofuran  (75  mL)  then  cooled  to -78
°C. n-Butyl lithium (1.6 M in hexanes, 11.3 mL, 18.0 mmol) was added dropwise to the solution 
of  alkyne  via  syringe  and  the  reaction  was  stirred  for  an  additional  30  min  at -78 °C  after  the 
addition  was  complete.  Methyl  chloroformate  (1.5  mL,  19.5  mmol)  was added  dropwise  via 
syringe and stirred for 30 min at -78 °C before allowing the reaction to warm to rt for 3 h when it 
was complete by TLC. The reaction was quenched by addition of saturated aqueous ammonium 
chloride  (30  mL)  and  the  solution  was  transferred  to  a  separatory  funnel.  The  layers  were 
separated, and the aqueous layer was extracted with diethyl ether (3 x 50 mL). The organic layers 
were  combined,  washed  with  brine  (50  mL),  dried  over  magnesium  sulfate,  gravity  filtered, 
concentrated  by  rotary  evaporation  (30 °C)  and  purified  by  silica  gel  flash  column 
chromatography eluting with 20% diethyl ether in hexanes to yield alkynoate 3.61 (2.14 g, 72%)
as a clear liquid.
Data for 3.61: (PAJ 6-62, 2.14 g, 72%)
1H NMR (300 MHz, CDCl3)
δ 3.98-3.89 (m, 4H), 3.74 (s, 3H), 2.42 (t, J = 7.9 Hz, 2H), 1.95 (t, J = 7.9 Hz,
2H), 1.31 (s, 3H) ppm
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13C NMR  (100 MHz, CDCl3) 
  δ 154.4, 108.8, 89.7, 72.7, 65.0 (2C), 52.7,36.9, 24.0, 13.6 ppm 
TLC  Rf = 0.23 (20% Et2O/hexanes) [silica gel, UV, KMnO4] 
 
2-(Chloromethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.62): Following a procedure 
analogous to those previously reported,181 a flame-dried, single-necked, 250-mL, round-
bottomed flask equiped with a stir-bar, septum, and nitrogen inlet needle was charged with 
trimethyl borate (8.6 mL, 77 mmol) and bromochloromethane (5.5 mL, 85 mmol) and cooled to -
78 °C. n-Butyl lithium (1.6 M in hexanes, 53 mL, 85 mmol) was added dropwise via syringe 
pump over 35 min. Upon completion of addition, the solution was maintained at -78 °C for an 
additional 30 min. Chlorotrimethylsilane (12 mL, 92 mmol) was added dropwise at -78 °C and 
the reaction was allowed to warm to rt by removal of the dry ice/acetone bath. The reaction stood 
for 16 h (without stirring), then pinacol (10.0 g, 85 mmol) was added and the reaction was stirred 
for 1 h at rt. The reaction was poured into a separatory funnel containing water (100 mL) and 
diethyl ether (100 mL). The organic layer was separated, washed with brine (50 mL), dried over 
magnesium sulfate, gravity filtered, concentrated by rotary evaporation (37 °C) and the residue 
transferred to a 25-mL, single-necked, round-bottomed flask. This residue was fractionally 
distilled under reduced pressure (14 mmHg, 108-115 °C) using a short, jacketed vigreux 
fractionating column connected to a short-path distillation head to give chloromethylpinacol 
boronate 3.62 as a colorless liquid (8.89 g, 65%).  
Data for 3.62: (PAJ 6-66, 8.89 g, 65%) 
  
1H NMR  (300 MHz, CDCl3) 
  δ 2.94 (s, 2H), 1.28 (s, 12H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 84.7, 24.8 (4C) ppm 
11B NMR (128 MHz, CDCl3) 
  δ 31.42 ppm 
IR  3459, 2980, 2935, 1352, 1273, 1143 cm-1 
TLC  Rf = 0.45 (10% Et2O/hexanes) [silica gel, KMnO4] 
 
 
 
Methyl  5-(2-methyl-1,3-dioxolan-2-yl)-2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)methyl)pent-2-enoate  (3.60): Prepared  using  a  procedure  analogous  to  that  previously 
reported.117, 137 A  flame-dried,  100-mL,  single-necked,  round-bottomed  flask  equipped  with  a 
magnetic stir bar, septum, and nitrogen inlet needle was charged with copper iodide (48 mg, 0.25 
mmol)  and  tetrahydrofuran  (8.4  mL),  then  cooled  to -30 °C.  Methyl  lithium  (1.6  M  solution  in 
diethyl  ether,  0.16  mL,  0.25  mmol)  was  added  dropwise  over  1  min.  Upon  completion  of 
addition the solution was maintained at -30 °C for an additional 20 min at which time it became 
dark brown to black in color. Toluene (18 mL) was added slowly to the reaction mixture over 10 
min  via  syringe,  followed  by  hexamethylphosphoramide  (0.88  mL,  5.1  mmol,  distilled  from 
calcium  hydride  and  stored  over  4  Å  molecular  sieves).  Diisobutylaluminum  hydride  (1  M 
solution in hexanes, 3.8 mL, 3.8 mmol) was added dropwise via syringe over 10 min at -30 °C, a
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temperature that was maintained for an additional 2 h. Alkynoate 3.61 (500 mg, 2.52 mmol) in 
toluene (12 mL) was added dropwise to the reaction mixture over 10 min via syringe, and the 
solution was allowed to warm to -20 °C, a temperature that was maintained for 5 h. The reaction 
was difficult to monitor by TLC, as the alkene byproduct and alkyne starting material had the 
same Rf, so aliquots were taken and 1H NMR was used to follow the reaction progress. Freshly 
distilled chloromethyl pinacol boronate 3.62 (623 mg, 3.53 mmol) in toluene (6 mL) was added 
dropwise via syringe over 5 min to the solution and this was allowed to warm to rt and stirred 16 
h. The reaction was diluted with diethyl ether (10 mL) and slowly quenched by dropwise 
addition of 1 N hydrochloric acid (2 mL) over 5 min. The layers were separated, and the organic 
layer was washed sequentially with 1 N hydrochloric acid (3 x 3 mL), saturated aqueous sodium 
bicarbonate (1 x 5 mL), water (2 x 5 mL), and brine (1 x 10 mL), dried over magnesium sulfate, 
gravity filtered, concentrated by rotary evaporation, and eluted through a plug of silica gel with 
20% diethyl ether in hexanes to yield allylboronate 3.60 (755 mg, 88%) as a pale yellow oil and 
a 2:1 ratio of Z:E isomers. The Z:E ratio was determined by integration of the alkene resonances 
at 5.92 ppm for the Z-isomer and 6.71 for the E-isomer. The allylboronate 3.60 was 
contaminated with about 5% of alkene byproducts 3.66 (2:1 Z:E), as determined by integration 
of the alkene resonances at 6.25 (dt) and 5.75 (dt) ppm for the Z-alkene and 6.96 (dt) and 5.90 
(dt) for the E-alkene. Purification of the allylboronate 3.60 from the alkene 3.66 by column 
chromatography resulted in significantly decreased yields of the allylboronate, so the mixture 
was generally taken on to the next step. 
 This reaction was repeated 10 times with an average yield of 76 ± 11% and gave Z:E 
ratios of 2:1 to 3:1. The amount of alkene byproduct generally ranged from 10-20%, and this 
reaction could be performed on gram scale. For example, alkynoate 3.61 (3.02 g, 15.1 mmol), 
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chloromethylpinacolboronate 3.62 (3.74 g, 21.2 mmol), copper iodide (288 mg, 1.51 mmol), 
methyl lithium (1.5 M in Et2O, 1.1 mL, 1.5 mmol), diisobutylaluminum hydride (1 M in hexanes, 
23 mL, 23 mmol), hexamethylphosphoramide (5.3 mL, 30 mmol), toluene (216 mL), and THF 
(50 mL) provided allylboronate 3.60 (3.73 g, 73%, 2:1 Z:E containing ~10% of the alkene 
byproduct) as a pale yellow oil.  
Data for 3.60: (PAJ 6-74 755 mg, 88%, Characterized as a mixture of Z:E isomers, resonances 
for Z-isomer; PAJ 8-20, 3.32 g, 64%, 2:1 Z:E; PAJ 7-138, 1.35 g, 78%, 2:1 Z:E) 
1H NMR  (400 MHz, CDCl3) 
  δ 5.92 (t, J = 7.6 Hz, 1H), 3.92-3.88 (m, 4H), 3.67 (s, 3H), 2.56 (app q, J = 7.6  
  Hz, 2H), 1.81 (d, J = 13.6 Hz, 2H), 1.77-1.71 (m, 2H), 1.30 (s, 3H), 1.20 (s, 12H) 
  E-isomer, where distinguishable 
  6.71 (t, J = 7.6 Hz, 1H), 2.25-2.19 (m, 2H) 
13C NMR  (100 MHz, CDCl3) 
δ 168.2, 142.9, 140.6, 129.3, 128.0, 109.9, 83.4, 64.8 (2C), 51.2, 38.6, 24.8, 24.0 
(4C) ppm 
  E-isomer 
δ 168.7, 142.9, 141.0, 129.2, 128.0, 109.6, 83.3, 64.8 (2C), 51.7, 37.8, 24.7, 23.7 
(4C) ppm 
IR  (thin film) 
  2981, 2884, 2240, 1716, 1645, 1437, 1351, 1257, 1145, 1055 cm-1 
HRMS  TOF MS ES+ [M+H]: C17H30BO6 
  Calc: 341.21300 Found: 341.21183 
TLC  Rf = 0.31 (25% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde stain] 
  
 
3-Phenylpropiolaldehyde (3.59): Propynal 3.59 was prepared as previously described and the 
spectral data matched that reported.235 Active γ-manganese dioxide was prepared from 
manganese sulfate and potassium permanganate according to the previously reported method.236 
Alternatively, propynal 3.59 was prepared according to the procedure for TIPS propynal (vide 
infra) in similar yields.183 
Data for 3.59: (PAJ 7-14, 75%) 
1H NMR  (400 MHz, CDCl3) 
  δ 9.43 (s, 1H), 7.62-7.60 (m, 2H), 7.51-7.47 (m, 1H), 7.43-7.39 (m, 2H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 177.0, 133.4 (2C), 131.4, 128.9 (2C), 119.6, 95.3, 88.6 ppm  
 
 
 
 
General Procedure A: α-Methylene Lactam Formation from Allylboronate
  This procedure was modified from the procedure reported by Hall and Elford.136 A 5-mL, 
single-necked,  round-bottomed  flask  equipped  with  a  magnetic  stir  bar,  septum,  and  nitrogen 
inlet  needle  was  charged  with  3-phenyl-1-propynal  (72  mg,  0.55  mmol)  and  ethanol  (1  mL). 
Ammonium hydroxide (28-30% ammonia in water, 0.74 mL) was added via syringe in a single 
portion.  The  nitrogen  inlet  needle  was  removed  and  the  reaction  was  stirred  for  20  min  at  rt.
Allylboronate 3.60 (171 mg, 0.50 mmol, 2:1 Z:E) in ethanol (1 mL) was added dropwise to the
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solution over 1 min and the reaction was stirred in the sealed flask for 5 h at rt. TLC showed 
consumption of the allylboronate, and the reaction was quenched by slow addition 1 N HCl (~5 
mL) until the pH was 1.5-2 (pH paper). The resulting solution was transferred to a separatory 
funnel and extracted with diethyl ether (4 x 10 mL). The combined organic layers were washed 
with brine (10 mL), dried over magnesium sulfate, gravity filtered, concentrated by rotary 
evaporation, and purified by silica gel flash column chromatography eluting with 30-50% ethyl 
acetate in hexanes to give lactams 3.74a (trans) and 3.74b (cis) (96 mg, 59%) in a 4:1 ratio. In 
some cases, the trans lactam was taken on as a single isomer or alternatively the mixture of trans 
and cis lactams could be taken on as a mixture and separated after formation of propargyl 
pivalates 3.113a (trans) and 3.113b (cis) with no difference in yields. The ratio of trans:cis 
isomeric ratio varied from 2-5:1. This reaction could be performed on a partially purified mixture 
of allylboronate 3.60 and alkene 3.66 isomers without significant effects on the yield, although 
purification became difficult when the allylboronate contained more than ~20% of alkene 
byproducts. 
This reaction was repeated 11 times with an average yield of 58 ± 13%. The ratio of 
trans:cis lactams ranged from 3:1 to 5:1, although the starting allylboronate was generally 2:1. It 
is unclear what the ratio of lactam products did not reflect the ratio of the starting allylboronate. 
This reaction could be performed on gram scale and 2 N HCl was also used to quench the 
reaction in some cases. For example, allylboronate 3.60 (1.66 g, 4.86 mmol, 2:1 Z:E), phenyl 
propynal 3.59 (696 mg, 5.35 mmol), ammonium hydroxide (28-30% NH3, 7.2 mL), and ethanol 
(20 mL) provided lactam 3.74a,b (1.38 g, 86%, 5:1 trans:cis) as a brown oil after column 
chromatography. Another example using allylboronate 3.60 (1.48 g, 4.35 mmol, 2:1 Z:E), phenyl 
propynal 3.59 (623 mg, 4.79 mmol), ammonium hydroxide (28-30% NH3, 6.7 mL), and ethanol 
  
(18 mL) provided 3 fractions after column chromatography: pure trans lactam 3.74a (349 mg, 
24%), a predominantly trans mixture of lactams 3.74a,b (380 mg, 27%, 3:1 trans:cis), and a 
predominantly cis mixture of lactams 3.74b (75 mg, 5%, 2:1 cis:trans). 
 
(4S*,5S*)-4-(2-(2-Methyl-1,3-dioxolan-2-yl)ethyl)-3-methylene-5-
(phenylethynyl)pyrrolidin-2-one (3.74a): 
Data for 3.74a: (PAJ 6-80B trans, 96 mg total, 59% overall, 2:1 trans:cis; Data for trans isomer, 
some baseline impurities were observed in the NMR spectra; PAJ 8-22, 1.38 g, 86%, 5:1 
trans:cis; PAJ 7-32, 349 mg, 24%, trans, 380 mg, 27%, trans:cis 3:1, 75 mg, 5%, cis:trans 2:1) 
1H NMR  (300 MHz, CDCl3) 
  δ 7.40-7.31 (m, 2H), 7.30-7.27 (m, 3H), 7.04 (bs, 1H), 6.10 (d, J = 2.8 Hz, 1H),  
  5.40, (d, J = 1.6 Hz, 1H), 4.24, (d, J = 4.0 Hz, 1H), 3.98-3.89 (m, 4H), 3.11-3.09  
  (m, 1H), 1.88-1.71 (m, 4H), 1.33 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 169.7, 142.2, 131.8 (2C), 128.7, 128.4 (2C), 122.3, 117.3, 109.7, 87.8, 84.5,  
  64.8 (2C), 48.8, 46.8, 35.8, 28.2, 24.1 ppm 
IR  (thin film) 
  2983, 1703, 1659, 1491, 1324, 1063 cm-1 
HRMS  TOF MS ES+ [M+H]: C19H22NO3 
  Calc: 312.1594 Found: 312.1585  
   TLC Rf = 0.17 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde stain]
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(4R*,5S*)-4-(2-(2-Methyl-1,3-dioxolan-2-yl)ethyl)-3-methylene-5-
(phenylethynyl)pyrrolidin-2-one (3.74b): 
Data for 3.74b: (PAJ 6-80B cis, 96 mg, 59%, 2:1 trans:cis overall, Data for cis isomer 
contaminated with about 30% of the trans isomer and some other baseline impurities) 
1H NMR  (400 MHz, CDCl3) 
δ 7.41-7.38 (m, 3H), 7.31-7.28 (m, 2H), 6.31 (br s, 1H), 6.11 (d, J = 2.4 Hz, 1H), 
5.39 (d, J = 2.4 Hz, 1H), 4.67 (d, J = 8.0 Hz, 1H), 3.93-3.87 (m, 4H), 3.12-3.08 
(m, 1H), 1.94-1.84 (m, 2H), 1.76-1.66 (m, 2H), 1.33 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 170.3, 141.8, 131.8 (2C), 129.0, 128.5 (2C), 122.3, 117.1, 109.9, 86.7, 85.0,  
  64.8, 64.7, 47.7, 42.7, 36.4, 24.7, 24.1 ppm 
IR  (thin film) 
  2983, 2245, 1704, 1659, 1490, 1321, 1269, 1062 cm-1   
HRMS  TOF MS ES+ [M+H]: C19H22NO3 
  Calc: 312.1594 Found: 312.1586 
TLC  Rf = 0.32 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
  3-(Triisopropylsilyl)  propiolaldehyde  (3.118): Aldehyde 3.118 was  prepared  as  previously
described and the spectral data matched.183
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Data for 3.118: (PAJ 7-2, 99%) 
1H NMR  (400 MHz, CDCl3) 
  δ 9.2 (s, 1H), 1.12-1.07 (m, 21H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 176.8, 104.6, 101.0, 18.6, 11.1 ppm 
 
 
  
 
 
 
 
  Prepared  according  to  general  procedure  A.  3-(Triisopropylsilyl)  propiolaldehyde  (340 
mg,  1.62  mmol)  ethanol  (6  mL),  ammonium  hydroxide  (28-30%  ammonia,  2.2  mL), 
allylboronate 3.60 (500  mg,  1.47  mmol,  15%  alkene 3.66,  2:1  Z:E)  were  stirred  for  5  h.  The 
reaction  was  quenched  with  2  N  HCl  (10  mL),  then  extracted  with  diethyl  ether  (3  x  20  mL). 
Column chromatography (gradient elution with 10-40% ethyl acetate in hexanes) provided trans- 
lactam 3.121a (126  mg,  18%),  cis-lactam 3.121b (23  mg,  3%,  contaminated  with  25%  trans 
isomer), and a 2.3:1 trans:cis mixture (217 mg, 31%) as yellow oils in a 53% overall yield and a 
ratio of 3.5:1 trans:cis lactams. The trans and cis isomers were separated for characterization, but 
in other cases the trans and cis isomers were not separated but taken on as a mixture.
  This  reaction  was  repeated  5  times  with  an  average  yield  of  75  ±  16%  and  good  be 
performed  on  gram  scale.  For  example,  allylboronate 3.60 (1.67  g,  4.86  mmol,  2:1  Z:E), 
triisopropylsilyl  propynal 3.118 (1.13  g,  5.35 mmol),  ammonium  hydroxide  (28-30%  NH3,  7.2 
mL), ethanol (20 mL), provided lactam 3.121a,b (1.72 g, 90%, 2:1 trans:cis) as a brown oil after
column chromatography.
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(4S*,5S*)-4-(2-(2-Methyl-1,3-dioxolan-2-yl)ethyl)-3-methylene-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.121a):  
Data for 3.121a: (PAJ 7-16, 366 mg, 53% overall, 3.5:1 trans:cis; Data for pure trans isomer; 
PAJ 8-120, 1.72 g, 90%, 2:1 trans:cis) 
1H NMR  (400 MHz, CDCl3) 
δ 6.06 (d, J = 2.6 Hz, 1H), 6.02 (br s, 1H), 5.37 (d, J = 2.6 Hz, 1H), 4.02 (d, J = 
5.2 Hz, 1H), 3.98-3.87 (m, 4H), 3.01-2.97 (m, 1H), 1.91-1.78 (m, 3H), 1.75-1.63 
(m, 1H), 1.31 (s, 3H), 1.05 (s, 21H) 
13C NMR  (100 MHz, CDCl3) 
  δ 169.3, 142.0, 117.0, 109.6, 106.0, 86.2, 64.9 (2C), 48.9, 47.4, 36.2, 27.7, 25.0,  
  18.7 (6C), 11.2 (3C) 
IR  (thin film) 
  2943, 2175, 1708, 1660, 1462, 1376, 1325, 1150, 1063 
HRMS  TOF MS ES+ [M+H]: C22H38NO3Si 
  Calc: 392.2616 Found: 392.2616  
TLC  Rf = 0.30 (50% EtOAc/hexanes) [silica gel, UV, KMnO4] 
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(4R*,5S*)-4-(2-(2-Methyl-1,3-dioxolan-2-yl)ethyl)-3-methylene-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.121b): 
Data for 3.121b: (PAJ 7-16, 366 mg, 53% overall, 3.5:1 trans:cis; NMR for cis isomer 
contaminated with 25% of the trans isomer) 
1H NMR  (300 MHz, CDCl3) 
  δ 6.23 (br s, 1H), 6.05 (d, J = 2.0 Hz, 1H), 5.34 (d, J = 2.0 Hz, 1H), 4.45 (d, J =  
  7.6 Hz, 1H), 3.95-3.79 (m, 4H), 3.00-2.97 (m, 1H), 1.90-1.82 (m, 3H), 1.80-1.70  
  (m, 1H), 1.31 (s, 3H), 1.02 (s, 21H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 170.3, 142.1, 116.8, 103.2, 109.9, 88.4, 64.8, 64.7, 47.9, 42.8, 36.4, 24.3, 23.9,  
  18.7 (6C), 11.2 (3C) ppm 
IR  (thin film) 
  3213, 2866, 2175, 1660, 1377, 1221, 1143, 1112 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H38NO3Si 
  Calc: 392.2616 Found: 392.2616  
TLC  Rf = 0.21 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4S*,5S*)-1-Methyl-4-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)-3-methylene-5 
(phenylethynyl)pyrrolidin-2-one (3.77): A flame-dried, 10-mL, single-necked, round-bottomed 
flask equipped with a magnetic stir bar, septum, and nitrogen inlet needle was charged with 
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trans-lactam 3.74a (337 mg, 1.03 mmol) dissolved in dimethylformamide (5.2 mL) and cooled to 
0 °C in an ice bath. Sodium hydride (60% in mineral oil, 62 mg, 1.5 mmol) was added in a single 
portion and the reaction was stirred 15 min at 0 °C. Iodomethane (0.13 mL, 2.1 mmol) was 
added dropwise over 1 min and the reaction was stirred at 0 °C for 15 min before removing the 
ice bath and allowing the reaction to warm to rt for 15 min. TLC showed consumption of the 
starting material, so it was quenched by pouring into a separatory funnel containing saturated 
aqueous ammonium chloride solution (20 mL). The mixture was extracted with diethyl ether (3 x 
25 mL). The organic layers were combined, washed with brine (10 mL), dried over magnesium 
sulfate, gravity filtered, concentrated by rotary evaporation, and purified by filtration through a 
plug of silica gel (elution with 50% ethyl acetate and hexanes) to provide the N-methyl lactam 
3.77 (225 mg, 67%) as a yellow oil. 
 This reaction was repeated 3 times with an average yield of 71 ± 4%. In one case ketal 
3.74a (430 mg, 1.3 mmol, 4:1 trans:cis), sodium hydride (60% in mineral oil, 105 mg, 2.6 
mmol), iodomethane (0.21 mL, 3.3 mmol), and DMF (7 mL) provided ketal 3.77 (321 mg, 71%, 
4:1 trans:cis) as a yellow oil after column chromatography. 
Data for 3.77: (PAJ 6-192, 225 mg, 67%, contaminated with 6% of the cis isomer and some 
other baseline impurities; 7-106, 321 mg, 71%, 4:1 trans:cis) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.42-7.40 (m, 2H), 7.34-7.31 (m, 3H), 6.08 (d, J = 2.4 Hz, 1H), 5.36 (d, J = 2.4  
  Hz, 1H), 4.12 (d, J = 4.0 Hz, 1H), 3.99-3.90 (m, 4H), 3.05-3.04 (m, 1H), 3.03 (s,  
  3H), 1.87-1.69 (m, 4H), 1.33 (s, 3H) 
13C NMR  (100 MHz, CDCl3) 
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  δ 167.2, 142.3, 131.8 (2C), 128.9, 128. 5 (2C), 122.2, 116.4, 109.7, 86.2, 85.7,  
  64.9 (2C), 55.4, 44.6, 35.9, 29.8, 28.5, 24.1 
IR  (thin film) 
  2925, 1697, 1660, 1427, 1396, 1145, 1082 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H24NO3 
  Calc: 326.1751 Found: 326.1752 
TLC  Rf = 0.39 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
General Procedure B: Hydrolysis of Ketal 
 
A 10-mL, single-necked, round-bottomed flask equipped with a magnetic stir bar was 
charged with ketal 3.74a,b (100 mg, 0.304 mmol, 5:1 trans:cis), acetone (4 mL), and water (0.3 
mL). Pyridinium para-toluene sulfonate (38 mg, 0.152 mmol) was added in a single portion, a 
reflux condenser capped with a septum and nitrogen inlet needle was attached and the reaction 
was refluxed for 16 h in a 70 °C oil bath. Upon completion of the reaction as observed by TLC, 
the reaction was allowed to cool to rt, diluted with ethyl acetate (20 mL), transferred to a 
separatory funnel, then washed consecutively with water (2 x 5 mL) and brine (1 x 5 mL), dried 
over magnesium sulfate, gravity filtered, concentrated by rotary evaporation, then eluted through 
a plug of silica gel with 75% ethyl acetate in hexanes to yield ketone 3.58a,b (63 mg, 73%, 5:1 
trans:cis) as a light yellow oil. In larger scale reactions, acetone was removed by rotary 
evaporation prior to dilution with ethyl acetate. The product contained 16% of the cis lactam 
  
isomer by integration of the trans lactam resonance for Ha at 4.21 ppm and the cis lactam 
resonance of Ha at 4.68 ppm.  
This reaction was repeated 9 times with an average yield of 83 ± 8%. The trans and cis 
isomers were generally taken on as a mixture and only isolated for characterization. This reaction 
could be performed on gram scale. For example, ketal 3.74a,b (1.66 g, 5.33 mmol, 3:1 trans:cis), 
pyridinium para-toluenesulfonate (670 mg, 2.7 mmol), acetone (72 mL), and water (4 mL) 
provided ketone 3.58a,b (1.3 g, 91%, 3:1 trans:cis) as a pale yellow oil after column 
chromatography. 
 
 
  
   
    
      
   
    
  
   
   
   
  
(4S*,5S*)-3-Methylene-4-(3-oxobutyl)-5-(phenylethynyl)pyrrolidin-2-one (3.58a):
Data for 3.58a: (PAJ 6-150, 63 mg, 73%, NMR contained 16% of the cis isomer)
1H NMR (300 MHz, CDCl3)
δ 7.38-7.37 (m 2H), 7.32-7.29 (m, 3H), 6.77 (br s, 1H). 6.11 (d, J = 2.4 Hz, 1H), 
5.40 (d, J = 2.4 Hz, 1H), 4.21 (d, J = 4.8 Hz, 1H), 3.16-3.08 (m, 1H), 2.64 (t, J = 
7.8 Hz, 2H), 2.14 (s, 3H), 2.14-2.13 (m, 1H), 1.92-1.80 (m, 1H) ppm
Cis isomer: 4.68 (d, J = 7.5 Hz, 1H)
13C NMR (100 MHz, CDCl3)
δ 207.5, 169.5, 141.8, 131.8 (2C), 128.9, 128.5 (2C), 122.1, 117.4, 87.4, 84.9,
48.8, 46.1, 39.9, 30.3, 27.0 ppm
IR (thin film)
3434, 2088, 1643 cm-1
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HRMS  TOF MS ES+ [M+H]: C17H18NO2 
  Calc: 268.1344 Found: 268.1332  
TLC  Rf = 0.32 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4R*,5S*)-3-Methylene-4-(3-oxobutyl)-5-(phenylethynyl)pyrrolidin-2-one (3.58b): Prepared 
according to general procedure B. Ketal 3.74a,b (426 mg, 1.30 mmol, 3:1 trans:cis), pyridinium 
para-toluene sulfonate (163 mg, 0.648 mmol), acetone (18 mL), and deionized water (1 mL) 
provided ketone 3.58a,b (307 mg, 88%, 3:1 trans:cis) as a clear oil after filtration through silica 
gel (elution with 50% ethyl acetate in hexanes). The cis isomer was isolated for characterization. 
Data for 3.58b: (7-46, 3:1 trans:cis, 307 mg, 88% overall, NMR for cis isomer contained 10% 
trans isomer) 
1H NMR  (300 MHz, CDCl3) 
  δ 7.39-7.37 (m 2H), 7.34-7.30 (m, 3H), 6.39 (br s, 1H). 6.13 (d, J = 2.3 Hz, 1H),  
  5.42 (d, J = 2.3 Hz, 1H), 4.70 (d, J = 7.5 Hz, 1H), 3.17-3.13 (m, 1H), 2.72-2.58  
  (m, 2H), 2.16 (s, 3H), 2.15-2.09 (m, 2H) ppm   
13C NMR  (100 MHz, CDCl3) 
  δ 207.9, 169.9, 141.5, 131.9 (2C), 129.0, 128.6 (2C), 122.0, 117.6, 87.2, 84.6,  
  47.5, 41.7, 40.5, 30.2, 24.5 ppm 
IR  (thin film) 
  3245, 2927, 1708, 1657, 1418, 1360, 1273, 1166 cm-1 
HRMS  TOF MS ES+ M+H]: C17H18NO2
206
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  Calc: 268.1332 Found: 268.1327 
TLC  Rf = 0.28 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4S*,5S*)-1-Methyl-3-methylene-4-(3-oxobutyl)-5-(phenylethynyl)pyrrolidin-2-one (3.78): 
Prepared according to general procedure B. trans-Ketal 3.77 (290 mg, 0.882 mmol, contaminated 
with 6% cis isomer), pyridinium para-toluene sulfonate (111 mg, 0.441 mmol), acetone (12 mL), 
and water (0.6 mL) provided the product 3.78 (164 mg, 66%) as a yellow oil after column 
chromatography. Another example of this reaction used ketal 3.77 (490 mg, 1.4 mmol, 5:1 
trans:cis), pyridinium para-toluenesulfonate (180 mg, 0.72 mmol, acetone (19 mL), and water (1 
mL) to provide trans ketone 3.78 (310 mg, 73%, 19:1 trans:cis) and cis ketone (not shown, 18 
mg, 4%, 7:1 cis:trans) each as clear oils after column chromatography. 
Data for 3.78: (PAJ 6-196, 164 mg, 66%, NMR contaminated with ~5% of cis isomer; PAJ 7-
108, 328 mg, 77% total) 
1H NMR  (500 MHz, CDCl3) 
  δ 7.42-7.40 (m, 2H), 7.35-7.32 (m, 3H), 6.11 (d, J = 2.5 Hz, 1H), 5.36 (d, J = 2.5  
  Hz, 1H), 4.08 (d, J = 4.5 Hz, 1H), 3.08-3.04 (m, 1H), 3.03 (s, 3H), 2.66-2.63 (app. 
  t, J = 7.5 Hz, 2H), 2.17 (s, 3H), 2.12-2.04 (m, 1H), 1.90-1.84 (m, 1H) ppm  
13C NMR  (125 MHz, CDCl3) 
  δ 207.5, 167.1, 142.0, 131.9 (2C), 129.0, 128.6 (2C), 122.1, 116.5, 86.1, 85.9,  
  55.4, 44.1, 40.1, 30.3, 28.5, 27.3 ppm 
IR  (thin film) 
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  2924, 1696, 1424, 1396, 1265 cm-1 
HRMS  TOF MS ES+ M+H]: C18H20NO2 
  Calc: 282.1489 Found: 282.1489 
TLC  Rf = 0.48 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4S*,5S*)-3-Methylene-4-(3-oxobutyl)-5-((triisopropylsilyl)ethynyl)pyrrolidin-2-one 
(3.122a): Prepared according to general procedure B. Ketal 3.121a (120 mg, 0.306 mmol, pure 
trans), pyridinium para-toluene sulfonate (39 mg, 0.15 mmol), acetone (4.1 mL), and water (0.3 
mL) provided ketone 3.122a (74 mg, 70%) as a pale yellow oil after filtration through a plug of 
silica (elution with 50% ethyl acetate in hexanes).  
 This reaction was repeated 6 times with an average yield of 73 ± 9%. The cis and trans 
isomers were generally taken on as a mixture but were isolated for characterization in some 
cases. The trans:cis ratio reflected the ratio of the starting ketal. This reaction could be performed 
on gram scale with good yields. For example, ketal 3.121a,b (1.74 g, 4.4 mmol, 2:1 trans:cis), 
pyridinium para-toluenesulfonate (552 mg, 2.2 mmol), acetone (60 mL), and water (3 mL) 
provided ketone 3.122a,b (1.05 g, 68%, 2:1 trans:cis) as a pale yellow oil after column 
chromatography. Another example used ketal 3.121a,b (350 mg, 0.89 mmol, 2:1 trans:cis), 
pyridinium para-toluenesulfonate (112 mg, 0.45 mmol), acetone (13 mL), and water (1 mL) to 
provide ketone 3.122a,b (265 mg, 85%, 1.5:1 trans:cis) as a clear oil after column 
chromatography. 
  
Data for 3.122a: (PAJ 7-20, 74 mg, 70%; 8-124, 1.05 g, 2:1 trans:cis; 7-146, 265 mg, 85%, 1.5:1 
trans:cis) 
1H NMR  (400 MHz, CDCl3) 
δ 6.26 (br s, 1H), 6.08 (d, J = 2.6 Hz, 1H), 5.38 (dd, J = 2.6 Hz, 0.8 Hz, 1H), 4.00 
(d, J = 4.8 Hz, 1H), 3.03-2.97 (m, 1H), 2.68-2.58 (m, 2H), 2.16 (s, 3H), 2.15-2.06 
(m, 1H), 1.85-1.75 (m, 1H), 1.05 (s, 21H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 207.3, 169.1, 141.6, 117.2, 105.9, 86.5, 48.9, 46.6, 40.3, 30.1, 26.9, 18.7 (6C),  
  11.2 (3C) ppm   
IR  (thin film) 
  2943, 2865, 2175, 1709, 1659, 1463, 1366, 1323 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H34O2NSi 
  Calc: 348.2359 Found: 348.2373  
TLC  Rf = 0.48 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
 
 
(4R*,5S*)-3-Methylene-4-(3-oxobutyl)-5-((triisopropylsilyl)ethynyl)pyrrolidin-2-one
(3.122b): Prepared  according  to  general  procedure  B.  Ketal 3.121a,b (1.72  g,  4.39  mmol,  4:1 
trans:cis),  pyridinium para-toluene  sulfonate  (552  mg,  2.20  mmol),  acetone  (60  mL),  and 
deionized  water  (3  mL)  provided  ketone 3.122a,b (1.22  g,  80%,  4:1  trans:cis)  and  ketone
3.122a,b (30  mg,  2%,  5:1  cis:trans)  each  as  a  pale  yellow  oil  after  column  chromatography
(gradient elution with 25-75% ethyl acetate in hexanes).
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Data for 3.122b: (PAJ 8-28, 1.25 g, 80%, 4:1 trans:cis, NMR contained ~20% of trans isomer) 
1H NMR  (400 MHz, CDCl3) 
  δ 6.48 (br s, 1H), 6.07 (d, J = 2.4 Hz, 1H), 5.37 (d, J = 2.4 Hz, 1H), 4.46 (d, J =  
  8.0 Hz, 1H), 3.04-2.99 (m, 1H), 2.69-2.51 (m, 2H), 2.14 (s, 3H), 2.13-1.97 (m,  
  2H), 1.0 (s, 21H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 207.5, 170.0, 141.5, 117.3, 102.8, 88.8, 47.5, 41.3, 40.5, 30.0, 24.3, 18.6 (6C),  
  11.2 (3C) ppm 
IR  (thin film) 
  3175, 2909, 2832, 2145, 1690, 1639, 1446, 1348, 1308, 1257, 1151 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H34O2NSi 
  Calc: 348.2353 Found: 348.2363 
TLC  Rf = 0.41 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
General Procedure C: Addition of Ethynyl Magnesium Bromide to Ketone 
 
 
  A  flame-dried,  100-mL,  single-necked,  round-bottomed  flask  equipped  with  a  magnetic 
stir  bar,  a  septum,  and  a  nitrogen  inlet  needle  was  charged  with  ketone 3.58a,b (558  mg,  2.08 
mmol, ~3:1 trans:cis) dissolved in tetrahydrofuran (25 mL). The solution was cooled to 0 °C in 
an  ice  bath,  then  ethynyl  magnesium  bromide  (0.5  M  solution  in  tetrahydrofuran,  17  mL,  8.5
mmol)  was  added  dropwise  via  syringe  over  15  min.  The  reaction  was  stirred  for  3  h  at  0 °C,
210
  
then quenched at 0 °C by dropwise addition of 1 N HCl (25 mL). The resulting solution was 
transferred to a separatory funnel and extracted with diethyl ether (4 x 40 mL). The organic 
layers were combined, washed with brine (20 mL), dried over magnesium sulfate, gravity 
filtered, concentrated by rotary evaporation, and purified by silica gel flash column 
chromatography eluting with 40-60% ethyl acetate in hexanes to provide trans propargyl alcohol 
3.112a (41 mg, 7%), cis propargyl alcohol 3.112b (1 mg, 1%, cis), and a 4:1 trans:cis mixture of 
propargyl alcohols 3.112a,b (385 mg, 63%) each as clear oils and a 1:1 ratio of diastereomers as 
determined by 13C NMR. 
The cis and trans isomers were generally taken on as a mixture, but were separated for 
characterization in some cases. This reaction was repeated 6 times with an average yield of 75 ± 
6% and the trans:cis ratio of propargyl alcohol products reflected the ratio of the ketone starting 
material. This reaction could be performed on gram scale. For example, ketone 3.58a,b (1.30 g, 
4.9 mmol, 3:1 trans:cis), ethynyl magnesium bromide (0.5 M in THF, 38 mL, 19 mmol), and 
THF (60 mL) provided propargyl alcohols 3.112a,b (1.13 g, 78%, 3:1 trans:cis) as a clear oil 
after column chromatography. Another example using ketone 3.58a,b (640 mg, 2.4 mmol, 4:1 
trans:cis), ethynyl magnesium bromide (0.5 M in THF, 19 mL, 9.5 mmol), and THF (29 mL) 
provided propargyl alcohols 3.112a,b in two fractions (528 mg, 75%, 6:1 trans:cis, and 39 mg, 
6%, 2:1 cis:trans) each as clear oils after column chromatography. 
 
(4S*,5S*)-4-(3-Hydroxy-3-methylpent-4-ynyl)-3-methylene-5-(phenylethynyl)pyrrolidin-2- 
one (3.112a):
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Data for 3.112a: (PAJ 7-62, 426 mg total, 70%, 4:1 trans:cis; PAJ 9-24, 1.13 g, 78%, 3:1 
trans:cis; PAJ 8-32, 528 mg, 75%, 6:1 trans:cis, 39 mg, 6%, 2:1 cis:trans) 
1H NMR  (500 MHz, CDCl3) 
δ 7.40-7.38 (m, 2H), 7.31-7.27 (m, 3H), 6.98 (br s, 1H), 6.12 (d, J = 2.0 Hz, 1H), 
5.43 (d, J = 2.0 Hz, 1H), 4.26 (d, J = 4.5 Hz, 1H), 3.14-3.11 (m, 1H), 2.62 (br s, 
1H), 2.46 (s, 1H), 2.04-1.96 (m, 1H), 1.90-1.79 (m, 3H), 1.52 (s, 3H) ppm 
Et2O detected at 3.48 and 1.21 ppm 
13C NMR  (125 MHz, CDCl3) 
δ 169.8, 142.0, 131.8 (2C), 128.8, 128.5 (2C), 122.2, 117.6, 117.5*, 87.7, 87.4, 
84.7, 72.01, 71.97*, 67.67, 67.65*, 48.9, 48.8*, 46.80, 46.78*, 39.9, 39.8*, 30.3, 
30.2*, 28.9, 28.8* ppm 
  *Discernible signals for one of two diastereomers  
Et2O detected at 65.9 and 15.2 ppm 
IR  (thin film) 
  3448, 1652, 1156 cm-1 
HRMS  TOF MS ES+ [M+H]: C19H20NO2 
  Calc: 294.1489 Found: 294.1477  
TLC  Rf = 0.36 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4R*,5S*)-4-(3-Hydroxy-3-methylpent-4-yn-1-yl)-3-methylene-5-(phenylethynyl)pyrrolidin-
2-one (3.112b):
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Data for 3.112b: (PAJ 7-62, 426 mg, 4:1 trans:cis, NMR contained ~15% of the trans isomer) 
1H NMR  (500 MHz, CDCl3) 
δ 7.41-7.39 (m, 2H), 7.33-7.27 (m, 3H), 6.19 (br s, 1H), 6.13 (d, J = 2.3 Hz, 1H), 
5.44 (d, J = 2.3 Hz, 1H), 5.42 (d, J = 2.0 Hz, 1H)*, 4.70 (d, J = 7.5 Hz, 1H), 4.69 
(d, J = 8.0 Hz, 1H)*, 3.16-3.13 (m, 1H), 2.36 (s, 1H), 2.16 (s, 1H)*, 2.14-2.06 (m, 
2H), 1.95-1.90 (m, 1H), 1.84-1.78 (m, 1H), 1.53 (s, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 170.2, 141.7, 131.9 (2C), 131.85*(2C), 129.0, 128.9*, 128.6 (2C), 128.5*,  
  122.2, 122.0*, 117.3, 117.2*, 87.3, 87.2*, 85.0, 84.9*, 72.1, 71.9*, 68.0, 67.8*,  
  47.74, 47.71*, 47.4, 46.2*, 42.74, 42.71*, 40.55, 40.51*, 30.4, 30.3*, 30.2, 30.1*  
  ppm  
*Discernible signals for one of two diastereomers  
IR  (thin film) 
  2929, 2231, 2145, 1686, 1660, 1490, 1435, 1400, 1276, 1082 cm-1 
HRMS  TOF MS ES+ [M+H]: C19H20NO2 
  Calc: 294.1489 Found: 294.1477 
TLC  Rf = 0.29 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
 
(4S*,5S*)-4-(3-Hydroxy-3-methylpent-4-ynyl)-1-methyl-3-methylene-5-
(phenylethynyl)pyrrolidin-2-one  (3.79): Prepared  according  to  general  procedure  C.  Ketone
3.78 (310 mg, 1.04 mmol, trans:cis 7:1), THF (14 mL) and ethynyl magnesium bromide (0.5 M
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solution in THF, 6.3 mL, 3.1 mmol) provided propargyl alcohol 3.79 (198 mg, 62%, trans:cis  
7:1, 1:1 ratio of diastereomers) as a white, sticky solid after column chromatography (gradient 
elution with 20-60% ethyl acetate in hexanes). The diastereomeric ratio is based on the 13C 
NMR, as the diastereomers were indistinguishable by 1H NMR. 
Data for 3.79: (PAJ 7-114, 198 mg, 62%, trans:cis 7:1, NMR contaminated with about 7% of the 
ketone starting material) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.42-7.39 (m, 2H), 7.34-7.31 (m, 3H), 6.09 (d, J = 2.6 Hz, 1H), 5.38 (d, J = 2.6  
  Hz, 1H), 4.13 (d, J = 4.0 Hz, 1H), 3.07-3.05 (m, 1H), 3.03 (s, 3H), 2.47 (s, 1H),  
  2.28 (br s, 1H), 2.06-1.95 (m, 1H), 1.87-1.78 (m, 3H), 1.53 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 167.2, 142.14, 142.12*, 131.9 (2C), 128.9, 128.5 (2C), 122.1, 116.64, 116.66*,  
  87.2, 86.1, 85.9, 72.13, 72.09*, 67.8, 67.7*, 55.4, 55.3*, 44.6, 44.5*, 39.9, 39.8*,  
  30.4, 30.3*, 29.2, 29.0*, 28.6 ppm  
*Discernible signals for one of two diastereomers  
IR  (thin film) 
  3298, 2979, 2929, 2231, 2108, 1680, 1659, 1490, 1432, 1292, 1159, 1084 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H22NO2 
  Calc: 308.1651 Found: 308.1658 
TLC  Rf = 0.60 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
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(4S*,5S*)-4-(3-Hydroxy-3-methylpent-4-ynyl)-3-methylene-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.123a): Prepared according to general procedure 
C. Ketone 3.122a (270 mg, 0.78 mmol, pure trans), ethynyl magnesium bromide (0.5 M solution 
in tetrahydrofuran, 6.2 mL, 3.1 mmol), and tetrahydrofuran (9.3 mL) yielded the propargyl 
alcohol 3.123a (265 mg, 91%) as a pale yellow oil and a 1:1 mixture of diastereomers based on 
the 13C NMR. 
This reaction was repeated 5 times with an average yield of 82 ± 9% and the trans:cis 
ratio remained the same as the starting material. For example, ketone 3.122a,b (2.30 g, 6.62 
mmol, 2.3:1 trans:cis), ethynyl magnesium bromide (0.5 M in THF, 53 mL, 27 mmol), and THF 
(79 mL) provided propargyl alcohol 3.123a,b (2.25 g, 6.02 mmol, 2.3:1 trans:cis) in 91% yield.  
Data for 3.123a: (PAJ 7-44, 265 mg, 91%, 1:1 mixture of diastereomers) 
1H NMR  (500 MHz, CDCl3) 
δ 6.09 (d, J = 3.0 Hz, 1H), 5.90 (br s, 1H), 5.41 (s, 1H), 4.05 (d, J = 5.0 Hz, 1H), 
3.05-3.04 (m, 1H), 2.47 (s, 1H)*, 2.46 (s, 1H), 2.16-2.03 (m, 1H), 1.93-1.77 (m, 
4H), 1.24 (s, 3H), 1.05 (s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 169.1, 141.8, 117.13, 117.09*, 105.9, 87.2, 87.1*, 86.4, 72.1, 67.80, 67.77*, 
49.0, 48.9*, 47.4, 47.3*, 30.5, 30.3*, 28.45, 28.40*, 25.0, 18.7 (6C), 11.2 (3C) 
ppm   
*Discernible signals for one of two diastereomers  
IR  (thin film) 
  2943, 2865, 1703, 1660, 1462, 1323, 1260, 1093, 1019 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H36NO2Si 
  
  Calc: 374.2515 Found: 374.2508  
TLC  Rf = 0.33 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
 
 
 
 
 
   
      
   
   
  
   
   
  
(4R*,5S*)-4-(3-Hydroxy-3-methylpent-4-yn-1-yl)-3-methylene-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.123b): Prepared according to general procedure 
C.  Ketone 3.122a,b (1.22  g,  3.51  mmol,  4:1  trans:cis),  ethynyl  magnesium  bromide  (0.5  M 
solution in THF, 28 mL, 14 mmol), and THF (42 mL) provided trans propargyl alcohol 3.123a,b
(1.07 g, 82%, 4:1 trans:cis) and cis propargyl alcohol 3.123b,a (52 mg, 4%, 2:1 cis:trans) each as 
a white sticky solid after column chromatography (gradient elution with 50-75% ethyl acetate in 
hexanes).  The  ratio  of  diastereomers  was  estimated  to  be  about  1.5:1  based  on  the  ratio  of 13C 
NMR peaks, but the peaks could not be separately integrated in the 1H NMR.
Data for 3.123b: (PAJ 8-34, 1.12 g, 86%, ~4:1 trans:cis overall, NMR contained ~56% of trans 
isomer)
1H NMR (400 MHz, CDCl3)
δ 6.52 (br s, 1H), 6.06 (d, J = 1.8 Hz, 1H), 5.38 (d, J = 1.8 Hz, 1H), 4.48 (app t, J
= 6.6 Hz, 1H), 3.04-3.00 (m, 1H), 2.42 (s, 1H), 2.41*(s, 1H), 2.04-1.95 (m, 2H),
1.89-1.75 (m, 2H), 1.50 (s, 3H), 1.49* (s, 3H), 1.02 (s, 21H) ppm
13C NMR (100 MHz, CDCl3)
δ 170.3, 170.2*, 141.8, 117.2, 116.9*, 103.2, 103.0*, 88.7, 88.5*, 87.7, 87.3*,
72.0, 71.7*, 67.9, 67.7*, 48.0, 47.9*, 42.8, 42.7*, 40.4, 40.2*, 30.2, 30.0*, 25.2,
25.0*, 18.70 (6C), 18.67*, 11.2 (3C) ppm
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*Discernible signals for one of two diastereomers  
IR  (thin film) 
  2943, 2246, 2172, 1703, 1658, 1544, 1462, 1321, 1172, 1072 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H36NO2Si 
  Calc:308.1651 Found: 308.1658 
TLC  Rf = 0.22 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
3-Methyl-5-((2S*,3S*)-1-methyl-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)pent-
1-yn-3-yl acetate (3.80):  A flame-dried, 5-mL, single-necked, round-bottomed flask equipped 
with a stir bar, septum, and nitrogen inlet needle was charged with dimethylaminopyridine 
(DMAP, 4 mg, 0.03 mmol) and propargyl alcohol 3.79 (86 mg, 0.27 mmol) dissolved in DCM 
(1.3 mL) and cooled to 0 °C. Triethylamine (0.37 mL, 2.7 mmol) was added dropwise via 
syringe over 2 min, followed by dropwise addition of acetic anhydride (0.12 mL, 1.3 mmol) over 
1 min via syringe. The ice bath was removed, and the mixture was allowed to warm to rt for 3 h. 
TLC showed consumption of the starting material, so the mixture was diluted with DCM (25 
mL) and transferred to a separatory funnel. The organic layer was washed with saturated aqueous 
ammonium chloride (5 mL), then brine (5 mL), dried over magnesium sulfate, gravity filtered, 
concentrated by rotary evaporation, and purified by flash column chromatography on silica gel 
(gradient elution with 40-50% ethyl acetate in hexanes) to provide lactam 3.80 (50 mg, 54%) as a 
clear oil and a 1:1 ratio of diastereomers based on ratio of peaks in the 13C NMR. 
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 Using acetic anhydride and following general procedure D (see below) 30% of acetate 
3.80 was obtained after column chromatography. 
Data for 3.80: (PAJ 6-206, 50 mg, 54%) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.42-7.40 (m, 2H), 7.34-7.29 (m, 3H), 6.13 (d, J = 2.4 Hz, 1H), 5.37 (d, J = 2.4  
  Hz, 1H), 4.11 (d, J = 4.0 Hz, 1H), 3.08-3.05 (m, 1H), 3.03 (s, 3H), 2.58 (s, 1H),  
  2.16-2.07 (m, 1H), 2.03 (s, 3H), 1.98-1.81 (m, 3H), 1.70 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 169.42, 169.39*, 167.1, 142.0, 131.9 (2C), 129.0, 128.5 (2C), 122.1, 116.6, 
116.5*, 86.0, 83.42, 83.39*, 74.51, 74.48*, 74.02, 74.00*, 55.3, 55.2*, 44.5, 
44.4*, 38.23, 38.19*, 28.63, 28.57, 28.5, 26.71, 26.66*, 22.01 ppm 
*Discernible signals for one of two diastereomers  
IR  (thin film) 
  3292, 2937, 2243, 2120, 1742, 1697, 1661, 1427, 1243, 1173, 1082 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H24NO3 
  Calc: 350.1751 Found: 350.1751 
TLC  Rf = 0.26 (50% EtOAc/hexanes, [silica gel, UV, KMnO4] 
General Procedure D: Formation of Propargyl Pivalate from Propargyl Alcohol 
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 This reaction was generally performed on a mixture of cis and trans propargyl alcohols 
3.112a,b and separated after this reaction as the pivalates 3.113a,b were the most easily 
separable cis and trans lactam isomers.  
A flame-dried, 10-mL test tube equipped with a magnetic stir bar, septum, and nitrogen 
inlet needle was charged with propargyl alcohol 3.112a (56 mg, 0.18 mmol, pure trans) dissolved 
in acetonitrile (0.72 mL). Trimethyl acetic anhydride (0.05 mL, 0.2 mmol) was then added via 
syringe followed by scandium(III) trifluoromethanesulfonate (36 mg, 0.073 mmol). The reaction 
was stirred at rt for 16 h. TLC showed consumption of the starting material, so the reaction was 
diluted with diethyl ether (20 mL), transferred to a separatory funnel, then washed with saturated 
sodium bicarbonate solution (10 mL). The aqueous layer was extracted with diethyl ether (2 x 10 
mL), the organic layers were combined, washed with brine, dried over magnesium sulfate, 
gravity filtered, concentrated by rotary evaporation, and purified by silica gel flash column 
chromatography (gradient elution with 15-30% ethyl acetate in hexanes) to provide propargyl 
pivalate 3.113a (54 mg, 76%) as a clear oil. The diastereomers were not distinguishable by 1H 
NMR. 13C NMR showed a 1:1 mixture of diastereomers. 
This reaction was repeated 7 times with a yield of 69 ± 11%. The ratio of isolated 
trans:cis products reflected the ratio of the propargyl alcohol starting materials. For example, 
propargyl alcohol 3.112a,b (368 mg, 1.25 mmol, 3.5:1 trans:cis), pivalic anhydride (0.36 mL, 1.8 
mmol), scandium(III) trifluoromethanesulfonate (246 mg, 0.50 mmol), and MeCN (5 mL) 
provided trans pivalate 3.113a (299 mg, 61%) and cis pivalate 3.113b (79 mg, 16%) after 
column chromatography. Another example, propargyl alcohol 3.112a,b (1.13 g, 3.85 mmol, 3:1 
trans:cis), pivalic anhydride (0.94 mL, 4.62 mmol), scandium(III) trifluoromethanesulfonate (758 
mg, 1.54 mmol), and acetonitrile (15 mL) provided trans pivalate 3.113a (490 mg, 34%), cis 
  
pivalate 3.113b (163 mg, 11%), and a 4:1 trans:cis mixture (176 mg, 12%) each as a clear oil 
after column chromatography. 
 
 
 
 
    
    
    
   
  
 
   
   
   
   
   
   
3-Methyl-5-((2S*,3S*)-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)pent-1-yn-3-yl 
pivalate (3.113a):
Data for 3.113a: (PAJ 6-160, 54 mg, 76%; PAJ 7-184, 299 mg trans, 79 mg cis, 77% total; PAJ 
9-26, 490 mg trans, 163 mg cis, 176 mg mix, 57% total)
1H NMR (500 MHz, CDCl3)
δ 7.35-7.34 (m, 2H), 7.27-7.21 (m, 3H), 6.98 (s, 1H), 6.08 (d, J = 2 Hz, 1H), 5.36
(s, 1H), 4.21 (d, J = 4.5 Hz, 1H), 3.10-3.09 (m, 1H), 2.50 (s, 1H), 2.12-2.04 (m, 
1H), 1.95-1.90 (m, 2H), 1.84-1.77 (m, 1H), 1.64 (s, 3H), 1.13 (s, 9H) ppm
13C NMR (125 MHz, CDCl3)
δ 176.6, 169.6, 142.0, 131.8 (2C), 128.8, 128.4 (2C), 122.2, 117.3, 117.2*, 87.5, 
84.8,  83.52,  83.47*,  74.0,  73.9*,  73.7,  73.6*,  48.8,  48.7*,  46.7,  39.3,  38.34, 
38.27*, 28.2, 27.1 (3C), 26.6 ppm
*Discernible signals for one of two diastereomers
IR (thin film)
2926, 1702, 1711, 1456, 1153 cm-1
HRMS TOF MS ES+ [M+H]: C24H28NO3
Calc: 378.2064 Found: 378.2049
TLC Rf = 0.47 (50% EtOAc/hexanes) [silica gel, UV, KMnO4]
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3-Methyl-5-((2S*,3R*)-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)pent-1-yn-3-yl 
pivalate (3.113b): Propargyl pivalate 3.113b was prepared according to general procedure D. A 
mixture  of  propargyl  alcohols 3.113a,b (140  mg,  0.48  mmol,  5:1  trans:cis), trimethyl  acetic 
anhydride (0.12 mL, 0.57 mmol), scandium(III) trifluoromethane sulfonate (94 mg, 0.19 mmol), 
and  acetonitrile  (1.9  mL)  provided  trans  isomer 3.113a (99  mg,  55%)  as  a  clear  oil,  cis  isomer
3.113b (20  mg,  11%)  as  a  clear  oil,  and  a  2:1  trans:cis  mixture  (7  mg,  4%)  as  a  clear  oil  after 
column chromatography (gradient elution with 15-30% ethyl acetate in hexanes). A 1.5:1 ratio of 
diastereomers  was  determined  by  integration  of  terminal  alkyne  resonances  in  the 1H  NMR  at 
2.48 (major) and 2.43 ppm (minor).
Data for 3.113b: (PAJ 7-68, 20 mg cis, 99 mg trans, 66% total, 5:1 trans:cis isolated ratio; PAJ 
7-184,  299  mg  trans,  79  mg  cis,  77%  total;  PAJ  9-26,  490  mg  trans,  163  mg  cis,  176  mg  mix, 
57% total)
1H NMR (500 MHz, CDCl3)
δ 7.39-7.38 (m, 2H), 7.31-7.28 (m, 3H), 6.58 (br s, 1H), 6.57* (br s, 1H), 6.13 (m, 
1H), 5.41-5.40 (m, 1H), 4.71 (d, J = 7.5 Hz, 1H), 4.70* (d, J = 7.5 Hz, 1H),
3.12-3.08 (m, 1H), 2.48 (s, 1H), 2.43* (s, 1H), 2.17-2.14 (m, 1H), 2.09-2.01
(m, 3H), 1.68 (s, 3H), 1.45*(s, 9H), 1.11 (s, 9H) ppm
13C NMR (125 MHz, CDCl3)
δ 176.7, 170.20, 170.15*, 141.8, 141.7*, 131.9 (2C), 128.9, 128.4 (2C) 122.20,
122.18*, 117.1, 87.03, 86.99*, 84.9, 84.8*, 83.8, 83.5*, 74.2, 73.9*, 73.7, 73.5*,
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  47.8, 42.70, 42.68*, 30.32, 39.30*, 39.1, 39.0*, 27.1 (3C), 26.7, 26.6*, 25.0,  
  24.8* ppm  
*Discernible signals for one of two diastereomers 
IR  (thin film) 
  2974, 2934, 1705, 1660, 1491, 1479, 1444, 1322, 1285, 1150, 1103 cm-1 
HRMS  TOF MS ES+ [M+H]: C24H28NO3 
  Calc: 378.2064 Found: 378.2068  
TLC  Rf = 0.37 (50% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
  
 
 
 
  
3-Methyl-5-((2S*,3S*)-4-methylene-5-oxo-2-((triisopropylsilyl)ethynyl)pyrrolidin-3-yl)pent- 
1-yn-3-yl  pivalate  (3.124a): Prepared  according  to  general  procedure  D.  Lactam 3.123a (100 
mg,  0.27  mmol,  pure  trans),  scandium(III)  trifluoromethanesulfonate  (53  mg,  0.11  mmol), 
pivalic anhydride (0.07 mL, 0.35 mmol), and acetonitrile (1.1 mL) provided pivalate 3.124a (118 
mg, 96%) as a clear oil after column chromatography (gradient elution with 20-50% ethyl acetate 
in hexanes). 13C NMR showed a 1:1 mixture of diastereomers.
  This  reaction  was  repeated  following  general  procedure  D.  Lactam 3.123a,b (230  mg, 
0.62  mmol,  2.5:1  trans:cis),  scandium(III)  trifluoromethanesulfonate  (121  mg,  0.25  mmol), 
pivalic  anhydride  (0.16  mL,  0.80  mmol),  and  acetonitrile  (2.5  mL)  provided  trans  pivalate
3.124a (110  mg,  39%)  and  cis  pivalate 3.124b (44  mg,  16%)  as   clear  oils  after  column 
chromatography  in  a  total  yield  of  55%.  Another  repetition  on  a  1  g  scale  is  shown  below  for
formation of cis pivalate 3.124b.
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Data for 3.124a: (PAJ 7-50, 118 mg, 96%; PAJ 7-152, 110 mg, 39% trans, 55% total, 2.5:1 
trans:cis; PAJ 8-38, 565 mg, 43% trans, 59% total, 4:1 trans:cis) 
1H NMR  (500 MHz, CDCl3) 
  6.49 (s, 1H), 6.08 (d, J = 2.6 Hz, 1H), 5.38 (d, J = 2.6 Hz, 1H), 5.37* (d, J = 2.4  
  Hz, 1H), 4.05 (d, J = 5.2 Hz, 1H), 4.04* (d, J = 5.2 Hz, 1H), 3.05-3.01 (m, 1H),  
  2.532 (s, 1H), 2.527* (s, 1H), 2.15-1.90 (m, 2H), 1.88-1.76 (m, 2H), 1.67 (s,  
  3H), 1.18 (s, 9H), 1.02 (s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
  176.6, 169.4, 141.83, 141.81*, 117.0, 116.9*, 105.75, 105.74*, 86.4, 83.43,  
  83.40*, 73.9, 73.8*, 73.65, 73.60*, 49.0, 48.9*, 47.0, 39.3, 38.73*, 38.69, 38.57*, 
  27.9, 27.8*, 27.3 (3C), 27.2* (3C), 26.51, 26.49*, 18.7 (6C), 11.2 (3C) ppm 
  *Discernible signals for one of two diastereomers 
IR  (thin film) 
  2943, 2866, 1709, 1660, 1462, 1367, 1325, 1285, 1101 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H44NO3Si 
  Calc: 458.3090 Found: 458.3059 
TLC  Rf = 0.37 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
 
 
3-Methyl-5-((2S*,3R*)-4-methylene-5-oxo-2-((triisopropylsilyl)ethynyl)pyrrolidin-3-
yl)pent-1-yn-3-yl  pivalate  (3.124b): Propargyl  pivalate 3.124b was  prepared  according  to
general  procedure  D.  Propargyl  alcohol 3.123a,b (1.07  g,  2.87  mmol,  4:1  trans:cis),  pivalic
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anhydride (0.70 mL, 3.5 mmol), scandium (III) trifluoromethanesulfonate (565 mg, 1.15 mmol), 
and acetonitrile (12 mL) provided trans lactam 3.124a (565 mg, 43%), cis lactam 3.124b (139 
mg, 11%), and a 2:1 trans:cis mixture (72 mg, 5%) each as a clear oil after column 
chromatography (gradient elution with 5-25% ethyl acetate in hexanes). A 1.7:1 ratio of 
diastereomers was determined by integration of methylene hydrogen resonances in the 1H NMR 
at 5.38 ppm for the major diastereomer and 5.40 ppm for the minor diastereomer. 
Data for 3.124b: (PAJ 8-38, 139 mg, 11% cis, 59% total, 4:1 trans:cis; PAJ 7-152, 110 mg, 39%, 
55% total, 2.5:1 trans:cis) 
1H NMR  (500 MHz, CDCl3) 
  δ 6.10 (app t, J = 2.8 Hz, 1H), 5.84 (br s, 1H), 5.40 (d, J = 2.0 Hz, 1H), 5.38*(d, J  
  = 1.5 Hz, 1H), 4.51 (app t, J = 7.0 Hz, 1H), 3.05-3.02 (m, 1H), 2.52 (s, 1H),  
  2.51*(s, 1H), 2.08-1.96 (m, 3H), 1.93-1.88 (m, 1H), 1.68 (s, 3H), 1.66*(s, 3H),  
  1.183 (s, 9H), 1.177*(s, 9H), 1.04 (s, 21H), 1.03*(s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 176.7, 169.85, 169.77*, 141.65, 141.61*, 117.3, 117.2*, 103.04, 102.99*, 89.0,  
  88.9*, 83.9, 83.4*, 74.3, 73.9*, 73.8, 73.4*, 47.9, 42.8, 42.6*, 39.4,   
  39.3*, 39.0, 38.8*, 27.20 (3C), 27.19*, 26.6, 26.3*, 25.0, 24.8*, 18.7 (6C), 11.2  
  (3C) ppm  
*Discernible signals for one of two diastereomers 
IR  (thin film) 
  3270, 2909, 2832, 2219, 2150, 1684, 1640, 1445, 1308 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H44NO3Si 
  Calc: 458.3085 Found: 458.3095  
  
TLC  Rf = 0.29 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
 
 
 
 
 
   
 
 
 
 
5-((2S*,3S*)-1-(tert-Butyldimethylsilyl)-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3- 
yl)-3-methylpent-1-yn-3-yl  pivalate  (3.137a):  A  flame-dried,  25-mL,  round-bottomed  flask 
equipped with a stir bar, septum, and nitrogen inlet needle was charged with lactam 3.113a (110 
mg,  0.29  mmol)  and  dichloromethane  (10  mL). tert-Butyl  silyl  chloride  (439  mg,  2.9  mmol), 
triethylamine (0.61 mL, 4.4 mmol), and dimethylaminopyridine (4 mg, 0.03 mmol) were added 
to the lactam solution in that order. A reflux condenser was attached, sealed with a septum, and 
the system evacuated and filled with nitrogen (3x) then the solution was lowered into a 40 °C oil 
bath  and  stirred  for  17  h.  TLC  analysis  showed  consumption  of  the  starting  material  so  the 
reaction  was  concentrated  by  rotary  evaporation,  then  purified  by  silica  gel  flash  column 
chromatography  eluting  with  5-10%  ethyl  acetate  in  hexanes.  The  desired  silyl  lactam 3.137a
was isolated as a clear oil (64 mg, 45%) and some loss of the silyl group during chromatography 
was observed (42 mg starting material recovered).
Data for 3.137a: (PAJ 8-196, 64 mg, 45%, unknown impurities present, peaks reported for 1 of 2 
diastereomers)
1H NMR (400 MHz, CDCl3)
δ  7.37-7.34  (m,  2H),  7.31-7.29  (m,  3H),  6.09  (d, J =  1.6  Hz,  1H),  5.39  (app s, 
1H), 4.17 (app t, J = 2.0 Hz, 1H), 3.08-3.06 (m, 1H), 1.92-1.79 (m, 4H), 1.67 (s, 
3H), 1.17 (s, 9H), 1.02 (s, 9H), 0.08 (s, 6H) ppm
13C NMR (100 MHz, CDCl3)
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δ 176.7, 174.4, 143.7, 131.6 (2C), 128.7, 128.5 (2C), 122.6, 117.6, 89.9, 84.6, 
83.6, 83.5, 74.0, 73.7, 53.3, 47.6, 39.4, 38.6, 29.9, 25.8 (3C), 18.1 (3C), -3.5 (2C) 
ppm  
IR  (thin film) 
  3307, 2957, 2248, 1735, 1692, 1660, 1479, 1395, 1149, 1090 cm-1 
HRMS  TOF MS ES+ [M+H]: C30H42NO3Si 
  Calc: 492.2929 Found: 492.2904 
TLC  Rf = 0.57 (25% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
 
General  Procedure  E:  Conversion  of  Propargyl  Ester  to  1,1-Disubstituted  Allenes  Using
(Triphenylphosphine)copper Hydride Hexamer
  A  flame-dried,  15-mL,  round-bottomed  flask  equipped  with  a  stir  bar,  septum,  and 
nitrogen inlet needle was charged with propargyl pivalate 3.113a (107 mg, 0.272 mmol), toluene
(7  mL),  and  deionized  water  (0.01  mL).  This  solution  was  degassed  by  bubbling  nitrogen 
through  the  solution  for  10  min,  then  the  solution  was  cooled  to -10 °C.
(Triphenylphosphine)copper  hydride  hexamer  (533  mg,  0.272  mmol)  was  weighed  in  a  glove 
box under a N2 atmosphere, removed, and added to the degassed solution in a single portion. The 
flask was evacuated and filled with nitrogen (3x) and stirred under nitrogen for 2 h. Completion 
of  the  reaction  was  observed  by  a 1H  NMR  aliquot  which  showed  the  disappearance  of  the 
terminal alkyne proton at 2.5 ppm. The reaction was quenched by pouring the reaction mixture
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into a cooled (0 °C) solution of saturated ammonium chloride. The mixture was diluted with 
Et2O (10 mL) and stirred open to air for 30 min, then poured into a separatory funnel and 
extracted with diethyl ether (3 x 10 mL). The organic layers were dried over magnesium sulfate, 
filtered through a plug of silica gel eluting with diethyl ether, concentrated by rotary evaporation, 
then purified by silica gel flash column chromatography eluting with 15-30% ethyl acetate in 
hexanes to give 1,1-disubstituted allene 3.114 (24 mg, 33%) as a clear oil. 
Initially when performing the allene formation with an older bottle of Stryker's reagent 
purchased from Sigma-Aldrich (90%) and had been stored in the glovebox, we did not see any 
reduction of the α-methylene, but when a new bottle from Acros (97%) was used, significant 
amounts of the reduced product (~1:1 desired to reduced) were obtained. Lowering the 
temperature to -10 °C gave better ratios near 10:1 of the desired product to the reduced product. 
Other commercial sources and batches of Stryker’s reagent (Sigma-Aldrich 90%, Acros 97%) or 
Stryker's reagent synthesized from copper (II) acetate, triphenylphosphine, and diphenylsilane189 
gave similar ratios and yields when the reaction was conducted at -10 °C. However, the ratio of 
products varied significantly (from 1:1 to 10:1) when the reaction was performed at rt. It should 
also be noted that the sources of Stryker’s reagent varied in appearance: Acros (97%) was bright 
to dark orange depending on batch, Sigma-Aldrich (90%) was brick red to light brown 
depending on batch, and freshly prepared Stryker’s reagent189 was a reddish orange color similar 
to that purchased from Acros. 
 
  
(4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dienyl)-5-(phenylethynyl)pyrrolidin-2-one 
(3.114): 
Data for 3.114: (PAJ 7-82, 24 mg, 33%) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.41-7.38 (m, 2H), 7.33-7.30 (m, 3H), 6.77 (br s, 1H), 6.11 (d, J = 2.2 Hz, 1H),  
  5.41 (d, J = 2.2 Hz, 1H), 4.66-4.64 (m, 2H), 4.26 (d, J = 4.0 Hz, 1H), 3.17-3.16  
  (m, 1H), 2.15-2.08 (m, 2H), 1.92-1.86 (m, 1H), 1.81-1.74 (m, 1H), 1.71 (t, J = 3.2 
  Hz, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 206.1, 169.7, 142.2, 131.8 (2C), 128.8, 128.5 (2C), 122.3, 117.3, 97.7, 87.8,  
  84.5, 75.3, 49.0, 46.4, 31.9, 29.9, 19.1 ppm 
IR  (thin film) 
  2922, 1741, 1736, 1445, 1372, 1270, 1216, 1110, 1042 cm-1 
HRMS  TOF MS ES+ [M+H]: C19H20NO 
  Calc: 278.1539 Found: 278.1533 
TLC  Rf = 0.44 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
 
 
(4S*,5S*)-1-Methyl-3-methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-
(phenylethynyl)pyrrolidin-2-one (3.57): Prepared according to general procedure E. Propargyl 
acetate 3.80 (69  mg,  0.20  mmol),  (triphenylphosphine)copper  hydride  hexamer  (385  mg,  0.196 
mmol), toluene (5.0 mL), and deionized water (0.01 ml) provided allene 3.57 (30 mg, 53%) as a
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clear oil after column chromatography (gradient elution with 10-20% ethyl acetate in hexanes). 
Some baseline impurities from triphenylphosphine byproducts of Stryker’s reagent were 
observed in the aromatic regions of the 1H and 13C NMR spectra. 
Data for 3.57: (PAJ 7-134, 30 mg, 53%)  
1H NMR  (500 MHz, CDCl3) 
  δ 7.41-7.40 (m, 2H), 7.34-7.30 (m, 3H), 6.07 (d, J = 1.5 Hz, 1H), 5.35 (s, 1H),  
  4.66- 4.64 (m, 2H), 4.11 (d, J = 4.0 Hz, 1H), 3.08 (app br s, 1H), 3.03 (s, 3H),  
  2.14-2.08 (m, 2H), 1.90-1.84 (m, 1H), 1.77-1.73 (m, 1H), 1.71 (t, J = 3.0 Hz, 3H)  
  ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 201.2, 167.3, 142.4, 131.9 (2C), 128.9, 128.5 (2C), 122.2, 116.3,  97.7, 86.2,  
  85.7, 75.2, 55.5, 44.2, 32.2, 30.0, 28.5, 19.1 ppm 
IR  (thin film) 
  2078, 1633, 1414, 1381, 1260, 1058 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H22NO 
  Calc: 292.1701 Found: 292.1712 
TLC  Rf = 0.66 (50% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
 The reduced product 3.115 was never completely characterized, but was evident by the 
presence of a methyl doublet at 1.03 ppm and a doublet at 4.23 ppm corresponding to Ha in the 
  
1H NMR spectra of allene-yne 3.114; similar resonances were observed for the reduced products 
with a TIPS-substituted alkyne 3.126 or terminal alkyne 3.208 (full characterization data below). 
 
(4R*,5S*)-3-Methyl-4-(3-methylpenta-3,4-dien-1-yl)-5-(phenylethynyl)pyrrolidin-2-one 
(3.134): Prepared according to general procedure E. Cis lactam 3.113b (75 mg, 0.19 mmol), 
(triphenylphosphine)copper hydride hexamer (373 mg, 0.19 mmol), toluene (5 mL), water (0.01 
mL) provided allene 3.134 (19 mg, 36%) after column chromatography (gradient elution with 
15-25% ethyl acetate in hexanes) as a clear oil and as the only product.  
Data for 3.134: (PAJ 7-192, 19 mg, 36%) 
1H NMR  (500 MHz, CDCl3) 
  δ 7.40-7.38 (m, 2H), 7.33-7.31 (m, 3H), 5.77 (br s, 1H), 4.64-4.61 (m, 2H), 4.51  
  (d, J = 7.0 Hz, 1H), 2.27-2.14 (m, 3H), 2.03-1.98 (m, 1H), 1.92-1.84 (m, 2H),  
  1.71 (t, J = 3.0 Hz, 3H), 1.20 (d, J = 7.0 Hz, 3H), ppm 
13C NMR  (125 MHz, CDCl3) 
δ 206.3, 179.8, 131.8 (2C), 128.8, 128.5 (2C), 122.5, 97.8, 86.4, 85.3, 74.7, 47.6, 
46.8, 40.3, 31.2, 28.0, 18.8, 13.8 ppm 
IR  (thin film) 
  3245, 2895, 1937, 1681, 1426, 1361 cm-1 
HRMS  TOF MS ES+ [M+H]: C19H22NO 
  Calc: 280.1696 Found: 280.1698 
   TLC Rf = 0.33 (50% EtOAc/hexanes) [silica gel, UV, vanillin]
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(4S*,5S*)-1-(tert-Butyldimethylsilyl)-3-methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-
(phenylethynyl)pyrrolidin-2-one (3.138a): Prepared according to general procedure E. 
Propargyl pivalate 3.137a (55 mg, 0.11 mmol), (triphenylphosphine)copper hydride hexamer 
(220 mg, 0.11 mmol), toluene (3.0 mL), and deionized water (0.01 ml) provided allene 3.138a 
(13 mg, 30%) as a pale yellow oil after column chromatography (gradient elution with 15-50% 
ethyl acetate in hexanes). 
Data for 3.138a: (PAJ 8-198, 13 mg, 30%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.37-7.35 (m, 2H), 7.31-7.29 (m, 3H), 6.06 (d, J = 1.2 Hz, 1H), 5.37 (d, J = 1.2 
Hz, 1H), 4.65 (app. q, J = 3.0 Hz, 2H), 4.17 (d, J = 2.0 Hz,1H), 3.10-3.07 (m, 
1H), 2.08-2.04 (m, 2H), 1.80-1.66 (m, 2H), 1.73 (t, J = 6.2 Hz, 3H), 1.02 (s, 9H), 
0.41 (s, 3H), 0.39 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 206.2, 174.6, 144.0, 131.6 (2C), 128.6, 128.5 (2C), 122.7, 117.3, 97.6, 90.3, 
84.4, 75.1, 53.5, 47.3, 33.1, 30.5, 30.0, 27.3, 25.8, 19.4, 19.0, -3.4, -4.7 ppm 
IR  (thin film) 
  3307, 2923, 2235, 1959, 1692, 1661, 1469, 1352, 1252 cm-1 
HRMS  TOF MS ES+ [M+H]: C25H34NOSi 
  Calc: 392.2404 Found: 392.2386 
TLC   Rf = 0.28 (25% EtOAc/hexanes) [silica gel, UV, KMnO4]
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(4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dienyl)-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one  (3.125): Prepared  according  to  general  procedure 
E  at -20  °C.  Propargyl pivalate 3.124a (110  mg,  0.24  mmol),  (triphenylphosphine)copper 
hydride hexamer (424 mg, 0.22 mmol), and toluene (6 mL) yielded allenes 3.125 (39 mg, 46%)
and 3.126 (9 mg, 11%) in a 4:1 ratio each as a clear oil after column chromatography (gradient 
elution with 5-25% ethyl acetate in hexanes). Other repetitions of this reaction gave 31-53% of 
the desired allene 3.125 with 0-31% of the reduced methylene product 3.126.
Data for 3.125: (8-62, 39 mg, 46%, baseline impurities which appear to be from reduction of the 
allene  or  alkyne  to  an  alkene  and  some  triphenylphosphine  byproducts  from  Stryker’s  reagent 
were present in 1H and 13C NMR)
1H NMR (400 MHz, CDCl3)
δ 6.24 (br s, 1H), 6.05 (d, J = 2.4 Hz, 1H), 5.36 (d, J = 2.4 Hz, 1H), 4.66-4.63 (m, 
2H),  4.03,  (d, J =  4.8  Hz,  1H),  3.08-3.03  (m,  1H),  2.16-2.09  (m,  1H),  2.06-1.99
(m, 1H), 1.93-1.84 (m, 1H), 1.72-1.61 (m, 1H) 1.69 (t, J = 3.0 Hz, 3H), 1.04 (s, 
21H) ppm
13C NMR (100 MHz, CDCl3)
δ 206.0, 169.5, 142.1, 117.0, 106.2, 97.9, 86.1, 75.4, 49.1, 47.0, 31.7, 30.1, 19.2, 
18.7 (6C), 11.2 (3C) ppm
IR (thin film)
2926, 2865, 1704, 1658, 1462, 1324 cm-1
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HRMS  TOF MS ES+ [M+H]: C22H36NOSi 
  Calc: 358.2561 Found: 358.2566  
TLC  Rf = 0.32 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
(4S*,5S*)-3-Methyl-4-(3-methylpenta-3,4-dien-1-yl)-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.126): The ratio of diastereomers was 
determined by integration of the resonances for Ha at 4.02 ppm for the minor diastereomer and 
3.95 ppm for the major diastereomer. 
Data for 3.126: (PAJ 8-62, 9 mg, 11%, 8.3:1 dr, peaks reported for major diastereomer only) 
1H NMR  (500 MHz, CDCl3) 
δ 5.77 (br s, 1H), 4.64-4.62 (m, 2H), 3.95 (d, J = 8.0 Hz, 1H), 2.18-2.11 (m, 1H), 
2.09-2.01 (m, 3H), 1.80-1.74 (m, 1H), 1.69 (t, J = 2.7 Hz, 3H), 1.69-1.60 (m, 1H), 
1.24 (d, J = 10.5 Hz, 3H), 1.05 (s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 206.0, 178.5, 106.3, 98.2, 85.9, 75.3, 51.5, 49.7, 42.4, 31.1, 31.0, 19.1, 18.7 
(6C), 15.1, 11.3 (3C) ppm 
IR  (thin film) 
  2908, 2831, 2156, 1961, 1685, 1443 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H38NOSi 
  Calc: 360.2717 Found: 360.2708  
   TLC Rf = 0.38 (35% EtOAc/hexanes) [silica gel, UV, vanillin]
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(4R*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-
((triisopropylsilyl)ethynyl)pyrrolidin-2-one (3.135): Prepared according to general procedure 
E. Propargyl pivalate 3.124b (40 mg, 0.087 mmol), (triphenylphosphine)copper hydride hexamer 
(170 mg, 0.087 mmol), toluene (2.2 mL), and deionized water (0.01 ml) provided allene 3.135 
(11 mg, 35%) as a clear oil after column chromatography (gradient elution with 5-15% ethyl 
acetate in hexanes). Baseline impurities were detected from reduction of the allene and/or alkyne 
to an alkene and from triphenylphosphine byproducts of Stryker’s reagent. This reaction was 
repeated according to general procedure E. Propargyl pivalate 3.124b (135 mg, 0.29 mmol), 
(triphenylphosphine)copper hydride hexamer (578 mg, 0.29 mmol), toluene (7.4 mL), and 
deionized water (0.01 ml) provided allene 3.135 and reduced methylene lactam 3.136 (2.5:1, 26 
mg, 25% overall yield) as a clear oil after column chromatography. The ratio was determined by 
integration of Ha next to the nitrogen which appeared as a doublet at 4.5 ppm for lactam xx and 
as a doublet at 4.3 ppm for the reduced methylene compound xx. 
Data for 3.135: (PAJ 7-156, 11 mg, 35%; PAJ 8-40, 26 mg, 25%) 
1H NMR  (400 MHz, CDCl3) 
  δ 6.06 (d, J = 2.4 Hz, 1H), 6.04 (br s, 1H), 5.46 (d, J = 2.4 Hz, 1H), 4.63-4.61 (m,  
  2H), 4.48 (d, J = 7.6 Hz, 1H), 3.07-3.03 (m, 1H), 2.15-2.03 (m, 2H), 2.00-1.87  
  (m, 2H), 1.69 (t, J = 3.0 Hz, 3H), 1.01 (s, 21H) ppm 
13C NMR  (100 MHz, CDCl3) 
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  δ 206.2, 170.2, 141.8, 116.9, 103.1, 97.7, 88.4, 75.0, 47.8, 41.8, 30.4, 27.6, 19.0,  
  18.7 (6C), 11.2 (3C) ppm 
IR  (thin film) 
  2942, 2176, 1960, 1709, 1660, 1463, 1324 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H36NOSi 
  Calc: 358.2561 Found: 358.2573 
TLC  Rf = 0.72 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
General Procedure F: Removal of TIPS Substituent from Alkyne 
 
A flame-dried, 5-mL, round-bottomed flask equipped with a stir bar, septum, and 
nitrogen inlet needle was charged with TIPS allene 3.125 (38 mg, 0.11 mmol, pure trans) 
dissolved in THF (1.1 mL) and cooled to 0 °C in an ice water bath. Tetrabutylammonium 
fluoride (1 M solution in THF, 0.15 mL, 0.15 mmol) was added dropwise via syringe and the 
reaction was stirred for 45 minutes when TLC showed consumption of the starting material. 
Saturated aqueous ammonium chloride (2 mL) was added to the cooled reaction mixture to 
quench the reaction and the biphasic mixture was transferred to a separatory funnel. The aqueous 
layer was extracted with ethyl acetate (4 x 5 mL). The combined organic layers were washed 
with brine (1 x 5 mL), dried over magnesium sulfate, gravity filtered, concentrated by rotary 
evaporation, and purified by silica gel flash column chromatography (gradient elution with 25-
75% ethyl acetate in hexanes) to provide allene 3.175 (12 mg, 57%) as a clear oil. This reaction 
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was repeated according to the above procedure. TIPS allene 3.125 (40 mg, 0.11 mmol, pure 
trans), tetrabutylammonium fluoride (1 M solution in THF, 0.17 mL, 0.17 mmol), THF (1.1 mL) 
provided allene 3.175 (18 mg, 82%) as a clear oil after column chromatography 
 
(4S*,5S*)-5-Ethynyl-3-methylene-4-(3-methylpenta-3,4-dien-1-yl)pyrrolidin-2-one (3.175): 
Data for 3.175: (PAJ 8-56, 12 mg, 57%; PAJ 7-168A, 18 mg, 82%; PAJ 8-66, 14 mg, 93%; PAJ 
8-88, 11 mg, 85%)  
1H NMR  (400 MHz, CDCl3) 
  δ 6.79 (br s, 1H), 6.07 (d, J = 2.2 Hz, 1H), 5.38 (d, J = 2.2 Hz, 1H), 4.65-4.63 (m,  
  2H), 4.02 (dd, J = 2.0, 4.0 Hz, 1H), 3.09-3.05 (m, 1H), 2.39 (d, J = 2.0 Hz, 1H),  
  2.10-2.02 (m, 2H), 1.88-1.80 (m, 1H), 1.73-1.71 (m, 1H), 1.70 (t, J = 3.0 Hz, 3H)  
  ppm 
13C NMR  (100 MHz, CDCl3) 
δ 206.1, 169.7, 141.9, 117.4, 97.6, 82.7, 75.3, 72.9, 48.1, 46.1, 31.9, 29.8, 19.0 
ppm 
IR  (thin film) 
  2094, 1936, 1633, 1411, 1308, 1061 cm-1 
HRMS  TOF MS ES+ [M+H]: C13H16NO 
  Calc: 202.1226 Found: 202.1227 
TLC  Rf = 0.36 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
  
 
(4R*,5S*)-5-Ethynyl-3-methylene-4-(3-methylpenta-3,4-dien-1-yl)pyrrolidin-2-one (3.182): 
Prepared according to general procedure F. TIPS allene 3.135 (11 mg, 0.031 mmol, pure cis), 
tetrabutylammonium fluoride (1 M solution in THF, 0.05 mL, 0.05 mmol), THF (0.31 mL) 
provided allene 3.182 (4 mg, 67%) as a clear oil after column chromatography (gradient elution 
with 50-75% ethyl acetate in hexanes). This reaction was repeated according to general 
procedure F. TIPS allene 3.135 (14 mg, 0.039 mmol), tetrabutylammonium fluoride (1 M 
solution in THF, 0.06 mL, 0.06 mmol), THF (0.4 mL) provided allene 3.182 (7 mg, 75%) as a 
clear oil after column chromatography.  
Data for 3.182: (PAJ 7-162, 4 mg, 67% contaminated with 17% lactam with reduced methylene 
and some baseline impurities; PAJ 8-44, 6 mg, 67%; PAJ 7-168B, 7 mg, 75%)  
1H NMR  (500 MHz, CDCl3) 
  δ 6.13 (br s, 1H), 6.09 (d, J = 2.5 Hz, 1H), 5.38 (d, J = 2.5 Hz, 1H), 4.65-4.63 (m,  
  2H), 4.46 (dd, J = 7.5, 2.0 Hz, 1H), 3.10-3.08 (m, 1H), 2.42 (d, J = 2.0 Hz, 1H),  
  2.14-2.04 (m, 2H), 1.97-1.89 (m, 2H), 1.72 (t, J = 3.2 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 206.3, 170.1, 141.5, 117.1, 97.5, 79.9, 75.2, 74.8, 46.9, 41.5, 30.5, 27.5, 18.8  
  ppm 
IR  (thin film) 
  2898, 2101, 1937, 1647, 1422, 1395, 1373, 1242, 1086 cm-1 
HRMS  TOF MS ES+ [M+H]: C13H16NO
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  Calc: 202.1226 Found: 202.1231 
TLC  Rf = 0.34 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(4S*,5S*)-5-Ethynyl-3-methyl-4-(3-methylpenta-3,4-dien-1-yl)pyrrolidin-2-one (3.208): 
Prepared according to general procedure F. Lactam 3.126 (26 mg, 0.072 mmol, 8:1 dr), 
tetrabutylammonium fluoride (1M in THF, 0.11 mL, 0.10 mmol), and THF (0.8 mL) yielded 
terminal alkyne 3.208 (14 mg, 86%) as a clear oil after column chromatography (gradient elution 
with 25-50% ethyl acetate in hexanes) and as an 8:1 mixture of diastereomers as determined by 
integration of the resonances for Ha at 3.93 for the minor diastereomer and 3.92 for the major 
diastereomer. 
Data for 3.208: (PAJ 8-74, 14 mg, 86%, 8:1 dr, peaks reported for major diastereomer only) 
1H NMR  (500 MHz, CDCl3) 
δ 6.04 (br s, 1H), 4.65-4.63 (m, 2H), 3.92 (dd, J = 7.5, 1.7 Hz, 1H), 2.39 (d, J = 
1.7 Hz, 1H), 2.17-2.01 (m, 4H), 1.79-1.68 (m, 2H), 1.70 (t, J = 3.2 Hz, 3H), 1.24 
(d, J = 7.0 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 206.1, 178.7, 98.0, 82.8, 75.3, 72.8, 50.6, 48.8, 42.2, 31.0, 30.7, 19.0, 15.3 ppm 
IR  (thin film) 
  3190, 2889, 2060, 1936, 1679, 1440, 1364 cm-1 
HRMS   
  
TOF MS ES+ [M+H]: C13H18NO
Calc: 204.1383 Found: 204.1378
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TLC  Rf = 0.24 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
tert- (4S*,5S*)Butyl -3-methylene-4-(3-methylpenta-3,4-dien-1-yl)-2-oxo-5-
(phenylethynyl)pyrrolidine-1-carboxylate (3.174): A 5-mL, flame-dried, test tube equipped 
with a stir bar, septum, and nitrogen inlet needle was charged with allene-yne 3.114 (15 mg, 
0.054 mmol) and dichloromethane (0.3 mL). Dimethylaminopyridine (1 mg, 0.008 mmol) was 
added and the solution was cooled to 0 °C. Triethylamine (0.08 mL, 0.5 mmol) was added 
dropwise followed by addition of di-tert-butyl dicarbonate (59 mg, 0.27 mmol) in a single 
portion. The ice bath was removed and the solution was allowed to warm to rt and stirred for 2 h. 
After consumption of the starting material was observed by TLC, the solution was diluted with 
dichloromethane (15 mL), transferred to a separatory funnel, and washed sequentially with 
saturated aqueous ammonium chloride (5 mL) and brine (5 mL). The organic layer was dried 
over magnesium sulfate, gravity filtered, concentrated by rotary evaporation, and purified by 
silica gel flash column chromatography (gradient elution with 5-25% ethyl acetate in hexanes) to 
provide allene-yne 3.174 (8 mg, 40%) as a clear oil. This reaction was repeated according to the 
procedure above. Lactam 3.114 (23 mg, 0.083 mmol), dimethylaminopyridine (1 mg, 0.008 
mmol), triethylamine (0.12 mL, 0.83 mmol), di-tert-butyl dicarbonate (90 mg, 0.41 mmol), and 
dichloromethane (0.4 mL) provided lactam 3.174 (17 mg, 54%) as a pale yellow oil after column 
chromatography. 
Data for 3.174: (PAJ 7-6, 8 mg, 40%; PAJ 6-198, 17 mg, 54%)  
  
1H NMR  (500 MHz, CDCl3) 
  δ 7.38-7.36 (m, 2H), 7.31-7.29 (m, 3H), 6.30 (d, J = 1.7 Hz, 1H), 5.54 (d, J = 1.7  
  Hz, 1H), 4.67-4.65 (m, 3H), 3.08-3.05 (m, 1H), 2.07-2.05 (m, 2H), 1.80-1.71 (m,  
  2H), 1.71 (t, J = 3.2 Hz, 3H), 1.57 (s, 9H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 206.3, 165.6, 149.9, 142.1, 131.8 (2C), 128.7, 128.5 (2C), 122.4, 121.6, 97.4,  
  87.5, 84.0, 83.7, 75.3, 52.8, 43.6, 32.8, 29.8, 28.2 (3C), 19.0 ppm 
IR  (thin film) 
  2969, 2915, 1793, 1759, 1717, 1401, 1302, 1153 cm-1 
HRMS  TOF MS ES+ [M+H]: C24H28NO3 
  Calc: 378.2069 Found: 378.2082 
TLC  Rf = 0.69 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
General Procedure G: Arylation of Lactam Nitrogen with Aryl Iodides 
 
 
 
  This procedure was modified from the method reported by Buchwald and coworkers for 
the  amidation  of  aryl  halides.173 A  flame-dried,  10-mL  test  tube  equipped  with  a  magnetic  stir 
bar  was  charged  with  copper  iodide  (4  mg,  0.02  mmol)  and  cesium  carbonate  (50  mg,  0.15 
mmol).  The  test  tube  was  capped  with  a  septum,  then  evacuated  and  filled  with  nitrogen  (3x). 
Iodobenzene  (13  μL,  0.11  mmol)  and trans-N,N'-dimethylcyclohexane-1,2-diamine  (8  μL,  0.05 
mmol),  were  added  via  syringe.  Lactam 3.114 (21  mg,  0.076  mmol)  was  dissolved  in  toluene
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(0.8 mL) and added to the test tube containing the other reagents via syringe. The test tube was 
evacuated and filled with nitrogen (3x), and the nitrogen inlet needle was removed. The test tube 
was then placed in an 80 °C oil bath for 20 h. TLC showed formation of a new product. The 
reaction was cooled to rt, filtered through a plug of silica gel eluting with 50% ethyl acetate in 
hexanes, concentrated, then purified by silica gel flash column chromatography eluting with 5-
15% ethyl acetate in hexanes to give lactam 3.168 as a clear oil (12 mg, 44%).  
Alternatively, N,N’-dimethylethylenediamine was used as the copper ligand with little 
difference in yield. When potassium carbonate was used as the base instead of cesium carbonate, 
lower yields and incomplete conversion to the product was observed. For example, lactam 3.114 
(10 mg, 0.033 mmol), iodobenzene (5 μL, 0.04 mmol), copper iodide (5 mg, 0.03 mmol), trans-
N,N'-dimethylcyclohexane-1,2-diamine (4 μL, 0.03 mmol) potassium carbonate (10 mg, 0.065 
mmol), and toluene (0.4 mL) provided lactam 3.168 (3 mg, 27%, PAJ 8-6) as a clear oil after 
column chromatography. 
(4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-1-phenyl-5-
(phenylethynyl)pyrrolidin-2-one (3.168): 
Data for 3.168: (PAJ 8-204, 12 mg, 44%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.77-7.75 (m, 2H), 7.44-7.40 (m, 2H), 7.30-7.20 (m, 6H), 6.25 (d, J = 2.2 Hz, 
1H), 5.51 (d, J = 2.2 Hz, 1H), 4.69-4.66 (m, 3H), 3.26-3.23 (m, 1H), 2.18-2.13 
(m, 2H), 1.91-1.83 (m, 2H), 1.73 (t, J = 3.2 Hz, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 206.2, 166.3, 143.0, 138.3, 131.8 (2C), 129.0 (2C), 128.8 (2C), 128.4, 125.7, 
122.2 (2C), 118.4, 97.6, 87.1, 85.8, 76.8, 75.4, 55.1, 44.6, 32.5, 30.0, 19.1 ppm 
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IR  (thin film) 
  2924, 2227, 1959, 1701, 1660, 1498, 1372 cm-1 
HRMS  TOF MS ES+ [M+H]: C25H24NO 
  Calc: 354.1852 Found: 354.1837 
TLC  Rf = 0.86 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
(4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-(phenylethynyl)-1-(4-
(trifluoromethyl)phenyl)pyrrolidin-2-one (3.169): Prepared according to general procedure G 
with potassium carbonate as base instead of cesium carbonate. Lactam 3.114 (24 mg, 0.087 
mmol), 4-benzotrifluoride (0.02 mL, 0.1 mmol), copper iodide (2 mg, 0.02 mmol), N,N’-
dimethylethylenediamine (4 μL, 0.04 mmol), cesium carbonate (57 mg, 0.17 mmol), and toluene 
(0.9 mL) provided lactam 3.169 (17 mg, 47%) as a clear oil after column chromatography 
(gradient elution with 5-10% ethyl acetate in hexanes). When potassium carbonate was used as a 
base only 14-16% of lactam 3.169 was isolated and 20-25% of the starting material was 
recovered (PAJ 8-100, PAJ 8-192). 
Data for 3.169: (PAJ 9-36, 17 mg, 47%, NMR contaminated with about 13% of the compound 
with the α-methylene of the lactam reduced)  
1H NMR  (400 MHz, CDCl3) 
  δ 7.96 (d, J = 8.6 Hz, 2H), 7.67 (d, J = 8.6 Hz, 2H), 7.32-7.28 (m, 5H), 6.29 (d, J  
  = 2.0 Hz, 1H), 5.56 (d, J = 2.0 Hz, 1H), 4.72 (d, J = 3.2 Hz, 1H), 4.68-4.66 (m,  
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  2H), 3.29-3.26 (m, 1H), 2.19-2.13 (m, 2H), 1.90-1.83 (m, 2H), 1.73 (t, J = 3.0 Hz, 
  3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 206.2, 166.5, 142.5, 141.3, 131.8 (2C), 129.1 (2C), 128.5 (2C), 127.2, 126.08 
(q, J = 4.0 Hz, 1C), 125.6, 121.9, 121.2 (2C), 119.5, 97.5, 86.3, 75.5, 54.7, 44.5, 
32.5, 29.9, 19.1 ppm 
IR  (thin film) 
  2942, 2381, 1715, 1325, 1213, 1122, 1068 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H23F3NO 
  Calc: 422.17263 Found: 422.17102 
TLC  Rf = 0.86 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
4-((4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-2-oxo-5-
(phenylethynyl)pyrrolidin-1-yl)benzonitrile (3.171): Prepared according to general procedure 
G. Lactam 3.114 (33 mg, 0.12 mmol), 4-iodobenzonitrile (38 mg, 0.17 mmol), copper iodide (5 
mg, 0.02 mmol), N,N’-dimethylethylenediamine (5 μL, 0.05 mmol), cesium carbonate (78 mg, 
0.24 mmol), and toluene (1.2 mL) provided lactam 3.171 (19 mg, 42%) as a pale yellow oil after 
column chromatography (gradient elution with 5-15% ethyl acetate in hexanes). 
Data for 3.171: (PAJ 9-46, 19 mg, 42%)  
1H NMR  (400 MHz, CDCl3) 
  
δ 7.99 (app dd, J = 2.0, 6.8 Hz, 2H), 7.70 (app dd, J = 2.0, 6.8 Hz, 2H), 7.33-7.28 
(m, 5H), 6.30 (d, J = 2.2 Hz, 1H), 5.59 (d, J = 2.2 Hz, 1H), 4.71 (d, J = 3.2 Hz, 
1H), 4.68-4.66 (m, 2H), 3.28-3.27 (m, 1H), 2.17-2.13 (m, 2H), 1.89-1.83 (m, 2H), 
1.73 (t, J = 3.2 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 206.2, 166.5, 142.2, 133.0 (2C), 131.8 (2C), 129.2, 128.5 (2C), 121.6, 121.0 
(2C), 120.0, 118.9, 108.11, 97.4, 86.5, 85.9, 75.5, 54.4, 44.3, 32.4, 29.9, 19.1 ppm 
IR  (thin film) 
  3432, 2101, 1642, 1511 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H23N2O 
  Calc: 379.1732 Found: 379.1735  
TLC  Rf = 0.43 (25% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
 
 
 
(4S*,5S*)-1-(4-Methoxyphenyl)-3-methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-
(phenylethynyl)pyrrolidin-2-one  (3.170): Prepared  according  to  general  procedure  G.  Lactam
3.114 (29 mg, 0.11 mmol), 4-iodoanisole (37 mg, 0.16 mmol), copper iodide (4 mg, 0.02 mmol),
N,N’-dimethylethylenediamine  (5  μL,  0.04  mmol),  cesium  carbonate  (68  mg,  0.21  mmol),  and 
toluene  (1  mL)  provided  lactam 3.170 (25  mg,  63%)  as  a  pale  yellow  oil  after  column 
chromatography  (gradient  elution  with  5-20%  ethyl  acetate  in  hexanes).  This  reaction  was  first 
performed according to general procedure G with potassium carbonate as a base. Lactam 3.114
(20  mg,  0.072  mmol),  4-iodoanisole  (20  mg,  0.087  mmol),  copper  iodide  (3  mg,  0.01  mmol),
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N,N’-dimethylethylenediamine (4 μL, 0.03 mmol), potassium carbonate (20 mg, 0.14 mmol), and 
toluene (0.72 mL) provided lactam 3.170 (5 mg, 19%) as a pale yellow oil after column 
chromatography; 25% (5 mg) of starting material 3.114 was also recovered (PAJ 8-118). 
Data for 3.170: (PAJ 9-30, 25 mg, 63%)  
1H NMR  (500 MHz, CDCl3) 
  δ 7.60 (d, J = 8.7 Hz, 2H), 7.32-7.27 (m, 5H), 6.94 (d, J = 8.7 Hz, 2H), 6.22 (d, J  
  = 1.5 Hz, 1H), 5.48 (d, J = 1.5 Hz, 1H), 4.68-4.66 (m, 2H), 4.62 (d, J = 3.0 Hz,  
  1H), 3.82 (s, 3H), 3.27-3.21 (m, 1H), 2.18-2.13 (m, 2H), 1.93-1.82 (m, 2H), 1.73  
  (t, J = 2.7 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 206.3, 166.3, 157.7, 143.1, 131.8 (2C), 131.3, 128.8, 128.4 (2C), 124.5 (2C),  
  122.3, 117.8, 114.3 (2C), 97.7, 87.3, 85.8, 75.3, 55.7, 55.6, 44.7, 32.5, 30.0, 19.1  
  ppm 
IR  (thin film) 
  2924, 1995, 1697, 1512, 1377, 1300, 1249 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H26NO2 
  Calc: 384.1958 Found: 384.1968 
TLC  Rf = 0.59 (50% EtOAc/hexanes) [silica gel, UV, Vanillin] 
 
  
(4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-(phenylethynyl)-1-(thiophen-2-
yl)pyrrolidin-2-one (3.172): Prepared according to general procedure G. Lactam 3.114 (21 mg,
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0.076 mmol), copper iodide (3 mg, 0.02 mmol), trans-N,N'-dimethylcyclohexane-1,2-diamine (5 
μL, 0.03 mmol), cesium carbonate (50 mg, 0.15 mmol), iodothiophene (12 μL, 0.10 mmol), and 
toluene (0.8 mL) provided lactam 3.172 (15 mg, 56%) as a pale yellow oil after column 
chromatography (5-10% ethyl acetate in hexanes gradient elution). This reaction was repeated 
according to general procedure G. Lactam 3.114 (23 mg, 0.083 mmol), copper iodide (3 mg, 0.02 
mmol), trans-N,N'-dimethylcyclohexane-1,2-diamine (4 μL, 0.03 mmol), cesium carbonate (52 
mg, 0.16 mmol), iodothiophene (10 μL, 0.11 mmol), and toluene (0.8 mL) provided lactam 3.172 
(19 mg, 63%) as a pale yellow oil after column chromatography 
Data for 3.172: (PAJ 8-206, 15 mg, 56%; PAJ 9-40, 19 mg, 63%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.38-7.36 (m, 2H), 7.32-7.28 (m, 3H), 7.03-7.02 (m, 1H), 6.97-6.94 (m, 2H), 
6.27 (d, J = 2.0 Hz, 1H), 5.54 (d, J = 2.0 Hz, 1H), 4.70 (d, J = 2.8 Hz, 1H), 4.68-
4.66 (m, 2H), 3.34-3.29 (m, 1H), 2.15-2.11 (m, 2H), 1.84 (app q, J = 7.6 Hz, 2H), 
1.73 (t, J = 3.2 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 206.2, 164.3, 141.5, 139.4, 131.9 (2C), 129.0, 128.5 (2C), 124.2, 122.0, 119.3, 
119.2, 113.0, 97.4, 86.1, 86.0, 75.4, 55.4, 44.9, 33.2, 29.8, 19.1 ppm 
IR  (thin film) 
  2924, 2227, 1959, 1695, 1534, 1451, 1399 cm-1 
HRMS  TOF MS ES+ [M+H]: C23H22NOS 
  Calc: 360.1417 Found: 360.1401 
TLC  Rf = 0.58 (25% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
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 (4S*,5S*)-3-Methylene-4-(3-methylpenta-3,4-dien-1-yl)-5-(phenylethynyl)-1-
tosylpyrrolidin-2-one (3.173): A flame-dried test tube equipped with a stir bar, septum, and 
nitrogen inlet needle was charged with lactam 3.114 (20 mg, 0.07 mmol) and DMF (0.75 mL) 
and cooled to 0 °C under a nitrogen atmosphere. Sodium hydride (60% dispersion in mineral oil, 
6 mg, 0.14 mmol) was added in a single portion and the reaction mixture was stirred for 15 min 
at 0 °C. para-Toluene sulfonyl chloride (28 mg, 0.14 mmol) was then added in a single portion, 
the ice bath was removed, and the solution was allowed to warm to rt for 2.5 h. TLC analysis 
revealed consumption of the starting material, and the reaction was quenched by pouring it into a 
separatory funnel containing saturated aqueous ammonium chloride (5 mL). The aqueous layer 
was extracted with ethyl acetate (3 x 10 mL). The organic layers were combined, dried over 
magnesium sulfate, gravity filtered, concentrated by rotary evaporation, and purified by silica gel 
flash column chromatography eluting with 10-25% ethyl acetate in hexanes. Lactam 3.173 was 
obtained as a pale yellow oil (9 mg, 29%). This reaction was repeated, but it was kept at 0 °C for 
1 h after addition of para-toluene sulfonyl chloride, then allowed to warm to rt for 1 h before 
quenching. Lactam 3.114 (18 mg, 0.069 mmol), sodium hydride (60% dispersion in mineral oil, 
5 mg, 0.1 mmol), para-toluene sulfonyl chloride (25 mg, 0.13 mmol), and DMF (0.7 mL) 
provided lactam 3.173 (14 mg, 48%) as a yellow oil after column chromatography; some 
unidentified contaminants were observed in the 1H NMR. Additional purification by column 
chromatography provided allene-yne 3.186 (4 mg, 18%) as a clear oil. 
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Data for 3.173: (PAJ 8-4, 9 mg, 29%; PAJ 8-82, 14 mg, 48% (impure) and 4 mg, 18% (pure))  
1H NMR  (500 MHz, CDCl3) 
  δ 8.08 (d, J = 8.0 Hz, 2H), 7.25-7.28 (m, 5H), 7.22 (d, J = 8.0 Hz, 2H), 6.23 (d, J= 
  1.7 Hz, 1H), 5.54 (d, J = 1.7 Hz, 1H), 4.98 (d, J = 1.5 Hz, 1H), 4.68-4.67 (m, 2H), 
  3.11-3.08 (m, 1H), 2.38 (s, 3H), 2.08-2.05 (m, 2H), 1.88-1.84 (m, 1H), 1.74-1.69  
  (m, 1H), 1.71 (t, J = 3.3 Hz, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 206.3, 164.9, 145.3, 141.1, 135.6, 131.9 (2C), 131.7, 129.8 (2C), 129.5 (2C),  
  128.5 (2C), 122.6, 121.9, 97.2, 86.3, 85.9, 75.4, 53.6, 45.5, 32.8, 29.8, 21.8, 19.0  
  ppm 
IR  (thin film) 
  2891, 2218, 1937, 1697, 1579, 1429, 1356, 1160, 1078, 804, 750 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H26NO3S 
  Calc: 432.1628 Found: 432.1641 
TLC  Rf = 0.66 (25% EtOAc/hexanes) [silica gel, UV, vanillin] 
General Procedure H: Allenic Pauson-Khand Reaction (Slow Addition of Allene-Yne to 
Rhodium Catalyst) 
 
A flame-dried, 10-mL, 2-necked round-bottomed flask equipped with a magnetic stir bar, 
condenser capped with septum, and a septum was charged with rhodium dicarbonyl chloride 
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dimer (2 mg, 0.004 mmol) and toluene (3.4 mL). The apparatus was evacuated via a needle 
attached to a vacuum line for 2-3 seconds then filled with carbon monoxide (3x) via a needle 
attached to a balloon, then lowered into a prewarmed oil bath set to 110 °C. The allene-yne 3.114 
(13 mg, 0.044 mmol) was dissolved in toluene (1.1 mL) and added dropwise to the stirring 
solution of rhodium dicarbonyl chloride dimer over 1 h using a syringe pump. After the addition 
was complete, the reaction was stirred an additional 30 min at 110 °C and TLC showed 
consumption of the starting material. The reaction was removed from the oil bath and allowed to 
cool to rt, then polymer bound triphenylphosphine (3 mmol/g, 60 mg) was added and stirred 4 h. 
The polymer was removed by vacuum filtration, then the solution was concentrated, and purified 
by silica gel flash column chromatography with gradient elution using 25-75% ethyl acetate in 
hexanes to yield tricycle 3.116 as a white solid (9 mg, 64%). This reaction was repeated 
according to the procedure above. Allene-yne 3.114 (21 mg, 0.076 mmol), rhodium dicarbonyl 
chloride dimer (3 mg, 0.008 mmol), and toluene (7.6 mL) provided tricycle 3.116 (19 mg, 79%) 
as a white solid after column chromatography. The compound was crystallized by vapor 
diffusion using ethyl acetate and pentanes, and X-ray crystallography confirmed the structure 
and trans stereochemistry of the lactam substituents. 
General Procedure I: Alternative Procedure for Allenic Pauson-Khand Reaction 
To a flame-dried, 2-necked, 25-mL round-bottomed flask equipped with a septum, 
condenser capped with a septum, and a magnetic stir bar was added rhodium dicarbonyl chloride 
dimer (4 mg, 0.01 mmol) and toluene (7 mL). The apparatus was evacuated via a needle attached 
to a vacuum line for 2-3 seconds and filled with carbon monoxide (3x) via a needle attached to a 
balloon, then lowered into a prewarmed oil bath set to 110 °C with stirring. Allene 3.114 (30 mg, 
0.11 mmol) was then dissolved in toluene (4 mL) and added to the stirring solution of rhodium 
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catalyst via syringe in a single portion and the reaction was stirred 1 h. Consumption of the 
starting material was observed by TLC, and the crude reaction mixture was concentrated by 
rotary evaporation. The crude residue was purified by silica gel flash column chromatography 
eluting with a gradient of 30-75% ethyl acetate in hexanes to give tricycle 3.116 as a white solid 
(25 mg, 75%). 
 
(3aS*,9bS*)-6-Methyl-3-methylene-9-phenyl-3,3a,4,5-tetrahydro-1H-azuleno[4,5-b]pyrrole-
2,8(7H,9bH)-dione (3.116): 
Data for 3.116: (PAJ 6-176, 9 mg, 64%; PAJ 7-84, 19 mg, 79%; PAJ 7-200, 25 mg, 75%) 
1H NMR  (400 MHz, CDCl3) 
δ 7.46-7.40 (m, 3H), 7.25-7.24 (m, 2H), 5.98 (d, J = 3.2 Hz, 1H), 5.58 (br s, 1H), 
5.27 (d, J = 3.2 Hz, 1H), 4.82 (d, J = 8.4 Hz, 1H), 3.18, 3.11 (ABq, J = 20.0 Hz, 
2H), 3.05-3.02 (m, 1H), 2.77-2.72 (m, 1H), 2.42-2.35 (m, 2H), 1.99 (s, 3H), 1.91-
1.83 (m, 1H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 202.0, 168.6, 165.5, 143.1, 140.8, 135.7, 131.8, 131.3, 129.3 (4C), 128.4, 115.3, 
  56.2, 44.3, 40.9, 31.8, 26.6, 24.8 ppm 
IR  (thin film) 
  3419, 2950, 2865, 1697, 1675, 1460, 1380, 1305, 1201 cm-1 
HRMS  TOF MS ESI+ [M + H]: C20H20NO2 
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  Calcd: 306.1489 Found: 306.1479  
TLC  Rf = 0.22 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(3aS*,9bS*)-1,6-Dimethyl-3-methylene-9-phenyl-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-
b]pyrrole-2,8(3H)-dione (3.56): Prepared according to general procedure H. Allene 3.57 (30 
mg, 0.1 mmol), rhodium dicarbonyl chloride dimer (4 mg, 0.009 mmol), and toluene (8.6 mL) 
provided tricycle 3.56 (24 mg, 75%) as a white solid after column chromatography (gradient 
elution with 25-75% ethyl acetate in hexanes). 
Data for 3.56: (PAJ 7-136, 24 mg, 75%) 
1H NMR  (400 MHz, CDCl3) 
δ 7.33-7.31 (m, 3H), 7.11-7.10 (m, 2H), 6.10 (d, J = 3.2 Hz, 1H), 5.34 (d, J = 3.2 
Hz, 1H), 4.52 (d, J = 8.0 Hz, 1H), 3.17, 3.10 (ABq, J = 21.2 Hz, 2H), 3.20-3.07 
(m, 1H), 2.93-2.84 (m, 1H), 2.57-2.46 (m, 1H), 2.42 (app dd, J = 4.2, 16.2 Hz, 
1H), 2.01 (s, 3H), 1.99 (s, 3H), 1.96-1.88 (m, 1H) ppm 
13C NMR  (100 MHz, CDCl3) 
  δ 202.8, 168.8, 165.5, 143.2, 137.6, 136.6, 130.6, 130.3 (2C), 128.4, 127.7 (2C),  
  115.6, 62.1, 41.7, 40.5, 32.3, 30.4, 29.8, 28.5, 25.8 ppm 
IR  (thin film) 
  2885, 1670, 1638, 1422, 1378, 1296, 1257, 1141, 1080 cm-1 
HRMS  TOF MS ESI+ [M + H]: C21H22NO2 
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  Calc: 320.1645 Found: 320.1651  
TLC  Rf = 0.36 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
tert-Butyl (3aS*,9bS*)-6-methyl-3-methylene-2,8-dioxo-9-phenyl-2,3,3a,4,5,7,8,9b-
octahydro-1H-azuleno[4,5-b]pyrrole-1-carboxylate (3.192): Prepared according to general 
procedure H. Allene-yne 3.174 (7 mg, 0.018 mmol), rhodium dicarbonyl chloride dimer (1 mg, 
0.002 mmol), and toluene (1.9 mL) provided tricycle 3.192 (3 mg, 40%) as a pale yellow solid 
after column chromatography (gradient elution with 15-50% ethyl acetate in hexanes). Tricycle 
3.192 was also prepared according to general procedure I. Allene-yne 3.174 (16 mg, 0.042 
mmol), rhodium dicarbonyl chloride dimer (2 mg, 0.004 mmol), and toluene (4.2 mL) provided 
tricycle 3.192 (7 mg, 41%) as a pale yellow solid after column chromatography. 
Data for 3.192: (PAJ 7-4, 3 mg, 40%; PAJ 6-204, 7 mg, 41%) 
1H NMR  (500 MHz, CDCl3) 
δ 7.35-7.27 (m, 3H), 7.05-7.04 (m, 2H), 6.29 (d, J = 3.5 Hz, 1H), 5.50 (d, J = 3.5 
Hz, 1H), 5.12 (d, J = 9.0 Hz, 1H), 3.17 (d, J = 21.0 Hz, 1H), 3.17, 3.06 (ABq, J = 
21.0 Hz, 2H), 3.14-3.11 (m, 1H), 3.01-2.92 (m, 1H), 2.56-2.50 (m, 1H), 2.43-2.39 
(m, 1H), 2.00 (s, 3H), 1.95-1.92 (m, 1H), 1.18 (s, 9H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 202.7, 165.0, 164.8, 150.4, 142.8, 137.9, 135.7, 131.0 (2C), 130.6, 130.2, 127.9 
(2C), 119.9, 83.5, 60.5, 58.5, 40.6, 39.8, 31.9, 28.9, 27.9 (3C), 25.7 
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IR  (thin film) 
  2969, 2915, 1793, 1757, 1717, 1401, 1302, 1153 cm-1 
HRMS  TOF MS ESI+ [M + H]: C25H28NO4 
  Calc: 406.2013 Found: 406.2013 
TLC  Rf = 0.65 (50% EtOAc/hexanes, [silica gel, UV, p-anisaldehyde] 
 
(3aS*,9bS*)-6-Methyl-3-methylene-9-(triisopropylsilyl)-3,3a,4,5-tetrahydro-1H-
azuleno[4,5-b]pyrrole-2,8(7H,9bH)-dione (3.184): Prepared according to general procedure H. 
Allene-yne 3.125 (20 mg, 0.056 mmol), rhodium dicarbonyl chloride dimer (2 mg, 0.006 mmol), 
and toluene (5.7 mL) provided tricycle 3.184 (11 mg, 50%) as a clear oil after column 
chromatography (gradient elution with 15-30% ethyl acetate in hexanes). This reaction was 
repeated according to general procedure H. Allene-yne 3.125 (25 mg, 0.078 mmol), rhodium 
dicarbonyl chloride dimer (3 mg, 0.008 mmol), and toluene (8 mL) provided tricycle 3.184 (11 
mg, 41%) as a white solid after column chromatography. 
Data for 3.184: (PAJ 7-78, 11 mg, 50%; PAJ 8-58, 11 mg, 41%) 
1H NMR  (300 MHz, CDCl3) 
δ 6.19 (br s, 1H), 6.07 (d, J = 3.1 Hz, 1H), 5.31 (d, J = 3.1 Hz, 1H), 4.65 (d, J = 
8.1 Hz, 1H), 3.05-3.00 (m, 1H), 3.0 (s, 2H), 2.99-2.65 (m, 1H), 2.45-2.27 (m, 2H), 
1.95 (s, 3H), 1.90-1.80 (m, 1H), 1.63-1.53 (m, 3H), 1.13 (d, J = 2.0 Hz, 9H), 1.09 
(d, J = 2.0 Hz, 9H) ppm 
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13C NMR  (100 MHz, CDCl3) 
  δ 208.2, 179.9, 169.3, 143.1, 137.9, 134.1, 133.9, 115.7, 56.8, 44.2, 41.4, 31.9,  
  27.1, 25.4, 19.5 (3C), 19.4 (3C), 13.0 (3C) ppm 
IR  (thin film) 
  2943, 2881, 1719, 1688, 1518, 1504 cm-1 
HRMS  TOF MS ESI+ [M + H]: C23H36NO2Si 
  Calc: 386.2510 Found: 386.2515 
TLC  Rf = 0.37 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(3aR*,9bS*)-6-Methyl-3-methylene-9-(triisopropylsilyl)-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.196): Prepared according to general procedure H. 
Allene 3.135 (3:1 mixture of α-methylene lactam and α-methyl lactam, 10 mg, 0.028 mmol), 
rhodium dicarbonyl chloride dimer (1 mg, 0.003 mmol), and toluene (2.8 mL) provided tricycle 
3.196 (2 mg, 40%) as a white solid after column chromatography (gradient elution with 15-30% 
ethyl acetate in hexanes).  
Data for 3.196: (PAJ 8-42, 2 mg, 40%; PAJ 8-50, 40%)  
1H NMR  (500 MHz, CDCl3) 
δ 6.21 (d, J = 1.5 Hz, 1H), 5.50 (br s, 1H), 5.46 (app s, 1H), 5.01 (d, J = 7.5 Hz, 
1H), 3.40 (app br s, 1H), 3.12, 3.00 (ABq, J = 20.5 Hz, 2H), 2.50-2.44 (m, 1H), 
  
2.14-2.08 (m, 2H), 1.92-1.88 (m, 1H), 1.82 (s, 3H), 1.54-1.48 (m, 3H), 1.07-1.04 
(m, 18H) ppm 
13C NMR  (126 MHz, CDCl3) 
  δ 208.7, 176.6, 170.1, 143.6, 143.4, 139.3, 131.2, 118.5, 56.8, 44.3, 41.5, 35.2,  
  31.8, 24.4, 19.2 (2C), 19.1 (2C), 18.7 (2C), 12.3 (3C) ppm 
IR  (thin film) 
  2909, 2833, 1688, 1640, 1445, 1135 cm-1 
HRMS  TOF MS ES+ [M+H]: C23H36NO2Si 
  Calc: 386.2510 Found: 386.2422 
TLC  Rf = 0.33 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
 
 
 
 
  
  
(3aS*,9bS*)-6-Methyl-3-methylene-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-b]pyrrole-
2,8(3H)-dione  (3.185): Prepared  according  to  general  procedure  H.  Allene-yne 3.175 (12  mg, 
0.060  mmol),  rhodium  dicarbonyl  chloride  dimer  (3  mg,  0.006  mmol),  and  toluene  (6  mL)
provided 3.185 (9 mg, 64%) as a white solid after column chromatography (gradient elution with 
50-100% ethyl acetate in hexanes). This reaction was repeated according to general procedure H. 
Allene-yne 3.175 (17 mg, 0.085 mmol), rhodium dicarbonyl chloride dimer (4 mg, 0.008 mmol), 
and  toluene  (8.6  mL)  provided  tricycle 3.185 (8  mg,  42%)  as  a  white  solid  after  column 
chromatography.
Data for 3.185: (PAJ 8-60, 9 mg, 64%; PAJ 7-172, 8 mg, 42%)
1H NMR (500 MHz, CDCl3)
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δ 7.86 (br s, 1H), 6.14 (s, 1H), 6.06 (d, J = 3.0 Hz, 1H), 5.32 (d, J = 3.0 Hz, 1H), 
4.58 (d, J = 8.5 Hz, 1H), 3.00 (s, 2H), 2.86-2.82 (m, 1H), 2.76-2.71 (m, 1H), 2.42-
2.31 (m, 2H), 1.94 (s, 3H), 1.93-1.87 (m, 1H) ppm 
13C NMR  (126 MHz, CDCl3) 
  δ 204.0, 173.0, 170.7, 143.9, 137.1, 131.6, 126.6, 115.8, 56.1, 43.4, 41.3, 32.0,  
  26.8, 24.9 ppm 
IR  (thin film) 
  2895 ,1685, 1556, 1420, 1327, 1231, 1149 cm-1 
HRMS  TOF MS ES+ [M+H]: C14H16NO2 
  Calc: 230.1179 Found: 230.1176 
TLC  Rf = 0.15 (100% EtOAc) [silica gel, UV, p-anisaldehyde] 
 
(3aR*,9bS*)-6-Methyl-3-methylene-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-b]pyrrole-
2,8(3H)-dione (3.199) and (3aR*,9bS*)-3,6-dimethyl-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.200): Prepared according to general procedure I. 
Allene 3.182 (10 mg, 0.05 mmol, 5:1 ratio of 3.182 to reduced α-methylene compound 3.183), 
rhodium dicarbonyl chloride dimer (2 mg, 0.005 mmol), and toluene (5 mL) provided 3.199 and 
3.200 (4 mg, 40%) as a white solid in a 3:1 ratio after column chromatography (gradient elution 
with 50-100% ethyl acetate in hexanes). Preparation according to general procedure H on a 0.03 
mmol scale of 3.182 (2:1 3.182  to reduced α-methylene compound 3.183) gave a similar yield of 
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43% (2:1 3.199 to reduced α-methylene compound 3.200). The ratio was determined by 
integration of the resonance for Ha which appeared as a doublet at 4.73 for 3.199 and 4.52 for 
3.200. 
Data for 3.199: (PAJ 7-176, 4 mg, 40%, Data reported for major product only; PAJ 8-48, 3 mg, 
57%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.21-6.90 (br s, 1H), 6.13 (s, 1H), 6.06 (d, J = 2.6 Hz, 1H), 5.33 (d, J = 2.6 Hz, 
1H), 4.73 (d, J = 9.2 Hz, 1H), 3.51-3.46 (m, 1H), 3.10, 2.99 (ABq, J = 20.8 Hz, 
2H), 2.50-2.22 (m, 4H), 1.93 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 203.6, 170.6, 142.3, 141.7, 137.7, 131.2, 126.4, 56.4, 44.8, 42.7, 41.2, 28.1, 
24.8, 24.2 ppm 
IR  (thin film) 
  2909, 1715, 1688, 1640, 1445, 1351, 1135 cm-1 
HRMS  TOF MS ES+ [M+H]: C14H16NO2 
  Calc: 230.1179 Found: 230.1166 
TLC  Rf = 0.08 (75% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(3aS*,9bS*)-6-Methyl-3-methylene-1,9-diphenyl-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-
b]pyrrole-2,8(3H)-dione (3.186): Prepared according to general procedure I. Allene-yne 3.168 
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(11 mg, 0.031 mmol), rhodium dicarbonyl chloride dimer (1.2 mL of a 1 mg/mL toluene 
solution, 0.003 mmol), and toluene (3.1 mL) provided tricycle 3.186 (8 mg, 67% ) as a white 
solid after column chromatography (gradient elution with 25-50% ethyl acetate in hexanes). This 
reaction was repeated according to general procedure I. Allene-yne 3.168 (3 mg, 0.008 mmol), 
rhodium dicarbonyl chloride dimer (0.5 mL of a 1 mg/mL solution in toluene), and toluene (0.5 
mL) provided tricycle 3.186 (2 mg, 66%) as a white solid after column chromatography. 
Data for 3.186: (PAJ 9-4, 8 mg, 67%; PAJ 8-8, 2 mg, 66%)  
1H NMR  (500 MHz, CDCl3) 
δ 7.10-7.07 (m, 1H), 7.02-6.97 (m, 2H), 6.96-6.94 (m, 2H), 6.91-6.90 (m, 1H), 
6.89-6.86 (m, 2H), 6.53-6.52 (m, 2H), 6.24 (d, J = 3.3 Hz, 1H), 5.46 (d, J = 3.3 
Hz, 1H), 5.34 (d, J = 8.0 Hz, 1H), 3.31-3.29 (m, 1H), 3.17, 3.08 (ABq, J = 21.0 
Hz, 2H), 3.08-3.02 (m, 1H), 2.63-2.60 (m, 1H), 2.52-2.47 (m, 1H), 2.05 (s, 3H), 
2.08-2.03 (m, 1H) ppm 
13C NMR  (126 MHz, CDCl3) 
  δ 202.5, 166.4, 163.3, 143.6, 139.4, 137.6, 136.4, 130.6, 130.5, 129.6 (2C), 128.1  
  (2C), 127.5, 127.4 (2C), 124.1, 119.3 (2C), 117.1, 59.1, 40.9, 40.6, 32.4, 28.7,  
  25.9 ppm 
IR  (thin film) 
  2891, 1675, 1631, 1477, 1356 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H24NO2 
  Calc: 382.1802 Found: 382.1807  
TLC  Rf = 0.35 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 259 
 
(3aS*,9bS*)-6-Methyl-3-methylene-9-phenyl-1-(4-(trifluoromethyl)phenyl)-1,3a,4,5,7,9b-
hexahydro-2H-azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.187): Prepared according to general 
procedure H. Allene-yne 3.169 (17 mg, 0.04 mmol), rhodium dicarbonyl chloride dimer (2 mg, 
0.004 mmol), and toluene (4 mL) provided tricycle 3.187 (13 mg, 72%) as a white solid after 
column chromatography (gradient elution with 15-50% ethyl acetate in hexanes). Tricycle 3.187 
was also prepared according to general procedure I. Allene-yne 3.169 (6 mg, 0.01 mmol), 
rhodium dicarbonyl chloride dimer (0.5 mL of a 1 mg/mL solution in toluene), and toluene (0.9 
mL) provided tricycle 3.187 (4 mg, 67%) as a white solid after column chromatography. 
Data for 3.187: (PAJ 9-38, 13 mg, 72%; PAJ 8-108, 4 mg, 67%)  
1H NMR  (500 MHz, CDCl3) 
δ 7.20 (app d, J = 8.5 Hz, 2H) 7.10 (app t, J = 7.5 Hz, 1H), 7.00 (app d, J = 9.0 
Hz, 4H), 6.50 (app br s, 2H), 6.28 (d, J = 3.5 Hz, 1H), 5.52 (d, J = 3.5 Hz, 1H), 
5.33 (d, J = 8.5 Hz, 1H), 3.34-3.31 (m, 1H), 3.17, 3.10 (ABq, J = 21.0 Hz, 2H), 
3.09-3.02 (m, 1H), 2.66-2.59 (m, 1H), 2.53-2.49 (m, 1H), 2.10-1.99 (m, 1H), 2.06 
(s, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 202.3, 166.5, 162.5, 143.0, 140.4, 139.3, 136.9, 130.38, 130.36, 129.6 (2C), 
127.6 (2C), 127.5 (2C), 125.8, 125.6 (q, J = 32.5 Hz, 1C), 125.2 (q, J = 3.7 Hz, 
1C), 122.8, 119.3, 118.2, 59.1, 40.9, 40.5, 32.3, 28.6, 25.9 ppm 
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IR  (thin film) 
  2930, 1698, 1615, 1325, 1168, 1117 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H23NO2F3 
  Calc: 450.1675 Found: 450.1655  
TLC  Rf = 0.36 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
4-((3aS*,9bS*)-6-Methyl-3-methylene-2,8-dioxo-9-phenyl-2,3,3a,4,5,7,8,9b-octahydro-1H-
azuleno[4,5-b]pyrrol-1-yl)benzonitrile (3.188): Prepared according to general procedure H. 
Allene-yne 3.171 (17 mg, 0.045 mmol), rhodium dicarbonyl chloride dimer (2 mg, 0.0045 
mmol), and toluene (4.5 mL) provided tricycle 3.188 (13 mg, 72%) as a light yellow solid after 
column chromatography (gradient elution with 15-35% ethyl acetate in hexanes. 
Data for 3.188: (PAJ 9-48, 13 mg, 72%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.27-7.25 (m, 2H), 7.13-7.11 (m, 1H), 7.09-7.03 (m, 4H), 6.53 (app br s, 2H), 
6.30 (d, J = 3.4 Hz, 1H), 5.55 (d, J = 3.4 Hz, 1H), 5.31 (d, J = 8.4 Hz, 1H), 3.35-
3.31 (m, 1H), 3.19, 3.10 (ABq, J = 21.0, 36.6 Hz, 2H), 3.06-3.01 (m, 1H,), 2.68-
2.59 (m, 1H), 2.55-2.49 (m, 1H), 2.10-2.03 (m, 1H), 2.08 (s, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
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δ 202.1, 166.6, 162.2, 142.6, 141.4, 139.2, 137.0, 132.1 (2C), 130.3, 130.2, 129.7 
(2C), 127.8, 127.5 (2C), 119.6 (2C), 119.0, 118.8, 107.0, 58.9, 40.8, 40.5, 32.2, 
28.6, 25.9 ppm 
IR  (thin film) 
  2925, 2854, 2224, 1704, 1659, 1604, 1509, 1345, 1179 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H23N2O2 
  Calc: 407.1754 Found:  406.1753 
TLC  Rf = 0.27 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(3aS*,9bS*)-1-(4-Methoxyphenyl)-6-methyl-3-methylene-9-phenyl-1,3a,4,5,7,9b-hexahydro-
2H-azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.189): Prepared according to general procedure I. 
Allene-yne 3.170 (6 mg, 0.2 mmol), rhodium dicarbonyl chloride dimer (0.5 mL of a 1 mg/mL 
toluene solution, 0.001 mmol), and toluene (1.3 mL) provided tricycle 3.189 (5 mg, 76%) as a 
white solid after column chromatography (gradient elution with 15-35% ethyl acetate in 
hexanes). This product was also prepared according to general procedure H. Allene-yne 3.170 
(25 mg, 0.065 mmol), rhodium biscarbonyl chloride dimer (3 mg, 0.006 mmol), and toluene (6.6 
mL) to provide tricycle 3.189 (20 mg, 77%) as a white solid after column chromatography. 
Data for 3.189: (PAJ 8-122, 5 mg, 76%; PAJ 9-32, 20 mg, 77%)  
1H NMR  (500 MHz, CDCl3) 
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δ 7.12-7.10 (m, 1H), 7.06-7.03 (m, 2H), 6.79-6.77 (m, 2H), 6.58-6.57 (m, 2H), 
6.51-6.49 (m, 2H), 6.22 (d, J = 3.2 Hz, 1H), 5.45 (d, J = 3.2 Hz, 1H), 5.31 (d, J = 
8.5 Hz, 1H), 3.72 (s, 3H), 3.31-3.28 (m, 1H), 3.17, 3.08 (ABq, J = 21.0 Hz, 2H), 
3.09-3.01 (m, 1H), 2.62-2.58 (m, 1H), 2.51-2.46 (m, 1H), 2.10-2.00 (m, 1H), 2.05 
(s, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 202.4, 166.2, 163.4, 156.3, 143.7, 139.3, 136.4, 131.2, 130.7, 129.6 (2C), 127.6, 
127.4 (2C), 120.6 (2C), 116.7, 113.5 (2C), 59.2, 55.6, 41.0, 40.6, 32.4, 29.9, 28.7, 
25.8 ppm 
IR  (thin film) 
  2924, 1700, 1511, 1250 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H26NO3 
  Calc: 412.1907 Found: 412.1901 
TLC  Rf = 0.23 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
(3aS*,9bS*)-6-Methyl-3-methylene-9-phenyl-1-(thiophen-2-yl)-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.190): Prepared according to general procedure I. 
Allene-yne 3.172 (12 mg, 0.033 mmol), rhodium biscarbonyl chloride dimer (1.3 mL of a 1 
mg/mL toluene solution, 0.003 mmol), and toluene (3.3 mL) provided tricycle 3.190 (7 mg, 
54%) as a pale yellow solid after column chromatography (gradient elution with 25-50% ethyl 
  
acetate in hexanes). This product was also synthesized following general procedure H. Allene-
yne 3.172 (18 mg, 0.050 mmol), rhodium biscarbonyl chloride dimer (2 mg, 0.005 mmol), and 
toluene (5 mL) provided tricycle 3.190 (15 mg, 79%) as a pale yellow solid after column 
chromatography. 
Data for 3.190: (PAJ 9-2, 7 mg, 54%; PAJ 9-44, 15 mg, 79%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.10-7.04 (m, 3H), 6.70 (dd, J = 1.4, 5.4 Hz, 1H), 6.65-6.59 (m, 3H), 6.25 (d, J 
= 3.6 Hz, 1H), 6.24 (d, J = 3.2 Hz, 1H), 5.49 (d, J = 3.2 Hz, 1H), 5.16 (d, J = 8.0 
Hz, 1H), 3.40-3.34 (m, 1H), 3.21, 3.12 (ABq, J = 21.0 Hz, 2H), 3.08-2.98 (m, 
1H), 2.69-2.58 (m, 1H), 2.55-2.48 (m, 1H), 2.06 (s, 3H), 2.03-1.99 (m, 1H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 202.4, 164.6, 163.1, 141.8, 139.5, 139.0, 136.2, 130.4, 130.1, 129.3 (2C), 127.8, 
127.2 (2C), 123.0, 119.2, 117.8, 111.8, 60.8, 41.9, 40.5, 32.2, 28.5, 25.9 ppm 
IR  (thin film) 
  3434, 1693, 1575, 1360, 1305 cm-1 
HRMS  TOF MS ES+ [M+1]: C24H22NO2S 
  Calc: 388.1366 Found: 388. 1357 
TLC  Rf = 0.31 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
 
(3aS*,9bS*)-6-Methyl-3-methylene-9-phenyl-1-tosyl-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione  (3.191): Prepared  according  to  general  procedure  I.
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Allene-yne 3.173 (4 mg, 0.009 mmol), rhodium biscarbonyl chloride dimer (0.5 mL of a 1 
mg/mL toluene solution, 0.001 mmol), and toluene (1 mL) provided tricycle 3.191 (3 mg, 75%) 
as a white solid after column chromatography (gradient elution with 25-50% ethyl acetate in 
hexanes). This reaction was repeated according to general procedure I. Allene-yne 3.173 (9 mg, 
0.02 mmol), rhodium biscarbonyl chloride (1 mg, 0.002), and toluene (2.1 mL) provided tricycle 
3.191 (6 mg, 67%) as a white solid after column chromatography. 
Data for 3.191: (PAJ 8-84, 3 mg, 75%; PAJ 8-10, 6 mg, 67%)  
1H NMR  (500 MHz, CDCl3) 
δ 7.64 (d, J = 8.5 Hz, 2H), 7.40-7.38 (m, 3H), 7.21 (d, J = 8.5 Hz, 2H), 7.12 (app 
br s, 2H), 6.16 (d, J = 3.5 Hz, 1H), 5.43 (d, J = 3.5 Hz, 1H), 5.07 (d, J = 8.5 Hz, 
1H), 3.23-3.22 (m, 1H), 3.23, 3.10 (ABq, J = 20.5 Hz, 2H), 2.96-2.86 (m, 1H), 
2.56-2.47 (m, 1H), 2.43-2.38 (m, 1H), 2.37 (s, 3H), 2.01 (s, 3H), 1.80-1.74 (m, 
1H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 202.6, 166.5, 164.6, 145.3, 140.7, 139.3, 134.8, 134.7, 132.0, 131.4 (2C), 130.9, 
130.4, 129.7 (2C), 128.5 (2C), 127.8 (2C), 121.4, 60.2, 41.5, 40.7, 31.9, 29.3, 
25.7, 21.8 ppm 
IR  (thin film) 
  2888, 1714, 1674, 1358, 1160 cm-1 
HRMS  TOF MS ES+ [M+H]: C27H26NO4S 
  Calc: 460.1577 Found: 460.1577 
TLC  Rf = 0.23 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
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(3aR*,9bS*)-3,6-Dimethyl-9-phenyl-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-b]pyrrole-
2,8(3H)-dione (3.193): Prepared according to general procedure I. Allene-yne 3.134 (17 mg, 
0.061 mmol), rhodium dicarbonyl chloride dimer (3 mg, 0.0061 mmol), and toluene (6 mL) 
yielded tricycle 3.193 (14 mg, 77%) as a white solid after purification by column 
chromatography (gradient elution with 50-100% ethyl acetate in hexanes). 
Data for 3.193: (PAJ 7-196, 14 mg, 77%)  
1H NMR  (400 MHz, CDCl3) 
δ 7.44-7.38 (m, 3H), 7.17-7.15 (m, 2H), 5.21 (br s, 1H), 4.98 (d, J = 7.6 Hz, 1H), 
3.19, 3.12 (ABq, J = 20.8 Hz, 2H), 2.59-2.46 (m, 2H), 2.35-2.24 (m, 2H), 2.09-
2.02 (m, 1H), 1.90 (s, 3H), 1.86-1.81 (m, 1H), 1.22 (d, J = 7.2 Hz, 3H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 202.5, 179.8, 163.0, 144.7, 140.9, 131.2, 129.5 (2C), 129.0, 128.8 (2C), 128.7, 
55.3, 45.6, 42.4, 42.1, 32.7, 31.9, 24.2, 15.6 ppm 
IR  (thin film) 
  3374, 2902, 1673, 1431 cm-1 
HRMS  TOF MS ES+ [M+H]: C20H22NO2 
  Calc: 308.1645 Found: 308.1649 
TLC  Rf = 0.15 (75% EtOAc/hexanes) [silica gel, UV, vanillin] 
  
 
(3aS*,9bS*)-3,6-Dimethyl-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-b]pyrrole-2,8(3H)-dione 
(3.195): Prepared according to general procedure H. Allene-yne 3.194 (12 mg, 0.059 mmol, 9:1 
ratio of diastereomers), rhodium dicarbonyl chloride dimer (2 mg, 0.005 mmol), and toluene (5 
mL) provided tricycle 3.195 (11 mg, 78%) as a white solid after column chromatography 
(gradient elution with 25-100% ethyl acetate in hexanes). The ratio of diastereomers was 
determined to be 7:1 based on integration of the resonances for Ha which appeared as doublets at 
4.56 (minor) and 4.51 (major), and the major diastereomer is depicted in 3.195. 
Data for 3.195: (PAJ 8-76, 11 mg, 78%)  
1H NMR  (500 MHz, CDCl3) 
δ 7.47 (br s, 1H)*, 7.36 (br s, 1H), 6.10 (s, 1H)*, 6.07 (s, 1H), 4.56 (d, J = 10.5 
Hz, 1H)*, 4.51 (d, J = 10.0 Hz, 1H), 3.00 (s, 2H), 2.76-2.70 (m, 1H), 2.31-2.18 
(m, 3H), 1.91 (s, 3H), 1.95-1.87 (m, 1H), 1.77-1.70 (m, 1H), 1.20 (d, J = 7.0 Hz, 
3H) ppm 
*Minor diastereomer where distinguishable 
13C NMR  (126 MHz, CDCl3) 
δ 204.0, 179.5, 173.3, 137.5, 131.2, 126.6, 57.1*, 56.6, 47.3, 45.0, 42.0*, 41.5*, 
41.4, 33.3*, 32.7, 28.1, 24.8, 23.7*, 13.8, 12.0* ppm 
IR  (thin film) 
  3196, 2893, 1680, 1553, 1438, 1231, 1156 cm-1 
HRMS  TOF MS ES+ [M+H]: C14H18NO2
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  Calc: 232.1259 Found: 232.1339 
TLC  Rf = 0.11 (100% EtOAc) [silica gel, UV, p-anisaldehyde] 
General Procedure J: Acetylation of Lactam Nitrogen 
 
(3aS*,9bS*)-1-Acetyl-6-methyl-3-methylene-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-
b]pyrrole-2,8(3H)-dione (3.196): A flame-dried test tube equipped with a stir bar, septum, and 
nitrogen inlet needle was charged with tricycle 3.185 (8 mg, 0.03 mmol) dissolved in DCM (0.4 
mL). Dimethylaminopyridine (1 mg, 0.008 mmol) was added and the solution was cooled to 0 
°C. Triethylamine (0.05 mL, 0.3 mmol) was added dropwise via syringe followed by dropwise 
addition of acetic anhydride (0.02 mL, 0.2 mmol) via syringe. The reaction was allowed to warm 
to rt with stirring for 2 h, and TLC showed consumption of starting material. The reaction was 
diluted with DCM (10 mL) and transferred to a separatory funnel. The organic layer was washed 
with saturated ammonium chloride (5 mL), brine (5 mL), dried over magnesium sulfate, gravity 
filtered, concentrated by rotary evaporation, and purified by silica gel flash column 
chromatography (gradient elution with 50-75% ethyl acetate in hexanes) to provide N-acetyl 
lactam 3.196 (7 mg, 78%) as a white, sticky solid. 
Data for 3.196: (PAJ 8-68, 7 mg, 78%)  
1H NMR  (400 MHz, CDCl3) 
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δ 6.27 (d, J = 3.6 Hz, 1H), 5.63 (s, 1H), 5.49 (d, J = 3.6 Hz, 1H), 5.03 (d, J = 9.2 
Hz, 1H), 3.02, 2.94 (ABq, J = 20.8 Hz, 2H), 2.89-2.75 (m, 2H), 2.65 (s, 3H), 
2.56-2.41 (m, 1H), 2.37-2.31 (m, 1H), 1.94 (s, 3H), 1.87-1.79 (m, 1H) ppm 
13C NMR  (100 MHz, CDCl3) 
δ 203.6, 172.4, 171.9, 167.6, 142.4, 136.1, 131.8, 126.9, 120.3, 57.8, 41.0, 39.6, 
31.2, 27.7, 25.8, 24.9 ppm 
IR  (thin film) 
  2890, 1710, 1653, 1555, 1351, 1299, 1145 cm-1 
HRMS  TOF MS ES+ [M+H]: C16H18NO3 
  Calc: 272.1281 Found: 272.1277 
TLC  Rf = 0.57 (100% EtOAc) [silica gel, UV, p-anisaldehyde] 
 
(3aS*,9bS*)-1-Acetyl-6-methyl-3-methylene-9-phenyl-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.196): Prepared according to general procedure J, 
except that the reaction was not complete after 5 h, so it was stirred for 20 h at rt. Tricycle 3.116 
(9 mg, 0.03 mmol), dimethylaminopyridine (1 mg, 0.008 mmol), triethylamine (0.04 mL, 0.3 
mmol), acetic anhydride (0.02 mL, 0.2 mmol), and DCM (0.2 mL) provided N-acetyl lactam 
3.196 (6 mg, 60%) as a pale yellow solid after column chromatography (gradient elution with 
15-50% ethyl acetate in hexanes). 
Data for 3.196: (PAJ 7-124, 6 mg, 60%)  
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1H NMR  (500 MHz, CDCl3) 
δ 7.35-7.29 (m, 3H), 7.04-6.49 (app br s, 2H), 6.29 (d, J = 3.2 Hz, 1H), 5.54 (d, J 
= 3.2 Hz, 1H), 5.16 (d, J = 8.5 Hz, 1H), 3.17, 3.06 (ABq, J = 21.0 Hz, 2H), 3.12-
3.10 (m, 1H), 2.99-2.91 (m, 1H), 2.59-2.51 (m, 1H), 2.44-2.39 (m, 1H), 2.00 (s, 
3H), 1.91-1.88 (m, 1H), 1.59 (s, 3H) ppm 
13C NMR  (126 MHz, CDCl3) 
δ 202.7, 171.8, 166.4, 164.5, 142.8, 138.3, 135.8, 131.2, 131.0 (2C), 130.6, 127.8 
(2C), 120.6, 57.4, 40.5, 39.7, 31.8, 29.7, 28.6, 25.7, 23.9 ppm 
IR  (thin film) 
  3390, 2892, 1689, 1355, 1273, 1164 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H22NO3 
  Calc: 348.1521 Found: 348.1518 
TLC  Rf = 0.31 (50% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
(3aS*,9bS*)-1-Acetyl-3,6-dimethyl-1,3a,4,5,7,9b-hexahydro-2H-azuleno[4,5-b]pyrrole-
2,8(3H)-dione (3.198): Prepared according to general procedure J; TLC showed consumption of 
the starting material after 6.5 h. Tricycle 3.195 (11 mg, 0.05 mmol, 9:1 ratio of diastereomers), 
dimethylaminopyridine (1 mg, 0.008 mmol), triethylamine (0.07 mL, 0.5 mmol), acetic 
anhydride (0.02 mL), and DCM (0.5 mL) provided N-acetyl lactam 3.198 (6 mg, 46%) as a white 
solid after column chromatography (gradient elution with 25-75% ethyl acetate in hexanes) and 
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as a 4.75:1 mixture of diastereomers based on integration of the resonances corresponding to Ha 
appearing as doublets at 5.08 (minor) and 5.02 (major) 
Data for 3.198: (PAJ 8-78, 6 mg, 46%)  
1H NMR  (500 MHz, CDCl3) 
δ 5.59 (s, 1H), 5.08 (d, J = 5.5 Hz, 1H)*, 5.02 (d, J = 10.5 Hz, 1H), 3.01, 2.94 
(ABq, J = 21.0 Hz, 2H), 2.87-2.81 (m, 1H), 2.57 (s, 3H), 2.41-2.26 (m, 3H), 1.93 
(s, 3H), 1.87-1.79 (m, 1H), 1.71-1.65 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H) ppm 
13C NMR  (126 MHz, CDCl3) 
δ 203.7, 177.1, 172.5, 171.7, 136.5, 131.7, 127.1, 66.0, 58.3, 45.7, 42.3*, 41.0, 
31.6, 29.0, 25.4, 24.7, 15.4*, 13.7 ppm 
* Discernible signals for 1 of 2 diastereomers 
IR  (thin film) 
  2893, 1721, 1681, 1661, 1544, 1353, 1254 cm-1 
HRMS  TOF MS ES+ [M+H]: C16H20NO3 
  Calc: 274.1438 Found: 274.1438 
TLC  Rf = 0.46 (75% EtOAc/hexanes) [silica gel, UV, vanillin] 
General Procedure K: Monitoring the Reaction of α-Methylene-γ-Lactams with 
Cysteamine by 1H NMR 
 
  
 Tricyclic lactam 3.116 (8 mg, 0.03 mmol) was dissolved in chloroform-d (0.5 mL) and 
transferred to an NMR tube. Cysteamine (30 mg, 0.4 mmol) was dissolved in chloroform-d 
separately, transferred to the NMR tube containing lactam 3.116 via pipet and the NMR tube was 
capped and shaken vigorously by hand for 2 min. The 1H NMR was monitored for the 
disappearance of the methylene hydrogen resonances (Ha and Hb) which appeared as doublets at 
5.99 ppm and 5.28 ppm. Integration of the methylene hydrogen resonances showed about 5% 
remaining starting material after 8 days and this remained the same at 9 days. Product formation 
was first observed after 24 h at rt where new resonances for the amide hydrogen (Hd, 5.51 and 
5.44) and the hydrogen on the carbon next to the nitrogen (Hc, 5.01 and 4.75) were detected 
indicating the formation of 2 diastereomers in about a 2:1 ratio. The products were unable to be 
isolated for structural confirmation. 
 
 
  
 
 
 
  The reaction was monitored according to general procedure K. Tricyclic lactam 3.187 (2 
mg,  0.004  mmol),  cysteamine  (5  mg,  0.07  mmol),  and  chloroform-d (0.7  mL)  were  used. 
Complete  disappearance  of  the  α-methylene  resonances  at  6.29  and  5.53  was  observed  after 
about  2.5  d.  Minimal  product  formation  was  detected  after  21  h,  and  it  was  observed  that 
cysteamine  had  mostly  oxidized  to  the  disulfide,  thus  more  cysteamine  was  added  at  this  time 
point (10 mg, 0.15 mmol). Hc appeared at the same chemical shift for both the starting material
3.187 and  the  product 3.204.  Product  formation  was  initially  observed  2  h  after  this  additional
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cysteamine was added (23 h total reaction time) by a new aromatic peak shifted upfield relative 
to the starting material at 6.89 ppm. The area of this peak increased over time as the area of the 
α-methylene resonances decreased. 32 h after additional cysteamine was added (53 h total), the 
α-methylene resonances were nearly gone and further measurements became difficult due to the 
large amount of cysteamine and disulfide present in the reaction, so complete adduct formation 
was estimated as about 2.5 days. 
 
 This reaction was monitored according to general procedure K. Tricyclic lactam 3.196 (2 
mg, 0.006 mmol), cysteamine (7 mg, 0.09 mmol), and chloroform-d (1 mL) were used. Complete 
disappearance of the α-methylene resonances at 6.26 and 5.48 was observed after 55 min. 
Significant product formation (more than 50% SM reacted) was observed in less than 10 min as 
two new peaks, corresponding to two diastereomers, for Hc (5.18 and 5.03) and Hd (5.56 and 
5.57) were observed as a 2:1 ratio of diastereomers and a 2.3:1 ratio of products to starting 
material. 
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 This reaction was monitored according to general procedure K. Tricyclic lactam 191 (2 
mg, 0.004 mmol), cysteamine (5 mg, 0.07 mmol), and chloroform-d (0.7 mL) were used. 
Complete disappearance of the α-methylene resonances at 6.17 and 5.44 was observed in less 
than 10 min. Only a single resonance was observed for Hc, suggesting that a single diastereomer 
was formed. 
 
(3aS*,9bS*)-3-((tert-Butylthio)methyl)-1,6-dimethyl-9-phenyl-1,3a,4,5,7,9b-hexahydro-2H-
azuleno[4,5-b]pyrrole-2,8(3H)-dione (3.207): A 2-mL vial equipped with a magnetic stir bar 
was charged with tricyclic lactam 3.56 (10 mg, 0.03 mmol), tert-butyl thiol (0.02 mL, 0.2 mmol), 
acetone (0.5 mL), and phosphate buffered saline (pH = 8.0, 0.5 mL). The vial was capped with a 
septum and allowed to stir at rt for 24 h. Only starting material was detected by TLC analysis, so 
the pH was raised to 12 (pH paper) by addition of potassium hydroxide (2 mg, 0.04 mmol) and 
the starting material was consumed within 30 min as observed by TLC. The reaction was then 
poured into a separatory funnel containing deionized water (3 mL) and DCM (10 mL). The 
layers were separated. The aqueous layer was extracted with DCM (2 x 5 mL). The organic 
layers were combined, washed with brine (5 mL), dried over magnesium sulfate, filtered, and 
concentrated by rotary evaporation and purified by flash column chromatography on silica gel 
(gradient elution with 25-50% ethyl acetate in hexanes) to provide thiol adduct 3.207 (3 mg, 
23%, 1.6:1 diastereomeric ratio) as a clear oil. Diastereomeric ratio determined by integration of 
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resonances corresponding to Ha at 4.66 (J = 10.0 Hz) for the minor diastereomer and 4.50 (J = 
8.5 Hz) for the major diastereomer. 
Data for 3.207: (PAJ 8-130, 3 mg, 23%, 1.6:1 dr)  
1H NMR  (500 MHz, CDCl3) 
δ 7.33-7.27 (m, 3H), 7.23-7.21 (m, 2H), 4.66 (d, J = 10.0 Hz, 1H)*, 4.50 (d, J = 
8.5 Hz, 1H), 3.17-3.07 (m, 3H), 2.94-2.79 (m, 2H), 2.75-2.69 (m, 1H), 2.51-2.41 
(m, 2H), 2.37-2.30 (m, 2H), 1.98 (s, 3H), 1.90 (s, 3H), 1.37 (s, 9H) ppm  
13C NMR  (100 MHz, CDCl3) 
δ 202.92, 202.86*, 175.3, 166.1, 138.5, 137.7, 137.1, 130.8, 130.73*, 130.67 
(2C), 128.5, 128.4*, 127.7 (2C), 127.6*, 62.7, 61.7*, 50.3, 44.2, 43.2*, 42.7, 
42.6*, 40.6, 34.3, 33.4*, 32.6, 31.1, 31.0*, 30.8, 30.4*, 30.32, 30.30*, 29.4, 25.7, 
25.6*, 21.0 ppm 
* Discernible signals for 1 of 2 diastereomers 
IR  (thin film) 
  3407, 2927, 1686, 1445, 1079 cm-1 
HRMS  TOF MS ES+ [M+H]: C25H32NO2S 
  Calc: 410.2148 Found: 410.2144 
TLC  Rf = 0.32 (50% EtOAc/hexanes) [silica gel, UV, vanillin] 
 
General Procedure K: Acetylation of Nitrogen and Oxygen 
 
  
A flame dried, 5 mL round bottom flask under a nitrogen atmosphere equipped with a 
magnetic stir bar, a septum, and nitrogen inlet needle was charged with alcohol 4.15 (92 mg, 
0.31 mmol, 4:1 trans:cis), dichloromethane (1.6 mL), and 4-dimethylaminopyridine (4 mg, 0.03 
mmol), then cooled to 0 °C in an ice bath. Triethylamine (0.44 mL, 3.1 mmol) was added 
dropwise via syringe, followed by dropwise addition of acetic anhydride (0.15 mL, 1.6 mmol). 
The ice bath was removed and the reaction was allowed to warm to rt over 3 h. The reaction was 
transferred to a separatory funnel, diluted with dichloromethane (25 mL), washed sequentially 
with saturated aqueous ammonium chloride (10 mL) and brine (10 mL), dried over magnesium 
sulfate, filtered, concentrated by rotary evaporation, and purified by silica gel flash column 
chromatography eluting with 10-20% ethyl acetate in hexanes to yield the trans bis acetylated 
lactam xx (62 mg, 53%) as a clear oil and the cis bis acetylated lactam 4.17 (9 mg, 8%) as a clear 
oil. 
 
 
  
   
     
    
   
  
5-((2S*,3S*)-1-Acetyl-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)-3-methylpent-
1-yn-3-yl acetate (4.17):
Data for 4.17: (PAJ 7-64, 77 mg, 66% total, 7:1 trans:cis)
1H NMR (400 MHz, CDCl3)
δ 7.39-7.38 (m, 2H), 7.30-7.27 (m, 3H), 6.38 (d, J = 2.0 Hz, 1H), 5.66 (d, J = 2.0 
Hz, 1H), 4.87 (d, J = 2.0 Hz, 1H), 3.11-3.08 (m, 1H), 2.62 (s, 3H), 2.58 (s, 0.5H), 
2.57* (s, 0.5H), 2.11-2.06 (m, 1H), 2.03 (s, 3H), 1.91-1.76 (m, 3H), 1.69 (s, 3H)
ppm
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13C NMR  (100 MHz, CDCl3) 
  δ 171.0, 169.31, 169.29*, 166.3, 142.55, 142.49*, 132.0 (2C), 128.8, 128.4 (2C),  
  122.91, 122.88*, 122.2, 86.84, 86.81*, 84.1, 83.2, 83.1*, 74.24, 74.22*, 74.18,  
  51.2, 51.1*, 44.11, 44.06*, 38.4, 38.3*, 29.9, 29.8*, 26.67, 26.66*, 25.5, 22.0  
  ppm 
IR  (thin film) 
  3268, 2938, 1738, 1705, 1652, 1371, 1303, 1243, 1174, 1017 cm-1 
HRMS  TOF MS ES+ [M+H]: C23H24NO4 
  Calc: 378.1700 Found: 378.1684 
TLC  Rf = 0.29 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
5-((2S*,3R*)-1-Acetyl-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)-3-methylpent-
1-yn-3-yl acetate (4.17b): 
Data for 4.17b: (PAJ 7-64, 77 mg, 66%, 7:1 trans:cis)  
1H NMR  (400 MHz, CDCl3) 
  δ7.40-7.37 (m, 2H), 7.30-7.26 (m, 3H), 6.33 (d, J = 3.0 Hz, 1H), 5.59 (app t, J =  
  2.3 Hz, 1H), 5.32 (d, J = 8.0 Hz, 1H), 2.98-2.93 (m, 1H), 2.61 (s, 3H), 2.51 (s,  
  0.5H), 2.45* (0.5H), 2.26-2.06 (m, 4H), 2.06 (s (1.5H), 1.89* (s, 1.5H), 1.72 (s,  
  1.5H), 1.70* (s, 1.5H) ppm 
13C NMR  (100 MHz, CDCl3) 
  
  δ 170.6, 169.38, 169.34*, 166.9, 142.83, 142.81*, 132.1 (2C), 128.9, 128.3 (2C),  
  122.2, 122.1*, 120.6, 85.97, 85.96*, 83.5, 83.31*, 83.29, 83.1*, 74.6, 74.3*, 74.2, 
  73.9*, 50.00, 49.98*, 40.8, 40.7*, 39.0, 38.6*, 29.8, 26.8, 26.7*, 25.4*, 23.5,  
  23.2*, 22.0, 21.8* ppm 
IR  (thin film) 
   2932, 1715, 1685, 1447cm-1 
HRMS  TOF MS ES+ [M+H]: C23H24NO4 
  Calc: 378.1700 Found: 378.1684  
TLC  Rf = 0.25 (25% EtOAc/hexanes) [silica gel, UV, KMnO4] 
 
  
 
 
  
   
     
   
  
5-((2S*,3S*)-1-Acetyl-4-methylene-5-oxo-2-((triisopropylsilyl)ethynyl)pyrrolidin-3-yl)-3- 
methylpent-1-yn-3-yl  acetate  (4.18): Prepared  according  to  general  procedure  K;  lactam 4.16
(85  mg,  0.23  mmol,  4:1  trans:cis),  dichloromethane  (1.2  mL),  4-dimethylaminopyridine  (3  mg, 
0.02  mmol),  triethylamine  (0.32  mL,  2.3  mmol),  and  acetic  anhydride  (0.11  mL,  1.1  mmol)
provided bis acetylated lactam 4.18 (70 mg, 67%, 4:1 trans:cis) as clear oils after silica gel flash 
column chromatography.
Data for 4.18: (PAJ 7-34, 70 mg,, 67%, 4:1 trans:cis, 1:1 mixture of diastereomers)
1H NMR (300 MHz, CDCl3)
δ 6.31 (d, J = 3.0 Hz, 1H), 5.59 (d, J = 1.8 Hz, 1H), 4.60-4.59 (m, 1H), 2.98-2.92
(m, 1H), 2.55 (s, 3H), 2.54 (s, 1H), 2.06-2.01 (m, 1H), 2.00 (s, 3H), 1.98-1.71 (m,
3H), 1.69 (s, 3H), 1.01 (s, 21H) ppm
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13C NMR  (125 MHz, CDCl3) 
  δ 170.7, 169.3, 166.3, 142.5, 122.4, 105.2, 85.7, 83.2, 74.2, 51.4, 51.3, 44.3, 38.5,  
  29.5, 26.6, 25.4, 21.9, 18.6 (6C), 11.1 (3C) ppm 
IR  (thin film) 
  3269, 2943, 2866, 2175, 1739, 1709, 1463, 1371, 1350, 1294, 1243, 1174 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H40NO4Si 
  Calc: 458.2727 Found: 458.2728  
TLC  Rf = 0.67 (25% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
3-Methyl-5-((2S*,3S*)-1-methyl-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)pent-
1-yn-3-yl acetate (4.46):  General procedure K was followed. Lactam 3.79 (86 mg, 0.27 mmol), 
triethylamine (0.37 mL, 2.7 mmol), dimethylaminopyridine (4 mg, 0.03 mmol), acetic anhydride 
(0.12 mL, 1.3 mmol), and DCM (1.3 mL) yielded lactam bis acetylated lactam 4.46 as a clear oil 
(50 mg, 54%) 
Data for 4.46: (PAJ 6-206, 50 mg, 54%) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.42-7.40 (m, 2H), 7.34-7.29 (m, 3H), 6.13 (d, J = 2.4 Hz, 1H), 5.37 (d, J = 2.4  
  Hz, 1H), 4.11 (d, J = 4 Hz, 1H), 3.08-3.05 (m, 1H), 3.03 (s, 3H), 2.58 (s, 1H),  
  2.16-2.07 (m, 1H), 2.03 (s, 3H), 1.98-1.81 (m, 3H), 1.70 (s, 3H) 
13C NMR  (100 MHz, CDCl3) 
  
  δ 169.4, 167.1, 142.0, 131.9 (2C), 129.0, 128.5 (2C), 122.1, 116.6, 86.0, 83.4,  
  74.5, 74.0, 55.3, 44.5, 38.2, 28.6 (2C), 28.5, 26.7, 22.01 
IR  (thin film) 
  3292, 2937, 2243, 2120, 1742, 1697, 1661, 1427, 1243, 1173, 1082 cm-1 
HRMS  TOF MS ES+ [M+H]: C22H24NO3 
  Calc: 350.1751 Found: 350.1751 
TLC  Rf = 0.26 (50% EtOAc/hexanes, [silica gel, UV, KMnO4] 
General Procedure L: Formal [3,3] Sigmatropic Rearrangement of Propargyl Acetates 
 
 
 
 
5-((2S*,3S*)-1-Acetyl-4-methylene-5-oxo-2-(phenylethynyl)pyrrolidin-3-yl)-3-methylpenta- 
1,2-dienyl acetate (4.19): A flame dried test tube equipped with a magnetic stir bar was charged 
with rhodium (II) trifluoroacetate dimer (6 mg, 0.008 mmol) in a nitrogen glove box, sealed with 
a  septum,  removed,  and  placed  under  nitrogen  via  a  needle  in  a  fume  hood.  Propargyl  acetate
4.17 (62 mg, 0.16 mmol) was dissolved in degassed toluene (0.8 mL) then transferred to the tube 
containing the rhodium (II) trifluoroacetate dimer by syringe. The tube was evacuated and filled 
with nitrogen (3x), the nitrogen inlet needle was removed, and the solution was heated to 60 °C
(sealed  tube)  in  a  prewarmed  oil  bath  for  1  h.  The  solution  was  removed  from  the  heat  and 
allowed  to  cool to  rt,  then  applied  directly  to  a  silica  gel  column  and  purified  by  flash  column 
chromatography  eluting  with  5-15%  ethyl  acetate  in  hexanes  to  yield  allenyl  acetate 4.19 as  a
clear oil (46 mg, 74%).
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Data for 4.19: (PAJ 7-70, 46 mg, 74%) 
1H NMR  (400 MHz, CDCl3) 
  δ 7.39-7.37 (m, 2H), 7.35-7.33 (m, 1H), 7.31-7.26 (m, 3H), 6.36 (app t, J = 2 Hz,  
  1H), 5.64 (d, J = 7.2 Hz, 0.5H), 5.63*(d, J = 7.2 Hz, 0.5H), 4.85 (s, 1H), 3.12- 
  3.09 (m, 1H), 2.616 (s, 3H), 2.615* (s, 3H), 2.23-2.18 (m, 2H), 2.14 (s, 1.5H),  
  2.12* (s, 1.5H), 1.859 (s, 1.5H), 1.855* (s, 1.5H), 1.80 (m, 1H), 1.73-1.67 (m, 1H) 
  ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 189.9, 189.8*, 171.09, 171.07*, 168.83, 168.79*, 166.4, 142.7, 142.6*, 132.0  
  (2C), 128.8, 128.4 (2C), 122.9, 122.8*, 122.3, 114.7, 114.6*, 110.8, 110.7*,  
  86.92, 86. 90*, 84.1, 84.0*, 51.25, 51.18*, 43.72, 43.69*, 32.84, 32.78*, 31.6,  
  31.5*, 25.5, 21.0, 20.99, 20.93* ppm 
  *Discernible signals for one of two diastereomers 
IR  (thin film) 
  2922, 1741, 1491, 1445, 1372, 1270, 1216, 1110, 1042 cm-1 
HRMS  TOF MS ES+ [M+H]: C23H24NO4 
  Calc: 378.1700 Found: 378.1707  
TLC  Rf = 0.65 (40% EtOAc/hexanes, [silica gel, UV, p-anisaldehyde] 
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5-((2S*,3S*)-1-Acetyl-4-methylene-5-oxo-2-((triisopropylsilyl)ethynyl)pyrrolidin-3-yl)-3-
methylpenta-1,2-dienyl acetate (4.20): General procedure L was followed. Rhodium (II) 
trifluoroacetate dimer (3 mg, 0.005 mmol), propargyl acetate 4.18 (43 mg, 0.094 mmol), and 
toluene (0.5 mL) were used. Purification by silica gel flash chromatography eluting with 5-10% 
ethyl acetate in hexanes yielded allenyl acetate 4.20 (42 mg, 97%) as a clear oil. 
Data for 4.20: (PAJ 7-38, 42 mg, 97%) 
1H NMR  (500 MHz, CDCl3) 
  δ 7.32-7.31 (m, 1H), 6.31 (d, J = 2Hz, 1H), 6.30*(d, J = 2 Hz, 1H), 5.59 (d, J =  
  1.5 Hz, 1H), 5.57*(d, J = 2 Hz, 1H), 4.61 (d, J = 1 Hz, 1H), 3.01-2.96 (m, 1H),  
  2.56 (s, 3H), 2.21-2.12 (m, 2H), 2.124 (s, 3H), 2.116* (s, 3H), 1.833 (s,   
 1.5H), 1.829* (s, 1.5H), 1.73-1.62 (m, 2H), 1.0 (s, 21H) 
13C NMR  (125 MHz, CDCl3) 
  δ 189.7, 189.6*, 170.73, 170.72*, 168.81, 168.76*, 166.4, 142.7, 142.6*, 122.5,  
  122.4*, 114.8, 114.6*, 110.8, 110.7*, 105.3, 85.6, 85.5*, 51.32, 51.27*, 44.1,  
  43.9*, 32.7, 32.6*, 31.54, 31.51*, 25.3, 21.03, 21.01*, 20.9, 18.6 (6C), 11.1 (3C) 
  *Discernible signals for one of two diastereomers 
IR  (thin film) 
  3266, 2931, 1715, 1447 cm-1 
HRMS  TOF MS ES+ [M+H]: C26H40NO4Si 
  Calc: 458.2721 Found: 458.2742 
TLC  Rf = 0.52 (25% EtOAc/hexanes, [silica gel, UV, p-anisaldehyde] 
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 A flame-dried test tube was charged with rhodium biscarbonyl chloride dimer (8 mg, 
0.02 mmol) and dichloroethane (0.7 mL). Triphenylphosphine (17 mg, 0.06 mmol) was 
dissolved in dichloroethane (0.7 mL) and added to the rhodium and this was stirred 15 min under 
a nitrogen atmosphere. Silver tetrafluoroborate (9 mg, 0.05 mmol) was weighed into test tube in 
glove box, sealed with a septum, removed, and dissolved in dichloroethane (0.6 mL). The silver 
tetrafluoroborate solution was added dropwise over 5 min to the rhodium and triphenylphosphine 
solution. The stir plate was turned off and the precipitate was allowed to settle to the bottom of 
the test tube for 1 h, then the rhodium catalyst solution (1.1 mL, 0.01M in rhodium) was 
carefully removed via syringe, leaving the precipitate in the bottom of the test tube. This solution 
was transferred to a dry 5 mL round bottom flask under an atmosphere of 10% carbon monoxide 
in argon via syringe. A solution of allenyl acetate 4.19 (40 mg, 0.11 mmol) in dichloroethane 
(1.3 mL) was added via syringe to the rhodium catalyst solution, then this mixture was placed in 
a preheated oil bath at 50 °C and stirred for 2 h. The crude reaction mixture was filtered through 
a plug of silica gel eluting with 50% ethyl acetate in hexanes, concentrated, then purified by 
silica gel flash column chromatography (gradient elution with 15-45% ethyl acetate in hexanes) 
to provide [2 + 2] cycloaddition product 4.22 (15 mg, 34%) and Pauson-Khand product 4.21 (11 
mg, 25%) each as pale yellow oils. 
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(3aS*,9bS*)-1-Acetyl-6-methyl-3-methylene-2,8-dioxo-9-phenyl-2,3,3a,4,5,7,8,9b-
octahydro-1H-azuleno[4,5-b]pyrrol-7-yl acetate (4.21): 
Data for 4.21: (PAJ 6-164, 11 mg, 25%) 
1H NMR  (500 MHz, CDCl3) 
δ 7.38-7.31 (m, 3H), 7.01-6.89 (m, 2H), 6.31 (d, J = 3.5 Hz, 1H), 6.29* (d, J = 3.5 
Hz, 1H), 5.82 (s, 1H), 5.59* (s, 1H), 5.56 (d, J = 3.5 Hz, 1H), 5.53* (d, J = 3.5 
Hz, 1H), 5.23 (d, J = 8.5 Hz, 1H), 5.11* (d, J = 9.0 Hz, 1H), 3.22-3.15 (m, 1H), 
3.12-3.17* (m, 1H), 3.06-2.99 (m, 2H), 2.61-2.57* (m, 2H), 2.40 (dt, J = 16.0, 5.0 
Hz, 2H), 2.19 (s, 3H), 2.10* (s, 3H), 2.02 (s, 3H), 2.00* (s, 3H), 1.93-1.89* (m, 
2H), 1.59 (s, 3H), 1.58* (s, 3H) ppm 
13C NMR  (125 MHz, CDCl3) 
δ 198.7, 198.4*, 171.8, 171.6*, 170.0, 169.7*, 166.2, 165.1*, 163.5, 142.6, 
142.4*, 140.3, 139.7*, 135.4, 135.2*, 134.93*, 134.88, 134.83*, 131.0, 130.9*, 
130.7, 130.42*, 130.38, 130.3*, 130.2, 128.3*, 128.1, 128.0*, 127.96, 127.8*, 
121.0, 120.8*, 72.9, 70.4*, 57.4, 57.3*, 39.3, 39.1*, 32.7, 32.1*, 28.9, 28.7*, 25.2, 
25.1*, 23.9, 23.8*, 20.8, 20.6* ppm 
*Other diastereomer where distinguishable 
IR  (thin film) 
  2926, 1735, 1709, 1438, 1371, 1281, 1227, 1171, 1119, 1041 cm-1 
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HRMS  TOF MS ES+ [M+H]: C24H24NO5 
  Calc: 406.1654 Found: 406.1660 
TLC  Rf = 0.27 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
 
(Z)-((3S*,3aS*)-2-Acetyl-5a-methyl-1-oxo-3-((triisopropylsilyl)ethynyl)hexahydro-1H-
cyclobuta[1,5]cyclopenta[1,2-c]pyrrol-6(7H)-ylidene)methyl acetate (4.44): A 2-neck, 15-
mL, flame-dried round bottom flask equipped with a magnetic stir bar, a septum, and a 
condenser capped with a septum and attached to a vacuum line with a needle was charged with 
rhodium bis carbonyl chloride (4 mg, 0.009 mmol) and toluene (6.7 mL). The apparatus was 
evacuated and filled with CO(g) via a balloon (3x), then lowered into a preheated oil bath set to 
110 °C. Allenyl acetate 4.20 (40 mg, 0.087 mmol) was dissolved in toluene (2 mL) and added 
slowly to the stirring mixture of rhodium bis carbonyl chloride via syringe pump over 1 h (2 
mL/h). The reaction was stirred an additional 30 min after addition of the allenyl acetate 4.20 
was complete, then an aliquot of the reaction mixture showed completion by 1HNMR. The 
solution was allowed to cool to rt, filtered through a plug of silica gel eluting with 75% ethyl 
acetate in hexanes, then concentrated by rotary evaporation. The concentrated product was 
purified by silica gel flash column chromatography eluting with 5-75% ethyl acetate in hexanes 
to yield tricycle 4.44 as a clear oil (25 mg, 55%) 
Alternatively, tricycle 4.44 was prepared in a similar yield under thermal conditions by 
dissolving allenyl acetate 4.20 (25 mg, 0.044 mmol) in toluene (4.4 mL) in a flame dry 10 mL 
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flask equipped with a reflux condenser and heating to 110 °C in an oil bath for 2.5 h. The 
solution was purified as described above by filtration through a plug of silica gel, concentration 
by rotary evaporation, and silica gel flash column chromatography to yield the title compound 
4.44 as a clear oil (14 mg, 56%). 
Data for 4.44: (PAJ 7-40, 25 mg, 55%) (Thermal conditions, PAJ 7-58, 14 mg, 56%) 
1H NMR  (500 MHz, CDCl3) 
  δ 7.01 (t, J = 3 Hz, 1H), 4.19 (d, J = 7.5 Hz, 1H), 3.29 (dd, J = 16.7 Hz, 3 Hz,  
  1H), 2.71 (t, J = 6.7 Hz, 1H), 2.50 (s, 3H), 2.43 (dd, J = 16.7 Hz, 3 Hz), 2.33-2.22 
  (m, 1H), 2.13 (s, 3H), 2.03 (dd, J = 12.5 Hz, 7.5 Hz, 1H), 1.93 (dd, J = 13.5 Hz,  
  6.5 Hz, 1H), 1.56 (dt, J = 13 Hz, 6.5 Hz, 1H), 1.20 (s, 3H), 1.03 (s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 174.4, 170.3, 167.9, 129.2, 126.7, 105.4, 85.6, 59.9, 57.2, 51.6, 51.2, 38.5, 30.0,  
  28.4, 25.5, 21.2, 20.8, 18.7 (6C), 11.2 (3C) ppm 
IR  (thin film) 
  2943, 2865, 2176, 1740, 1710, 1463, 1371, 1313, 1300, 1269, 1214, 1096 cm-1 
HRMS  TOF MS ES+ [M+H]: C24H24NO5 
  Calc: 458.2727 Found: 458.2730 
TLC  Rf = 0.47 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
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(E*)-5-((2S*,3S*)-1-Acetyl-4-methylene-5-oxo-2-((triisopropylsilyl)ethynyl)pyrrolidin-3-yl)-
3-methylpent-2-enal (S1):  
Data for S1: (PAJ 7-56, 32-34, Major isomer, 14 mg, 39%) 
1H NMR  (500 MHz, CDCl3) 
  δ 9.98 (d, J = 8 Hz, 1H), 6.35 (d, J = 2 Hz, 1H), 5.87 (d, J = 8 Hz, 1H), 5.61 (d, J  
  = 1.6 Hz, 1H), 4.63 (d, J = 2.4 Hz, 1H), 2.96 (dt, J = 7.6 Hz, 2 Hz, 1H), 2.57 (s,  
  3H), 2.35-2.30 (m, 1H), 2.17 (d, J = 1.2 Hz, 3H), 1.78-1.71 (m, 2H), 1.01 (s, 21H) 
  ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 191.0, 170.7, 166.1, 161.4, 142.4, 127.8, 122.7, 104.9, 86.0, 51.1, 44.1, 37.1,  
  32.5, 25.3, 18.6, 17.9, 11.1 ppm 
IR  (thin film) 
  3406, 2943, 2865, 1736, 1707, 1674, 1463, 1372, 1288, 1160, 1110 cm-1 
HRMS  TOF MS ES+ [M+H]: C24H24NO5 
  Calc: 416.2616 Found: 416.2608 
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TLC  Rf = 0.27 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
Data for S1: (PAJ 7-56, 30-31, Minor isomer, 7 mg, 19%) 
1H NMR  (500 MHz, CDCl3) 
  δ 9.91 (d, J = 7.6 Hz, 1H), 6.37 (d, J = 2 Hz, 1H), 5.92 (d, J = 7.6 Hz, 1H), 5.63  
  (d, J = 1.6 Hz, 1H), 4.67 (d, J = 2 Hz, 1H), 3.03-2.99 (m, 1H), 2.68 (t, J = 8.2 Hz,  
  2H), 2.58 (s, 3H), 1.98 (d, J = 1.2 Hz, 3H), 1.85-1.68 (m, 2H), 1.01 (s, 21H) ppm 
13C NMR  (125 MHz, CDCl3) 
  δ 190.0, 170.6, 166.0, 161.7, 142.3, 128.7, 122.8, 104.8, 86.1, 51.1, 44.6, 34.1,  
  29.8, 25.4, 25.2, 18.6 (6C), 11.1 (3C) ppm 
IR  (thin film) 
  2943, 2865, 2177, 1735, 1707, 1673, 1463, 1349, 1290cm-1 
HRMS  TOF MS ES+ [M+H]: C24H24NO5 
  Calc: 416.2616 Found: 416.2605 
TLC  Rf = 0.34 (50% EtOAc/hexanes) [silica gel, UV, p-anisaldehyde] 
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APPENDIX B 
1H AND 13C NMR SPECTRA 
 
x
x
 
x
x
 
 289 
 
3
.6
0
 
 290 
 
3
.6
0
 
 291 
 
3
.7
4
a
 
 292 
 
3
.7
4
a
 
 293 
 
3
.7
4
b
 
 294 
 
3
.7
4
b
 
 295 
 
3
.7
7
 
 296 
 
3
.7
7
 
 297 
 
3
.1
2
1
a
 
 298 
 
3
.1
2
1
a
 
 299 
 
3
.1
2
1
b
 
 300 
 
3
.1
2
1
b
 
 301 
 
3
.5
8
a
 
6
.4
:1
 tra
n
s
:c
is
 
 302 
 
3
.5
8
a
 
6
.4
:1
 tra
n
s
:c
is
 
 303 
 
3
.5
8
b
 
9
8
:1
 c
is
:tra
n
s
 
 304 
 
3
.5
8
b
 
9
.8
:1
 c
is
:tra
n
s
 
 305 
 
3
.7
8
 
1
9
.6
:1
 tra
n
s
:c
is
 
 306 
 
3
.7
8
 
1
9
.6
:1
 tra
n
s
:c
is
 
 307 
 
3
.1
2
2
a
 
 308 
 
3
.1
2
2
a
 
 309 
 
3
.1
2
2
b
 
4
.4
:1
 c
is
:tra
n
s
 
 310 
 
3
.1
2
2
b
 
4
.4
:1
 c
is
:tra
n
s
 
 311 
 
3
.1
1
2
a
 
1
:1
 d
r 
 312 
 
3
.1
1
2
a
 
1
:1
 d
r 
 313 
 
3
.1
1
2
b
 
6
.5
:1
 c
is
:tra
n
s
 
1
:1
 d
r 
 314 
 
3
.1
1
2
b
 
6
.5
:1
 c
is
:tra
n
s
 
1
:1
 d
r 
 315 
 
3
.7
9
 
1
:1
 d
r 
 316 
 
3
.7
9
 
1
:1
 d
r 
 317 
 
3
.1
2
3
a
 
1
:1
 d
r 
 318 
 
3
.1
2
3
a
 
1
:1
 d
r 
 319 
 
3
.1
2
3
b
 
1
.8
:1
 c
is
:tra
n
s
 
1
:1
 d
r 
 320 
 
3
.1
2
3
b
 
1
.8
:1
 c
is
:tra
n
s
 
1
:1
 d
r 
 321 
 
3
.8
0
 
1
:1
 d
r 
 322 
 
3
.8
0
 
1
:1
 d
r 
 323 
 
3
.1
1
3
a
 
1
:1
 d
r 
 324 
 
3
.1
1
3
a
 
1
:1
 d
r 
 325 
 
3
.1
1
3
b
 
1
:1
 d
r 
 326 
 
3
.1
1
3
b
 
1
:1
 d
r 
 327 
 
3
.1
2
4
a
 
1
:1
 d
r 
 328 
 
3
.1
2
4
a
 
1
:1
 d
r 
 329 
 
3
.1
2
4
b
 
1
:1
 d
r 
 330 
 
3
.1
2
4
b
 
1
:1
 d
r 
 331 
 
3
.1
1
4
 
 332 
 
3
.1
1
4
 
 333 
 
3
.1
3
4
 
 334 
 
3
.1
3
4
 
 335 
  
3
.1
2
5
 
 336 
  
3
.1
2
5
 
 337 
 
3
.1
2
6
 
8
.3
:1
 d
r 
 338 
 
3
.1
2
6
 
8
.3
:1
 d
r 
 339 
 
3
.1
3
5
 
 340 
 
3
.1
3
5
 
 341 
 
3
.5
7
 
 342 
 
3
.5
7
 
 343 
 
3
.1
7
5
 
 344 
 
3
.1
7
5
 
 345 
 
3
.1
8
2
 
5
.8
:1
 
p
ro
d
u
c
t:re
d
u
c
e
d
 
m
e
th
y
le
n
e
 
 346 
 
3
.1
8
2
 
5
.8
:1
 p
ro
d
u
c
t: re
d
u
c
e
d
 m
e
th
y
le
n
e
 
 347 
 
3
.2
0
8
 
8
:1
 d
r 
 348 
 
3
.2
0
8
 
8
:1
 d
r 
 349 
 
3
.1
7
4
 
 350 
 
3
.1
7
4
 
 351 
 
3
.1
6
8
 
 352 
 
3
.1
6
8
 
 353 
 
3
.1
6
9
 
 354 
 
3
.1
6
9
 
 355 
 
3
.1
7
1
 
 356 
 
3
.1
7
1
 
 357 
 
3
.1
7
0
 
 358 
 
3
.1
7
0
 
 359 
 
3
.1
7
2
 
 360 
 
3
.1
7
2
 
 361 
 
3
.1
7
3
 
 362 
 
3
.1
7
3
 
 363 
 
3
.1
1
6
 
 364 
 
3
.1
1
6
 
 365 
 
3
.5
6
 
 366 
 
3
.5
6
 
 367 
 
3
.1
9
2
 
 368 
 
3
.1
9
2
 
 369 
 
3
.1
8
4
 
 370 
 
3
.1
8
4
 
 371 
 
3
.1
9
9
 
 372 
 
3
.1
9
9
 
 373 
 
3
.1
8
5
 
 374 
 
3
.1
8
5
 
 375 
 
3
.1
8
6
 
 376 
 
3
.1
8
6
 
 377 
 
3
.1
8
7
 
 378 
 
3
.1
8
7
 
 379 
 
3
.1
8
8
 
 380 
 
3
.1
8
8
 
 381 
 
3
.1
8
9
 
 382 
 
3
.1
8
9
 
 383 
 
3
.1
9
0
 
 384 
 
3
.1
9
0
 
 385 
 
3
.1
9
1
 
 386 
 
3
.1
9
1
 
 387 
 
3
.1
9
3
 
 388 
 
3
.1
9
3
 
 389 
 
3
.1
9
5
 
7
.3
:1
 d
r 
 390 
 
3
.1
9
5
 
7
.3
:1
 d
r 
 391 
 
3
.1
9
6
 
 392 
 
3
.1
9
6
 
 393 
 
3
.1
9
7
 
 394 
 
3
.1
9
7
 
 395 
 
3
.1
9
8
 
4
.7
5
:1
 d
r 
 396 
 
3
.1
9
8
 
4
.7
5
:1
 d
r 
 397 
 
3
.1
1
6
 S
M
 
c
y
s
te
a
m
in
e
 
a
d
d
itio
n
 
 398 
 
3
.1
1
6
 
 399 
 
3
.1
1
6
 
3
.2
0
3
 
2
:1
 d
r 
 400 
 
3
.1
1
6
 
3
.2
0
3
 
2
:1
 d
r 
 401 
 
3
.1
1
6
 
3
.2
0
3
 
1
.6
:1
 d
r 
 402 
 
3
.1
8
7
 S
M
 
c
y
s
te
a
m
in
e
 
a
d
d
itio
n
 
 403 
 
3
.1
8
7
 
 404 
 
3
.1
8
7
 
 405 
 
3
.1
8
7
 
 406 
 
3
.1
8
7
 
3
.2
0
4
 
 407 
 
3
.2
0
4
 
3
.1
8
7
 
 408 
 
3
.2
0
4
 
3
.1
8
7
 
 409 
 
3
.2
0
4
 3.1
8
7
 
 410 
 
3
.1
9
6
 S
M
 
c
y
s
te
a
m
in
e
 
a
d
d
itio
n
 
 411 
 
3
.2
0
5
 
3
.1
9
6
 
2
.5
:1
 d
r 
 412 
 
3
.1
9
6
 
x
x
 
2
.6
:1
 d
r 
3
.2
0
5
 
 413 
 
2
.6
:1
 d
r 
3
.2
0
5
 
 414 
 
3
.1
9
1
 S
M
 
c
y
s
te
a
m
in
e
 
a
d
d
itio
n
 
 415 
 
3
.2
0
6
 
 416 
 
x
x
 
3
.2
0
7
 1
.6
:1
 d
r 
 417 
 
1
.6
:1
 d
r 
3
.2
0
7
 
 418 
 
X
x
 
1
.4
:1
 d
r 
4
.2
1
 
 419 
 
1
.4
:1
 d
r 
4
.2
1
 
 420 
 
1
.4
:1
 d
r 
4
.2
1
 
 421 
 
4
.4
4
 
 422 
 
4
.4
4
 
 423 
 
4
.4
4
 
 424 
 
x
x
 
4
.4
4
 
 425 
 
4
.4
4
 
 426 
 
4
.4
4
 
 427 
Mass Spectral Data from Rate Experiments with Glutathione 
Starting material, control 
 
15 min 
 428 
 
30 min 
 429 
 
45 min 
 430 
 
60 min 
 431 
 
75 min 
 432 
 
90 min 
 433 
 
105 min 
 434 
 
120 min 
  
BIBLIOGRAPHY 
 
1. 
 
 
 
2. 
 
 
 
3. 
 
 
 
4. 
 
 
 
5. 
 
 
6. 
 
 
7.  
 
 
8. 
 
 
9. 
Afatanib.
http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm360574.htm
(accessed 8/8/16).
FDA  Approves  New  Pill  to  Treat  Certain  Patients  with  Non-Small  Cell  Lung  Cancer. 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472525.htm
(accessed 8/8/2016).
FDA  Approves  Imbruvica  to  Treat  Chronic  Lymphocytic  Leukemia. 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm385764.htm
(accessed 8/8/16).
FDA  Approves  Imbruvica  for  Rare  Blood  Cancer. 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm374761.htm
(accessed 8/8/16).
Kwak, E. L.; Sordella, R.; Bell, D. W.; Godin-Heymann, N.; Okimoto, R. A.; Brannigan, 
B. W.; Harris, P. L.; Driscoll, D. R.; Fidias, P.; Lynch, T. J.; Rabindran, S. K.; McGinnis, 
J. P.; Wissner, A.; Sharma, S. V.; Isselbacher, K. J.; Settleman, J.; Haber, D. A., Irreversible 
Inhibitors of the EGF Receptor May Circumvent Acquired Resistance to Gefitinib. PNAS
2005, 102, 7665-7670.
Kohler, J.; Schuler, M., Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR 
Mutation-Positive Lung Adenocarcinoma: A Review. Onkologie 2013, 36, 510-518.
Lou, Y.; Owens, T. D.; Kuglstatter, A.; Kondru, R. K.; Goldstein, D. M., Bruton's Tyrosine 
Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical 
Evaluation for Inflammatory Diseases and B Cell Malignancies. J. Med. Chem. 2012, 55, 
4539-4550.
Cross, D. A. E.; Ashton, S. E.; Ghiorghiu, S.; Eberlein, C.; Nebhan, C. A.; Spitzler, P. J.;
Orme, J. P.; Finlay, M. R. V.; Ward, R. A.; Mellor, M. J.; Jin, H.; Ballard, P.; Al-Kadhimi, 
K.;  Rowlinson,  R.;  Klinowska,  T.;  Richmond,  G.  H.  P.;  Cantarini,  M.;  Kim,  D.-W.;
Ranson,  M.  R.;  Pao,  W.,  AZD9291,  an  Irreversible  EGFR  TKI,  Overcomes  T790M- 
Mediated Resistance to EGFR Inhibitors in Lung Cancer. Cancer Discov. 2014, 4, 1046-
1061.
Hagel, M.; Niu, D.; Martin, T. S.; Sheets, M. P.; Qiao, L.; Bernard, H.; Karp, R. M.; Zhu,
Z.;  Labenski,  M.  T.;  Chaturvedi,  P.;  Nacht,  M.; Westlin, W.  F.;  Petter,  R.  C.; Singh, J.,
435
  
 
 
10. 
 
 
11. 
 
 
12. 
 
 
13. 
 
 
 
14. 
 
 
15. 
  
 
16. 
 
 
17. 
 
 
18. 
 
 
19. 
Selective Irreversible Inhibition of a Protease by Targeting a Noncatalytic Cysteine. Nat. 
Chem. Biol. 2011, 7, 22-24.
Solca,  F.;  Dahl,  G.;  Zoephel,  A.;  Bader,  G.;  Sanderson,  M.;  Klein,  C.;  Kraemer,  O.;
Himmelsbach,  F.;  Haaksma,  E.;  Adolf,  G.  R.,  Target  Binding  Properties  and  Cellular 
Activity  of  Afatinib  (BIBW  2992),  an  Irreversible  ErbB  Family  Blocker. J.  Pharmacol. 
Exp. Ther. 2012, 343, 342-50.
Zhou, W.; Hur, W.; McDermott, U.; Dutt, A.; Xian, W.; Ficarro, S. B.; Zhang, H.; Sharma, 
S. V.; Brugge, J.; Meyerson, M.; Settleman, J.; Gray, N. S., A Structure Guided Approach 
to Creating Covalent FGFR Inhibitors. Chem. Biol. 2010, 17, 285-295.
Pan, Z.; Scheerens, H.; Li, S.-J.; Schultz, B. E.; Sprengeler, P. A.; Burrill, L. C.; Mendonca, 
R. V.; Sweeney, M. D.; Scott, K. C. K.; Grothaus, P. G.; Jeffery, D. A.; Spoerke, J. M.;
Honigberg, L. A.; Young, P. R.; Dalrymple, S. A.; Palmer, J. T., Discovery of Selective 
Irreversible Inhibitors for Bruton's Tyrosine Kinase. ChemMedChem 2007, 2, 58-61.
Zhang, T.; Inesta-Vaquera, F.; Niepel, M.; Zhang, J.; Ficarro, S. B.; Machleidt, T.; Xie, T.;
Marto, J. A.; Kim, N.; Sim, T.; Laughlin, J. D.; Park, H.; LoGrasso, P. V.; Patricelli, M.;
Nomanbhoy,  T.  K.;  Sorger,  P.  K.;  Alessi,  D.  R.;  Gray,  N.  S.,  Discovery of  Potent  and 
Selective Covalent Inhibitors of JNK. Chem. Biol. 2012, 19, 140-154.
Nacht, M.; Qiao, L.; Sheets, M. P.; Martin, T. S.; Labenski, M.; Mazdiyasni, H.; Karp, R.;
Zhu, Z.; Chaturvedi, P.; Bhavsar, D.; Niu, D.; Westlin, W.; Petter, R. C.; Medikonda, A. 
P.; Singh, J., Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of 
the Lipid Kinase PI3K. J. Med. Chem. 2013, 56, 712-721.
Potashman, M. H.; Duggan, M. E., Covalent Modifiers: An Orthogonal Approach to Drug 
Design. J. Med. Chem. 2009, 52, 1231-1246.
Singh, J.; Petter, R. C.; Baillie, T. A.; Whitty, A., The Resurgence of Covalent Drugs. Nat. 
Rev. Drug Disc. 2011, 10, 307-317.
Barf, T.; Kaptein, A., Irreversible Protein Kinase Inhibitors: Balancing the Benefits and the 
Risks. J. Med. Chem. 2012, 55, 6243-6262.
Wissner,  A.;  Overbeek,  E.;  Reich,  M.  F.;  Floyd,  M.  B.;  Johnson,  B.  D.;  Mamuya,  N.;
Rosfjord, E. C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S. K.; Gruber, B. C.; Ye, F.;
Hallett, W. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L. M.; Tsou, H.-R., 
Synthesis and Structure-Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3- 
carbonitriles.  The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase 
Activity  of  the  Epidermal  Growth  Factor  Receptor  (EGFR)  and  the  Human  Epidermal
Growth Factor Receptor-2 (HER-2). J. Med. Chem. 2003, 46, 49-63.
Tsou, H.-R.; Mamuya, N.; Johnson, B. D.; Reich, M. F.; Gruber, B. C.; Ye, F.; Nilakantan,
R.;  Shen,  R.;  Discafani,  C.;  DeBlanc,  R.;  Davis,  R.;  Koehn,  F.  E.;  Greenberger,  L.  M.;
436
  
 
 
20.  
 
 
21. 
 
 
22. 
 
 
23. 
 
 
24. 
 
 
25. 
 
 
26. 
 
 
27. 
 
 
28.  
 
29. 
 
 
30. 
Wang, Y.-F.; Wissner, A., 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative 
Irreversible  Inhbitors  of  the  Epidermal  Growth  Factor  Receptor  (EGFR)  and  Human 
Epidermal Growth Factor Receptor (HER-2) with Enhanced Antitumor Activity. J. Med. 
Chem. 2001, 44, 2719-2734.
Drew,  D.  P.;  Krichau,  N.;  Reichwald,  K.;  Simonsen,  H. T.,  Guaianolides  in  Apiaceae:
Perspectives  on  Pharmacology  and  Biosynthesis. Phytochemistry  Reviews 2009, 8,  581- 
599.
Simonsen, H.; Weitzel, C.; Christensen, S., Guaianolide Sesquiterpenoids: Pharmacology 
and  Biosynthesis.  In Natural  Products,  Ramawat,  K.  G.;  Mérillon,  J.-M.,  Eds.  Springer 
Berlin Heidelberg: 2013; pp 3069-3098.
Kitson, R. R.; Millemaggi, A.; Taylor, R. J., The Renaissance of alpha-Methylene-gamma- 
Butyrolactones: New Synthetic Approaches. Angew. Chem. Int. Ed. 2009, 48, 9426-9451.
Beekman, A. C.; Woerdenbag, H. J.; Uden, W.; Pras, N.; Konings, A. W.; Wikstrom, H. 
V.;  Schmidt,  T.  J.,  Structure-Cytotoxicity  Relationships  of  Some  Helenanolide-Type 
Sesquiterpene Lactones. J. Nat. Prod. 1997, 60, 252-257.
Csuk,  R.;  Heinold,  A.;  Siewert,  B.;  Schwarz,  S.;  Barthel,  A.;  Kluge,  R.;  Strohl,  D., 
Synthesis  and  Biological  Evaluation  of  Antitumor-Active  Arglabin  Derivatives. Arch 
Pharm (Weinheim) 2012, 345, 215-222.
Siedle, B.; García-Piñeres, A. J.; Murillo, R.; Schulte-Mönting, J.; Castro, V.; Rüngeler, 
P.; Klaas, C. A.; Da Costa, F. B.; Kisiel, W.; Merfort, I., Quantitative Structure−Activity 
Relationship of Sesquiterpene Lactones as Inhibitors of the Transcription Factor NF-κB. J. 
Med. Chem. 2004, 47, 6042-6054.
Dey,  A.;  Tergaonkar,  V.;  Lane,  D.  P.,  Double-edged  swords  as  cancer  therapeutics:
simultaneously targeting p53 and NF-[kappa]B pathways. Nat Rev Drug Discov 2008, 7,
1031-1040.
Gilmore, T. D.; Herscovitch, M., Inhibitors of NF-[kappa]B signaling: 785 and counting.
Oncogene 2006, 25, 6887-6899.
Guterman, L., Covalent Drugs Form Long-Lived Ties. Chem. Eng. News 2011, 89, 19-26.
Grillot, A. L.; Farmer, L. J.; Rao, B. G.; Taylor, W. P.; Weisberg, I. S.; Jacobson, I. M.;
Perni, R. B.; Kwong, A. D., Discovery and Development of Telaprevir. In Antiviral Drugs:
From Basic Discovery through Clinical Trials, Kazmierski, W. M., Ed. Wiley: Hoboken, 
NJ, 2011; pp 207-224.
Blazer, L. L.; Neubig, R. R., Small Molecule Protein-Protein Interaction Inhibitors as CNS 
Therapeutic  Agents:  Current  Progress  and  Future  Hurdles. Neuropsychopharmacology
2009, 34, 126-141.
437
 
  
 
31. 
 
 
32. 
 
 
33. 
 
 
34. 
 
 
35. 
 
 
 
36. 
 
 
37. 
 
 
38. 
 
 
39. 
 
 
40. 
 
 
41. 
Way, J. C., Covalent Modification as a Strategy to Block Protein-Protein Interactions with 
Small-Molecule Drugs. Curr. Opin. Chem. Biol. 2000, 4, 40-46.
Arkin,  M.  R.;  Wells,  J.  A.,  Small-Molecule  Inhibitors  of  Protein-Protein  Interactions:
Progressing Towards the Dream. Nature Reviews: Drug Discovery 2004, 3, 301-317.
Kimple, A. J.; Willard, F. S.; Giguère, P. M.; Johnston, C. A.; Mocanu, V.; Siderovski, D. 
P.,  The  RGS  Protein  Inhibitor  CCG-4986  is  a  Covalent  Modifier  of  the  RGS4  Ga- 
Interaction Face. Biochim. Biophys. Acta 2007, 1774, 1213-1220.
Leproult, E.; Barluenga, S.; Moras, D.; Wurtz, J.-M.; Winssinger, N., Cysteine Mapping 
in Conformationally Distinct Kinase Nucleotide Binding Sites: Application to the Design 
of Selective Covalent Inhibitors. J. Med. Chem. 2011, 54, 1347-1355.
Parsons, Z. D.; Gates, K. S., Redox Regulation of Protein Tyrosine Phosphatases: Methods 
for Kinetic Analysis of Covalent Enzyme Inactivation. In Methods in Enzymology Volume 
528: Hydrogen Peroxide and Cell Signaling Part C, Cadenas, E.; Packer, L., Eds. Elsevier 
Science Publishing Co Inc: San Diego, 2013; Vol. 528, pp 130-154.
Kitz,  R.;  Wilson,  I.  B.,  Esters  of  Methanesulfonic  Acid  as  Irreversible  Inhibitors  of 
Acetylcholinesterase. J. Biol. Chem. 1962, 237, 3245-3249.
Nagahara, N.; Sawada, N.; Nakagawa, T., Affinity Labeling of a Catalytic Site, Cysteine 
247,  in  Rat  Mercaptopyruvate  Sulfurtransferase  by  Chloropyruvate  as  an  Analog  of  a 
Substrate. Biochimie 2004, 86, 723-729.
Michalczyk, A.; Klüter, S.; Rode, H. B.; Simard, J. R.; Grütter, C.; Rabiller, M.; Rauh, D., 
Structural  Insights  into  How  Irreversible  Inhibitors  Can  Overcome  Drug  Resistance  in 
EGFR. Biorg. Med. Chem. 2008, 16, 3482-3488.
Engel,  J.;  Lategahn,  J.;  Rauh,  D.,  Hope  and  Disappointment:  Covalent  Inhibitors  to 
Overcome Drug Resistance in Non-Small Cell Lung Cancer. ACS Med. Chem. Lett. 2016,
7, 2-5.
Sequist, L. V.; Soria, J. C.; Goldman, J. W.; Wakelee, H. A.; Gadgeel, S. M.; Varga, A.;
Papadimitrakopoulou, V.; Solomon, B. J.; Oxnard, G. R.; Dziadziuszko, R.; Aisner, D. L.;
Doebele, R. C.; Galasso, C.; Garon, E. B.; Heist, R. S.; Logan, J.; Neal, J. W.; Mendenhall, 
M. A.; Nichols, S.; Piotrowska,  Z.; Wozniak, A.  J.; Raponi, M.; Karlovich, C. A.; Jaw- 
Tsai, S.; Isaacson, J.; Despain, D.; Matheny, S. L.; Rolfe, L.; Allen, A. R.; Camidge, D. R., 
Rociletinib in EFGR-Mutated Non-Small-Cell Lung Cancer. N. Engl. J. Med. 2015, 372, 
1700-1709.
Walter, A. O.; Sjin, R. T. T.; Haringsma, H. J.; Ohashi, K.; Sun, J.; Lee, K.; Dubrovskiy, 
A.;  Labenski,  M.;  Zhu,  Z.;  Wang,  Z.;  Sheets,  M.; Martin,  T.  S.;  Karp,  R.;  Kalken,  D.;
Chaturvedi,  P.;  Niu,  D.;  Nacht,  M.;  Petter,  R.  C.;  Westlin,  W.;  Lin,  K.;  Jaw-Tsai,  S.;
438
 439 
Raponi, M.; Dyke, T. V.; Etter, J.; Weaver, Z.; Pao, W.; Singh, J.; Simmons, A. D.; 
Harding, T. C.; Allen, A., Discovery of a Mutant-Selective Covalent Inhibitor of EGFR 
that Overcomes T790M-Mediated Resistance in NSCLC. Cancer Discov. 2013, 3, 1404-
1415. 
42. Thress, K. S.; Paweletz, C. P.; Felip, E.; Cho, B. C.; Stetson, D.; Dougherty, B.; Lai, Z.; 
Markovets, A.; Vivancos, A.; Kuang, Y.; Ercan, D.; Matthews, S. E.; Cantarini, M.; 
Barrett, J. C.; Janne, P. A.; Oxnard, G. R., Acquired EGFR C797S Mutation Mediates 
Resistance to AZD9291 in Non-small Cell Lung Cancer Harboring EGFR T790M. Nat. 
Med. 2015, 21, 560-562. 
 
43. Rockoff, J. D.; Loftus, P. AbbVie to Buy Pharmacyclics in $21 Billion Deal. 
http://www.wsj.com/articles/abbvie-to-buy-pharmacyclics-in-21-billion-deal-
1425528086 (accessed 9/8/16). 
 
44. D'Cruz, O. J.; Uckun, F. M., Novel Bruton's Tyrosine Kinase Inhibitors Currently in 
Development. Onco Targets Ther. 2013, 6, 161-176. 
 
45. Eda, H.; Santo, L.; Cirstea, D. D.; Yee, A. J.; Scullen, T. A.; Nemani, N.; Mishima, Y.; 
Waterman, P. R.; Arastu-Kapur, S.; Evans, E.; Singh, J.; Kirk, C. J.; Westlin, W. F.; Raje, 
N. S., A Novel Bruton's Tyrosine Kinase Inhibitor CC-292 in Combination with the 
Proteasome Inhibitor Carfilzomib Impacts the Bone Microenvironment in a Multiple 
Myeloma Model with Resultant Antimyeloma Activity. Leukemia 2014, 28, 1892-1901. 
 
46. Liu, Q.; Sabnis, Y.; Zhao, Z.; Zhang, T.; Buhrlage, S. J.; Jones, L. H.; Gray, N. S., 
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome. Chem. Biol. 2013, 
20, 146-159. 
 
47. Jones, D. P.; Go, Y.-M., Mapping the Cysteine Proteome: Analysis of Redox-sensing 
Thiols. Curr. Opin. Chem. Biol. 2011, 15, 103-112. 
 
48. Liu, F.; Zhang, X.; Weisberg, E.; Chen, S.; Hur, W.; Wu, H.; Zhao, Z.; Wang, W.; Mao, 
M.; Cai, C.; Simon, N. I.; Sanda, T.; Wang, J.; Look, A. T.; Griffin, J. D.; Balk, S. P.; Liu, 
Q.; Gray, N. S., Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer. 
ACS Chem. Biol. 2013, 8, 1423-1428. 
 
49. Kwiatkowski, N.; Zhang, T.; Rahl, P. B.; Abraham, B. J.; Reddy, J.; Ficarro, S. B.; Dastur, 
A.; Amzallag, A.; Ramaswamy, S.; Tesar, B.; Jenkins, C. E.; Hannett, N. M.; McMillin, 
D.; Sanda, T.; Sim, T.; Kim, N. D.; Look, T.; Mitsiades, C. S.; Weng, A. P.; Brown, J. R.; 
Benes, C. H.; Marto, J. A.; Young, R. A.; Gray, N. S., Targeting Transcription Regulation 
in Cancer with a Covalent CDK7 Inhibitor. Nature 2014, 511, 616-620. 
 
50. Serafimova, I. M.; Pufall, M. A.; Krishnan, S.; Duda, K.; Cohen, M. S.; Maglathlin, R. L.; 
McFarland, J. M.; Miller, R. M.; Frodin, M.; Taunton, J., Reversible Targeting of 
Noncatalytic Cysteines with Chemically Tuned Electrophiles. Nat. Chem. Biol. 2012, 8, 
471-476. 
 
  
51. 
 
 
52. 
 
53. 
 
 
54. 
 
 
55. 
 
 
56. 
 
 
57. 
 
 
58. 
 
 
59. 
 
 
60. 
 
 
61. 
 
 
62. 
 
 
63. 
Miller, R. M.; Paavilainen, V. O.; Krishnan, S.; Serafimova, I.; Taunton, J., Electrophilic 
Fragment-Based Design of Reversible Covalent Kinase Inhibitors. J. Am. Chem. Soc. 2013,
135, 5298-5301.
Garuti,  L.; Roberti, M.; Bottegoni, G.,  Irreversible Protein Kinase  Inhibitors Curr. Med. 
Chem. 2011, 18, 2981-2994.
Mah, R.; Thomas, J. R.; Shafer, C. M., Drug Discovery Considerations in the Development 
of Covalent Inhibitors. Bioorg. Med. Chem. Lett. 2014, 24, 33-39.
Bauer,  R.  A.,  Covalent  Inhibitors  in  Drug  Discovery:  From  Accidental  Discoveries  to 
Avoided Liabilities and Designed Therapies. Drug Discov. Today 2015, 20, 1061-1073.
Johnson, D. S.; Weerapana, E.; Cravatt,  B.  F., Strategies for Discovering  and Derisking 
Covalent, Irreversible Enzyme Inhibitors. Future Med. Chem 2010, 2, 949-964.
Woods, J. R.; Mo, H. P.; Bieberich, A. A.; Alavanja, T.; Colby, D. A., Amino-Derivatives 
of  the  Sesquiterpene  Lactone  Class  of  Natural  Products  as  Prodrugs. MedChemComm
2013, 4, 27-33.
Amslinger, S., The Tunable Functionality of alpha,beta-Unsaturated Carbonyl Compounds 
Enables  Their  Differential  Application  in  Biological  Systems. ChemMedChem 2010, 5, 
351-356.
Ghantous, A.; Gali-Muhtasib, H.; Vuorela, H.; Saliba, N. A.; Darwiche, N., What Made 
Sesquiterpene Lactones Reach Cancer Clinical Trials? Drug Discov. Today 2010, 15, 668- 
678.
Kupchan,  S.  M.;  Fessler,  D.  C.;  Eakin,  M.  A.;  Giacobbe,  T.  J.,  Reactions  of  alpha 
Methylene Lactone Tumor Inhibitors with Model Biological Nucleophiles. Science 1970,
168, 376-378.
Hall, I. H.; Lee, K.-H.; Mar, E. C.; Starnes, C. O.; Waddell, T. G., Antitumor Agents 21. 
A  Proposed  Mechanism  for  Inhibition  of  Cancer  Growth  by  Tenulin  and  Helenalin  and 
Related Cyclopentenones. J. Med. Chem. 1977, 20, 333-337.
Schmidt, T. J., Helenanolide-Type Sesquiterpene Lactones-III. Rates and Stereochemistry 
in  the  Reaction  of  Helenalin  and  Related  Helenanolides  with  Sulfhydryl  Containing 
Biomolecules. Biorg. Med. Chem. 1997, 5, 645-653.
Schmidt,  T.  J.;  LyB,  G.;  Pahl, H.  L.;  Merfort,  I.,  Helenanolide  Type  Sesquiterpene 
Lactones.  Part  5.  The  Role  of  Glutathione  Addition  Under  Physiological  Conditions.
Bioorg. Med. Chem. 1999, 7, 2849-2855.
Pei,  S.  S.;  Minhajuddin,  M.;  Callahan,  K.  P.;  Balys,  M.;  Ashton,  J.  M.;  Neering,  S.  J.;
Lagadinou, E. D.; Corbett, C.; Ye, H. B.; Liesveld, J. L.; O'Dwyer, K. M.; Li, Z.; Shi, L.;
Greninger, P.; Settleman, J.; Benes, C.; Hagen, F. K.; Munger, J.; Crooks, P. A.; Becker,
440
  
 
 
 
64. 
 
 
65. 
 
 
66. 
 
 
67. 
 
 
68. 
 
 
69. 
 
 
70. 
 
 
71. 
 
 
72. 
 
 
73. 
 
 
74. 
M.  W.;  Jordan,  C.  T.,  Targeting  Aberrant  Glutathione  Metabolism to  Eradicate  Human 
Acute Myelogenous Leukemia Cells. J. Biol. Chem. 2013, 288, 33542-33558.
Nasim, S.; Pei, S. S.; Hagen, F. K.; Jordan, C. T.; Crooks, P. A., Melampomagnolide B: A 
New Antileukemic Sesquiterpene. Biorg. Med. Chem. 2011, 19, 1515-1519.
Kwok,  B.  H.;  Koh,  B.;  Ndubuisi,  M.  I.;  Elofsson,  M.;  Crews,  C.  M.,  The  Anti- 
Inflammatory  Natural  Product  Parthenolide  from  the  Medicinal  Herb  Feverfew  Directly 
Binds to and Inhibits IkappaB Kinase. Chem Biol 2001, 8, 759-766.
Kunzmann,  M.  H.;  Bach,  N.  C.;  Bauer,  B.;  Sieber,  S.  A.,  alpha-Methylene-gamma- 
Butyrolactones  Attenuate  Staphylococcus  Aureus  Virulence  by  Inhibition  of 
Transcriptional Regulation. Chem. Sci. 2014, 5, 1158-1167.
Kunzmann,  M.  H.;  Sieber,  S.  A.,  Target  Analysis  of -Alkylidene--Butyrolactones  in 
Uropathogenic E. Coli. Mol. BioSyst. 2012, 8, 3061-3067.
Polo, L. M.; Castro, C. M.; Cruzado, M. C.; Collino, C. J. G.; Cuello-Carrión, F. D.; Ciocca, 
D.  R.;  Giordano,  O.  S.;  Ferrari,  M.;  López,  L.  A.,  11,13-Dihydro-dehydroleucodine,  a 
Derivative  of  Dehydroleucodine  with  an  Inactivated  Alkylating  Function  Conserves  the 
Anti-proliferative  Activity  in  G2  but  does  not  Cause  Cytotoxicity. Eur.  J.  Pharmacol.
2007, 556, 19-26.
Albrecht, A.; Albrecht, L.; Janecki, T., Recent Advances in the Synthesis of -Alkylidene- 
substituted -Lactones, -Lactams and -Lactams. Eur. J. Org. Chem. 2011, 2747-2766.
Di Maso, M. J.; Nepomuceno, G. M.; St. Peter, M. A.; Gitre, H. H.; Martin, K. S.; Shaw, 
J.  T.,  Synthesis  of  (±)-Bisavenanthramide  B-6  by  an  Anionic  Anhydride  Mannich 
Reaction. Org. Lett. 2016, 18, 1740-1743.
Janecka,  A.;  Wyrębska,  A.;  Gach,  K.;  Fichna,  J.;  Janecki,  T.,  Natural  and  Synthetic - 
Methylenelactones  and -Methylenelactams  with  Anticancer  Potential. Drug  Discov. 
Today 2012, 17, 561-572.
Janecki, T.; Blaszczyk, E.; Studzian, K.; Janecka, A.; Krajewska, U.; Rozalski, M., Novel 
Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationship Studies of a Series of 
alpha-Alkylidene-gamma-Lactones and Lactams. J. Med. Chem. 2005, 48, 3516-3521.
Albrecht,  A.;  Koszuk,  J.  F.;  Modranka,  J.;  Różalski,  M.;  Krajewska,  U.;  Janecka,  A.;
Studzian,  K.;  Janecki,  T.,  Synthesis  and  Cytotoxic  Activity  of -Aryl  Substituted - 
Alkylidene--lactones  and -Alkylidene--lactams. Biorg.  Med.  Chem. 2008, 16,  4872- 
4882.
Krawczyk,  H.; Albrecht, Ł.; Wojciechowski, J.; Wolf, W. M.; Krajewska, U.; Różalski, 
M., A Convenient Synthesis and Cytotoxic Evaluation of N-Unsubstituted -Methylene--
lactams. Tetrahedron 2008, 64, 6307-6314.
441
 
 442 
 
75. Janecki, T.; Wąsek, T.; Różalski, M.; Krajewska, U.; Studzian, K.; Janecka, A., 4-
Methylideneisoxazolidin-5-ones--A New Class of -Methylidene--lactones with High 
Cytostatic Activity. Bioorg. Med. Chem. Lett. 2006, 16, 1430-1433. 
 
76. Albrecht, A.; Albrecht, Ł.; Różalski, M.; Krajewska, U.; Janecka, A.; Studzian, K.; Janecki, 
T., A Convenient Synthesis and Cytotoxic Evaluation of -Aryl--methylidene--lactones 
and -Aryl--methylidene--lactams. New J. Chem. 2010, 34, 750-761. 
77. Elford, T. G.; Ulaczyk-Lesanko, A.; Pascale, G. D.; Wright, G. D.; Hall, D. G., Diversity-
Oriented Synthesis and Preliminary Biological Screening of Highly Substituted Five-
Membered Lactones and Lactams Originating From an Allylboration of Aldehydes and 
Imines. J. Comb. Chem. 2009, 11, 155-168. 
 
78. Avonto, C.; Taglialatela-Scafati, O.; Pollastro, F.; Minassi, A.; Marzo, V. D.; Petrocellis, 
L. D.; Appendino, G., An NMR Spectroscopic Method to Identify and Classify Thiol-
Trapping Agents: Revival of Michael Acceptors for Drug Discovery. Angew. Chem. Int. 
Ed. 2011, 50, 467-471. 
 
79. Hanson, R. L.; Lardy, H. A.; Kupchan, S. M., Inhibition of Phosphofructokinase by 
Quinone Methide and alpha-Methylene Lactone Tumor Inhibitors. Science 1970, 168, 378-
80. 
 
80. Fukuda, K.; Akao, S.; Ohno, Y.; Yamashita, K.; Fujiwara, H., Inhibition by Costunolide 
of Phorbol Ester-induced Transcriptional Activation of Inducible Nitric Oxide Synthase 
Gene in a Human Monocyte Cell Line THP-1. Cancer Lett. 2001, 164, 7-13. 
 
81. Arumugam, V.; Routledge, A.; Abell, C.; Balasubramanian, S., Synthesis of 2-Oxindole 
Derivatives via the Intramolecular Heck Reaction on Solid Support. Tet. Lett. 1997, 38, 
6473-6476. 
 
82. Kornet, M. J., Synthesis and Anticonvulsant Activity of 1-Aryl-3-Methylene-2-
Pyrrolidinone Adducts. J. Heterocycl. Chem. 1985, 22, 129-130. 
 
83. Pettigrew, N. E.; Brush, E. J.; Colman, R. F., 3-Methyleneoxindole: An Affinity Label of 
Glutathione S-Transferase pi Which Targets Tryptophan 38. Biochem. 2001, 40, 7549-
7558. 
 
84. Wieland, T.; Unger, O., Synthese Einiger Methoxy-oxindole Und-indoline. Chem. Ber. 
1963, 96, 253-259. 
 
85. Klutchko, S.; Hoefle, M. L.; Smith, R. D.; Essenburg, A. D.; Parker, R. B.; Nemeth, V. L.; 
Ryan, M. J.; Dugan, D. H.; Kaplan, H. R., Synthesis and Angiotensin-Converting Enzyme 
Inhibitory Activity of 3-(Mercaptomethyl)-2-Oxo-1-Pyrrolidineacetic Acids and 3-
(Mercaptomethyl)-2-Oxo-1-Piperidineacetic Acids. J. Med. Chem. 1981, 24, 104-109. 
 
 443 
86. Drahl, C.; Cravatt, B. F.; Sorenson, E. J., Protein-Reactive Natural Products. Angew. Chem. 
Int. Ed. 2005, 44, 5788-5809. 
 
87. Kondo, F.; Ikai, Y.; Oka, H.; Okumura, M.; Ishikawa, N.; Harada, K.-I.; Matsuura, K.; 
Murata, H.; Suzuki, M., Formation, Characterization, and Toxicity of the Glutathione and 
Cysteine Conjugates of Toxic Heptapeptide Microcystins. Chem. Res. Toxicol. 1992, 5, 
591-596. 
 
88. Runnegar, M.; Berndt, N.; Kong, S.-M.; Lee, E. Y. C.; Zhang, L., In Vivo and In Vitro 
Binding of Microcystin to Protein Phosphatases 1 and 2A. Biochem. Biophys. Res. 
Commun. 1995, 216, 162-169. 
 
89. Craig, M.; Luu, H. A.; McCready, T. L.; Holmes, C. F. B.; Williams, D.; Andersen, R. J., 
Molecular Mechanisms Underlying the Interaction of Motuporin and Microcystins with 
Type-1 and Type-2A Protein Phosphatases. Biochem. Cell 1996, 74, 569-578. 
 
90. Clement, L. L.; Tsakos, M.; Schaffert, E. S.; Scavenius, C.; Enghild, J. J.; Poulsen, T. B., 
The Amido-Pentadienoate-Functionality of the Rakicidins is a Thiol Reactive Electrophile 
- Development of a General Synthetic Strategy. Chem. Commun. 2015, 51, 12427-12430. 
 
91. Cee, V. J.; Volak, L. P.; Chen, Y.; Bartberger, M. D.; Tegley, C.; Arvedson, T.; McCarter, 
J.; Tasker, A. S.; Fotsch, C., Systematic Study of the Glutathione (GSH) Reactivity of N-
Arylacrylamides: 1. Effects of Aryl Substitution. J. Med. Chem. 2015, 58, 9171-9178. 
 
92. ln([electrophile]) = (-kpseudofirst)t + ln([electrophile]) 
 
93. Flanagan, M. E.; Abramite, J. A.; Anderson, D. P.; Aulabaugh, A.; Dahal, U. P.; Gilbert, 
A. M.; Li, C.; Montgomery, J.; Oppenheimer, S. R.; Ryder, T.; Schuff, B. P.; Uccello, D. 
P.; Walker, G. S.; Wu, Y.; Brown, M. F.; Chen, J. M.; Hayward, M. M.; Noe, M. C.; Obach, 
R. S.; Philippe, L.; Shanmugasundaram, V.; Shapiro, M. J.; Starr, J.; Stroh, J.; Che, Y., 
Chemical and Computational Methods for the Characterization of Covalent Reactive 
Groups for the Prospective Design of Irreversible Inhibitors. J. Med. Chem. 2014, 57, 
10072-10079. 
 
94. Krishnan, S.; Miller, R. M.; Tian, B.; Mullins, R. D.; Jacobson, M. P.; Taunton, J., Design 
of Reversible, Cysteine-Targeted Michael Acceptors Guided by Kinetic and 
Computational Analysis. J. Am. Chem. Soc. 2014, 136, 12624-12630. 
 
95. Ray, A. K.; Nilsson, U.; Magnusson, G., Synthesis and Conformational Analysis of GM3 
Lactam, a Hydrolytically Stable Analogue of GM3 Ganglioside Lactone. J. Am. Chem. Soc. 
1992, 114, 2256-2257. 
 
96. Nilsson, J.; Gidlöf, R.; Johansson, M.; Sterner, O., Lactam Analogues of Galiellalactone. 
Tetrahedron 2012, 68, 3336-3341. 
 
 444 
97. Torok, D. S.; Ziffer, H.; Meshnick, S. R.; Pan, X.-Q.; Ager, A., Syntheses and Antimalarial 
Activities of N-Substituted 11-Azaartemisinins. J. Med. Chem. 1995, 38, 5045-5050. 
 
98. Balan, D.; Burns, C. J.; Gisk, N. G.; Hügel, H.; Huang, D. C. S.; Segal, D.; White, C.; 
Wagler, J.; Rizzacasa, M. A., Synthesis and Biological Evaluation of a Potent 
Salicylihalamide A Lactam Analogue. Org. Biomol. Chem. 2012, 10, 8147-8153. 
 
99. Borzilleri, R. M.; Zheng, X.; Schmidt, R. J.; Johnson, J. A.; Kim, S.-H.; DiMarco, J. D.; 
Fairchild, G. R.; Gougoatas, J. Z.; Lee, F. Y. F.; Long, B. H.; Vite, G. D., A Novel 
Application of a Pd(0)-Catalyzed Nucleophilic Substitution Reaction to the Regio- and 
Stereoselective Synthesis of Lactam Analogues of the Epothilone Natural Products. J. Am. 
Chem. Soc. 2000, 122, 8890-8897. 
 
100. Hunt, J. T., Discovery of Ixabepilone. Molecular Cancer Therapeutics 2009, 8, 275-281. 
101. Sayed, K. A. E.; Orabi, K. Y.; Dunbar, D. C.; Hamann, M. T.; Avery, M. A.; Sabnis, Y. 
A.; Mossa, J. S.; El-Feraly, F. S., Transformation of lactone to lactam in sarcophine and 
antimalarial activity of the resulting N-substituted azasarcophines. Tetrahedron 2002, 58, 
3699-3708. 
 
102. Matsuya, Y.; Kawaguchi, T.; Nemoto, H., New Strategy for the Total Synthesis of 
Macrosphelides A and B Based on Ring-Closing Metathesis. Org. Lett. 2003, 5, 2939-
2941. 
 
103. Sugimoto, K.; Kobayashi, Y.; Hori, A.; Kondo, T.; Toyooka, N.; Nemoto, H.; Matsuya, 
Y., Syntheses of Aza-Analogues of Macrosphelides via RCM Strategy and Their 
Biological Evaluation. Tetrahedron 2011, 67, 7681-7685. 
 
104. Canova, S.; Lépine, R.; Thys, A.; Baron, A.; Roche, D., Synthesis and Biological 
Properties of Macrolactam Analogs of the Natural Product Macrolide (-)-A26771B. 
Bioorg. Med. Chem. Lett. 2011, 21, 4768-4772. 
 
105. Wilstermann, M.; Kononov, L. O.; Nilsson, U.; Ray, A. K.; Magnusson, G., Synthesis of 
Ganglioside Lactams Corresponding to GM1-, GM2-, GM3-, and GM4-Ganglioside 
Lactones. J. Am. Chem. Soc. 1995, 117, 4742-4754. 
 
106. Hossain, N.; Zapata, A.; Wilstermann, M.; Nilsson, U.; Magnusson, G., Synthesis of GD3-
lactam: A Potential Ligand for the Development of an Anti-Melanoma Vaccine. 
Carbohydr. Res. 2002, 337, 569-580. 
 
107. Brase, S.; Glaser, F.; Kramer, C. S.; Lindner, S.; Linsenmeier, A. M.; Masters, K.-S.; 
Meister, A. C.; Ruff, B. M.; Zhong, S., The Chemistry of Mycotoxins. 1 ed.; Springer-
Verlag Wein: Heidelberg, New York, Dordrecht, London, 2013; Vol. 97, p 300. 
 
108. Winssinger, N.; Barluenga, S., Chemistry and Biology of Resorcylic Acid Lactones. Chem. 
Commun. 2007, 22-36. 
 
  
109. 
 
 
110. 
 
 
111. 
 
 
112. 
  
 
113. 
 
 
 
114. 
 
 
115. 
 
 
116. 
 
 
117. 
 
 
118. 
 
 
119. 
 
 
120. 
 
 
121. 
Ayers, S.; Graf, T. N.; Adcock, A. F.; Kroll, D. J.; Matthew, S.; de Blanco, E. J. C.; Shen, 
Q.; Swanson, S. M.; Wani, M. C.; Pearce, C. J.; Oberlies, N. H., Resorcylic Acid Lactones 
with  Cytotoxic  and  NF-kappa  B  Inhibitory  Activities  and  Their  Structure-Activity 
Relationships. J. Nat. Prod. 2011, 74, 1126-1131.
Wei,  L.;  Wu,  J.;  Li,  G.;  Shi,  N., Cis-Enone  Resorcylic  Acid  Lactones  (RALs)  as 
Irreversible Protein Kinase Inhibitors. Curr. Pharm. Des. 2012, 18, 1186-1198.
Schirmer, A.; Kennedy, J.; Murli, S.; Reid, R.; Santi, D. V., Targeted Covalent Inactivation 
of Protein Kinases by Resorcylic Acid Lactone Polyketides. PNAS 2006, 103, 4234-4239.
Jogireddy,  R.;  Barluenga,  S.;  Winssinger,  N.,  Molecular  Editing  of  Kinase-Targeting 
Resorcylic Acid Lactones (RAL): Fluoroenone RAL. ChemMedChem 2010, 5, 670-673.
Xu,  J.;  Chen,  A.; Joy,  J.;  Xavier,  V.  J.;  Ong,  E.  H.  Q.;  Hill, J.;  Chai, C. L.  L.,  Rational 
Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by 
Tuning the Reactivity of an Enamide Michael Acceptor. ChemMedChem 2013, 8, 1483- 
1494.
Long, J.; Ding, Y.-H.; Wang, P.-P.; Zhang, Q.; Chen, Y., Total Syntheses and Structure- 
Activity Relationship Study of Parthenolide Analogues. Tet. Lett. 2016, 57, 874-877.
Lachia, M.; Wolf, H. C.; Jung, P. J. M.; Screpanti, C.; De Mesmaeker, A., Strigolactam:
New Potent Strigolactone Analogues for the Germination of Orobanche Cumana. Bioorg. 
Med. Chem. Lett. 2015, 25, 2184-2188.
Jackson,  P.  A.;  Widen,  J.  C.;  Harki,  D.  A.;  Brummond,  K.  M.,  Covalent  Modifiers:  A 
Chemical  Perspective  on  the  Reactivity  of  α,β-Unsaturated  Carbonyls  with  Thiols  via 
Hetero-Michael Addition Reactions. J. Med. Chem. 2017, 60, 839-885.
Grillet, F.; Huang, C.; Brummond, K. M., An Allenic Pauson-Khand Approach to 6,12- 
Guaianolides. Org. Lett. 2011, 13, 6304-6307.
Wen,  B.;  Hexum,  J.  K.;  Widen,  J.  C.;  Harki,  D.  A.;  Brummond,  K.  M.,  A  Redox 
Economical Synthesis of Bioactive 6,12-Guaianolides. Org. Lett. 2013, 15, 2644-2647.
Xie,  X.;  Lu,  X.;  Liu,  Y.;  Xu,  W.,  Palladium(II)-Catalyzed  Synthesis  of  α-Alkylidene-γ- 
butyrolactams from N-Allylic 2-Alkynamides. Total Synthesis of (±)-Isocynodine and (±)- 
Isocynometrine. The Journal of Organic Chemistry 2001, 66, 6545-6550.
Reddy,  L.  R.;  Saravanan,  P.;  Corey,  E.  J.,  A  Simple  Stereocontrolled  Synthesis  of 
Salinosporamide A. J. Am. Chem. Soc. 2004, 126, 6230-6231.
Thuong, M. B. T.; Sottocornola, S.; Prestat, G.; Broggini, G.; Madec, D.; Poli, G., New 
Access to Kainic Acid via Intramolecular Palladium-Catalyzed Allylic Alkylation. Synlett
2007, 2007, 1521-1524.
445
 
 446 
 
122. Pérard-Viret, J.; Souquet, F.; Manisse, M.-L.; Royer, J., An expeditious total synthesis of 
(±)-jamtine using condensation between imine and acid anhydride. Tet. Lett. 2010, 51, 96-
98. 
 
123. Wang, L.; Xu, C.; Chen, L.; Hao, X.; Wang, D. Z., Asymmetric Synthesis of the Tricyclic 
Core oc Calyciphylline A-Type Alkaloids via Intramolecular [3 + 2] Cycloadditon. Org. 
Lett. 2014, 16, 1076-1079. 
 
124. Basavaiah, D.; Reddy, G. C.; Bharadwaj, K. C., The Acrylamide Moiety as an Activated 
Alkene Component in the Intramolecular Baylis-Hillman Reaction: Facile Synthesis of 
Functionalized -Methylene Lactam and Spirolactam Frameworks. Eur. J. Org. Chem. 
2014, 1157-1162. 
 
125. Basavaiah, D.; REddy, G. C.; Bharadwaj, K. C., Less Reactive Ketones as Electrophiles 
and Acrylamides as Activated Alkenes in INtramolecular Baylis-Hillman Reaction: Facile 
Synthesis of FUnctionalized -Lactam Frameworks. Tetrahedron 2014, 70, 7991-7995. 
 
126. Lee, K. Y.; Lee, Y. J.; Kim, J. N., Synthesis of b,y-Disubstituted a-Methylene-g-
butyrolactams Starting from the Baylis-Hillman Adducts. Bull. Korean Chem. Soc. 2007, 
28, 143-146. 
 
127. Sing, V.; Kanojiya, S.; Batra, S., Studies on the Reduction of the Nitro Group in 3-Aryl-2-
methylene-4-nitro-alkanoates afforded by the Baylis-Hillman Adducts: Synthesis of 4-
Aryl-3-methylene-2-pyrrolidinones and 3-(1-Alkoxycarbonyl-vinyl)-1H-indole-2-
carboxylates. Tetrahedron 2006, 62, 10100-10110. 
 
128. Companyó, X.; Geant, P.-Y.; Mazzanti, A.; Moyano, A.; Rios, R., Catalytic Asymmetric 
One-Pot Synthesis of -Methylene--lactams. Tetrahedron 2014, 70, 75-82. 
 
129. Pan, F.; Chen, J.-M.; Zhuang, Z.; Fang, Y.-Z.; Zhang, S. X.-A.; Liao, W.-W., Construction 
of Highly Functional -Amino Nitriles via a Novel Multicomponent Tandem 
Organocatalytic Reaction: A Facile Access to -Methylene--lactams. Org. Biomol. Chem. 
2012, 10, 2214-2217. 
 
130. Dembélé, Y. A.; Belaud, C.; Hitchcock, P.; Villiéras, J., Stereocontrolled Addition of 
Organozinc Reagents Derived from 2-(Bromomethyl)acrylates to Chiral Imines. 
Tetrahedron: Asymmetry 1992, 3, 351-354. 
 
131. Dembélé, Y. A.; Belaud, C.; Villiéras, J., Stereocontrolled Preparation of Chiral Secondary 
-Methylene--lactams by Addition of Organozinc Reagents derived from 2-
(Bromomethyl)acrylates to Imines using -Aminoalcohols as Chiral Auxiliaries. 
Tetrahedron: Asymmetry 1992, 3, 511-514. 
 
  
132. 
 
 
133. 
 
 
134. 
 
 
135. 
 
 
136. 
 
 
137. 
 
 
138. 
 
 
139. 
 
 
140. 
 
 
141. 
 
 
142. 
 
 
143. 
Nyzam, V.; Belaud, C.; Zammatio, F.; Villieras, J., Stereocontrolled Synthesis of Chiral 
Secondary (-Methylene--substituted)--lactams by Addiiton of -Funtional Crotylzinc 
Reagents to Chiral Imines. Tetrahedron: Asymmetry 1996, 7, 1835-1843.
Choudhury, P. K.; Foubelo, F.; Yus, M., Indium-Promoted Preparation of a-Methylene-g- 
butyrolactams from 2-(Bromomethyl)acrylic Acid and Aldimines. J. Org. Chem. 1999, 64, 
3376-3378.
Shen,  A.;  Liu,  M.;  Jia,  Z.-S.;  Xu,  M.-H.;  Lin,  G.-Q.,  One-Pot  Synthesis  of  Chiral  a- 
Methylene-g-lactams  with  Excellent  Diastereoselectivities  and  Enantioselectivities. Org. 
Lett. 2010, 12, 5154-5157.
Tan,  Y.;  Yang,  X.-D.;  Liu,  W.-J.;  Sun,  X.-W.,  Novel  One-Pot  Asymmetric  Cascade 
Approach Toward Densely Substituted Enantioenriched -Methylene--lactams. Tet. Lett.
2014, 55, 6105-6108.
Elford, T. G.; Hall, D. G., Imine Allylation Using 2-Alkoxycarbonyl Allylboronates as an 
Expedient  Three-Component  Reaction  to  Polysubstituted -exo-Methylene--Lactams.
Tet. Lett. 2008, 49, 6995-6998.
Chataigner, I.; Zammattio, F.; Lebreton, J.; Villiéras, J., Enantioselective Addition of - 
Functionalized Allylboronates to Aldehydes and Aldimines. Stereocontrolled Synthesis of
-Methylene--lactones and Lactams. Tetrahedron 2008, 64, 2441-2455.
Deredas, D.; Albrecht, Ł.; Krawczyk, H., An Efficient Synthesis of -Trisubstituted-- 
diethoxyphosphoryl--lactams:  A  Convenient  Approach  to -Methylene--Lactams. Tet. 
Lett. 2013, 54, 3088-3090.
Riofski, M. V.; John, J. P.; Zheng, M. M.; Kirshner, J.; Colby, D. A., Exploiting the Facile 
Release  of  Trifluoroacetate  for  a-Methylenation  of  the  Sterically  Hindered  Carbonyl 
groups on (+)-Sclareolide and (-)-Eburnamonine. J. Org. Chem. 2011, 76, 3676-3683.
Kürti,  L.;  Czakó,  B., Strategic  Applications  of  Named  Reactions  in  Organic  Synthesis:
Background and Detailed Mechanisms. Elsevier: 2005; p 864.
Craven, P.; Aimon, A.; Dow, M.; Fleury-Bregeot, N.; Guilleux, R.; Morgentin, R.; Roche, 
D.;  Kalliokoski,  T.;  Foster,  R.;  Marsden,  S.  P.;  Nelson,  A.,  Design,  Synthesis  and 
Decoration  of  Molecular  Scaffolds  for  Exploitation  in  the  Production  of  Alkaloid-like 
Libraries. Biorg. Med. Chem. 2015, 23, 2629-2635.
Neuhaus,  K.;  Ritter,  H.,  Forgotten  Monomers:  Isotactic  Polymers  from  N-Benzyl-3- 
methylenepyrrolidin-2-one via Free Radical Polymerization. Polym. Int. 2015, 64, 1690-
1694.
Kornet, M. J., Synthesis of a-Methylenebutyrolactams as Potential Antitumor Agents. J.
Pharm. Sci. 1979, 68, 350-353.
447
 
 448 
 
144. Ryu, I.; Miyazato, H.; Kuriyama, H.; Matsu, K.; Tojino, M.; Fukuyama, T.; Minakata, S.; 
Komatsu, M., Broad-Spectrum Radical Cyclizations Boosted by Polarity Matching. 
Carbonylative Access to α-Stannylmethylene Lactams from Azaenynes and CO. J. Am. 
Chem. Soc. 2003, 125, 5632-5633. 
 
145. Denmark, S. E.; Baiazitov, R. Y., Tandem Double-Intramolecular [4 + 2]/[3 + 2] 
Cycloadditions of Nitroalkenes. Studies Toward a Total Synthesis of Daphnilactone B: 
Piperidine Ring Construction. J. Org. Chem. 2006, 71, 593-605. 
 
146. He, W.; Yip, K.-T.; Zhu, N.-Y.; Yang, D., Pd(II)/tBu-quinolineoxazoline: An Air-Stable 
and Modular Chiral Catalyst System for Enantioselective Oxidative Cascade Cyclization. 
Org. Lett. 2009, 11, 5626-5628. 
 
147. Förster, S.; Helmchen, G., Stereoselective Synthesis of a Lactam Analogue of Brefeldin C. 
SYNLETT 2008, 6, 831-836. 
 
148. Baell, J.; Walters, M. A., Chemical Con Artists Foil Drug Discovery. Nature 2014, 513, 
481-483. 
 
149. Baell, J. B.; Holloway, G. A., New Substructure Filters for Removal of Pan Assay 
Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in 
Bioassays. J. Med. Chem. 2010, 53, 2719-2740. 
 
150. Baell, J., Observations on Sreening-based Research and Some Concerning Trends in the 
Literature. Future Med. Chem 2010, 2, 1529-1546. 
 
151. Schall, A.; Reiser, O., Synthesis of Biologically Active Guaianolides with a trans-
Annulated Lactone Moiety. Eur. J. Org. Chem. 2008, 2353-2364. 
 
152. Zhai, J.-D.; Li, D.; Long, J.; Zhang, H.-L.; Lin, J.-P.; Qiu, C.-J.; Zhang, Q.; Chen, Y., 
Biomimetic Semisynthesis of Arglabin from Parthenolide. The Journal of Organic 
Chemistry 2012, 77, 7103-7107. 
 
153. Marx, J. N.; White, E. H., The stereochemistry and synthesis of Achillin. Tetrahedron 
1969, 25, 2117-2120. 
 
154. Edgar, M. T.; Greene, A. E.; Crabbe, P., Stereoselective synthesis of (-)-estafiatin. The 
Journal of Organic Chemistry 1979, 44, 159-160. 
 
155. Bargues, V.; Blay, G.; Cardona, L.; García, B.; Pedro, J. R., Stereoselective Synthesis of 
(+)-11βH,13-Dihydroestafiatin, (+)-11βH,13-Dihydroludartin, (−)-Compressanolide, and 
(−)-11βH,13-Dihydromicheliolide from Santonin. J. Nat. Prod. 2002, 65, 1703-1706. 
 
 449 
156. Lee, E.; Yoon, C. H., Stereoselective Favorskii rearrangement of carvone chlorohydrin; 
expedient synthesis of (+)-dihydronepetalactone and (+)-iridomyrmecin. J. Chem. Soc., 
Chem. Commun. 1994, 479-481. 
 
157. Andrews, S. P.; Ball, M.; Wierschem, F.; Cleator, E.; Oliver, S.; Högenauer, K.; Simic, O.; 
Antonello, A.; Hünger, U.; Smith, M. D.; Ley, S. V., Total Synthesis of Five Thapsigargins: 
Guaianolide Natural Products Exhibiting Sub-Nanomolar SERCA Inhibition. Chemistry – 
A European Journal 2007, 13, 5688-5712. 
 
158. Devreese, A. A.; Demuynck, M.; De Clercq, P. J.; Vandewalle, M., Guaianolides 1. 
Perhydroazulenic Lactones as Intermediates for Total Synthesis. Tetrahedron 1983, 39, 
3039-3048. 
 
159. Carret, S.; Deprés, J.-P., Access to Guaianolides: Highly Efficient Stereocontrolled Total 
Synthesis of (±)-Geigerin. Angew. Chem. Int. Ed. 2007, 46, 6870-6873. 
 
160. McKerrall, S. J.; Jørgensen, L.; Kuttruff, C. A.; Ungeheuer, F.; Baran, P. S., Development 
of a Concise Synthesis of (+)-Ingenol. J. Am. Chem. Soc. 2014, 136, 5799-5810. 
 
161. Kawamura, S.; Chu, H.; Felding, J.; Baran, P. S., Nineteen-Step Total Synthesis of (+)-
Phorbol. Nature 2016, 532, 90-93. 
 
162. Jørgensen, L.; McKerrall, S. J.; Kuttruff, C. A.; Ungeheuer, F.; Felding, J.; Baran, P. S., 
14-Step Synthesis of (+)-Ingenol from (+)-3-Carene. Science 2013, 341, 878-882. 
 
163. Wells, S. M.; Brummond, K. M., Conditions for a Rh(I)-catalyzed [2+2+1] cycloaddition 
reaction with methyl substituted allenes and alkynes. Tet. Lett. 2015, 56, 3546-3549. 
 
164. Kang, S. W.; Kim, Y. H.; Kim, J. J.; Lee, J. H.; Kim, S. H., A Convenient Synthesis of 
Polycyclic -Lactams via Pauson-Khand Reaction. Bull. Korean Chem. Soc. 2009, 30, 691-
694. 
 
165. Strübing, D.; Neumann, H.; Hübner, S.; Klaus, S.; Beller, M., Straightforward synthesis of 
di-, tri- and tetracyclic lactams via catalytic Pauson–Khand and Alder–Ene reactions of 
MCR products. Tetrahedron 2005, 61, 11345-11354. 
 
166. Alcaide, B.; Almendros, P.; Aragoncillo, C., Additions of Allenyl/Propargyl 
Organometallic Reagents to 4-Oxoazetidine-2-carbaldehydes: Novel Palladium-Catalyzed 
Domino Reactions in Allenynes. Chemistry – A European Journal 2002, 8, 1719-1729. 
 
167. Painter, T. O.; Wang, L.; Majumder, S.; Xie, X.-Q.; Brummond, K. M., Diverging DOS 
Strategy Using an Allene-Containing Tryptophan Scaffold and a Library Design that 
Maximizes Biologically Relevant Chemical Space While Minimizing the Number of 
Compounds. ACS Combinatorial Science 2011, 13, 166-174. 
 
  
168. 
 
 
169.  
 
 
 
170. 
 
 
171. 
 
 
172. 
 
 
173. 
 
 
174. 
 
 
175. 
 
 
176. 
 
 
177. 
 
 
178. 
 
 
179. 
 
 
180. 
Grillet,  F.;  Brummond,  K.  M.,  Enantioselective  Synthesis  of  5,7-Bicyclic  Ring  Systems 
from Axially Chiral Allenes Using a Rh(I)-Catalyzed Cyclocarbonylation Reaction. The 
Journal of Organic Chemistry 2013, 78, 3737-3754.
Brummond, K.  M.;  Painter,  T.  O.;  Probst,  D.  A.;  Mitasev,  B.,  Rhodium(I)-Catalyzed 
Allenic Carbocyclization Reaction Affording δ- and ε-Lactams. Org. Lett. 2007, 9, 347- 
349.
Brummond,  K.  M.;  Lu,  J.,  A  Short  Synthesis  of  the  Potent  Antitumor  Agent  (±)- 
Hydroxymethylacylfulvene Using an Allenic Pauson-Khand Type Cycloaddition. J. Am. 
Chem. Soc. 1999, 121, 5087-5088.
Daeuble,  J.  F.;  Stryker,  J.  M.;  Chiu,  P.;  Ng,  W.  H.,  Hexa-μ- 
hydrohexakis(triphenylphosphine)hexacopper.  In Encyclopedia  of  Reagents  for  Organic 
Synthesis, John Wiley & Sons, Ltd: 2001.
Elford,  T.  G.;  Hall,  D.  G.,  Total  Synthesis  of  (+)-Chinensiolide  B  via  Tandem 
Allylboration/Lactonization. J. Am. Chem. Soc. 2010, 132, 1488-1489.
Klapars, A.; Huang, X.; Buchwald, S. L., A General and Efficient Copper Catalyst for the 
Amidation of Aryl Halides. J. Am. Chem. Soc. 2002, 124, 7421-7428.
Görl,  C.;  Alt,  H.  G.,  The  combination  of  mononuclear  metallocene  and  phenoxyimine 
complexes to give trinuclear catalysts for the polymerization of ethylene. J. Organomet. 
Chem. 2007, 692, 5727-5753.
Abidi,  S.  L.,  Direct  conversion  of  terpenylalkanolamines  to  ethylidyne  N-nitroso 
compounds. J. Org. Chem. 1986, 51, 2687-2694.
Balog, A.; Curran, D. P., Ring-Enlarging Annulations. A One-Step Conversion of Cyclic 
Silyl Acyloins and .omega.-Alkynyl Acetals to Polycyclic Enediones. J. Org. Chem. 1995,
60, 337-344.
Hoye, T. R.; Aspaas, A. W.; Eklov, B. M.; Ryba, T. D., Reaction Titration: A Convenient 
Method for Titering Reactive Hydride Agents (Red-Al, LiAlH4, DIBALH, L-Selectride, 
NaH, KH, by No-D NMR Spectroscopy. Org. Lett. 2005, 7, 2205-2208.
Nyzam,  V.;  Belaud,  C.;  Villiéras,  J.,  Preparation  of  (2-methoxycarbonyl)allylboronates 
from (α-methoxycarbonyl)vinylalanate. Tet. Lett. 1993, 34, 6899-6902.
Tsuda, T.; Yoshida, T.; Kawamoto, T.; Saegusa, T., Conjugate reduction of .alpha.,.beta.- 
acetylenic  ketones  and  esters  by  diisobutylaluminum  hydride-hexamethylphosphoric
triamide. The Journal of Organic Chemistry 1987, 52, 1624-1627.
Tsuda, T.; Hayashi, T.; Satomi, H.; Kawamoto, T.; Saegusa, T., Methylcopper(I)-catalyzed
selective conjugate reduction of .alpha.,.beta.-unsaturated carbonyl compounds by di-iso-
450
  
 
 
181.  
 
 
182. 
 
 
183. 
 
 
184. 
 
 
 
185.  
 
  
186. 
 
 
187. 
 
 
188. 
 
 
189. 
 
 
190. 
 
 
191. 
 
 
192. 
 
butylaluminum hydride in the presence of hexamethylphosphoric triamide. The Journal of 
Organic Chemistry 1986, 51, 537-540.
Whiting, A., A Convenient Preparation of -Boronate Carbonyl Derivatives. Evidence for 
the Intervention of Boronate "Ate"-Complexes in Enloate Alkylations. Tet. Lett. 1991, 32, 
1503-1506.
Cahiez,  G.;  Alami,  M.,  Manganese  Dioxide.  In Encyclopedia  of  Reagents  for  Organic 
Synthesis, John Wiley & Sons, Ltd: 2001.
Kern,  N.;  Hoffmann,  M.;  Blanc,  A.;  Weibel,  J.-M.;  Pale,  P.,  Gold(I)-Catalyzed 
Rearrangement of N-Aryl 2-Alkynylazetidines to Pyrrolo[1,2-a]indoles. Org. Lett. 2013,
15, 836-839.
Alam,  R.;  Das,  A.;  Huang,  G.;  Eriksson,  L.;  Himo,  F.;  Szabó,  K.  J.,  Stereoselective 
Allylboration of Imines and Indoles Under Mild Conditions. An in situ E/Z Isomerization 
of Imines by Allylboroxines. Chem. Sci. 2014, 5, 2732-2738.
Hall, D. G., Lewis and Bronsted Acid Catalyzed Allylboration of Carbonyl Compounds:
From Discvoery to Mechanism and Applications. Synlett 2007, 11, 1644-1655.
Brestensky,  D.  M.;  Stryker,  J.  M.,  Regioselective  Conjugate  Reduction  and  Reductive 
Silylation of α,β-Unsaturated Ketones. Tet. Lett. 1989, 30, 5677-5680.
Koenig, T. M.; Daeuble, J. F.; Brestensky, D. M.; Stryker, J. M., Conjugate Reduction of 
Polyfunctional α,β-Unsaturated Carbonyl Compounds using [(Ph3P)CuH]6. Compatibility 
with Halogen, Sulfonate, and γ-Oxygen and Sulfur Substituents. Tet. Lett. 1990, 31, 3237- 
3240.
Daeuble,  J.  F.;  McGettigan,  C.;  Stryker,  J.  M.,  Selective  Reduction  of  Alkynes  to  cis- 
Alkenes by Hydrometallation using [(Ph3P)CuH]6. Tet. Lett. 1990, 31, 2397-2400.
Lee,  D.-w.;  Yun,  J.,  Direct  Synthesis  of  Stryker's  Reagent  from  a  Cu(II)  Salt. Tet.  Lett.
2005, 46, 2037-2039.
Sass,  D.  C.;  Heleno,  V.  C.  G.;  Cavalcante,  S.;  da  Silva  Barbosa,  J.;  Soares,  A.  C.  F.;
Constantino, M. G., Solvent Effect in Reactions Using Stryker’s Reagent. The Journal of 
Organic Chemistry 2012, 77, 9374-9378.
Pelšs,  A.;  Kumpulainen,  E.  T.  T.;  Koskinen,  A.  M.  P.,  Highly  Chemoselective  Copper- 
Catalyzed  Conjugate  Reduction  of  Stereochemically  Labile  α,β-Unsaturated  Amino 
Ketones. The Journal of Organic Chemistry 2009, 74, 7598-7601.
Zhong, C.; Sasaki, Y.; Ito, H.; Sawamura, M., The Synthesis of Allenes by Cu(I)-Catalyzed 
Regio- and Stereoselective Reduction of Propargylic Carbonates with Hydrosilanes. Chem.
Commun. 2009, 5850-5852.
451
 
  
 
193. 
 
 
194. 
 
 
195. 
 
 
196. 
 
 
197. 
 
 
198. 
 
 
199. 
 
 
200. 
 
 
201. 
 
 
202.  
 
203. 
 
 
204. 
 
 
205. 
Deutsch,  C.;  Lipshutz,  B.  H.;  Krause,  N.,  (NHC)CuH-Catalyzed  Entry  to  Allenes  via 
Propargylic Carbonate SN2′-Reductions. Org. Lett. 2009, 11, 5010-5012.
Urbach, A.; Muccioli, G. G.; Stern, E.; Lambert, D. M.; Marchand-Brynaert, J., 3-Alkenyl- 
2-azetidinones as Fatty Acid Amide Hydrolase Inhibitors. Bioorg. Med. Chem. Lett. 2008,
18, 4163-4167.
Reisman, S. E.; Ready, J. M.; Weiss, M. M.; Hasuoka, A.; Hirata, M.; Tamaki, K.; Ovaska, 
T. V.; Smith, C. J.; Wood, J. L., Evolution of a Synthetic Strategy:  Total Synthesis of (±)- 
Welwitindolinone A Isonitrile. J. Am. Chem. Soc. 2008, 130, 2087-2100.
Myers,  A.  G.;  Zheng,  B.,  New  and  Stereospecific  Synthesis  of  Allenes  in  a  Single  Step 
from Propargylic Alcohols. J. Am. Chem. Soc. 1996, 118, 4492-4493.
Liu,  Z.;  Liao,  P.;  Bi,  X.,  Lewis  and  Bronsted  Acid  Cocatalyzed  Reductive 
Deoxyallenylation of Propargylic Alcohols with 2-Nitrobenzenesulfonylhydrazide. Chem. 
Eur. J. 2014, 20, 17277-17281.
Petasis,  N.  A.;  Hu,  Y.-H.,  Allenation  of  Carbonyl  Compounds  with  Alkenyltitanocene 
Derivatives. The Journal of Organic Chemistry 1997, 62, 782-783.
Tsuji,  J.;  Sugiura,  T.;  Yuhara,  M.;  Minami,  I.,  Palladium-Catalysed  Preparation  of  1,2- 
Dienes by Selective Hydrogenolysis of Alk-2-ynyl Carbonates with Ammonium Formate.
J. Chem. Soc., Chem. Commun. 1986, 922-924.
Mandai, T.; Matsumoto, T.; Tsujiguchi, Y.; Matsuoka, S.; Tsuji, J., Palladium-Catalyzed 
Hydrogenolysis  of  2-Alkynyl  Formates  and  Elimination  of  2-Alkynyl  Carbonates.  2- 
Alkynylpalladium  Complex  vs.  Allenylpalladium  Complex  as  Intermediates. J. 
Organomet. Chem. 1994, 473, 343-352.
Tsuji, J.; Sugiura, T.; Minami,  I., Preparation of  1,2-Dienes by the Palladium-Catalyzed 
Hydrogenolysis of 3-Methoxycarbonyloxy-1-alkynes with Ammonium Formate. Synthesis
1987, 1987, 603-606.
unpublished results
Huang, M.-Y.; Chen, L.; Li, R.; Jia, X.; Hong, R., Synthesis of (±)-Bakuchiol via a Pot- 
Economy Approach. Chin. J. Chem . 2014, 32, 715-720.
Ohmiya, H.; Yang, M.; Yamauchi, Y.; Ohtsuka, Y.; Sawamura, M., Selective Synthesis of 
Allenes  and  Alkynes  through  Ligand-Controlled,  Palladium-Catalyzed  Decarboxylative
Hydrogenolysis of Propargylic Formates. Org. Lett. 2010, 12, 1796-1799.
Doyle,  M.  P.;  Hu,  W.;  Wee,  A.  G.  H.;  Wang,  Z.;  Duncan,  S.  C.,  Influences  of  Catalyst
Configuration  and  Catalyst  Loading  on  Selectivities  in  Reactions  of  Diazoacetamides.
452
 453 
Barrier to Equilibrium between Diastereomeric Conformations. Org. Lett. 2003, 5, 407-
410. 
 
206. Trost, B. M.; Zhang, Y.; Zhang, T., Direct N-Carbamoylation of 3-Monosubstituted 
Oxindoles with Alkyl Imidazole Carboxylates. The Journal of Organic Chemistry 2009, 
74, 5115-5117. 
 
207. Amin, R.; Ardeshir, K.; Heidar Ali, A.-N.; Zahra, T.-R., Formylation of Alcohol with 
Formic Acid under Solvent-Free and Neutral Conditions Catalyzed by Free I2 or I2 
Generated in situ from Fe(NO3)3·9H2O/NaI. Chinese Journal of Catalysis 2011, 32, 60-
64. 
 
208. Schor, L.; Seldes, A. M.; Gros, E. G., Zinc(II)-promoted stereospecific rearrangement of 
17-hydroxy-20-oxopregnane derivatives. J. Chem. Soc., Perkin Trans. 1 1990, 163-166. 
 
209. Zalesskiy, S. S.; Ananikov, V. P., Pd2(dba)3 as a Precursor of Soluble Metal Complexes 
and Nanoparticles: Determination of Palladium Active Species for Catalysis and Synthesis. 
Organometallics 2012, 31, 2302-2309. 
 
210. Effenberger, F.; Keil, M.; Bessey, E., Darstellung von N-Formylpyridonen — Selektive 
Veresterung primärer, sekundärer und tertiärer Alkohole mit N-Acylpyridonen. Chem. Ber. 
1980, 113, 2110-2119. 
 
211. Yin, J.; Buchwald, S. L., Pd-Catalyzed Intermolecular Amidation of Aryl Halides: The 
Discovery that Xantphos Can Be Trans-Chelating in a Palladium Complex. J. Am. Chem. 
Soc. 2002, 124, 6043-6048. 
 
212. Strieter, E. R.; Bhayana, B.; Buchwald, S. L., Mechanistic Studies on the Copper-Catalyzed 
N-Arylation of Amides. J. Am. Chem. Soc. 2009, 131, 78-88. 
 
213. Yoshioka, S.; Nagatomo, M.; Inoue, M., Application of Two Direct C(sp3)–H 
Functionalizations for Total Synthesis of (+)-Lactacystin. Org. Lett. 2015, 17, 90-93. 
 
214. Kallepalli, V. A.; Shi, F.; Paul, S.; Onyeozili, E. N.; Maleczka, R. E.; Smith, M. R., Boc 
Groups as Protectors and Directors for Ir-Catalyzed C−H Borylation of Heterocycles. The 
Journal of Organic Chemistry 2009, 74, 9199-9201. 
 
215. Garcı́a-Piñeres, A. J.; Castro, V. c.; Mora, G.; Schmidt, T. J.; Strunck, E.; Pahl, H. L.; 
Merfort, I., Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by 
Sesquiterpene Lactones. J. Biol. Chem. 2001, 276, 39713-39720. 
 
216. Lyß, G.; Knorre, A.; Schmidt, T. J.; Pahl, H. L.; Merfort, I., The Anti-inflammatory 
Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly 
Targeting p65. J. Biol. Chem. 1998, 273, 33508-33516. 
 
 454 
217. Widen, J. C.; Kempema, A. M.; Villalta, P. W.; Harki, D. A., Targeting NF-κB p65 with a 
Helenalin Inspired Bis-electrophile. ACS Chem. Biol. 2017, 12, 102-113. 
 
218. Hexum, J. K.; Tello-Aburto, R.; Struntz, N. B.; Harned, A. M.; Harki, D., Bicyclic 
Cyclohexenones as Inhibitors of NF-B Signaling. ACS Med. Chem. Lett. 2012, 3, 459-
464. 
 
219. Chen, J.; Ng, M. M.-L.; Chu, J. J. H., Activation of TLR2 and TLR6 by Dengue NS1 
Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection. PLOS 
Pathogens 2015, 11, e1005053. 
 
220. Chu, H.; Smith, J. M.; Felding, J.; Baran, P. S., Scalable Synthesis of (−)-Thapsigargin. 
ACS Central Science 2017, 3, 47-51. 
 
221. Burns, N. Z.; Baran, P. S.; Hoffmann, R. W., Redox Economy in Organic Synthesis. 
Angew. Chem. Int. Ed. 2009, 48, 2854-2867. 
 
222. Brummond, K. M.; Davis, M. M.; Huang, C., Rh(I)-Catalyzed Cyclocarbonylation of 
Allenol Esters To Prepare Acetoxy 4-Alkylidenecyclopent-3-en-2-ones. The Journal of 
Organic Chemistry 2009, 74, 8314-8320. 
 
223. Dr. Francois Grillet, unpublished resuls 
 
224. Alcaide, B.; Almendros, P.; Aragoncillo, C., Exploiting [2+2] Cycloaddition Chemistry: 
Achievements with Allenes. Chem. Soc. Rev. 2010, 39, 783-816. 
225. Carreira, E. M.; Hastings, C. A.; Shepard, M. S.; Yerkey, L. A.; Millward, D. B., 
Asymmetric Induction in Intramolecular [2 + 2]-Photocycloadditions of 1,3-Disubstituted 
Allenes with Enones and Enoates. J. Am. Chem. Soc. 1994, 116, 6622-6630. 
 
226. Becker, D.; Nagler, M.; Sahali, Y.; Haddad, N., Regiochemistry and stereochemistry of 
intramolecular [2+2] photocycloaddition of carbon-carbon double bonds to 
cyclohexenones. The Journal of Organic Chemistry 1991, 56, 4537-4543. 
 
227. Schuster, H. F.; Coppola, G. M., Allenes in Organic Synthesis. John Wiley & Sons: 1984. 
 
228. Padwa, A.; Meske, M.; Murphree, S. S.; Watterson, S. H.; Ni, Z., (Phenylsulfonyl)allenes 
as Substrates for Cycloaddition Reactions: Intramolecular Cyclizations onto Unactivated 
Alkenes. J. Am. Chem. Soc. 1995, 117, 7071-7080. 
 
229. Xu, Y.; Conner, M. L.; Brown, M. K., Cyclobutane and Cyclobutene Synthesis: Catalytic 
Enantioselective [2+2] Cycloadditions. Angew. Chem. Int. Ed. 2015, 54, 11918-11928. 
 
230. Conner, M. L.; Brown, M. K., Synthesis of 1,3-Substituted Cyclobutanes by Allenoate-
Alkene [2 + 2] Cycloaddition. The Journal of Organic Chemistry 2016, 81, 8050-8060. 
 
 455 
231. Conner, M. L.; Xu, Y.; Brown, M. K., Catalytic Enantioselective Allenoate–Alkene [2 + 
2] Cycloadditions. J. Am. Chem. Soc. 2015, 137, 3482-3485. 
 
232. Luzung, M. R.; Mauleón, P.; Toste, F. D., Gold(I)-Catalyzed [2 + 2]-Cycloaddition of 
Allenenes. J. Am. Chem. Soc. 2007, 129, 12402-12403. 
 
233. González, A. Z.; Benitez, D.; Tkatchouk, E.; Goddard, W. A.; Toste, F. D., 
Phosphoramidite Gold(I)-Catalyzed Diastereo- and Enantioselective Synthesis of 3,4-
Substituted Pyrrolidines. J. Am. Chem. Soc. 2011, 133, 5500-5507. 
 
234. Jia, M.; Monari, M.; Yang, Q.-Q.; Bandini, M., Enantioselective gold catalyzed 
dearomative [2+2]-cycloaddition between indoles and allenamides. Chem. Commun. 2015, 
51, 2320-2323. 
 
235. Serra, S.; Fuganti, C., Benzannulation of Substituted 3-Alkoxycarbonylhex-3-en-5-ynoic 
Acids: A New Route to 4-Substituted 3,5-Dihydroxybenzoic Acids Derivatives. Synlett 
2002, 2002, 1661-1664. 
 
236. Fatiadi, A. J., Active Manganese Dioxide Oxidation in Organic Chemistry. Synthesis 1976, 
65-167. 
 
 
 
